Prevalence	O
of	O
Local	O
Immune	O
Response	O
against	O
Oral	O
Infection	O
in	O
a	O
Drosophila	B-Organism
/	O
Pseudomonas	B-Organism
Infection	O
Model	O

Pathogens	O
have	O
developed	O
multiple	O
strategies	O
that	O
allow	O
them	O
to	O
exploit	O
host	O
resources	O
and	O
resist	O
the	O
immune	O
response	O
.	O

To	O
study	O
how	O
Drosophila	B-Organism
flies	O
deal	O
with	O
infectious	O
diseases	O
in	O
a	O
natural	O
context	O
,	O
we	O
investigated	O
the	O
interactions	O
between	O
Drosophila	B-Organism
and	O
a	O
newly	O
identified	O
entomopathogen	O
,	O
Pseudomonas	B-Organism
entomophila	I-Organism
.	O

Flies	O
orally	O
infected	O
with	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
rapidly	O
succumb	O
despite	O
the	O
induction	O
of	O
both	O
local	O
and	O
systemic	O
immune	O
responses	O
,	O
indicating	O
that	O
this	O
bacterium	O
has	O
developed	O
specific	O
strategies	O
to	O
escape	O
the	O
fly	O
immune	O
response	O
.	O

Using	O
a	O
combined	O
genetic	O
approach	O
on	O
both	O
host	O
and	O
pathogen	O
,	O
we	O
showed	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
is	O
multi	O
-	O
factorial	O
with	O
a	O
clear	O
differentiation	O
between	O
factors	O
that	O
trigger	O
the	O
immune	O
response	O
and	O
those	O
that	O
promote	O
pathogenicity	O
.	O

We	O
demonstrate	O
that	O
AprA	B-Protein
,	O
an	O
abundant	O
secreted	O
metalloprotease	O
produced	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
is	O
an	O
important	O
virulence	O
factor	O
.	O

Inactivation	O
of	O
aprA	B-Protein
attenuated	O
both	O
the	O
capacity	O
to	O
persist	O
in	O
the	O
host	O
and	O
pathogenicity	O
.	O

Interestingly	O
,	O
aprA	B-Protein
mutants	O
were	O
able	O
to	O
survive	O
to	O
wild	O
-	O
type	O
levels	O
in	O
immune	O
-	O
deficient	O
Relish	B-Organism
flies	I-Organism
,	O
indicating	O
that	O
the	O
protease	O
plays	O
an	O
important	O
role	O
in	O
protection	O
against	O
the	O
Drosophila	B-Organism
immune	O
response	O
.	O

Our	O
study	O
also	O
reveals	O
that	O
the	O
major	O
contribution	O
to	O
the	O
fly	O
defense	O
against	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
is	O
provided	O
by	O
the	O
local	O
,	O
rather	O
than	O
the	O
systemic	O
immune	O
response	O
.	O

More	O
precisely	O
,	O
our	O
data	O
points	O
to	O
an	O
important	O
role	O
for	O
the	O
antimicrobial	O
peptide	O
Diptericin	B-Protein
against	O
orally	O
infectious	O
Gram	O
-	O
negative	O
bacteria	O
,	O
emphasizing	O
the	O
critical	O
role	O
of	O
local	O
antimicrobial	O
peptide	O
expression	O
against	O
food	O
-	O
borne	O
pathogens	O
.	O

Introduction	O

Host	O
-	O
pathogen	O
interactions	O
are	O
complex	O
relationships	O
in	O
which	O
the	O
success	O
of	O
each	O
organism	O
depends	O
on	O
its	O
ability	O
to	O
overcome	O
the	O
other	O
.	O

Consequently	O
,	O
hosts	O
have	O
evolved	O
surveillance	O
and	O
defense	O
mechanisms	O
to	O
detect	O
and	O
eliminate	O
invading	O
microorganisms	O
,	O
whereas	O
pathogens	O
use	O
sophisticated	O
strategies	O
to	O
counteract	O
such	O
responses	O
.	O

In	O
recent	O
years	O
,	O
Drosophila	B-Organism
has	O
emerged	O
as	O
a	O
powerful	O
model	O
for	O
the	O
study	O
of	O
host	O
-	O
pathogen	O
interactions	O
[	O
1	O
,	O
2	O
]	O
.	O

An	O
attractive	O
feature	O
of	O
the	O
Drosophila	B-Organism
system	O
is	O
the	O
existence	O
of	O
multiple	O
defense	O
reactions	O
that	O
are	O
shared	O
with	O
higher	O
organisms	O
[	O
3	O
-	O
5	O
]	O
.	O

These	O
strategies	O
include	O
physical	O
barriers	O
,	O
together	O
with	O
the	O
local	O
and	O
systemic	O
immune	O
responses	O
.	O

Several	O
tissues	O
participate	O
in	O
a	O
coordinated	O
defense	O
against	O
microbial	O
infection	O
.	O

Firstly	O
,	O
epithelia	O
,	O
such	O
as	O
alimentary	O
tract	O
and	O
tracheae	O
,	O
are	O
the	O
first	O
line	O
of	O
defense	O
against	O
pathogens	O
and	O
produce	O
both	O
antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
and	O
reactive	B-Chemical
oxygen	I-Chemical
species	I-Chemical
.	O

Secondly	O
,	O
specialized	O
hemocytes	O
participate	O
in	O
phagocytosis	O
and	O
encapsulation	O
of	O
foreign	O
intruders	O
.	O

Finally	O
,	O
the	O
fat	O
body	O
,	O
a	O
functional	O
equivalent	O
of	O
the	O
mammalian	O
liver	O
,	O
is	O
the	O
site	O
of	O
the	O
humoral	O
response	O
.	O

Several	O
genetic	O
studies	O
have	O
demonstrated	O
the	O
regulation	O
of	O
AMP	O
synthesis	O
by	O
the	O
Toll	B-Protein
and	O
immune	O
-	O
deficient	O
(	O
Imd	B-Protein
)	O
pathways	O
.	O

The	O
Toll	B-Protein
pathway	O
is	O
mainly	O
activated	O
by	O
Gram	O
-	O
positive	O
bacteria	O
and	O
fungi	O
,	O
and	O
controls	O
,	O
to	O
a	O
large	O
extent	O
,	O
the	O
expression	O
of	O
AMPs	O
(	O
e	O
.	O
g	O
.	O
,	O
Drosomycin	B-Protein
)	O
through	O
the	O
nuclear	O
factor	O
-	O
kappaB	O
transactivators	O
Dif	B-Protein
and	O
Dorsal	B-Protein
.	O

In	O
contrast	O
,	O
the	O
Imd	B-Protein
pathway	O
mainly	O
responds	O
to	O
Gram	O
-	O
negative	O
bacterial	O
infections	O
and	O
controls	O
different	O
AMP	O
genes	O
(	O
e	O
.	O
g	O
.	O
,	O
Diptericin	B-Protein
)	O
via	O
the	O
activation	O
of	O
the	O
nuclear	O
factor	O
-	O
kappaB	O
transactivator	O
Relish	B-Protein
(	O
Rel	B-Protein
)	O
[	O
3	O
,	O
4	O
,	O
6	O
]	O
.	O

In	O
addition	O
,	O
the	O
Imd	B-Protein
pathway	O
plays	O
a	O
predominant	O
role	O
in	O
the	O
regulation	O
of	O
AMPs	O
in	O
the	O
alimentary	O
tract	O
and	O
tracheal	O
epithelia	O
[	O
7	O
]	O
.	O

Our	O
knowledge	O
of	O
the	O
Drosophila	B-Organism
immune	O
response	O
is	O
mainly	O
based	O
on	O
the	O
analysis	O
of	O
host	O
reactions	O
following	O
direct	O
injection	O
of	O
non	O
-	O
pathogenic	O
bacteria	O
into	O
the	O
insect	O
hemocoel	O
.	O

One	O
limitation	O
associated	O
with	O
this	O
approach	O
is	O
that	O
it	O
bypasses	O
the	O
initial	O
steps	O
of	O
naturally	O
occurring	O
infections	O
,	O
including	O
bacterial	O
colonization	O
and	O
persistence	O
and	O
host	O
local	O
immune	O
responses	O
.	O

Septic	O
injury	O
is	O
probably	O
of	O
little	O
consequence	O
in	O
nature	O
,	O
unlike	O
oral	O
infection	O
upon	O
ingestion	O
.	O

In	O
addition	O
,	O
the	O
response	O
to	O
non	O
-	O
pathogenic	O
microorganisms	O
does	O
not	O
necessarily	O
reflect	O
a	O
natural	O
host	O
reaction	O
to	O
a	O
real	O
pathogen	O
.	O

Recently	O
we	O
have	O
developed	O
the	O
use	O
of	O
natural	O
oral	O
infection	O
to	O
dissect	O
host	O
responses	O
of	O
Drosophila	B-Organism
after	O
challenge	O
with	O
bacteria	O
demonstrated	O
to	O
be	O
infectious	O
for	O
this	O
insect	O
.	O

We	O
have	O
isolated	O
several	O
Erwinia	B-Organism
carotovora	I-Organism
strains	O
,	O
such	O
as	O
Ecc15	B-Organism
,	O
for	O
their	O
capacity	O
to	O
persist	O
in	O
the	O
Drosophila	B-Organism
larval	O
gut	O
and	O
to	O
trigger	O
a	O
strong	O
systemic	O
immune	O
response	O
following	O
oral	O
infection	O
[	O
8	O
]	O
.	O

Although	O
not	O
a	O
pathogen	O
to	O
Drosophila	B-Organism
,	O
use	O
of	O
Ecc15	B-Organism
has	O
been	O
pivotal	O
in	O
revealing	O
the	O
ability	O
of	O
Drosophila	B-Organism
to	O
activate	O
an	O
adapted	O
response	O
to	O
persistent	O
microorganisms	O
in	O
the	O
gut	O
,	O
including	O
the	O
induction	O
of	O
local	O
immune	O
responses	O
.	O

More	O
recently	O
,	O
we	O
isolated	O
Pseudomonas	B-Organism
entomophila	I-Organism
,	O
a	O
Gram	O
-	O
negative	O
natural	O
bacterial	O
pathogen	O
of	O
Drosophila	B-Organism
,	O
from	O
flies	O
in	O
Guadeloupe	O
[	O
9	O
]	O
.	O

We	O
demonstrated	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
induces	O
both	O
systemic	O
and	O
local	O
immune	O
responses	O
in	O
Drosophila	B-Organism
and	O
causes	O
a	O
food	O
-	O
uptake	O
cessation	O
following	O
oral	O
infection	O
in	O
larvae	O
.	O

Importantly	O
,	O
in	O
contrast	O
to	O
Ecc15	B-Organism
,	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
is	O
highly	O
pathogenic	O
for	O
Drosophila	B-Organism
as	O
well	O
as	O
for	O
species	O
from	O
a	O
different	O
insect	O
order	O
(	O
Lepidoptera	O
)	O
.	O

The	O
genome	O
sequence	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
has	O
been	O
completed	O
and	O
reveals	O
the	O
existence	O
of	O
a	O
large	O
set	O
of	O
genes	O
encoding	O
putative	O
virulence	O
factors	O
such	O
as	O
proteases	O
,	O
lipases	O
,	O
toxins	O
,	O
alginate	O
synthesis	O
,	O
and	O
adhesion	O
factors	O
[	O
10	O
]	O
.	O

Transposon	O
mutagenesis	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
allowed	O
us	O
to	O
identify	O
several	O
regulatory	O
genes	O
required	O
to	O
infect	O
or	O
to	O
kill	O
Drosophila	B-Organism
.	O

Among	O
them	O
we	O
identified	O
the	O
GacS	B-Protein
/	O
GacA	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
which	O
,	O
in	O
Pseudomonas	B-Organism
fluorescens	I-Organism
,	O
has	O
been	O
well	O
characterized	O
and	O
demonstrated	O
to	O
be	O
an	O
essential	O
regulator	O
of	O
virulence	O
[	O
11	O
]	O
.	O

P	O
.	O
entomophila	O
gacA	B-Protein
mutants	O
are	O
non	O
-	O
pathogenic	O
and	O
fail	O
to	O
trigger	O
a	O
systemic	O
immune	O
response	O
after	O
ingestion	O
,	O
indicating	O
that	O
the	O
GacS	B-Protein
/	O
GacA	B-Protein
two	O
-	O
component	O
system	O
regulates	O
important	O
bacterial	O
virulence	O
effectors	O
required	O
to	O
infect	O
and	O
kill	O
flies	O
[	O
9	O
]	O
.	O

Despite	O
these	O
studies	O
,	O
little	O
is	O
known	O
about	O
the	O
mechanisms	O
used	O
by	O
bacterial	O
pathogens	O
to	O
interfere	O
with	O
the	O
corresponding	O
insect	O
host	O
defenses	O
.	O

Here	O
we	O
report	O
an	O
in	O
vivo	O
analysis	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
to	O
both	O
Drosophila	B-Organism
larvae	O
and	O
adult	O
flies	O
following	O
natural	O
oral	O
infection	O
.	O

We	O
present	O
in	O
vivo	O
evidence	O
for	O
a	O
direct	O
role	O
in	O
pathogenesis	O
of	O
the	O
secreted	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
zinc	B-Chemical
metalloprotease	O
,	O
AprA	B-Protein
,	O
which	O
counteracts	O
AMPs	O
synthesized	O
by	O
the	O
host	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
the	O
Drosophila	B-Organism
Imd	B-Protein
-	O
regulated	O
local	O
gut	O
response	O
is	O
necessary	O
to	O
combat	O
infection	O
and	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
AprA	B-Protein
-	O
regulation	O
via	O
GacS	B-Protein
/	O
GacA	B-Protein
and	O
PrtR	B-Protein
regulators	O
is	O
used	O
as	O
a	O
strategy	O
to	O
escape	O
AMP	O
activity	O
.	O

This	O
study	O
also	O
highlights	O
the	O
importance	O
of	O
the	O
gut	O
immune	O
response	O
in	O
the	O
control	O
of	O
food	O
-	O
borne	O
pathogens	O
.	O

Results	O

P	B-Organism
.	I-Organism
entomophila	I-Organism
Secretes	O
an	O
Abundant	O
Protease	O
A	O
common	O
strategy	O
used	O
by	O
bacterial	O
pathogens	O
is	O
to	O
secrete	O
toxins	O
and	O
other	O
virulence	O
factors	O
that	O
damage	O
host	O
tissues	O
.	O

To	O
test	O
whether	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
could	O
secrete	O
such	O
toxic	O
factors	O
,	O
a	O
supernatant	O
filtrate	O
from	O
a	O
bacterial	O
culture	O
was	O
tested	O
for	O
its	O
ability	O
to	O
kill	O
Drosophila	B-Organism
.	O

Figure	O
1A	O
shows	O
that	O
a	O
concentrated	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
culture	O
filtrate	O
had	O
a	O
moderate	O
but	O
significant	O
effect	O
on	O
Drosophila	B-Organism
larvae	O
survival	O
following	O
ingestion	O
.	O

Although	O
the	O
filtrate	O
did	O
not	O
kill	O
adult	O
flies	O
after	O
feeding	O
(	O
unpublished	O
data	O
)	O
,	O
it	O
was	O
highly	O
toxic	O
by	O
direct	O
injection	O
into	O
the	O
hemocoel	O
(	O
Figure	O
1B	O
)	O
.	O

No	O
killing	O
of	O
either	O
larvae	O
or	O
adults	O
was	O
observed	O
with	O
a	O
culture	O
filtrate	O
derived	O
from	O
the	O
avirulent	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
strain	O
carrying	O
a	O
Tn5	B-Protein
transposon	O
in	O
the	O
gacA	B-Protein
gene	O
[	O
9	O
]	O
.	O

These	O
data	O
suggested	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
secreted	O
one	O
or	O
more	O
factors	O
with	O
toxic	O
activity	O
under	O
the	O
control	O
of	O
the	O
GacS	B-Protein
/	O
GacA	B-Protein
two	O
-	O
component	O
system	O
.	O

In	O
an	O
attempt	O
to	O
identify	O
the	O
factor	O
(	O
s	O
)	O
responsible	O
for	O
toxicity	O
,	O
we	O
analyzed	O
the	O
proteins	O
present	O
in	O
the	O
supernatant	O
.	O

The	O
protein	O
profile	O
for	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
supernantant	O
(	O
Figure	O
1C	O
,	O
lane	O
2	O
)	O
shows	O
a	O
major	O
protein	O
band	O
at	O
51	O
kDa	O
and	O
several	O
minor	O
bands	O
.	O

MALDI	O
-	O
TOF	O
analysis	O
of	O
tryptic	O
fragments	O
of	O
the	O
51	O
-	O
kDa	O
band	O
identified	O
this	O
protein	O
as	O
a	O
homolog	O
of	O
the	O
previously	O
characterized	O
Apr	B-Regulon-operon
proteases	O
from	O
Pseudomonas	B-Organism
spp	O
.	O
,	O
Prt	B-Protein
proteases	O
from	O
Erwinia	B-Organism
spp	O
.	O
and	O
Photorhabdus	B-Organism
spp	O
.	O
,	O
and	O
serralysins	B-Protein
from	O
Serratia	B-Organism
spp	O
.	O

[	O
12	O
-	O
14	O
]	O
.	O

All	O
of	O
these	O
proteases	O
are	O
members	O
of	O
the	O
zinc	B-Chemical
metzincin	O
family	O
of	O
Type	O
I	O
-	O
secreted	O
RTX	O
proteins	O
[	O
15	O
]	O
.	O

We	O
subsequently	O
purified	O
this	O
protease	O
,	O
termed	O
AprA	B-Protein
,	O
to	O
homogeneity	O
from	O
the	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
supernatant	O
by	O
anion	O
exchange	O
chromatography	O
followed	O
by	O
size	O
exclusion	O
chromatography	O
(	O
Figure	O
1D	O
)	O
.	O

Injection	O
of	O
pure	O
AprA	B-Protein
into	O
the	O
hemocoel	O
rapidly	O
killed	O
adult	O
flies	O
,	O
identifying	O
this	O
protein	O
as	O
a	O
bacterial	O
toxin	O
(	O
Figure	O
1E	O
)	O
.	O

Feeding	O
of	O
larvae	O
with	O
high	O
concentrations	O
(	O
1	O
.	O
5	O
mg	O
/	O
ml	O
)	O
of	O
AprA	B-Protein
led	O
to	O
modest	O
lethality	O
(	O
unpublished	O
data	O
)	O
,	O
recapitulating	O
the	O
properties	O
of	O
the	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
supernatant	O
.	O

Interestingly	O
,	O
in	O
a	O
gacA	B-Protein
mutant	O
the	O
number	O
of	O
proteins	O
in	O
the	O
supernatant	O
was	O
greatly	O
reduced	O
,	O
including	O
the	O
complete	O
absence	O
of	O
the	O
51	O
-	O
kDa	O
band	O
corresponding	O
to	O
AprA	B-Protein
(	O
Figure	O
1C	O
,	O
lane	O
3	O
)	O
.	O

In	O
P	B-Organism
.	I-Organism
fluorescens	I-Organism
,	O
membrane	O
-	O
localized	O
anti	O
-	O
sigma	O
factor	O
PrtR	B-Protein
cleaves	O
the	O
extracytoplasmic	O
sigma	O
factor	O
PrtI	B-Protein
,	O
resulting	O
in	O
increased	O
expression	O
of	O
multiple	O
genes	O
,	O
including	O
one	O
encoding	O
for	O
a	O
metalloprotease	O
,	O
aprX	B-Protein
[	O
16	O
]	O
.	O

Two	O
independent	O
Tn5	B-Protein
insertions	O
in	O
the	O
prtR	B-Protein
gene	O
affecting	O
virulence	O
have	O
recently	O
been	O
identified	O
in	O
a	O
random	O
insertional	O
mutagenesis	O
screen	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
[	O
10	O
]	O
.	O

To	O
test	O
a	O
possible	O
role	O
of	O
prtR	B-Protein
in	O
the	O
regulation	O
of	O
aprA	B-Protein
expression	O
,	O
we	O
analyzed	O
the	O
proteins	O
present	O
in	O
the	O
supernatant	O
of	O
prtR	B-Protein
mutants	O
.	O

Interestingly	O
,	O
both	O
prtR	B-Protein
mutants	O
(	O
CL25	B-Organism
and	O
CU1	B-Organism
)	O
displayed	O
a	O
secreted	O
protein	O
profile	O
identical	O
to	O
the	O
wild	O
-	O
type	O
strain	O
except	O
for	O
a	O
marked	O
decrease	O
of	O
AprA	B-Protein
(	O
Figure	O
1C	O
,	O
lanes	O
4	O
and	O
5	O
)	O
.	O

Measurement	O
of	O
in	O
vitro	O
protease	O
activity	O
with	O
azocasein	O
revealed	O
that	O
the	O
gacA	B-Protein
mutant	O
secretes	O
no	O
detectable	O
protease	O
activity	O
and	O
that	O
prtR	B-Protein
mutants	O
retain	O
only	O
30	O
%	O
of	O
wild	O
-	O
type	O
supernatant	O
activity	O
,	O
thus	O
indicating	O
a	O
role	O
for	O
PrtR	B-Protein
in	O
the	O
regulation	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
protease	O
secretion	O
(	O
Figure	O
1F	O
)	O
.	O

Furthermore	O
,	O
the	O
prtR	B-Protein
supernatant	O
showed	O
no	O
toxicity	O
toward	O
flies	O
after	O
injection	O
,	O
suggesting	O
a	O
correlation	O
between	O
AprA	B-Protein
levels	O
and	O
virulence	O
(	O
unpublished	O
data	O
)	O
.	O

Altogether	O
,	O
this	O
analysis	O
indicates	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
gacA	B-Protein
and	O
prtR	B-Protein
genes	O
regulate	O
the	O
secretion	O
of	O
a	O
protease	O
with	O
toxic	O
activity	O
when	O
injected	O
into	O
flies	O
or	O
fed	O
to	O
larvae	O
.	O

The	O
P	O
.	O
entomophila	O
aprA	B-Protein
Mutant	O
Displays	O
Attenuated	O
Pathogenicity	O

The	O
experiments	O
described	O
above	O
suggested	O
that	O
AprA	B-Protein
plays	O
an	O
important	O
in	O
vivo	O
role	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
.	O

To	O
further	O
test	O
this	O
hypothesis	O
,	O
we	O
used	O
a	O
genetic	O
approach	O
by	O
inactivating	O
the	O
aprA	B-Protein
gene	O
.	O

Sequence	O
analysis	O
of	O
the	O
locus	O
corresponding	O
to	O
aprA	B-Protein
revealed	O
a	O
genetic	O
organization	O
characteristic	O
of	O
this	O
class	O
of	O
Type	O
I	O
-	O
secreted	O
proteases	O
[	O
14	O
]	O
.	O

The	O
structural	O
gene	O
for	O
the	O
metalloprotease	O
,	O
aprA	B-Protein
,	O
is	O
followed	O
by	O
a	O
gene	O
encoding	O
its	O
periplasmic	O
inhibitor	O
,	O
aprI	B-Protein
,	O
and	O
three	O
genes	O
encoding	O
the	O
Type	O
I	O
transporter	O
,	O
aprD	B-Protein
,	O
E	B-Protein
,	O
and	O
F	B-Protein
(	O
Figure	O
2A	O
)	O
.	O

Studies	O
in	O
other	O
bacteria	O
have	O
shown	O
that	O
AprD	B-Protein
,	O
E	B-Protein
,	O
and	O
F	B-Protein
participate	O
in	O
the	O
elaboration	O
of	O
a	O
Type	O
I	O
transporter	O
required	O
for	O
AprA	B-Protein
secretion	O
to	O
the	O
external	O
medium	O
[	O
17	O
]	O
.	O

We	O
inactivated	O
the	O
aprA	B-Protein
gene	O
by	O
inserting	O
a	O
tetracycline	B-Chemical
resistance	O
cassette	O
by	O
a	O
double	O
homologous	O
recombination	O
event	O
.	O

SDS	O
-	O
PAGE	O
protein	O
profiles	O
of	O
culture	O
supernatants	O
clearly	O
demonstrated	O
the	O
absence	O
of	O
the	O
51	O
-	O
kDa	O
band	O
,	O
and	O
in	O
vitro	O
protease	O
activity	O
of	O
the	O
aprA	B-Protein
mutant	O
confirmed	O
the	O
concomitant	O
absence	O
of	O
secreted	O
protease	O
activity	O
(	O
Figure	O
1C	O
,	O
lane	O
6	O
,	O
and	O
1F	O
)	O
.	O

To	O
analyze	O
the	O
in	O
vivo	O
contribution	O
of	O
AprA	B-Protein
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
,	O
we	O
performed	O
a	O
survival	O
analysis	O
of	O
Drosophila	B-Organism
larvae	O
and	O
adults	O
after	O
oral	O
infection	O
with	O
various	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
derivatives	O
.	O

Only	O
40	O
%	O
of	O
the	O
aprA	B-Protein
-	O
infected	O
larvae	O
succumbed	O
within	O
3	O
days	O
,	O
while	O
70	O
%	O
of	O
the	O
larvae	O
died	O
after	O
infection	O
with	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
demonstrating	O
that	O
the	O
aprA	B-Protein
mutant	O
was	O
attenuated	O
for	O
virulence	O
(	O
Figure	O
2B	O
)	O
.	O

Similarly	O
,	O
the	O
aprA	B-Protein
mutant	O
showed	O
reduced	O
pathogenicity	O
after	O
oral	O
infection	O
of	O
adult	O
flies	O
(	O
Figure	O
S1	O
)	O
.	O

Using	O
the	O
same	O
assay	O
,	O
both	O
prtR	B-Protein
and	O
gacA	B-Protein
mutants	O
were	O
almost	O
avirulent	O
toward	O
Drosophila	B-Organism
indicating	O
that	O
both	O
genes	O
regulate	O
other	O
virulence	O
factors	O
in	O
addition	O
to	O
AprA	B-Protein
(	O
Figure	O
2B	O
)	O
.	O

We	O
next	O
compared	O
persistence	O
of	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
the	O
aprA	B-Protein
mutant	O
by	O
quantifying	O
the	O
number	O
of	O
bacteria	O
in	O
larvae	O
and	O
adults	O
at	O
different	O
time	O
points	O
after	O
infection	O
.	O

Whereas	O
the	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
titer	O
remained	O
high	O
,	O
aprA	B-Protein
bacterial	O
levels	O
decreased	O
significantly	O
with	O
time	O
(	O
Figure	O
3A	O
,	O
not	O
shown	O
for	O
larvae	O
)	O
.	O

However	O
,	O
aprA	B-Protein
gut	O
persistence	O
remained	O
higher	O
than	O
that	O
of	O
gacA	B-Protein
mutants	O
.	O

We	O
could	O
not	O
exclude	O
that	O
the	O
aprA	B-Protein
mutant	O
phenotype	O
was	O
due	O
to	O
polar	O
effects	O
of	O
the	O
insertion	O
in	O
the	O
operon	O
upon	O
expression	O
of	O
apr	B-Protein
I	I-Protein
,	O
D	B-Protein
,	O
E	B-Protein
,	O
and	O
F	B-Protein
.	O

In	O
support	O
of	O
this	O
hypothesis	O
,	O
previous	O
studies	O
have	O
demonstrated	O
for	O
both	O
Serratia	B-Organism
marcescens	I-Organism
and	O
P	B-Organism
.	I-Organism
fluorescens	I-Organism
that	O
Type	O
I	O
transporters	O
can	O
be	O
polyvalent	O
and	O
secrete	O
different	O
types	O
of	O
proteins	O
such	O
as	O
proteases	O
and	O
lipases	O
[	O
18	O
,	O
19	O
]	O
.	O

Complementation	O
of	O
the	O
aprA	B-Protein
mutant	O
with	O
the	O
wild	O
-	O
type	O
apr	B-Regulon-operon
operon	O
restored	O
protease	O
secretion	O
and	O
activity	O
(	O
Figure	O
1C	O
,	O
lane	O
7	O
,	O
and	O
1F	O
)	O
and	O
resulted	O
in	O
a	O
complete	O
regain	O
of	O
function	O
with	O
respect	O
to	O
all	O
virulence	O
phenotypes	O
(	O
Figures	O
2B	O
and	O
S1	O
)	O
.	O

In	O
contrast	O
,	O
no	O
rescue	O
was	O
observed	O
with	O
a	O
plasmid	O
containing	O
the	O
full	O
apr	B-Regulon-operon
operon	O
but	O
carrying	O
a	O
non	O
-	O
polar	O
mutation	O
in	O
aprA	B-Protein
(	O
Figures	O
2B	O
and	O
S1	O
)	O
.	O

These	O
data	O
confirmed	O
that	O
the	O
protease	O
AprA	B-Protein
itself	O
contributes	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
.	O

The	O
aprA	B-Protein
Mutant	O
Retains	O
the	O
Capacity	O
to	O
Trigger	O
an	O
Immune	O
Response	O
and	O
to	O
Induce	O
Food	O
-	O
Uptake	O
Cessation	O

In	O
addition	O
to	O
its	O
pathogenicity	O
,	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
provokes	O
a	O
food	O
-	O
uptake	O
cessation	O
in	O
larvae	O
and	O
triggers	O
an	O
immune	O
response	O
in	O
both	O
larvae	O
and	O
adults	O
[	O
9	O
]	O
.	O

Feeding	O
of	O
larvae	O
with	O
medium	O
containing	O
bromophenol	O
blue	O
,	O
leads	O
to	O
a	O
clearly	O
visible	O
food	O
uptake	O
,	O
discernable	O
by	O
blue	O
coloration	O
throughout	O
the	O
gut	O
.	O

In	O
contrast	O
,	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
-	O
infected	O
larvae	O
show	O
only	O
a	O
pale	O
blue	O
coloration	O
indicating	O
that	O
infected	O
larvae	O
cease	O
to	O
ingest	O
food	O
.	O

Whereas	O
this	O
food	O
-	O
uptake	O
cessation	O
was	O
still	O
observed	O
in	O
aprA	B-Protein
and	O
prtR	B-Protein
mutants	O
,	O
it	O
was	O
not	O
evident	O
in	O
gacA	B-Protein
mutant	O
-	O
infected	O
larvae	O
(	O
Figure	O
2D	O
and	O
data	O
not	O
shown	O
for	O
prtR	O
)	O
.	O

The	O
kinetics	O
of	O
the	O
expression	O
of	O
the	O
AMP	O
,	O
Diptericin	B-Protein
,	O
in	O
larvae	O
and	O
adults	O
after	O
natural	O
infection	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
its	O
derivative	O
mutants	O
,	O
was	O
analyzed	O
by	O
real	O
time	O
quantitative	O
PCR	O
(	O
RT	O
-	O
qPCR	O
)	O
.	O

Diptericin	B-Protein
was	O
expressed	O
at	O
a	O
wild	O
-	O
type	O
level	O
following	O
oral	O
infection	O
with	O
the	O
aprA	B-Protein
and	O
prtR	B-Protein
mutants	O
,	O
but	O
no	O
expression	O
was	O
detected	O
in	O
the	O
case	O
of	O
the	O
gacA	B-Protein
mutant	O
(	O
Figures	O
2C	O
and	O
5A	O
)	O
.	O

Observation	O
of	O
green	B-Protein
fluorescent	I-Protein
protein	I-Protein
(	O
GFP	B-Protein
)	O
fluorescence	O
in	O
infected	O
larvae	O
carrying	O
a	O
Diptericin	B-Protein
-	O
GFP	B-Protein
reporter	O
gene	O
confirmed	O
that	O
prtR	B-Protein
and	O
aprA	B-Protein
mutants	O
elicited	O
an	O
immune	O
response	O
,	O
whereas	O
gacA	B-Protein
mutants	O
failed	O
to	O
do	O
so	O
(	O
unpublished	O
data	O
)	O
.	O

The	O
data	O
presented	O
above	O
clearly	O
indicate	O
that	O
AprA	B-Protein
is	O
a	O
major	O
virulence	O
factor	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
that	O
promotes	O
bacterial	O
persistence	O
and	O
killing	O
of	O
the	O
host	O
,	O
but	O
that	O
other	O
virulence	O
factors	O
controlled	O
by	O
gacA	B-Protein
and	O
prtR	B-Protein
exist	O
.	O

It	O
also	O
reveals	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
is	O
multi	O
-	O
factorial	O
with	O
a	O
clear	O
distinction	O
between	O
factors	O
that	O
promote	O
pathogenicity	O
and	O
those	O
that	O
trigger	O
the	O
immune	O
response	O
.	O

The	O
observation	O
that	O
both	O
factors	O
are	O
under	O
the	O
control	O
of	O
the	O
GacS	B-Protein
/	O
GacA	B-Protein
,	O
confirmed	O
that	O
this	O
two	O
-	O
component	O
system	O
is	O
the	O
master	O
regulator	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
.	O

AprA	B-Protein
Confers	O
Protection	O
against	O
the	O
Imd	B-Protein
-	O
Dependent	O
Immune	O
Response	O

Virulence	O
factors	O
allow	O
pathogens	O
to	O
survive	O
in	O
the	O
hostile	O
environment	O
of	O
the	O
host	O
,	O
to	O
escape	O
the	O
immune	O
system	O
,	O
or	O
to	O
establish	O
a	O
biotope	O
where	O
they	O
can	O
proliferate	O
by	O
altering	O
host	O
functions	O
.	O

The	O
observation	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
persistence	O
in	O
flies	O
and	O
larvae	O
is	O
lower	O
in	O
aprA	B-Protein
mutants	O
clearly	O
indicates	O
that	O
the	O
AprA	B-Protein
protease	O
promotes	O
bacterial	O
persistence	O
in	O
the	O
Drosophila	B-Organism
gut	O
.	O

Our	O
previous	O
study	O
had	O
already	O
revealed	O
that	O
the	O
humoral	O
arm	O
of	O
the	O
Drosophila	B-Organism
immune	O
response	O
mediated	O
by	O
the	O
Imd	B-Protein
pathway	O
contributes	O
to	O
resistance	O
against	O
orally	O
transmitted	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
since	O
flies	O
mutated	O
in	O
the	O
Relish	B-Protein
(	O
Rel	B-Protein
)	O
gene	O
showed	O
a	O
consistently	O
increased	O
mortality	O
rate	O
[	O
9	O
]	O
.	O

To	O
determine	O
whether	O
AprA	B-Protein
plays	O
a	O
role	O
in	O
counteracting	O
the	O
Imd	B-Protein
-	O
dependent	O
immune	O
response	O
,	O
we	O
compared	O
persistence	O
of	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
gacA	B-Protein
,	O
and	O
aprA	B-Protein
derivatives	O
by	O
quantifying	O
the	O
number	O
of	O
bacteria	O
in	O
Rel	B-Protein
flies	O
and	O
larvae	O
.	O

Whereas	O
the	O
titer	O
of	O
gacA	B-Protein
mutants	O
decreased	O
with	O
time	O
,	O
we	O
observed	O
that	O
the	O
aprA	B-Protein
derivative	O
persisted	O
at	O
a	O
level	O
similar	O
to	O
wild	O
-	O
type	O
bacteria	O
in	O
Rel	B-Protein
-	O
deficient	O
mutant	O
flies	O
and	O
larvae	O
(	O
Figure	O
3A	O
and	O
3B	O
,	O
and	O
unpublished	O
data	O
)	O
.	O

The	O
observation	O
that	O
AprA	B-Protein
was	O
required	O
to	O
promote	O
persistence	O
in	O
wild	O
-	O
type	O
flies	O
and	O
larvae	O
but	O
was	O
dispensable	O
in	O
a	O
Rel	B-Protein
background	O
,	O
indicates	O
that	O
AprA	B-Protein
plays	O
an	O
important	O
role	O
in	O
the	O
protection	O
against	O
the	O
Imd	B-Protein
-	O
dependent	O
immune	O
response	O
.	O

To	O
investigate	O
the	O
connection	O
between	O
activation	O
of	O
the	O
Imd	B-Protein
pathway	O
and	O
the	O
outcome	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
in	O
more	O
detail	O
,	O
we	O
focused	O
our	O
analysis	O
on	O
the	O
adult	O
stage	O
when	O
it	O
is	O
easier	O
to	O
monitor	O
survival	O
.	O

P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
triggers	O
Imd	B-Protein
pathway	O
activation	O
within	O
hours	O
.	O

To	O
determine	O
at	O
which	O
time	O
Imd	B-Protein
was	O
required	O
to	O
impede	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
,	O
we	O
monitored	O
survival	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
in	O
flies	O
in	O
which	O
the	O
Imd	B-Protein
pathway	O
was	O
artificially	O
activated	O
in	O
a	O
time	O
-	O
dependent	O
manner	O
.	O

We	O
utilized	O
an	O
engineered	O
fly	O
line	O
(	O
UAS	O
-	O
imd	B-Protein
,	O
hs	O
-	O
Gal4	B-Protein
)	O
over	O
-	O
expressing	O
imd	B-Protein
under	O
the	O
control	O
of	O
a	O
heat	O
-	O
shock	O
promoter	O
via	O
the	O
UAS	O
-	O
Gal4	B-Protein
system	O
,	O
which	O
consequently	O
leads	O
to	O
strong	O
expression	O
of	O
Imd	B-Protein
-	O
dependent	O
AMP	O
genes	O
.	O

Figure	O
4A	O
shows	O
that	O
over	O
-	O
expressing	O
imd	O
12	O
h	O
prior	O
to	O
infection	O
protected	O
flies	O
from	O
a	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
,	O
whereas	O
over	O
-	O
expressing	O
imd	O
6	O
h	O
before	O
contributed	O
only	O
modestly	O
to	O
survival	O
of	O
the	O
flies	O
.	O

This	O
experiment	O
indicates	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
can	O
be	O
eliminated	O
when	O
the	O
Imd	B-Protein
pathway	O
is	O
activated	O
at	O
a	O
high	O
level	O
prior	O
to	O
infection	O
.	O

It	O
further	O
suggests	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
is	O
sensitive	O
to	O
immune	O
defenses	O
during	O
a	O
short	O
time	O
frame	O
and	O
subsequently	O
becomes	O
insensitive	O
.	O

Since	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
is	O
pathogenic	O
under	O
normal	O
wild	O
-	O
type	O
conditions	O
,	O
it	O
may	O
overcome	O
the	O
immune	O
response	O
by	O
establishing	O
a	O
niche	O
in	O
the	O
gut	O
before	O
the	O
Imd	B-Protein
pathway	O
is	O
activated	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
in	O
agreement	O
with	O
the	O
results	O
described	O
above	O
,	O
persistence	O
of	O
both	O
the	O
aprA	B-Protein
mutant	O
and	O
wild	O
-	O
type	O
bacteria	O
was	O
significantly	O
altered	O
in	O
fly	O
lines	O
over	O
-	O
expressing	O
the	O
Imd	B-Protein
pathway	O
,	O
and	O
that	O
aprA	B-Protein
mutants	O
survived	O
less	O
than	O
wild	O
-	O
type	O
bacteria	O
(	O
Figure	O
4B	O
)	O
.	O

Altogether	O
,	O
these	O
data	O
reveal	O
that	O
the	O
Imd	B-Protein
pathway	O
is	O
crucial	O
for	O
host	O
survival	O
after	O
oral	O
infection	O
with	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
that	O
AprA	B-Protein
plays	O
a	O
key	O
role	O
in	O
counteracting	O
this	O
effect	O
.	O

Local	O
,	O
but	O
Not	O
Systemic	O
Immunity	O
,	O
Contributes	O
to	O
Resistance	O
against	O
Oral	O
Infection	O
with	O
P	B-Organism
.	I-Organism
entomophila	I-Organism

P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
but	O
not	O
the	O
gacA	B-Protein
derivative	O
,	O
rapidly	O
activates	O
both	O
the	O
local	O
and	O
systemic	O
Imd	B-Protein
-	O
dependent	O
immune	O
responses	O
in	O
Drosophila	B-Organism
adults	O
,	O
which	O
can	O
be	O
demonstrated	O
using	O
RT	O
-	O
qPCR	O
with	O
fat	O
body	O
and	O
gut	O
extracts	O
(	O
Figure	O
5A	O
)	O
.	O

Use	O
of	O
Diptericin	B-Protein
-	O
GFP	B-Protein
or	O
lacZ	B-Protein
reporter	O
genes	O
reveals	O
strong	O
Diptericin	B-Protein
expression	O
in	O
the	O
proventriculus	O
,	O
an	O
organ	O
that	O
acts	O
as	O
a	O
valve	O
between	O
the	O
oesophagus	O
and	O
the	O
anterior	O
midgut	O
(	O
Figure	O
5B	O
)	O
.	O

This	O
suggests	O
a	O
critical	O
role	O
of	O
this	O
organ	O
in	O
the	O
elimination	O
of	O
bacteria	O
.	O

We	O
next	O
examined	O
the	O
respective	O
contribution	O
of	O
the	O
local	O
gut	O
and	O
the	O
systemic	O
immune	O
responses	O
to	O
controlling	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
.	O

We	O
thus	O
compared	O
resistance	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
of	O
flies	O
that	O
were	O
previously	O
either	O
orally	O
infected	O
with	O
Ecc15	B-Organism
(	O
to	O
activate	O
a	O
local	O
immune	O
response	O
)	O
or	O
pricked	O
with	O
Ecc15	B-Organism
(	O
to	O
activate	O
a	O
systemic	O
immune	O
response	O
)	O
.	O

The	O
rationale	O
behind	O
this	O
experiment	O
is	O
based	O
on	O
previous	O
observations	O
that	O
an	O
oral	O
infection	O
with	O
Ecc15	B-Organism
triggers	O
a	O
local	O
,	O
but	O
not	O
a	O
systemic	O
immune	O
response	O
at	O
the	O
adult	O
stage	O
(	O
our	O
unpublished	O
data	O
)	O
[	O
8	O
]	O
.	O

Figure	O
5C	O
shows	O
that	O
a	O
prior	O
infection	O
with	O
Ecc15	B-Organism
protected	O
flies	O
against	O
a	O
subsequent	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
only	O
when	O
Ecc15	B-Organism
was	O
administrated	O
orally	O
,	O
indicating	O
that	O
the	O
local	O
,	O
but	O
not	O
the	O
systemic	O
immune	O
response	O
,	O
plays	O
an	O
important	O
role	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
clearance	O
.	O

To	O
ascertain	O
that	O
the	O
protection	O
was	O
due	O
to	O
Imd	B-Protein
pathway	O
activation	O
and	O
not	O
to	O
a	O
competition	O
between	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
Ecc15	B-Organism
,	O
we	O
next	O
monitored	O
resistance	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
of	O
wild	O
-	O
type	O
and	O
Rel	B-Protein
flies	O
orally	O
infected	O
by	O
Ecc15	O
evf	B-Protein
-	O
.	O

We	O
used	O
the	O
evf	B-Protein
-	O
deficient	O
derivative	O
because	O
this	O
bacterium	O
triggers	O
a	O
local	O
immune	O
response	O
without	O
persisting	O
in	O
the	O
gut	O
.	O

This	O
experiment	O
shows	O
that	O
wild	O
-	O
type	O
,	O
but	O
not	O
Rel	B-Protein
flies	O
previously	O
infected	O
with	O
Ecc15	O
evf	B-Protein
-	O
,	O
resisted	O
a	O
second	O
challenge	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
(	O
Figure	O
5D	O
)	O
.	O

This	O
demonstrates	O
that	O
the	O
protection	O
was	O
indeed	O
due	O
to	O
Imd	B-Protein
pathway	O
activation	O
in	O
the	O
gut	O
.	O

The	O
results	O
described	O
above	O
were	O
corroborated	O
by	O
the	O
over	O
-	O
expression	O
of	O
Imd	B-Protein
in	O
the	O
gut	O
or	O
in	O
the	O
fat	O
body	O
using	O
specific	O
Gal4	B-Protein
drivers	O
.	O

Over	O
-	O
expression	O
of	O
Imd	B-Protein
in	O
the	O
gut	O
protected	O
against	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
whereas	O
its	O
activation	O
in	O
the	O
fat	O
body	O
did	O
not	O
(	O
Figure	O
S2	O
)	O
.	O

However	O
,	O
the	O
previous	O
results	O
did	O
not	O
address	O
whether	O
the	O
Imd	B-Protein
pathway	O
induced	O
during	O
the	O
course	O
of	O
a	O
natural	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
contributes	O
to	O
fly	O
resistance	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
.	O

Thus	O
,	O
we	O
next	O
compared	O
survival	O
of	O
Rel	B-Protein
flies	O
specifically	O
expressing	O
a	O
wild	O
-	O
type	O
copy	O
of	O
Rel	B-Protein
in	O
the	O
intestine	O
using	O
caudal	O
(	O
cad	O
)	O
-	O
Gal4	B-Protein
.	O

These	O
flies	O
lack	O
a	O
functional	O
Imd	B-Protein
pathway	O
except	O
in	O
the	O
gut	O
where	O
cad	O
-	O
Gal4	B-Protein
is	O
expressed	O
.	O

In	O
these	O
flies	O
,	O
the	O
Imd	B-Protein
pathway	O
was	O
not	O
constitutively	O
active	O
in	O
the	O
gut	O
but	O
could	O
be	O
induced	O
upon	O
oral	O
bacterial	O
infection	O
similarly	O
to	O
the	O
wild	O
-	O
type	O
situation	O
(	O
Figure	O
S3A	O
)	O
.	O

Figure	O
5E	O
shows	O
that	O
Rel	B-Protein
flies	O
expressing	O
Rel	B-Protein
in	O
the	O
gut	O
survive	O
better	O
than	O
Rel	B-Protein
mutant	O
flies	O
.	O

These	O
data	O
demonstrate	O
that	O
the	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
-	O
induced	O
local	O
immune	O
response	O
in	O
the	O
intestine	O
plays	O
an	O
important	O
role	O
in	O
the	O
defense	O
against	O
this	O
Gram	O
-	O
negative	O
bacterium	O
.	O

AprA	B-Protein
Confers	O
Protection	O
against	O
Diptericin	B-Protein

We	O
have	O
shown	O
that	O
AprA	B-Protein
protects	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
against	O
the	O
Imd	B-Protein
-	O
regulated	O
immune	O
response	O
.	O

This	O
immune	O
pathway	O
regulates	O
the	O
expression	O
of	O
several	O
AMP	O
genes	O
,	O
as	O
well	O
as	O
many	O
other	O
immune	O
genes	O
.	O

Previous	O
studies	O
indicated	O
that	O
Attacin	B-Protein
A	I-Protein
and	O
Diptericin	B-Protein
are	O
the	O
AMP	O
genes	O
most	O
strongly	O
induced	O
in	O
the	O
gut	O
following	O
ingestion	O
of	O
infectious	O
bacteria	O
[	O
7	O
]	O
.	O

It	O
has	O
also	O
been	O
suggested	O
that	O
proteases	O
homologous	O
to	O
AprA	B-Protein
in	O
other	O
bacterial	O
species	O
degrade	O
AMPs	O
in	O
vitro	O
,	O
thereby	O
enabling	O
pathogens	O
to	O
withstand	O
the	O
attack	O
of	O
the	O
host	O
immune	O
system	O
[	O
20	O
,	O
21	O
]	O
.	O

We	O
confirmed	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
AprA	B-Protein
rapidly	O
degrades	O
Cecropin	B-Protein
A	I-Protein
in	O
vitro	O
(	O
unpublished	O
data	O
)	O
.	O

To	O
investigate	O
a	O
possible	O
in	O
vivo	O
role	O
of	O
AprA	B-Protein
in	O
the	O
protection	O
against	O
AMPs	O
synthesized	O
in	O
the	O
gut	O
,	O
we	O
compared	O
survival	O
to	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
in	O
imd	B-Protein
-	O
deficient	O
flies	O
over	O
-	O
expressing	O
Attacin	B-Protein
A	I-Protein
or	O
Diptericin	B-Protein
ubiquitously	O
under	O
the	O
control	O
of	O
the	O
daughterless	O
Gal4	B-Protein
driver	O
(	O
daGal4	B-Protein
)	O
using	O
the	O
UAS	O
-	O
Gal4	B-Protein
system	O
(	O
referred	O
to	O
as	O
imd	O
;	O
da	O
>	O
AMP	O
,	O
Figure	O
S3B	O
)	O
.	O

This	O
strategy	O
allowed	O
us	O
to	O
study	O
the	O
contribution	O
of	O
each	O
antibacterial	O
peptide	O
to	O
the	O
defense	O
against	O
a	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
.	O

In	O
a	O
first	O
set	O
of	O
experiments	O
,	O
we	O
compared	O
the	O
survival	O
rate	O
of	O
wild	O
-	O
type	O
,	O
imd	O
,	O
and	O
imd	O
;	O
da	O
>	O
Dpt	B-Protein
or	O
AttA	B-Protein
flies	O
to	O
natural	O
infection	O
with	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
.	O

Ubiquitous	O
expression	O
of	O
Attacin	B-Protein
A	I-Protein
and	O
Diptericin	B-Protein
with	O
the	O
da	O
-	O
Gal4	B-Protein
driver	O
greatly	O
increased	O
the	O
resistance	O
of	O
imd	B-Protein
mutant	O
flies	O
(	O
Figure	O
6A	O
)	O
.	O

This	O
experiment	O
demonstrates	O
that	O
these	O
AMPs	O
can	O
confer	O
protection	O
against	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
is	O
in	O
good	O
agreement	O
with	O
a	O
previous	O
study	O
showing	O
that	O
Attacin	B-Protein
is	O
the	O
most	O
potent	O
AMP	O
against	O
Gram	O
-	O
negative	O
bacteria	O
[	O
22	O
]	O
.	O

Importantly	O
,	O
it	O
also	O
reveals	O
for	O
the	O
first	O
time	O
a	O
major	O
contribution	O
of	O
Diptericin	B-Protein
to	O
host	O
defense	O
,	O
which	O
was	O
not	O
previously	O
detected	O
using	O
systemic	O
injection	O
of	O
microbes	O
[	O
22	O
]	O
.	O

To	O
investigate	O
the	O
in	O
vivo	O
relationship	O
between	O
AMP	O
activity	O
and	O
microbial	O
persistence	O
we	O
next	O
compared	O
the	O
numbers	O
of	O
bacteria	O
of	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
aprA	B-Protein
mutants	O
in	O
imd	O
fly	O
lines	O
over	O
-	O
expressing	O
Diptericin	B-Protein
.	O

Figure	O
6B	O
shows	O
that	O
the	O
aprA	B-Protein
mutant	O
persisted	O
less	O
well	O
than	O
wild	O
-	O
type	O
bacteria	O
in	O
imd	O
flies	O
over	O
-	O
expressing	O
Diptericin	B-Protein
.	O

This	O
result	O
clearly	O
indicates	O
an	O
in	O
vivo	O
action	O
of	O
AprA	B-Protein
against	O
Diptericin	B-Protein
.	O

No	O
effect	O
could	O
be	O
detected	O
when	O
Attacin	B-Protein
A	I-Protein
was	O
over	O
-	O
expressed	O
in	O
agreement	O
with	O
the	O
bacteriostatic	O
mode	O
of	O
action	O
of	O
this	O
AMP	O
(	O
unpublished	O
data	O
)	O
.	O

Altogether	O
,	O
our	O
results	O
provide	O
an	O
in	O
vivo	O
demonstration	O
that	O
AprA	B-Protein
functions	O
in	O
the	O
protection	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
against	O
Drosophila	B-Organism
AMPs	O
.	O

Discussion	O

Pathogens	O
have	O
developed	O
a	O
plethora	O
of	O
strategies	O
that	O
allow	O
them	O
to	O
exploit	O
host	O
resources	O
and	O
resist	O
the	O
attacks	O
of	O
the	O
host	O
immune	O
response	O
.	O

To	O
study	O
how	O
flies	O
deal	O
with	O
infections	O
in	O
a	O
natural	O
context	O
,	O
we	O
investigated	O
the	O
interactions	O
between	O
Drosophila	B-Organism
and	O
a	O
newly	O
identified	O
entomopathogen	O
,	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
.	O

Using	O
a	O
combined	O
genetic	O
approach	O
for	O
both	O
the	O
host	O
and	O
pathogen	O
we	O
reveal	O
the	O
importance	O
of	O
the	O
local	O
immune	O
response	O
in	O
host	O
defense	O
against	O
gastrointestinal	O
infections	O
and	O
provide	O
an	O
in	O
vivo	O
demonstration	O
for	O
the	O
role	O
of	O
a	O
bacterial	O
metalloprotease	O
in	O
protection	O
against	O
AMPs	O
.	O

Our	O
analysis	O
reveals	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
is	O
multi	O
-	O
factorial	O
,	O
as	O
one	O
might	O
expect	O
,	O
but	O
can	O
be	O
decrypted	O
through	O
genetic	O
analysis	O
of	O
the	O
two	O
interacting	O
partners	O
.	O

Local	O
Expression	O
of	O
AMP	O
Genes	O
Plays	O
a	O
Major	O
Role	O
against	O
Food	O
-	O
Borne	O
Infections	O
The	O
use	O
of	O
GFP	B-Protein
reporter	O
transgenes	O
in	O
Drosophila	B-Organism
has	O
revealed	O
that	O
,	O
in	O
addition	O
to	O
the	O
fat	O
body	O
,	O
AMP	O
genes	O
can	O
be	O
expressed	O
in	O
several	O
barrier	O
epithelia	O
that	O
are	O
in	O
direct	O
contact	O
with	O
microorganisms	O
from	O
the	O
environment	O
[	O
7	O
,	O
23	O
]	O
.	O

The	O
precise	O
relevance	O
of	O
this	O
local	O
immune	O
response	O
in	O
Drosophila	B-Organism
has	O
not	O
been	O
established	O
to	O
date	O
.	O

The	O
present	O
study	O
demonstrates	O
a	O
key	O
role	O
for	O
the	O
local	O
Imd	B-Protein
immune	O
response	O
in	O
the	O
gut	O
against	O
oral	O
infection	O
by	O
bacterial	O
pathogens	O
.	O

The	O
Imd	B-Protein
pathway	O
regulates	O
a	O
large	O
number	O
of	O
immune	O
genes	O
including	O
those	O
encoding	O
AMPs	O
;	O
and	O
two	O
peptides	O
,	O
Diptericin	B-Protein
and	O
Attacin	B-Protein
,	O
are	O
preferentially	O
synthesized	O
following	O
bacterial	O
infection	O
in	O
the	O
digestive	O
tract	O
of	O
Drosophila	B-Organism
[	O
7	O
]	O
.	O

To	O
explore	O
the	O
potential	O
implication	O
of	O
AMPs	O
in	O
the	O
Imd	B-Protein
immune	O
defense	O
against	O
oral	O
infection	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
we	O
compared	O
survival	O
of	O
flies	O
expressing	O
only	O
a	O
single	O
AMP	O
.	O

Our	O
study	O
reveals	O
that	O
over	O
-	O
expression	O
of	O
either	O
Diptericin	B-Protein
or	O
Attacin	B-Protein
confers	O
protection	O
against	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
.	O

This	O
observation	O
,	O
combined	O
with	O
our	O
data	O
demonstrating	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
expresses	O
specific	O
virulence	O
factors	O
in	O
order	O
to	O
resist	O
AMPs	O
,	O
underlines	O
the	O
critical	O
role	O
of	O
local	O
AMP	O
expression	O
against	O
food	O
-	O
borne	O
pathogens	O
.	O

Previous	O
studies	O
revealed	O
only	O
a	O
modest	O
contribution	O
of	O
Diptericin	B-Protein
to	O
resistance	O
against	O
Gram	O
-	O
negative	O
bacteria	O
during	O
systemic	O
infection	O
[	O
22	O
]	O
.	O

In	O
contrast	O
,	O
our	O
data	O
reveal	O
that	O
Diptericin	B-Protein
plays	O
an	O
essential	O
role	O
in	O
the	O
defense	O
against	O
Gram	O
-	O
negative	O
bacteria	O
when	O
they	O
are	O
ingested	O
.	O

The	O
antibacterial	O
activity	O
of	O
Diptericin	B-Protein
may	O
be	O
enhanced	O
in	O
the	O
gut	O
by	O
pH	O
and	O
other	O
factors	O
such	O
as	O
lysozymes	O
[	O
24	O
]	O
.	O

It	O
is	O
also	O
possible	O
that	O
Diptericin	B-Protein
could	O
reach	O
high	O
concentration	O
levels	O
in	O
restricted	O
areas	O
of	O
the	O
Drosophila	B-Organism
gut	O
such	O
as	O
the	O
proventriculus	O
and	O
thus	O
be	O
more	O
effective	O
against	O
pathogens	O
than	O
in	O
other	O
body	O
compartments	O
.	O

Our	O
study	O
suggests	O
that	O
Diptericin	B-Protein
expression	O
in	O
the	O
anterior	O
gut	O
provides	O
an	O
efficient	O
early	O
barrier	O
allowing	O
Drosophila	B-Organism
to	O
rapidly	O
eliminate	O
most	O
ingested	O
bacteria	O
.	O

Finally	O
,	O
it	O
remains	O
surprising	O
that	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
infection	O
triggers	O
a	O
systemic	O
immune	O
response	O
that	O
has	O
no	O
overt	O
function	O
against	O
the	O
bacteria	O
that	O
remain	O
in	O
the	O
gut	O
lumen	O
.	O

This	O
response	O
could	O
be	O
interpreted	O
as	O
anticipation	O
of	O
possible	O
breaching	O
of	O
the	O
gut	O
barrier	O
.	O

Alternatively	O
,	O
our	O
results	O
suggest	O
the	O
possibility	O
that	O
bacteria	O
such	O
as	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
may	O
subvert	O
insect	O
host	O
defenses	O
by	O
triggering	O
this	O
systemic	O
response	O
.	O

This	O
can	O
be	O
compared	O
with	O
many	O
human	B-Organism
pathogens	O
for	O
which	O
activation	O
of	O
an	O
inflammatory	O
response	O
represents	O
a	O
part	O
of	O
their	O
invasive	O
strategy	O
[	O
25	O
]	O
.	O

AprA	B-Protein
Protects	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
from	O
Antibacterial	O
Peptides	O

In	O
bacteria	O
,	O
nitrogen	B-Chemical
and	O
carbon	B-Chemical
sources	O
are	O
frequently	O
provided	O
by	O
enzymatic	O
degradation	O
of	O
extracellular	O
biopolymers	O
by	O
proteases	O
and	O
glycosidases	O
.	O

Proteases	O
,	O
especially	O
metalloproteases	O
,	O
are	O
also	O
known	O
to	O
contribute	O
to	O
virulence	O
in	O
some	O
pathogenic	O
bacteria	O
including	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
,	O
S	B-Organism
.	I-Organism
marcescens	I-Organism
,	O
and	O
Bacillus	B-Organism
thuringiensis	I-Organism
[	O
20	O
,	O
21	O
,	O
26	O
]	O
.	O

Molecular	O
mechanisms	O
for	O
pathogenesis	O
attributed	O
to	O
these	O
proteases	O
include	O
degradation	O
of	O
structural	O
matrices	O
and	O
destruction	O
of	O
proteins	O
involved	O
in	O
host	O
protective	O
functions	O
such	O
as	O
AMPs	O
or	O
complement	O
factors	O
.	O

However	O
,	O
in	O
most	O
cases	O
,	O
attempts	O
to	O
evaluate	O
the	O
role	O
of	O
metalloproteases	O
in	O
virulence	O
have	O
failed	O
to	O
obtain	O
conclusive	O
results	O
with	O
respect	O
to	O
a	O
specific	O
function	O
[	O
20	O
,	O
21	O
]	O
.	O

Thus	O
,	O
our	O
approach	O
focusing	O
on	O
both	O
host	O
and	O
pathogen	O
is	O
the	O
first	O
to	O
clearly	O
demonstrate	O
a	O
key	O
role	O
of	O
the	O
AprA	B-Protein
metalloprotease	O
in	O
the	O
protection	O
against	O
AMPs	O
in	O
vivo	O
.	O

This	O
conclusion	O
is	O
based	O
on	O
our	O
observations	O
that	O
(	O
i	O
)	O
aprA	B-Protein
mutants	O
show	O
attenuated	O
virulence	O
,	O
(	O
ii	O
)	O
aprA	B-Protein
mutants	O
survive	O
less	O
well	O
than	O
wild	O
-	O
type	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
in	O
Drosophila	B-Organism
and	O
are	O
more	O
sensitive	O
to	O
Imd	B-Protein
-	O
mediated	O
defense	O
,	O
and	O
(	O
iii	O
)	O
AprA	B-Protein
provides	O
specific	O
protection	O
in	O
vivo	O
against	O
Diptericin	B-Protein
.	O

Altogether	O
,	O
our	O
study	O
reveals	O
that	O
local	O
AMP	O
expression	O
plays	O
an	O
important	O
role	O
in	O
defense	O
against	O
oral	O
pathogens	O
and	O
that	O
entomopathogens	O
such	O
as	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
can	O
counteract	O
this	O
effect	O
by	O
expressing	O
aprA	B-Protein
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
S	B-Organism
.	I-Organism
marcescens	I-Organism
,	O
another	O
potent	O
oral	O
pathogen	O
of	O
Drosophila	B-Organism
,	O
also	O
expresses	O
a	O
protease	O
that	O
can	O
degrade	O
AMPs	O
in	O
vitro	O
[	O
12	O
]	O
.	O

However	O
,	O
in	O
the	O
absence	O
of	O
a	O
Serratia	B-Organism
protease	I-Organism
mutant	I-Organism
,	O
the	O
in	O
vivo	O
relevance	O
of	O
the	O
protease	O
is	O
not	O
yet	O
established	O
.	O

Taken	O
together	O
,	O
this	O
observation	O
and	O
our	O
findings	O
suggest	O
that	O
proteases	O
may	O
represent	O
a	O
common	O
strategy	O
used	O
by	O
Drosophila	B-Organism
pathogens	O
to	O
circumvent	O
the	O
potent	O
antimicrobial	O
host	O
defense	O
.	O

We	O
cannot	O
exclude	O
that	O
AprA	B-Protein
degrades	O
other	O
immune	O
effectors	O
or	O
participates	O
directly	O
as	O
a	O
toxic	O
factor	O
by	O
degrading	O
the	O
gut	O
epithelium	O
or	O
the	O
peritrophic	O
matrix	O
.	O

In	O
B	B-Organism
.	I-Organism
thuringiensis	I-Organism
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
protease	O
InhA2	B-Protein
participates	O
in	O
the	O
degradation	O
of	O
the	O
gut	O
,	O
thus	O
facilitating	O
the	O
action	O
of	O
the	O
Cry	B-Protein
toxins	O
[	O
27	O
,	O
28	O
]	O
.	O

Alternatively	O
,	O
in	O
Photorhabdus	B-Organism
luminescens	I-Organism
,	O
an	O
AprA	B-Protein
homologue	O
,	O
PrtA	B-Protein
,	O
has	O
been	O
proposed	O
not	O
to	O
be	O
a	O
virulence	O
factor	O
,	O
but	O
rather	O
to	O
be	O
involved	O
in	O
degrading	O
host	O
tissues	O
following	O
host	O
death	O
in	O
order	O
to	O
promote	O
efficient	O
nutrition	O
and	O
development	O
of	O
its	O
symbiotic	O
nematode	O
host	O
[	O
14	O
,	O
29	O
]	O
.	O

The	O
observation	O
that	O
injection	O
of	O
AprA	B-Protein
into	O
the	O
hemocoel	O
is	O
lethal	O
to	O
adult	O
flies	O
supports	O
the	O
hypothesis	O
of	O
additional	O
roles	O
for	O
the	O
protease	O
in	O
bacterial	O
pathogenesis	O
.	O

However	O
,	O
oral	O
ingestion	O
of	O
purified	O
AprA	B-Protein
induces	O
only	O
low	O
levels	O
of	O
lethality	O
,	O
indicating	O
that	O
AprA	B-Protein
alone	O
is	O
not	O
sufficient	O
to	O
kill	O
the	O
host	O
via	O
this	O
route	O
of	O
entry	O
,	O
and	O
other	O
factors	O
participate	O
in	O
oral	O
toxicity	O
.	O

P	B-Organism
.	I-Organism
entomophila	I-Organism
Virulence	O
Is	O
Multi	O
-	O
Factorial	O

In	O
agreement	O
with	O
previous	O
studies	O
,	O
we	O
show	O
that	O
aprA	B-Protein
expression	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
depends	O
on	O
both	O
PrtR	B-Protein
and	O
the	O
GacS	B-Protein
/	O
GacA	B-Protein
system	O
.	O

The	O
GacS	B-Protein
/	O
GacA	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
is	O
conserved	O
in	O
numerous	O
Gram	O
-	O
negative	O
bacteria	O
and	O
has	O
been	O
shown	O
to	O
regulate	O
a	O
wide	O
variety	O
of	O
cellular	O
functions	O
and	O
virulence	O
factors	O
[	O
30	O
,	O
31	O
]	O
.	O

Our	O
study	O
indicates	O
that	O
it	O
is	O
the	O
master	O
regulator	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
.	O

In	O
a	O
gacA	B-Protein
mutant	O
background	O
,	O
AprA	B-Protein
synthesis	O
is	O
not	O
restored	O
when	O
a	O
plasmid	O
with	O
the	O
aprA	B-Protein
locus	O
is	O
expressed	O
in	O
trans	O
(	O
unpublished	O
data	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
post	O
-	O
transcriptional	O
regulation	O
of	O
aprA	B-Protein
by	O
gacA	B-Protein
via	O
the	O
two	O
small	O
non	O
-	O
coding	O
RNAs	O
RsmY	B-Protein
and	O
RsmZ	B-Protein
[	O
11	O
]	O
.	O

As	O
opposed	O
to	O
the	O
pleiotropic	O
effects	O
of	O
GacS	B-Protein
/	O
GacA	B-Protein
,	O
PrtR	B-Protein
appears	O
to	O
be	O
a	O
more	O
specific	O
regulator	O
of	O
aprA	B-Protein
expression	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
reminiscent	O
of	O
aprX	B-Protein
regulation	O
in	O
P	B-Organism
.	I-Organism
fluorescens	I-Organism
[	O
32	O
]	O
.	O

Many	O
pseudomonads	B-Organism
and	O
other	O
bacteria	O
express	O
proteases	O
similar	O
to	O
AprA	B-Protein
but	O
are	O
not	O
able	O
to	O
infect	O
Drosophila	B-Organism
by	O
oral	O
ingestion	O
.	O

This	O
indicates	O
that	O
AprA	B-Protein
is	O
not	O
the	O
sole	O
virulence	O
factor	O
required	O
for	O
persistence	O
in	O
the	O
Drosophila	B-Organism
gastrointestinal	O
tract	O
.	O

The	O
difference	O
in	O
pathogenicity	O
exhibited	O
by	O
gacA	B-Protein
,	O
prtR	B-Protein
,	O
and	O
aprA	B-Protein
mutants	O
underlines	O
the	O
complexity	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
factors	O
.	O

The	O
observation	O
that	O
both	O
aprA	B-Protein
and	O
prtR	B-Protein
,	O
but	O
not	O
gacA	B-Protein
,	O
mutants	O
retained	O
the	O
capacity	O
to	O
trigger	O
a	O
systemic	O
immune	O
response	O
indicates	O
a	O
clear	O
distinction	O
between	O
pathogenicity	O
and	O
immune	O
activation	O
.	O

Our	O
current	O
hypothesis	O
is	O
that	O
systemic	O
immune	O
activation	O
is	O
linked	O
to	O
bacterial	O
persistence	O
in	O
the	O
gut	O
and	O
release	O
of	O
peptidoglycan	O
fragments	O
small	O
enough	O
to	O
cross	O
the	O
gut	O
barrier	O
[	O
33	O
]	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
GacS	B-Protein
/	O
GacA	B-Protein
two	O
-	O
component	O
system	O
regulates	O
one	O
or	O
several	O
genes	O
that	O
promote	O
bacterial	O
survival	O
in	O
the	O
gut	O
.	O

This	O
hypothesized	O
persistence	O
-	O
promoting	O
factor	O
may	O
have	O
a	O
function	O
similar	O
to	O
the	O
Erwinia	B-Protein
virulence	I-Protein
factor	I-Protein
(	O
evf	B-Protein
)	O
gene	O
of	O
E	B-Organism
.	I-Organism
carotovora	I-Organism
Ecc15	I-Organism
that	O
promotes	O
persistence	O
of	O
Gram	O
-	O
negative	O
bacteria	O
in	O
the	O
larval	O
gut	O
[	O
34	O
]	O
.	O

Since	O
gacA	B-Protein
mutants	O
did	O
not	O
persist	O
in	O
imd	O
-	O
deficient	O
mutant	O
hosts	O
,	O
we	O
speculate	O
that	O
this	O
persistence	O
-	O
promoting	O
factor	O
provides	O
general	O
protection	O
against	O
gut	O
intestinal	O
conditions	O
rather	O
than	O
a	O
specific	O
protection	O
against	O
the	O
fly	O
immune	O
response	O
.	O

Another	O
interesting	O
feature	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
virulence	O
is	O
the	O
food	O
-	O
uptake	O
cessation	O
which	O
is	O
observed	O
in	O
prtR	B-Protein
and	O
aprA	B-Protein
but	O
not	O
in	O
gacA	B-Protein
mutants	O
.	O

Food	O
-	O
uptake	O
cessation	O
or	O
blockage	O
in	O
insects	O
is	O
induced	O
by	O
several	O
other	O
entomopathogenic	O
bacteria	O
including	O
S	B-Organism
.	I-Organism
entomophila	I-Organism
and	O
Yersinia	B-Organism
pestis	I-Organism
,	O
enabling	O
persistence	O
in	O
the	O
digestive	O
tract	O
of	O
their	O
insect	O
hosts	O
[	O
35	O
,	O
36	O
]	O
.	O

This	O
observation	O
suggests	O
that	O
peristaltic	O
movements	O
of	O
the	O
gut	O
may	O
also	O
play	O
an	O
important	O
role	O
in	O
the	O
elimination	O
of	O
bacteria	O
,	O
and	O
that	O
entomopathogens	O
have	O
developed	O
strategies	O
to	O
abrogate	O
these	O
movements	O
.	O

In	O
S	B-Organism
.	I-Organism
entomophila	I-Organism
,	O
it	O
has	O
been	O
shown	O
that	O
genes	O
encoded	O
by	O
a	O
prophage	O
were	O
responsible	O
for	O
the	O
anti	O
-	O
feeding	O
reaction	O
in	O
its	O
natural	O
insect	O
host	O
,	O
the	O
grass	O
grub	O
Costelytra	B-Organism
zealandica	I-Organism
larvae	O
[	O
35	O
]	O
.	O

Y	B-Organism
.	I-Organism
pestis	I-Organism
is	O
able	O
to	O
multiply	O
in	O
the	O
flea	O
midgut	O
and	O
forms	O
cohesive	O
aggregates	O
.	O

The	O
absence	O
of	O
homologous	O
genes	O
to	O
these	O
factors	O
in	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
indicates	O
that	O
other	O
factors	O
are	O
probably	O
implicated	O
in	O
this	O
bacterium	O
[	O
10	O
]	O
.	O

Determining	O
the	O
cause	O
of	O
this	O
food	O
-	O
uptake	O
cessation	O
and	O
its	O
possible	O
link	O
to	O
the	O
persistence	O
-	O
promoting	O
factor	O
will	O
be	O
essential	O
for	O
the	O
elucidation	O
of	O
the	O
initial	O
events	O
involved	O
in	O
gut	O
colonization	O
.	O

Finally	O
,	O
our	O
study	O
shows	O
that	O
aprA	B-Protein
,	O
but	O
not	O
gacA	B-Protein
,	O
mutants	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
retain	O
a	O
moderate	O
capacity	O
to	O
kill	O
both	O
adult	O
flies	O
and	O
larvae	O
.	O

This	O
confirms	O
the	O
existence	O
of	O
other	O
bacterial	O
virulence	O
factors	O
.	O

The	O
genome	O
of	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
contains	O
several	O
genes	O
encoding	O
putative	O
insecticidal	O
toxins	O
(	O
e	O
.	O
g	O
.	O
,	O
Tc	O
toxins	O
,	O
hemolysins	O
,	O
and	O
lipopeptides	O
)	O
.	O

Therefore	O
,	O
it	O
remains	O
to	O
be	O
determined	O
whether	O
the	O
strategies	O
developed	O
by	O
P	B-Organism
.	I-Organism
entomophila	I-Organism
to	O
persist	O
in	O
the	O
larval	O
gut	O
and	O
to	O
kill	O
its	O
host	O
involves	O
genes	O
related	O
to	O
those	O
identified	O
in	O
other	O
entomopathogenic	O
bacteria	O
and	O
how	O
the	O
different	O
factors	O
contribute	O
to	O
pathogenesis	O
.	O

A	O
Comprehensive	O
Genetic	O
Characterization	O
of	O
Bacterial	O
Motility	O

We	O
have	O
developed	O
a	O
powerful	O
experimental	O
framework	O
that	O
combines	O
competitive	O
selection	O
and	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
to	O
comprehensively	O
reveal	O
the	O
genetic	O
basis	O
of	O
bacterial	O
behaviors	O
.	O

Application	O
of	O
this	O
method	O
to	O
Escherichia	B-Organism
coli	I-Organism
motility	O
identifies	O
95	O
%	O
of	O
the	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
,	O
and	O
reveals	O
three	O
dozen	O
novel	O
loci	O
that	O
,	O
to	O
varying	O
degrees	O
and	O
through	O
diverse	O
mechanisms	O
,	O
affect	O
motility	O
.	O

To	O
probe	O
the	O
network	O
context	O
in	O
which	O
these	O
genes	O
function	O
,	O
we	O
developed	O
a	O
method	O
that	O
uncovers	O
genome	O
-	O
wide	O
epistatic	O
interactions	O
through	O
comprehensive	O
analyses	O
of	O
double	O
-	O
mutant	O
phenotypes	O
.	O

This	O
allows	O
us	O
to	O
place	O
the	O
novel	O
genes	O
within	O
the	O
context	O
of	O
signaling	O
and	O
regulatory	O
networks	O
,	O
including	O
the	O
Rcs	O
phosphorelay	O
pathway	O
and	O
the	O
cyclic	B-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
second	O
-	O
messenger	O
system	O
.	O

This	O
unifying	O
framework	O
enables	O
sensitive	O
and	O
comprehensive	O
genetic	O
characterization	O
of	O
complex	O
behaviors	O
across	O
the	O
microbial	O
biosphere	O
.	O

Introduction	O

Structured	O
microbial	O
habitats	O
have	O
selected	O
for	O
a	O
dazzling	O
diversity	O
of	O
bacterial	O
behaviors	O
.	O

These	O
behaviors	O
are	O
contingent	O
on	O
sophisticated	O
sensory	O
systems	O
that	O
maximize	O
fitness	O
in	O
the	O
complex	O
and	O
highly	O
dynamic	O
environments	O
where	O
physical	O
,	O
chemical	O
,	O
and	O
biological	O
parameters	O
change	O
on	O
many	O
different	O
time	O
scales	O
.	O

Modern	O
genetic	O
and	O
molecular	O
studies	O
have	O
largely	O
focused	O
on	O
a	O
limited	O
repertoire	O
of	O
behaviors	O
of	O
a	O
few	O
model	O
organisms	O
in	O
the	O
non	O
-	O
native	O
context	O
of	O
the	O
laboratory	O
.	O

However	O
,	O
even	O
at	O
the	O
level	O
of	O
basic	O
phenomenology	O
,	O
the	O
vast	O
majority	O
of	O
phenotypes	O
in	O
the	O
microbial	O
biosphere	O
remain	O
uncharacterized	O
.	O

A	O
major	O
challenge	O
of	O
the	O
post	O
-	O
genome	O
era	O
is	O
the	O
development	O
of	O
efficient	O
and	O
comprehensive	O
methods	O
for	O
revealing	O
the	O
genetic	O
basis	O
of	O
these	O
behaviors	O
across	O
diverse	O
clades	O
,	O
especially	O
as	O
the	O
emerging	O
field	O
of	O
metagenomics	O
begins	O
to	O
reveal	O
the	O
wide	O
assortment	O
of	O
microbial	O
life	O
on	O
the	O
planet	O
[	O
1	O
]	O
.	O

Chemotaxis	O
,	O
the	O
capacity	O
to	O
move	O
up	O
and	O
down	O
chemical	O
gradients	O
,	O
is	O
widespread	O
in	O
the	O
bacterial	O
world	O
.	O

An	O
impressive	O
achievement	O
of	O
20th	O
-	O
century	O
biology	O
was	O
a	O
systems	O
-	O
level	O
understanding	O
of	O
bacterial	O
chemotaxis	O
in	O
terms	O
of	O
the	O
structures	O
,	O
interactions	O
,	O
and	O
organization	O
of	O
the	O
roughly	O
50	O
constituent	O
molecular	O
components	O
[	O
2	O
-	O
4	O
]	O
.	O

The	O
best	O
-	O
characterized	O
chemotaxis	O
machineries	O
are	O
those	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
and	O
its	O
close	O
relative	O
Salmonella	B-Organism
enterica	I-Organism
[	O
5	O
,	O
6	O
]	O
.	O

These	O
species	O
propel	O
themselves	O
by	O
rotating	O
multiple	O
extracellular	O
helical	O
filaments	O
called	O
flagella	O
.	O

When	O
the	O
filament	O
rotates	O
in	O
the	O
counterclockwise	O
(	O
CCW	O
)	O
direction	O
,	O
as	O
viewed	O
from	O
outside	O
the	O
cell	O
,	O
a	O
helical	O
wave	O
travels	O
down	O
the	O
filament	O
away	O
from	O
the	O
cell	O
body	O
.	O

In	O
this	O
CCW	O
mode	O
,	O
multiple	O
rotating	O
flagella	O
come	O
together	O
to	O
form	O
a	O
bundle	O
,	O
propelling	O
the	O
cell	O
forward	O
in	O
a	O
motion	O
called	O
"	O
smooth	O
swimming	O
.	O
"	O
When	O
one	O
or	O
more	O
motors	O
reverse	O
to	O
the	O
clockwise	O
(	O
CW	O
)	O
direction	O
,	O
the	O
bundle	O
comes	O
apart	O
and	O
the	O
cell	O
"	O
tumbles	O
"	O
briefly	O
,	O
reorienting	O
the	O
cell	O
in	O
a	O
new	O
direction	O
;	O
subsequent	O
motor	O
switching	O
to	O
the	O
CCW	O
direction	O
causes	O
the	O
cell	O
to	O
swim	O
forward	O
again	O
.	O

The	O
direction	O
of	O
rotation	O
is	O
influenced	O
by	O
the	O
output	O
of	O
the	O
chemotaxis	O
network	O
,	O
which	O
consists	O
of	O
a	O
signal	O
transduction	O
cascade	O
that	O
allows	O
robust	O
adaptation	O
to	O
local	O
concentrations	O
of	O
ligands	O
over	O
many	O
orders	O
of	O
magnitude	O
[	O
7	O
,	O
8	O
]	O
.	O

When	O
cells	O
detect	O
an	O
increase	O
in	O
the	O
concentration	O
of	O
an	O
attractant	O
,	O
tumbling	O
is	O
suppressed	O
so	O
as	O
to	O
allow	O
cells	O
to	O
migrate	O
towards	O
the	O
source	O
through	O
the	O
statistical	O
strategy	O
of	O
a	O
biased	O
random	O
walk	O
[	O
9	O
]	O
.	O

The	O
signaling	O
circuit	O
that	O
mediates	O
this	O
behavior	O
terminates	O
at	O
the	O
flagellar	O
machinery	O
,	O
which	O
is	O
synthesized	O
through	O
a	O
sequential	O
hierarchy	O
of	O
gene	O
activation	O
events	O
[	O
10	O
]	O
initiated	O
by	O
the	O
expression	O
of	O
the	O
master	O
transcriptional	O
regulator	O
FlhDC	B-Protein
.	O

These	O
events	O
yield	O
an	O
orderly	O
"	O
just	O
-	O
in	O
-	O
time	O
"	O
expression	O
and	O
assembly	O
of	O
the	O
flagellar	O
components	O
[	O
11	O
]	O
,	O
which	O
consist	O
of	O
a	O
basal	O
body	O
complex	O
and	O
a	O
filament	O
.	O

The	O
basal	O
body	O
complex	O
contains	O
a	O
central	O
rod	O
that	O
connects	O
the	O
motor	O
to	O
the	O
filament	O
through	O
a	O
short	O
hook	O
.	O

The	O
identification	O
of	O
the	O
molecular	O
components	O
and	O
their	O
organization	O
into	O
the	O
two	O
dominant	O
modules	O
-	O
the	O
chemotaxis	O
network	O
and	O
the	O
flagellum	O
/	O
basal	O
body	O
/	O
motor	O
system	O
-	O
took	O
the	O
better	O
part	O
of	O
40	O
years	O
and	O
the	O
work	O
of	O
dozens	O
of	O
laboratories	O
.	O

These	O
efforts	O
have	O
culminated	O
in	O
a	O
level	O
of	O
understanding	O
nearly	O
unmatched	O
in	O
any	O
other	O
domain	O
of	O
molecular	O
biology	O
.	O

For	O
these	O
reasons	O
,	O
flagellar	O
-	O
mediated	O
motility	O
is	O
an	O
ideal	O
test	O
case	O
for	O
any	O
modern	O
post	O
-	O
genomic	O
approach	O
that	O
attempts	O
to	O
efficiently	O
and	O
comprehensively	O
reveal	O
the	O
genetic	O
basis	O
of	O
a	O
complex	O
bacterial	O
phenotype	O
.	O

In	O
this	O
study	O
,	O
we	O
make	O
improvements	O
on	O
a	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
strategy	O
[	O
12	O
]	O
,	O
increasing	O
its	O
sensitivity	O
and	O
specificity	O
in	O
revealing	O
the	O
contribution	O
of	O
each	O
and	O
every	O
gene	O
in	O
the	O
genome	O
to	O
a	O
phenotype	O
of	O
interest	O
.	O

We	O
demonstrate	O
the	O
manner	O
in	O
which	O
this	O
strategy	O
can	O
be	O
used	O
to	O
explore	O
the	O
genetic	O
basis	O
of	O
complex	O
bacterial	O
behavior	O
by	O
following	O
the	O
population	O
dynamics	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
insertional	O
mutants	O
in	O
environments	O
where	O
reproductive	O
fitness	O
is	O
coupled	O
to	O
motility	O
.	O

To	O
fully	O
identify	O
the	O
genetic	O
determinants	O
for	O
this	O
phenotype	O
,	O
a	O
library	O
of	O
transposon	O
-	O
mutagenized	O
cells	O
was	O
functionally	O
enriched	O
en	O
masse	O
for	O
impaired	O
swimming	O
and	O
surface	O
-	O
mediated	O
swarming	O
motility	O
.	O

We	O
also	O
selected	O
for	O
resistance	O
to	O
bacteriophage	O
chi	B-Organism
,	O
which	O
is	O
known	O
to	O
infect	O
and	O
lyse	O
cells	O
only	O
when	O
they	O
are	O
motile	O
.	O

Additionally	O
,	O
we	O
identified	O
the	O
genetic	O
basis	O
of	O
motility	O
suppression	O
by	O
environmental	O
factors	O
.	O

Using	O
DNA	O
microarray	O
hybridization	O
,	O
we	O
monitored	O
the	O
relative	O
abundance	O
of	O
each	O
mutant	O
throughout	O
the	O
selections	O
.	O

The	O
comprehensive	O
nature	O
of	O
our	O
methodology	O
is	O
reflected	O
by	O
the	O
identification	O
of	O
nearly	O
all	O
of	O
the	O
known	O
structural	O
and	O
regulatory	O
components	O
of	O
flagellar	O
-	O
mediated	O
chemotaxis	O
.	O

Strikingly	O
,	O
we	O
also	O
identify	O
dozens	O
of	O
additional	O
loci	O
that	O
contribute	O
to	O
this	O
phenotype	O
.	O

Further	O
characterization	O
of	O
these	O
novel	O
genes	O
revealed	O
that	O
they	O
impair	O
motility	O
through	O
diverse	O
mechanisms	O
such	O
as	O
disrupting	O
signaling	O
through	O
phosphorelay	O
cascades	O
,	O
altering	O
concentrations	O
of	O
the	O
recently	O
appreciated	O
cyclic	B-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
(	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
)	O
second	O
messenger	O
,	O
and	O
by	O
mechanisms	O
that	O
have	O
yet	O
to	O
be	O
revealed	O
.	O

Subsequent	O
genome	O
-	O
wide	O
epistasis	O
analyses	O
allow	O
us	O
to	O
organize	O
the	O
discovered	O
loci	O
into	O
signaling	O
and	O
regulatory	O
pathways	O
.	O

This	O
systematic	O
framework	O
for	O
genetic	O
characterization	O
can	O
be	O
applied	O
to	O
any	O
microorganism	O
that	O
is	O
amenable	O
to	O
transposon	O
mutagenesis	O
,	O
making	O
it	O
accessible	O
to	O
the	O
vast	O
majority	O
of	O
bacterial	O
systems	O
of	O
importance	O
to	O
basic	O
,	O
industrial	O
,	O
environmental	O
,	O
and	O
clinical	O
research	O
.	O

Results	O
/	O
Discussion	O

Mapping	O
Phenotype	O
to	O
Genotype	O
Using	O
Microarray	O
-	O
Based	O
Genetic	O
Footprinting	O
Traditional	O
methods	O
of	O
genetic	O
investigation	O
have	O
been	O
extremely	O
successful	O
in	O
providing	O
a	O
deep	O
molecular	O
understanding	O
of	O
many	O
phenotypes	O
in	O
model	O
microorganisms	O
.	O

However	O
,	O
faced	O
with	O
literally	O
thousands	O
of	O
important	O
and	O
mostly	O
uncharacterized	O
bacterial	O
species	O
,	O
we	O
need	O
entirely	O
novel	O
methods	O
of	O
genetic	O
functional	O
analysis	O
and	O
pathway	O
elucidation	O
that	O
scale	O
to	O
the	O
task	O
at	O
hand	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
applied	O
a	O
systematic	O
genome	O
-	O
wide	O
strategy	O
to	O
determine	O
the	O
contribution	O
of	O
nearly	O
all	O
genetic	O
loci	O
in	O
the	O
genome	O
to	O
a	O
phenotype	O
of	O
interest	O
.	O

Our	O
approach	O
combines	O
genetic	O
footprinting	O
[	O
13	O
]	O
with	O
microarray	O
hybridization	O
[	O
14	O
]	O
in	O
order	O
to	O
monitor	O
,	O
in	O
parallel	O
,	O
the	O
relative	O
abundances	O
of	O
transposon	O
-	O
mutagenized	O
cells	O
throughout	O
a	O
competitive	O
selection	O
experiment	O
[	O
12	O
]	O
.	O

Saturation	O
transposon	O
mutagenesis	O
is	O
a	O
powerful	O
,	O
versatile	O
,	O
and	O
efficient	O
strategy	O
for	O
creating	O
comprehensive	O
mutant	O
libraries	O
for	O
genomic	O
functional	O
characterization	O
[	O
15	O
]	O
.	O

We	O
have	O
used	O
a	O
hyperactive	O
Tn5	B-Protein
transposition	O
system	O
with	O
reduced	O
target	O
specificity	O
[	O
16	O
]	O
to	O
create	O
a	O
library	O
of	O
approximately	O
5	O
x	O
105	O
independent	O
transposon	O
insertional	O
mutants	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
MG1655	I-Organism
.	O

Given	O
the	O
reduced	O
target	O
specificity	O
and	O
a	O
genome	O
of	O
approximately	O
4	O
,	O
300	O
genes	O
,	O
the	O
mutagenesis	O
of	O
our	O
library	O
is	O
saturating	O
with	O
an	O
average	O
of	O
approximately100	O
independent	O
insertions	O
within	O
each	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
.	O

In	O
each	O
of	O
our	O
experiments	O
,	O
a	O
population	O
of	O
mutants	O
is	O
challenged	O
for	O
competitive	O
growth	O
under	O
a	O
selection	O
of	O
interest	O
.	O

Each	O
mutant	O
within	O
the	O
population	O
is	O
uniquely	O
defined	O
by	O
the	O
local	O
sequence	O
flanking	O
the	O
transposon	O
insertion	O
site	O
.	O

The	O
series	O
of	O
molecular	O
manipulations	O
detailed	O
in	O
Figure	O
S1	O
allow	O
the	O
amplification	O
of	O
roughly	O
200	O
base	O
pairs	O
flanking	O
each	O
transposon	O
insertion	O
site	O
in	O
a	O
population	O
in	O
parallel	O
.	O

Fluorescent	O
labeling	O
and	O
hybridization	O
of	O
the	O
amplicons	O
to	O
a	O
spotted	O
DNA	O
microarray	O
(	O
created	O
as	O
described	O
in	O
Protocol	O
S1	O
)	O
reveal	O
the	O
relative	O
abundance	O
of	O
each	O
mutant	O
as	O
reflected	O
by	O
the	O
signal	O
intensity	O
of	O
the	O
corresponding	O
ORF	O
on	O
the	O
array	O
.	O

As	O
a	O
consequence	O
of	O
selection	O
,	O
individual	O
insertional	O
mutants	O
can	O
increase	O
or	O
decrease	O
in	O
abundance	O
during	O
the	O
course	O
of	O
an	O
experiment	O
,	O
and	O
these	O
relative	O
changes	O
can	O
be	O
monitored	O
by	O
comparing	O
genome	O
-	O
wide	O
hybridization	O
values	O
before	O
and	O
after	O
selection	O
.	O

In	O
a	O
proof	O
-	O
of	O
-	O
principle	O
analysis	O
of	O
the	O
unselected	O
transposon	O
library	O
,	O
we	O
show	O
that	O
the	O
hybridization	O
intensities	O
corresponding	O
to	O
known	O
essential	O
genes	O
are	O
strongly	O
biased	O
towards	O
the	O
lowest	O
values	O
,	O
consistent	O
with	O
their	O
inability	O
to	O
harbor	O
transposon	O
insertions	O
(	O
Figure	O
S2	O
)	O
.	O

Quantitative	O
Analysis	O
of	O
Selection	O
within	O
the	O
Pool	O
of	O
Mutants	O

To	O
determine	O
the	O
degree	O
to	O
which	O
each	O
gene	O
contributes	O
to	O
fitness	O
under	O
a	O
particular	O
selection	O
,	O
we	O
quantify	O
the	O
extent	O
of	O
enrichment	O
or	O
depletion	O
of	O
all	O
transposon	O
insertions	O
within	O
a	O
gene	O
after	O
a	O
selection	O
is	O
imposed	O
.	O

We	O
assign	O
the	O
total	O
hybridization	O
signal	O
for	O
each	O
ORF	O
on	O
the	O
array	O
as	O
the	O
sum	O
of	O
contributions	O
from	O
all	O
the	O
mutants	O
that	O
harbor	O
an	O
insertion	O
somewhere	O
within	O
or	O
in	O
close	O
proximity	O
to	O
the	O
ORF	O
.	O

The	O
ORF	O
intensities	O
from	O
five	O
hybridizations	O
of	O
the	O
maximally	O
diverse	O
unselected	O
library	O
(	O
Dataset	O
S1	O
)	O
are	O
used	O
as	O
a	O
statistical	O
reference	O
to	O
quantify	O
the	O
degree	O
of	O
enrichment	O
or	O
depletion	O
after	O
the	O
library	O
is	O
exposed	O
to	O
a	O
selection	O
of	O
interest	O
.	O

In	O
this	O
way	O
,	O
the	O
five	O
unselected	O
hybridizations	O
define	O
the	O
null	O
variation	O
with	O
respect	O
to	O
which	O
significant	O
differences	O
are	O
quantified	O
.	O

The	O
normalized	O
hybridization	O
intensity	O
value	O
(	O
x	O
)	O
of	O
an	O
ORF	O
from	O
a	O
selection	O
experiment	O
is	O
compared	O
to	O
the	O
null	O
distribution	O
for	O
that	O
ORF	O
(	O
mean	O
:	O
<	O
xn	O
>	O
,	O
standard	O
deviation	O
:	O
sigma	O
)	O
,	O
by	O
calculating	O
a	O
z	O
-	O
score	O
:	O
z	O
=	O
(	O
x	O
-	O
<	O
xn	O
>	O
)	O
/	O
sigma	O
.	O

ORFs	O
that	O
harbor	O
deleterious	O
mutations	O
during	O
the	O
selection	O
will	O
have	O
negative	O
z	O
-	O
scores	O
(	O
corresponding	O
to	O
depletion	O
)	O
,	O
whereas	O
ORFs	O
that	O
harbor	O
relatively	O
favorable	O
mutations	O
during	O
the	O
selection	O
will	O
have	O
positive	O
z	O
-	O
scores	O
(	O
corresponding	O
to	O
enrichment	O
)	O
.	O

In	O
other	O
words	O
,	O
the	O
z	O
-	O
score	O
reflects	O
the	O
number	O
of	O
standard	O
deviations	O
above	O
or	O
below	O
the	O
mean	O
of	O
the	O
unselected	O
replicates	O
.	O

Genetic	O
Basis	O
of	O
Swimming	O
Motility	O
and	O
Chemotaxis	O

Semi	O
-	O
solid	O
tryptone	O
agar	O
provides	O
a	O
robust	O
setting	O
for	O
studying	O
E	B-Organism
.	I-Organism
coli	I-Organism
chemotaxis	O
.	O

Once	O
inoculated	O
into	O
a	O
region	O
of	O
the	O
soft	O
agar	O
,	O
bacteria	O
deplete	O
local	O
nutrients	O
and	O
chemotax	O
radially	O
outward	O
following	O
the	O
concentration	O
gradient	O
of	O
preferred	O
substrates	O
[	O
17	O
]	O
.	O

To	O
systematically	O
and	O
completely	O
identify	O
the	O
genetic	O
determinants	O
for	O
swimming	O
motility	O
,	O
approximately107	O
cells	O
of	O
the	O
mutant	O
library	O
were	O
functionally	O
enriched	O
en	O
masse	O
for	O
an	O
impaired	O
ability	O
to	O
swim	O
through	O
soft	O
agar	O
.	O

After	O
an	O
8	O
-	O
h	O
incubation	O
to	O
allow	O
motile	O
cells	O
to	O
swim	O
away	O
from	O
the	O
site	O
of	O
inoculation	O
,	O
the	O
population	O
enriched	O
for	O
nonmotile	O
mutants	O
was	O
transferred	O
to	O
a	O
fresh	O
plate	O
for	O
further	O
enrichment	O
(	O
Figure	O
1A	O
)	O
.	O

The	O
percentage	O
of	O
nonmotile	O
mutants	O
was	O
determined	O
after	O
each	O
stage	O
of	O
enrichment	O
by	O
a	O
clonal	O
plating	O
assay	O
and	O
,	O
after	O
five	O
stages	O
,	O
96	O
%	O
of	O
the	O
mutants	O
showed	O
an	O
impaired	O
ability	O
to	O
swim	O
(	O
Figure	O
S3	O
)	O
.	O

The	O
amplification	O
of	O
transposon	O
insertion	O
sites	O
from	O
a	O
small	O
sample	O
of	O
these	O
mutants	O
showed	O
that	O
the	O
nonmotile	O
phenotype	O
is	O
the	O
result	O
of	O
a	O
single	O
gene	O
disruption	O
in	O
each	O
mutant	O
.	O

As	O
expected	O
,	O
the	O
vast	O
majority	O
of	O
these	O
disruptions	O
occurred	O
in	O
previously	O
known	O
flagellar	O
or	O
chemotaxis	O
genes	O
(	O
Table	O
S3	O
)	O
.	O

However	O
,	O
even	O
in	O
this	O
small	O
sample	O
,	O
we	O
found	O
transposon	O
insertions	O
in	O
genes	O
without	O
a	O
previously	O
known	O
role	O
in	O
motility	O
.	O

To	O
obtain	O
a	O
genome	O
-	O
wide	O
catalog	O
of	O
loci	O
involved	O
in	O
swimming	O
motility	O
,	O
we	O
applied	O
our	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
assay	O
to	O
the	O
population	O
of	O
mutants	O
at	O
the	O
end	O
of	O
the	O
enrichments	O
.	O

The	O
z	O
-	O
scores	O
reveal	O
that	O
the	O
vast	O
majority	O
of	O
ORFs	O
lie	O
within	O
a	O
tight	O
Gaussian	O
-	O
shaped	O
distribution	O
centered	O
around	O
zero	O
(	O
Figure	O
1B	O
)	O
.	O

However	O
,	O
of	O
the	O
115	O
ORFs	O
with	O
z	O
-	O
scores	O
greater	O
than	O
12	O
,	O
49	O
are	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
.	O

Since	O
the	O
microarray	O
contained	O
52	O
out	O
of	O
the	O
total	O
of	O
54	O
known	O
motility	O
genes	O
[	O
18	O
]	O
,	O
the	O
chance	O
likelihood	O
of	O
observing	O
this	O
level	O
of	O
enrichment	O
was	O
extremely	O
low	O
(	O
p	O
<	O
10	O
-	O
76	O
)	O
.	O

The	O
three	O
remaining	O
motility	O
genes	O
that	O
were	O
not	O
significantly	O
enriched	O
are	O
two	O
chemoreceptor	O
genes	O
,	O
trg	B-Protein
and	O
aer	B-Protein
,	O
and	O
the	O
filament	O
cap	O
chaperone	O
,	O
fliT	B-Protein
.	O

Based	O
on	O
the	O
hybridization	O
results	O
,	O
insertional	O
mutations	O
in	O
these	O
genes	O
should	O
not	O
measurably	O
impair	O
motility	O
.	O

We	O
confirmed	O
this	O
expectation	O
by	O
showing	O
that	O
deletions	O
of	O
fliT	B-Protein
and	O
aer	B-Protein
did	O
not	O
affect	O
motility	O
(	O
data	O
not	O
shown	O
)	O
.	O

The	O
neutral	O
behavior	O
of	O
the	O
fliT	B-Protein
mutation	O
is	O
not	O
surprising	O
since	O
fliT	B-Protein
null	O
strains	O
were	O
found	O
to	O
make	O
functional	O
flagella	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
[	O
19	O
]	O
.	O

In	O
addition	O
,	O
it	O
has	O
been	O
reported	O
that	O
fliT	B-Protein
mutations	O
enhance	O
expression	O
of	O
class	O
2	O
flagellar	O
operons	O
[	O
20	O
]	O
because	O
FliT	B-Protein
acts	O
as	O
a	O
negative	O
regulator	O
of	O
these	O
operons	O
by	O
binding	O
to	O
and	O
inhibiting	O
the	O
activity	O
of	O
FlhDC	B-Protein
[	O
21	O
]	O
.	O

The	O
protein	O
encoded	O
by	O
aer	O
mediates	O
oxygen	B-Chemical
and	O
redox	O
sensing	O
,	O
and	O
as	O
such	O
shares	O
overlapping	O
function	O
with	O
the	O
Tsr	B-Protein
receptor	O
[	O
22	O
]	O
.	O

Because	O
of	O
this	O
redundancy	O
,	O
only	O
aer	B-Protein
tsr	B-Protein
double	O
mutants	O
are	O
expected	O
to	O
show	O
a	O
motility	O
phenotype	O
in	O
tryptone	O
plates	O
.	O

Finally	O
,	O
the	O
product	O
of	O
trg	B-Protein
is	O
a	O
transmembrane	O
methyl	O
-	O
accepting	O
chemotaxis	O
protein	O
that	O
senses	O
ribose	O
and	O
galactose	B-Chemical
[	O
23	O
]	O
.	O

Although	O
these	O
sugars	O
are	O
absent	O
from	O
tryptone	O
plates	O
,	O
deletion	O
of	O
trg	B-Protein
did	O
result	O
in	O
a	O
measurable	O
motility	O
defect	O
(	O
unpublished	O
data	O
)	O
.	O

Therefore	O
,	O
of	O
the	O
more	O
than	O
50	O
known	O
genes	O
involved	O
,	O
trg	B-Protein
is	O
the	O
only	O
false	O
negative	O
under	O
the	O
motility	O
conditions	O
we	O
used	O
.	O

Remarkably	O
,	O
the	O
selection	O
results	O
revealed	O
many	O
genes	O
with	O
high	O
z	O
-	O
scores	O
without	O
a	O
previously	O
known	O
role	O
in	O
motility	O
.	O

We	O
were	O
concerned	O
that	O
some	O
marginally	O
high	O
z	O
-	O
scores	O
may	O
be	O
due	O
to	O
"	O
hitchhiking	O
"	O
of	O
spontaneously	O
arising	O
mutations	O
in	O
motility	O
genes	O
on	O
the	O
background	O
of	O
transposon	O
insertions	O
in	O
nonessential	O
genes	O
.	O

To	O
minimize	O
such	O
false	O
positives	O
,	O
we	O
demanded	O
that	O
a	O
candidate	O
motility	O
gene	O
obtain	O
a	O
z	O
-	O
score	O
above	O
12	O
in	O
at	O
least	O
two	O
of	O
the	O
three	O
replicate	O
selections	O
(	O
Datasets	O
S2	O
,	O
S3	O
,	O
and	O
S4	O
)	O
.	O

The	O
40	O
candidate	O
genes	O
that	O
fit	O
these	O
criteria	O
were	O
targeted	O
for	O
deletion	O
,	O
and	O
20	O
of	O
them	O
were	O
found	O
to	O
show	O
a	O
significant	O
defect	O
in	O
swimming	O
motility	O
(	O
Figure	O
1C	O
;	O
Table	O
S1	O
)	O
.	O

We	O
observed	O
that	O
some	O
false	O
positives	O
were	O
indeed	O
due	O
to	O
hitchhiking	O
,	O
but	O
others	O
were	O
due	O
to	O
polar	O
effects	O
of	O
transposon	O
insertions	O
on	O
downstream	O
genes	O
within	O
operons	O
.	O

Additionally	O
,	O
some	O
genes	O
may	O
be	O
deemed	O
false	O
positive	O
because	O
the	O
nature	O
of	O
the	O
mutation	O
caused	O
by	O
transposon	O
insertion	O
cannot	O
be	O
replicated	O
by	O
a	O
clean	O
deletion	O
of	O
the	O
gene	O
.	O

The	O
criteria	O
we	O
used	O
for	O
identifying	O
candidate	O
motility	O
genes	O
favored	O
sensitivity	O
(	O
essentially	O
100	O
%	O
)	O
over	O
specificity	O
.	O

However	O
,	O
the	O
number	O
of	O
false	O
positives	O
can	O
be	O
driven	O
lower	O
by	O
decreasing	O
the	O
cycles	O
of	O
selection	O
,	O
increasing	O
the	O
number	O
of	O
replicates	O
,	O
or	O
by	O
focusing	O
on	O
genes	O
with	O
relatively	O
high	O
z	O
-	O
scores	O
.	O

In	O
the	O
sections	O
that	O
follow	O
,	O
we	O
explore	O
the	O
manner	O
in	O
which	O
the	O
validated	O
newly	O
identified	O
genes	O
affect	O
motility	O
.	O

Identifying	O
Flagellar	O
Components	O
through	O
Bacteriophage	O
chi	O
Selection	O

As	O
a	O
complementary	O
approach	O
to	O
determining	O
the	O
components	O
necessary	O
for	O
a	O
functioning	O
flagellum	O
,	O
we	O
designed	O
a	O
simple	O
selection	O
to	O
identify	O
mutants	O
resistant	O
to	O
chi	B-Organism
-	O
phage	O
infection	O
.	O

Bacteriophage	O
chi	B-Organism
infects	O
E	B-Organism
.	I-Organism
coli	I-Organism
by	O
attaching	O
to	O
and	O
traveling	O
along	O
flagellar	O
filaments	O
[	O
24	O
]	O
.	O

CCW	O
flagellar	O
rotation	O
and	O
the	O
correct	O
pattern	O
of	O
grooves	O
on	O
the	O
surface	O
of	O
the	O
flagellum	O
are	O
thought	O
to	O
drive	O
chi	B-Organism
-	O
phage	O
down	O
the	O
filament	O
to	O
the	O
surface	O
of	O
the	O
membrane	O
,	O
very	O
similar	O
to	O
how	O
a	O
nut	O
follows	O
the	O
grooves	O
of	O
a	O
rotating	O
bolt	O
[	O
25	O
]	O
.	O

The	O
library	O
of	O
transposon	O
insertional	O
mutants	O
was	O
exposed	O
to	O
chi	B-Organism
-	O
phage	O
in	O
an	O
environment	O
conducive	O
to	O
motility	O
(	O
Figure	O
2A	O
)	O
.	O

Survival	O
of	O
a	O
mutant	O
meant	O
either	O
the	O
loss	O
of	O
its	O
flagella	O
,	O
the	O
loss	O
of	O
flagellar	O
CCW	O
rotation	O
,	O
or	O
the	O
loss	O
of	O
other	O
components	O
necessary	O
for	O
infection	O
.	O

In	O
a	O
sample	O
of	O
mutants	O
taken	O
after	O
selection	O
,	O
98	O
%	O
were	O
completely	O
nonmotile	O
(	O
Figure	O
S4	O
)	O
.	O

Figure	O
2B	O
shows	O
the	O
distribution	O
of	O
z	O
-	O
scores	O
after	O
library	O
selection	O
upon	O
exposure	O
to	O
bacteriophage	O
chi	B-Organism
,	O
and	O
the	O
complete	O
microarray	O
results	O
for	O
duplicate	O
selections	O
can	O
be	O
found	O
in	O
Datasets	O
S5	O
and	O
S6	O
.	O

As	O
expected	O
,	O
insertional	O
mutations	O
in	O
flagellar	O
genes	O
conferred	O
resistance	O
to	O
chi	B-Organism
-	O
phage	O
infection	O
.	O

In	O
contrast	O
,	O
while	O
mutants	O
of	O
the	O
chemotaxis	O
sensory	O
network	O
were	O
in	O
high	O
abundance	O
after	O
the	O
chemotaxis	O
selection	O
,	O
insertional	O
mutants	O
of	O
cheA	B-Protein
,	O
cheB	B-Protein
,	O
cheR	B-Protein
,	O
cheW	B-Protein
,	O
tap	B-Protein
,	O
tar	B-Protein
,	O
trg	B-Protein
,	O
and	O
tsr	B-Protein
were	O
in	O
low	O
abundance	O
after	O
exposure	O
to	O
chi	B-Organism
-	O
phage	O
.	O

This	O
is	O
to	O
be	O
expected	O
,	O
since	O
null	O
mutations	O
in	O
these	O
genes	O
do	O
not	O
entirely	O
abolish	O
CCW	O
flagellar	O
rotation	O
.	O

The	O
only	O
exception	O
among	O
the	O
che	O
genes	O
is	O
cheZ	B-Protein
,	O
whose	O
z	O
-	O
score	O
of	O
+	O
8	O
.	O
7	O
indicates	O
a	O
CW	O
flagellar	O
rotation	O
bias	O
and	O
reduced	O
susceptibility	O
to	O
chi	B-Organism
-	O
phage	O
infection	O
.	O

CheZ	B-Protein
is	O
a	O
phosphatase	O
of	O
CheY	B-Protein
,	O
the	O
protein	O
whose	O
phosphorylated	O
state	O
biases	O
the	O
flagella	O
toward	O
the	O
CW	O
direction	O
[	O
26	O
,	O
27	O
]	O
.	O

Therefore	O
,	O
in	O
the	O
absence	O
of	O
CheZ	B-Protein
,	O
CheY	B-Protein
is	O
maintained	O
in	O
the	O
phosphorylated	O
state	O
,	O
"	O
locking	O
"	O
flagellar	O
rotation	O
in	O
the	O
CW	O
direction	O
,	O
and	O
hence	O
minimizing	O
infection	O
by	O
chi	B-Organism
-	O
phage	O
.	O

In	O
addition	O
to	O
these	O
findings	O
,	O
the	O
selection	O
results	O
revealed	O
that	O
cellular	O
structures	O
other	O
than	O
the	O
flagella	O
may	O
be	O
required	O
for	O
infection	O
(	O
Table	O
S1	O
)	O
.	O

The	O
role	O
these	O
structures	O
play	O
in	O
chi	B-Organism
-	O
phage	O
infection	O
and	O
the	O
impact	O
they	O
have	O
on	O
motility	O
are	O
discussed	O
in	O
a	O
separate	O
section	O
below	O
.	O

Genetic	O
Basis	O
of	O
Swarming	O
Motility	O

Whereas	O
flagellar	O
-	O
mediated	O
swimming	O
is	O
among	O
the	O
best	O
-	O
understood	O
bacterial	O
behaviors	O
,	O
very	O
little	O
is	O
known	O
about	O
the	O
genetic	O
program	O
that	O
leads	O
to	O
the	O
development	O
of	O
swarming	O
.	O

Swarming	O
is	O
exhibited	O
by	O
many	O
flagellated	O
bacteria	O
,	O
and	O
is	O
defined	O
as	O
a	O
coordinated	O
multicellular	O
migration	O
across	O
a	O
solid	O
surface	O
by	O
morphologically	O
differentiated	O
cells	O
[	O
28	O
]	O
.	O

Confocal	O
fluorescence	O
microscopy	O
shows	O
swarming	O
cells	O
aligning	O
themselves	O
lengthwise	O
and	O
moving	O
coordinately	O
in	O
groups	O
,	O
forming	O
"	O
rafts	O
"	O
(	O
Movie	O
S1	O
)	O
.	O

In	O
this	O
context	O
,	O
the	O
cells	O
appear	O
to	O
execute	O
smooth	O
swimming	O
behavior	O
almost	O
exclusively	O
,	O
in	O
contrast	O
to	O
the	O
extensive	O
switching	O
back	O
and	O
forth	O
seen	O
during	O
chemotaxis	O
.	O

Aside	O
from	O
the	O
requirement	O
for	O
flagella	O
,	O
other	O
aspects	O
of	O
the	O
behavior	O
are	O
poorly	O
understood	O
.	O

Because	O
the	O
genetic	O
basis	O
of	O
swarming	O
is	O
not	O
well	O
characterized	O
,	O
this	O
behavior	O
is	O
well	O
suited	O
for	O
comprehensive	O
analysis	O
using	O
our	O
approach	O
.	O

In	O
order	O
to	O
explore	O
the	O
genetic	O
basis	O
of	O
swarming	O
,	O
we	O
expressed	O
this	O
phenotype	O
in	O
terms	O
of	O
a	O
quantitative	O
selection	O
,	O
much	O
as	O
was	O
done	O
for	O
swimming	O
motility	O
.	O

A	O
single	O
round	O
of	O
enrichment	O
consisted	O
of	O
inoculating	O
our	O
library	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
mutants	O
onto	O
the	O
center	O
of	O
agar	O
plates	O
,	O
incubating	O
the	O
plates	O
to	O
allow	O
the	O
cells	O
to	O
migrate	O
outward	O
from	O
the	O
site	O
of	O
inoculation	O
,	O
and	O
transferring	O
bacteria	O
from	O
the	O
original	O
area	O
of	O
inoculation	O
to	O
a	O
fresh	O
plate	O
.	O

After	O
twenty	O
rounds	O
of	O
daily	O
successive	O
transfers	O
(	O
Figure	O
3A	O
)	O
,	O
more	O
than	O
90	O
%	O
of	O
the	O
population	O
exhibited	O
a	O
defect	O
in	O
swarming	O
(	O
Figure	O
S5	O
)	O
.	O

The	O
enriched	O
mutants	O
were	O
then	O
subjected	O
to	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
.	O

As	O
expected	O
,	O
the	O
selection	O
results	O
were	O
dominated	O
by	O
flagellar	O
and	O
chemotaxis	O
genes	O
(	O
Figure	O
3B	O
)	O
.	O

While	O
mutants	O
with	O
a	O
defect	O
in	O
the	O
flagellar	O
apparatus	O
did	O
not	O
swarm	O
,	O
chemotaxis	O
mutants	O
formed	O
swarming	O
patterns	O
as	O
finger	O
-	O
like	O
projections	O
,	O
in	O
contrast	O
to	O
the	O
more	O
uniform	O
swarming	O
patterns	O
generated	O
by	O
the	O
wild	O
-	O
type	O
parent	O
strain	O
(	O
Figure	O
3C	O
)	O
.	O

These	O
observations	O
indicate	O
that	O
the	O
chemotaxis	O
sensory	O
system	O
and	O
flagellar	O
switching	O
have	O
an	O
effect	O
on	O
,	O
but	O
are	O
not	O
critical	O
for	O
,	O
surface	O
motility	O
.	O

Although	O
this	O
observation	O
contradicts	O
earlier	O
studies	O
on	O
swarming	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
and	O
S	B-Organism
.	I-Organism
enterica	I-Organism
[	O
29	O
]	O
,	O
more	O
recent	O
work	O
has	O
shown	O
that	O
chemotaxis	O
mutants	O
are	O
capable	O
of	O
surface	O
motility	O
when	O
the	O
surface	O
of	O
the	O
agar	O
is	O
sprayed	O
with	O
a	O
fine	O
mist	O
of	O
water	B-Chemical
[	O
30	O
]	O
,	O
or	O
when	O
the	O
agar	O
concentration	O
of	O
the	O
swarming	O
media	O
is	O
reduced	O
from	O
0	O
.	O
6	O
%	O
to	O
0	O
.	O
45	O
%	O
[	O
31	O
]	O
.	O

The	O
microarray	O
results	O
(	O
Datasets	O
S7	O
-	O
S10	O
)	O
guided	O
the	O
interrogation	O
of	O
additional	O
genes	O
that	O
may	O
have	O
a	O
role	O
in	O
swarming	O
.	O

In	O
addition	O
to	O
flagellar	O
genes	O
,	O
we	O
found	O
other	O
loci	O
that	O
also	O
contribute	O
to	O
swarming	O
motility	O
(	O
Table	O
S1	O
)	O
,	O
which	O
are	O
discussed	O
in	O
more	O
detail	O
below	O
.	O

Novel	O
Genes	O
Implicated	O
in	O
Swimming	O
,	O
Swarming	O
,	O
and	O
chi	O
-	O
Phage	O
Infection	O

Application	O
of	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
to	O
swimming	O
,	O
swarming	O
,	O
and	O
chi	B-Organism
-	O
phage	O
selection	O
was	O
effective	O
in	O
identifying	O
nearly	O
all	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
.	O

Remarkably	O
,	O
the	O
selection	O
results	O
guided	O
the	O
identification	O
of	O
three	O
dozen	O
additional	O
genes	O
that	O
affect	O
motility	O
,	O
most	O
of	O
which	O
have	O
no	O
previous	O
evidence	O
of	O
involvement	O
in	O
motility	O
(	O
Table	O
S1	O
)	O
.	O

Most	O
of	O
these	O
non	O
-	O
flagellar	O
genes	O
encode	O
components	O
of	O
the	O
cell	O
envelope	O
.	O

For	O
example	O
,	O
of	O
the	O
20	O
non	O
-	O
flagellar	O
genes	O
revealed	O
to	O
affect	O
swimming	O
motility	O
,	O
twelve	O
encode	O
constituents	O
of	O
the	O
inner	O
membrane	O
and	O
periplasmic	O
space	O
.	O

These	O
gene	O
products	O
include	O
transport	O
proteins	O
(	O
SdaC	B-Protein
,	O
TatA	B-Protein
,	O
TatB	B-Protein
,	O
TatC	B-Protein
,	O
and	O
WzxE	B-Protein
)	O
,	O
enzymes	O
(	O
DsbA	B-Protein
and	O
Prc	B-Protein
)	O
,	O
periplasmic	O
glucan	O
synthesis	O
proteins	O
(	O
MdoG	B-Protein
and	O
MdoH	B-Protein
)	O
,	O
members	O
of	O
a	O
signaling	O
pathway	O
(	O
RcsC	B-Protein
and	O
RcsD	B-Protein
)	O
,	O
and	O
a	O
predicted	O
inner	O
membrane	O
protein	O
of	O
unknown	O
function	O
(	O
YrfF	B-Protein
)	O
.	O

Of	O
these	O
,	O
only	O
the	O
genes	O
encoding	O
RcsD	B-Protein
and	O
glucan	O
synthesis	O
proteins	O
had	O
been	O
previously	O
implicated	O
in	O
swimming	O
motility	O
[	O
32	O
,	O
33	O
]	O
.	O

In	O
addition	O
,	O
we	O
identified	O
several	O
genes	O
that	O
encode	O
cytoplasmic	O
components	O
and	O
other	O
genes	O
of	O
unknown	O
function	O
,	O
including	O
fimE	B-Protein
,	O
hycG	B-Protein
,	O
intG	B-Protein
,	O
rep	B-Protein
,	O
ulaE	B-Protein
,	O
and	O
yhjH	B-Protein
.	O

We	O
systematically	O
tested	O
all	O
newly	O
identified	O
swimming	O
mutants	O
for	O
surface	O
motility	O
,	O
and	O
found	O
that	O
deletions	O
of	O
dsbA	B-Protein
,	O
intG	B-Protein
,	O
prc	B-Protein
,	O
rcsC	B-Protein
,	O
rep	B-Protein
,	O
tatB	B-Protein
,	O
tatC	B-Protein
,	O
wzxE	B-Protein
,	O
and	O
yrfF	B-Protein
strongly	O
impair	O
swarming	O
.	O

Surprisingly	O
,	O
while	O
mutants	O
with	O
deletions	O
of	O
rcsD	B-Protein
,	O
sdaC	B-Protein
,	O
tatA	B-Protein
,	O
and	O
yhjH	B-Protein
were	O
impaired	O
in	O
swimming	O
,	O
these	O
mutants	O
swarmed	O
normally	O
(	O
unpublished	O
data	O
)	O
.	O

Interrogation	O
of	O
genes	O
with	O
high	O
z	O
-	O
scores	O
in	O
the	O
enrichment	O
for	O
mutants	O
incapable	O
of	O
swarming	O
identified	O
two	O
additional	O
genes	O
that	O
impact	O
surface	O
motility	O
:	O
hns	B-Protein
,	O
encoding	O
a	O
global	O
transcriptional	O
regulator	O
,	O
and	O
yfiR	B-Protein
,	O
encoding	O
a	O
predicted	O
periplasmic	O
protein	O
of	O
unknown	O
function	O
.	O

In	O
-	O
frame	O
deletions	O
of	O
these	O
genes	O
abolished	O
swarming	O
;	O
however	O
,	O
while	O
the	O
Deltahns	B-Protein
mutant	O
showed	O
a	O
severe	O
swimming	O
defect	O
,	O
the	O
swimming	O
motility	O
of	O
the	O
DeltayfiR	B-Protein
mutant	O
was	O
only	O
mildly	O
impaired	O
(	O
Figures	O
3D	O
and	O
4	O
)	O
.	O

Among	O
the	O
loci	O
exhibiting	O
high	O
z	O
-	O
scores	O
after	O
chi	O
-	O
phage	O
selection	O
were	O
the	O
rfa	O
and	O
mdo	O
gene	O
clusters	O
responsible	O
for	O
the	O
structural	O
assembly	O
of	O
lipopolysaccharides	B-Chemical
(	O
LPS	B-Chemical
)	O
and	O
osmoregulated	B-Chemical
periplasmic	I-Chemical
glucans	I-Chemical
(	O
OPG	B-Chemical
)	O
.	O

Genes	O
involved	O
with	O
the	O
synthesis	O
of	O
LPS	B-Chemical
and	O
OPG	B-Chemical
precursors	O
(	O
hldD	B-Protein
,	O
hldE	B-Protein
,	O
galU	B-Protein
,	O
gmhA	B-Protein
,	O
gmhB	B-Protein
,	O
and	O
pgm	B-Protein
)	O
were	O
also	O
highly	O
abundant	O
after	O
chi	B-Organism
-	O
phage	O
selection	O
.	O

These	O
findings	O
suggested	O
that	O
mutations	O
in	O
LPS	B-Chemical
and	O
OPG	B-Chemical
biosynthetic	O
genes	O
may	O
compromise	O
motility	O
.	O

We	O
confirmed	O
this	O
expectation	O
by	O
creating	O
in	O
-	O
frame	O
deletions	O
of	O
nearly	O
all	O
genes	O
involved	O
in	O
LPS	B-Chemical
and	O
OPG	B-Chemical
biosynthesis	O
and	O
assaying	O
the	O
mutants	O
for	O
motility	O
.	O

OPG	B-Chemical
mutants	O
were	O
defective	O
in	O
both	O
swimming	O
and	O
swarming	O
;	O
surprisingly	O
,	O
however	O
,	O
only	O
mutants	O
with	O
large	O
LPS	B-Chemical
truncations	O
showed	O
significant	O
defects	O
in	O
these	O
behaviors	O
(	O
Figures	O
3E	O
and	O
4	O
)	O
.	O

The	O
wide	O
functional	O
repertoire	O
of	O
gene	O
products	O
found	O
to	O
affect	O
motility	O
prompted	O
us	O
to	O
examine	O
whether	O
genetic	O
perturbations	O
in	O
these	O
loci	O
affect	O
motility	O
by	O
signaling	O
upstream	O
of	O
the	O
regulatory	O
circuit	O
that	O
controls	O
flagellar	O
biogenesis	O
,	O
resulting	O
in	O
repression	O
of	O
the	O
flhDC	B-Protein
flagellar	O
master	O
operon	O
.	O

To	O
investigate	O
this	O
possibility	O
,	O
we	O
introduced	O
flhDC	B-Protein
-	O
lacZ	B-Protein
translational	O
fusions	O
in	O
the	O
deletion	O
strains	O
and	O
performed	O
beta	B-Protein
-	I-Protein
galactosidase	I-Protein
assays	O
.	O

Surprisingly	O
,	O
a	O
large	O
fraction	O
of	O
the	O
mutants	O
tested	O
showed	O
significant	O
reduction	O
in	O
flhDC	B-Protein
-	O
lacZ	B-Protein
expression	O
values	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
,	O
demonstrating	O
that	O
the	O
motility	O
defects	O
can	O
be	O
partly	O
attributed	O
to	O
reduced	O
expression	O
of	O
the	O
flhDC	B-Protein
operon	O
.	O

In	O
addition	O
,	O
we	O
noticed	O
that	O
LPS	B-Chemical
mutants	O
varied	O
widely	O
in	O
flhDC	B-Protein
expression	O
and	O
that	O
the	O
repression	O
of	O
this	O
operon	O
,	O
and	O
the	O
corresponding	O
motility	O
defect	O
,	O
were	O
related	O
to	O
the	O
degree	O
of	O
LPS	B-Chemical
truncation	O
(	O
Figure	O
4	O
)	O
.	O

LPS	B-Chemical
and	O
OPG	B-Chemical
Mutations	O
Impair	O
Motility	O
by	O
Repressing	O
Flagellar	O
Gene	O
Expression	O
through	O
the	O
Rcs	O
Signaling	O
Pathway	O

The	O
widespread	O
influence	O
of	O
LPS	B-Chemical
and	O
OPG	B-Chemical
mutations	O
on	O
swimming	O
,	O
swarming	O
,	O
and	O
chi	B-Organism
-	O
phage	O
infection	O
prompted	O
us	O
to	O
explore	O
the	O
genetic	O
mechanism	O
of	O
these	O
mutations	O
in	O
more	O
detail	O
.	O

Previous	O
evidence	O
links	O
LPS	B-Chemical
and	O
OPG	B-Chemical
mutations	O
to	O
the	O
activation	O
of	O
the	O
Rcs	O
phosphorelay	O
system	O
[	O
34	O
,	O
35	O
]	O
,	O
and	O
the	O
Rcs	O
system	O
is	O
known	O
to	O
negatively	O
regulate	O
the	O
flhDC	B-Protein
operon	O
[	O
36	O
]	O
.	O

The	O
Rcs	O
pathway	O
consists	O
of	O
a	O
phosphotransfer	O
protein	O
(	O
RcsD	B-Protein
)	O
that	O
mediates	O
phosphate	B-Chemical
transfer	O
from	O
a	O
sensor	O
kinase	O
(	O
RcsC	B-Protein
)	O
to	O
a	O
response	O
regulator	O
(	O
RcsB	B-Protein
)	O
that	O
binds	O
DNA	O
with	O
an	O
accessory	O
protein	O
(	O
RcsA	B-Protein
)	O
.	O

Phosphorylated	O
RcsB	B-Protein
is	O
known	O
to	O
bind	O
upstream	O
of	O
the	O
flhDC	B-Protein
operon	O
and	O
to	O
repress	O
its	O
expression	O
.	O

The	O
pathway	O
also	O
includes	O
a	O
recently	O
identified	O
outer	O
membrane	O
lipoprotein	O
(	O
RcsF	B-Protein
)	O
that	O
is	O
known	O
to	O
activate	O
the	O
Rcs	O
system	O
[	O
37	O
]	O
.	O

To	O
determine	O
the	O
role	O
of	O
the	O
Rcs	O
signaling	O
pathway	O
in	O
LPS	B-Chemical
/	O
OPG	B-Chemical
mediated	O
repression	O
of	O
motility	O
,	O
we	O
disrupted	O
each	O
of	O
the	O
components	O
of	O
the	O
Rcs	O
system	O
in	O
most	O
of	O
our	O
LPS	B-Chemical
and	O
OPG	B-Chemical
mutants	O
.	O

We	O
found	O
that	O
deletion	O
of	O
rcsB	B-Protein
,	O
rcsD	B-Protein
,	O
or	O
rcsF	B-Protein
was	O
sufficient	O
to	O
rescue	O
motility	O
in	O
both	O
LPS	B-Chemical
and	O
OPG	B-Chemical
mutants	O
(	O
Figure	O
S6	O
)	O
,	O
providing	O
strong	O
evidence	O
that	O
perturbations	O
in	O
these	O
structures	O
repress	O
motility	O
by	O
signaling	O
through	O
the	O
Rcs	O
pathway	O
.	O

Deletion	O
of	O
rcsC	B-Protein
rescued	O
motility	O
to	O
a	O
lesser	O
extent	O
.	O

This	O
observation	O
is	O
consistent	O
with	O
the	O
dual	O
functional	O
role	O
of	O
RcsC	B-Protein
as	O
both	O
kinase	O
and	O
phosphatase	O
,	O
moving	O
phosphates	B-Chemical
both	O
to	O
and	O
away	O
from	O
RcsB	B-Protein
via	O
RcsD	B-Protein
,	O
and	O
that	O
RcsB	B-Protein
remains	O
phosphorylated	O
in	O
rcsC	B-Protein
null	O
mutants	O
[	O
38	O
,	O
39	O
]	O
.	O

Therefore	O
,	O
while	O
rcsC	B-Protein
mutations	O
disrupt	O
the	O
RcsF	B-Protein
-	O
-	O
>	O
RcsC	B-Protein
-	O
-	O
>	O
RcsD	B-Protein
-	O
-	O
>	O
RcsB	B-Protein
phosphorelay	O
cascade	O
,	O
the	O
phosphorylation	O
of	O
RcsB	B-Protein
cannot	O
be	O
fully	O
reversed	O
in	O
the	O
absence	O
of	O
RcsC	B-Protein
phosphatase	O
activity	O
,	O
as	O
observed	O
by	O
the	O
reduced	O
flhDC	B-Protein
-	O
lacZ	B-Protein
expression	O
and	O
motility	O
exhibited	O
by	O
rcsC	B-Protein
and	O
rcsD	B-Protein
mutants	O
(	O
Figure	O
4	O
)	O
.	O

This	O
conclusion	O
is	O
further	O
supported	O
by	O
the	O
dramatic	O
reduction	O
in	O
swimming	O
motility	O
by	O
rcsC137	B-Protein
mutants	O
(	O
Figure	O
S7	O
)	O
,	O
in	O
which	O
the	O
rcsC137	B-Protein
gene	O
product	O
has	O
lost	O
its	O
phosphatase	O
activity	O
[	O
40	O
]	O
.	O

The	O
chi	O
-	O
phage	O
selection	O
results	O
suggest	O
that	O
LPS	B-Chemical
and	O
OPG	B-Chemical
are	O
necessary	O
for	O
infection	O
.	O

However	O
,	O
since	O
functional	O
flagella	O
are	O
a	O
prerequisite	O
for	O
chi	B-Organism
-	O
phage	O
infection	O
,	O
we	O
sought	O
to	O
determine	O
whether	O
defects	O
in	O
LPS	B-Chemical
and	O
OPG	B-Chemical
affect	O
chi	B-Organism
-	O
phage	O
infection	O
directly	O
or	O
whether	O
the	O
observed	O
selection	O
results	O
are	O
primarily	O
due	O
to	O
reduced	O
flagellar	O
expression	O
.	O

To	O
evaluate	O
the	O
necessity	O
of	O
LPS	B-Chemical
and	O
OPG	B-Chemical
for	O
phage	O
infection	O
,	O
we	O
needed	O
mutants	O
that	O
were	O
defective	O
in	O
these	O
structures	O
but	O
still	O
synthesized	O
functional	O
flagella	O
and	O
were	O
motile	O
.	O

Therefore	O
,	O
we	O
created	O
double	O
mutants	O
combining	O
an	O
LPS	B-Chemical
or	O
OPG	B-Chemical
mutation	O
and	O
a	O
secondary	O
mutation	O
in	O
one	O
of	O
the	O
components	O
of	O
the	O
Rcs	O
signaling	O
pathway	O
.	O

These	O
mutants	O
were	O
used	O
in	O
an	O
infectivity	O
assay	O
in	O
which	O
plaque	O
-	O
forming	O
units	O
(	O
PFUs	O
)	O
are	O
monitored	O
over	O
time	O
to	O
assess	O
sensitivity	O
to	O
phage	O
infection	O
[	O
25	O
]	O
.	O

An	O
flhD	B-Protein
mutant	O
was	O
used	O
as	O
a	O
chi	B-Organism
-	O
phage	O
-	O
resistant	O
control	O
and	O
,	O
as	O
expected	O
,	O
showed	O
no	O
sensitivity	O
,	O
whereas	O
chi	B-Organism
-	O
phage	O
multiplied	O
rapidly	O
in	O
the	O
presence	O
of	O
the	O
wild	O
-	O
type	O
strain	O
(	O
Figure	O
5A	O
)	O
.	O

Both	O
OPG	B-Chemical
and	O
LPS	B-Chemical
mutants	O
showed	O
decreased	O
sensitivity	O
to	O
chi	B-Organism
-	O
phage	O
,	O
and	O
the	O
decrease	O
in	O
sensitivity	O
was	O
eliminated	O
by	O
introducing	O
DeltarcsF	B-Protein
deletions	O
,	O
indicating	O
that	O
OPG	B-Chemical
and	O
LPS	B-Chemical
are	O
not	O
directly	O
required	O
for	O
chi	B-Organism
-	O
phage	O
infection	O
(	O
Figures	O
5B	O
-	O
D	O
)	O
.	O

We	O
also	O
observed	O
that	O
sensitivity	O
to	O
chi	B-Organism
-	O
phage	O
was	O
higher	O
in	O
rfaI	B-Protein
mutants	O
than	O
rfaC	B-Protein
mutants	O
,	O
indicating	O
that	O
chi	B-Organism
-	O
phage	O
infectivity	O
is	O
directly	O
related	O
to	O
the	O
degree	O
of	O
flhDC	B-Protein
expression	O
(	O
Figures	O
4	O
,	O
5B	O
,	O
and	O
5C	O
)	O
.	O

In	O
a	O
previous	O
study	O
,	O
the	O
swarming	O
deficiency	O
of	O
LPS	O
mutants	O
had	O
suggested	O
an	O
essential	O
role	O
for	O
LPS	O
in	O
swarming	O
behavior	O
[	O
41	O
]	O
.	O

To	O
test	O
whether	O
such	O
a	O
direct	O
role	O
exists	O
,	O
we	O
interrogated	O
our	O
collection	O
of	O
LPS	B-Chemical
and	O
OPG	B-Chemical
mutants	O
for	O
swarming	O
proficiency	O
.	O

We	O
found	O
that	O
mutants	O
with	O
OPG	B-Chemical
defects	O
and	O
severe	O
LPS	B-Chemical
truncations	O
were	O
incapable	O
of	O
swarming	O
and	O
that	O
introducing	O
DeltarcsF	B-Protein
deletions	O
into	O
these	O
mutants	O
was	O
sufficient	O
to	O
rescue	O
the	O
phenotype	O
(	O
Figures	O
3F	O
and	O
S6	O
)	O
.	O

These	O
data	O
indicate	O
that	O
LPS	B-Chemical
and	O
OPG	B-Chemical
are	O
not	O
directly	O
necessary	O
for	O
swarming	O
,	O
and	O
that	O
the	O
behavior	O
exhibited	O
by	O
such	O
mutants	O
results	O
from	O
Rcs	O
-	O
mediated	O
repression	O
of	O
the	O
flhDC	B-Protein
operon	O
.	O

A	O
model	O
summarizing	O
the	O
involvement	O
of	O
Rcs	O
signaling	O
on	O
swimming	O
,	O
swarming	O
,	O
and	O
chi	B-Organism
-	O
phage	O
infection	O
is	O
shown	O
in	O
Figure	O
3G	O
.	O

yhjH	B-Protein
Affects	O
Flagellar	O
Motor	O
Bias	O

Mutations	O
in	O
yhjH	B-Protein
were	O
recently	O
found	O
to	O
impair	O
swimming	O
motility	O
[	O
42	O
]	O
.	O

Consistent	O
with	O
this	O
,	O
we	O
found	O
that	O
insertions	O
in	O
yhjH	B-Protein
exhibit	O
a	O
high	O
average	O
z	O
-	O
score	O
of	O
+	O
277	O
in	O
our	O
enrichment	O
for	O
nonmotile	O
mutants	O
.	O

Surprisingly	O
,	O
this	O
gene	O
showed	O
a	O
negative	O
z	O
-	O
score	O
of	O
-	O
8	O
after	O
bacteriophage	O
chi	O
selection	O
,	O
indicating	O
that	O
this	O
mutant	O
is	O
impaired	O
in	O
swimming	O
motility	O
but	O
may	O
show	O
increased	O
susceptibility	O
to	O
chi	B-Organism
-	O
phage	O
infection	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
.	O

Based	O
on	O
these	O
observations	O
,	O
we	O
hypothesized	O
that	O
this	O
mutant	O
has	O
flagella	O
with	O
an	O
extreme	O
CCW	O
rotation	O
bias	O
,	O
a	O
phenotype	O
also	O
exhibited	O
,	O
to	O
varying	O
degrees	O
,	O
by	O
cheA	B-Protein
,	O
cheR	B-Protein
,	O
and	O
cheW	B-Protein
mutants	O
[	O
43	O
]	O
.	O

To	O
further	O
characterize	O
the	O
effect	O
of	O
this	O
mutation	O
on	O
motility	O
,	O
an	O
in	O
-	O
frame	O
deletion	O
of	O
yhjH	B-Protein
was	O
constructed	O
.	O

Electron	O
microscopy	O
of	O
DeltayhjH	B-Protein
mutants	O
showed	O
the	O
appearance	O
of	O
flagella	O
,	O
and	O
light	O
microscopy	O
showed	O
vigorous	O
cellular	O
movement	O
(	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
the	O
flagella	O
are	O
capable	O
of	O
rotating	O
;	O
still	O
,	O
this	O
mutant	O
exhibited	O
severe	O
impairment	O
in	O
swimming	O
(	O
Figure	O
1C	O
)	O
.	O

To	O
determine	O
whether	O
the	O
absence	O
of	O
yhjH	B-Protein
alters	O
the	O
direction	O
of	O
flagellar	O
rotation	O
,	O
several	O
functional	O
studies	O
were	O
performed	O
.	O

First	O
,	O
chi	B-Organism
-	O
phage	O
infectivity	O
assays	O
with	O
DeltayhjH	B-Protein
mutants	O
showed	O
comparable	O
levels	O
of	O
infection	O
to	O
cheR	B-Protein
mutants	O
(	O
which	O
exhibit	O
CCW	O
flagellar	O
rotation	O
bias	O
)	O
in	O
contrast	O
to	O
the	O
reduced	O
sensitivity	O
displayed	O
by	O
cheZ	B-Protein
mutants	O
(	O
which	O
have	O
CW	O
flagellar	O
rotation	O
bias	O
)	O
,	O
consistent	O
with	O
the	O
z	O
-	O
scores	O
of	O
our	O
chi	O
-	O
phage	O
selection	O
(	O
Figure	O
5E	O
)	O
.	O

Second	O
,	O
while	O
DeltayhjH	B-Protein
mutants	O
are	O
impaired	O
in	O
swimming	O
motility	O
,	O
they	O
did	O
not	O
show	O
a	O
measurable	O
defect	O
in	O
swarming	O
(	O
Figure	O
6A	O
)	O
,	O
which	O
is	O
in	O
agreement	O
with	O
our	O
finding	O
that	O
flagellar	O
motor	O
switching	O
is	O
not	O
critical	O
for	O
swarming	O
.	O

In	O
a	O
final	O
functional	O
test	O
,	O
individual	O
cells	O
of	O
four	O
different	O
strains	O
-	O
wild	O
-	O
type	O
cells	O
and	O
mutants	O
with	O
yhjH	B-Protein
,	O
cheR	B-Protein
,	O
and	O
cheZ	B-Protein
deletions	O
-	O
were	O
tethered	O
to	O
a	O
microscope	O
slide	O
and	O
the	O
frequency	O
of	O
flagellar	O
rotation	O
switching	O
was	O
measured	O
using	O
computer	O
tracking	O
software	O
in	O
a	O
fashion	O
similar	O
to	O
Block	O
et	O
al	O
.	O

[	O
44	O
]	O
.	O

These	O
measurements	O
revealed	O
that	O
indeed	O
the	O
flagella	O
of	O
DeltayhjH	B-Protein
mutants	O
,	O
while	O
not	O
strictly	O
locked	O
in	O
one	O
direction	O
of	O
rotation	O
,	O
exhibit	O
a	O
strong	O
CCW	O
bias	O
with	O
a	O
rotational	O
switching	O
frequency	O
intermediate	O
between	O
that	O
found	O
in	O
wild	O
-	O
type	O
cells	O
and	O
in	O
DeltacheR	B-Protein
mutants	O
(	O
Figure	O
6B	O
)	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
chi	B-Organism
-	O
phage	O
selection	O
results	O
.	O

Tether	O
assays	O
with	O
DeltayhjH	B-Protein
DeltacheZ	B-Protein
double	O
mutants	O
showed	O
flagellar	O
rotation	O
indistinguishable	O
from	O
cheZ	B-Protein
single	O
mutants	O
(	O
unpublished	O
data	O
)	O
,	O
indicating	O
that	O
null	O
mutations	O
in	O
cheZ	B-Protein
are	O
epistatic	O
to	O
null	O
mutations	O
in	O
yhjH	B-Protein
.	O

Together	O
,	O
these	O
results	O
indicate	O
that	O
the	O
yhjH	B-Protein
gene	O
product	O
is	O
involved	O
with	O
the	O
frequency	O
of	O
flagellar	O
motor	O
switching	O
,	O
a	O
process	O
that	O
is	O
among	O
the	O
remaining	O
puzzles	O
in	O
bacterial	O
chemotaxis	O
[	O
45	O
]	O
.	O

Genome	O
-	O
Wide	O
Identification	O
of	O
Genetic	O
Interactions	O

The	O
identification	O
of	O
novel	O
genes	O
that	O
influence	O
the	O
expression	O
of	O
a	O
phenotype	O
is	O
only	O
the	O
first	O
step	O
towards	O
understanding	O
its	O
genetic	O
basis	O
.	O

Gene	O
products	O
function	O
within	O
the	O
context	O
of	O
highly	O
interconnected	O
structural	O
and	O
regulatory	O
networks	O
.	O

We	O
can	O
dissect	O
the	O
genetic	O
network	O
context	O
in	O
which	O
newly	O
identified	O
genes	O
function	O
by	O
making	O
libraries	O
of	O
double	O
mutants	O
in	O
which	O
a	O
transposon	O
library	O
is	O
constructed	O
in	O
the	O
background	O
of	O
a	O
mutation	O
of	O
interest	O
.	O

The	O
phenotypic	O
characterization	O
of	O
this	O
library	O
by	O
a	O
screen	O
or	O
selection	O
can	O
identify	O
genetic	O
interactions	O
between	O
the	O
query	O
mutation	O
and	O
all	O
possible	O
insertional	O
mutations	O
in	O
the	O
genome	O
,	O
thereby	O
revealing	O
the	O
local	O
genetic	O
context	O
in	O
which	O
the	O
query	O
locus	O
functions	O
to	O
influence	O
the	O
phenotype	O
.	O

Systematic	O
analyses	O
of	O
such	O
interactions	O
in	O
yeast	B-Organism
[	O
46	O
,	O
47	O
]	O
are	O
providing	O
a	O
wealth	O
of	O
knowledge	O
about	O
gene	O
function	O
and	O
pathway	O
organization	O
.	O

An	O
important	O
class	O
of	O
such	O
interactions	O
is	O
suppressor	O
mutations	O
that	O
either	O
partially	O
or	O
fully	O
restore	O
the	O
phenotype	O
deficits	O
of	O
a	O
query	O
mutation	O
.	O

In	O
a	O
genome	O
-	O
wide	O
effort	O
to	O
identify	O
suppressors	O
of	O
swimming	O
defects	O
,	O
additional	O
libraries	O
of	O
transposon	O
insertional	O
mutants	O
were	O
created	O
in	O
genetic	O
backgrounds	O
containing	O
gene	O
deletions	O
of	O
interest	O
.	O

Secondary	O
insertional	O
mutations	O
were	O
observed	O
to	O
suppress	O
motility	O
defects	O
in	O
Deltahns	B-Protein
and	O
DeltayhjH	B-Protein
genetic	O
backgrounds	O
(	O
Figures	O
6C	O
and	O
S8A	O
)	O
.	O

These	O
suppressor	O
mutations	O
were	O
identified	O
by	O
inoculating	O
soft	O
-	O
agar	O
plates	O
with	O
approximately108	O
double	O
mutants	O
and	O
extracting	O
cells	O
from	O
the	O
motile	O
front	O
after	O
approximately20	O
h	O
of	O
incubation	O
at	O
30	O
degreesC	O
.	O

A	O
sample	O
of	O
suppressor	O
mutants	O
extracted	O
from	O
the	O
extreme	O
edge	O
of	O
the	O
motile	O
front	O
was	O
used	O
for	O
both	O
microarray	O
-	O
based	O
genetic	O
footprinting	O
,	O
and	O
for	O
isolation	O
of	O
individual	O
mutants	O
for	O
subsequent	O
characterization	O
.	O

Transposon	O
insertion	O
sites	O
were	O
identified	O
in	O
individual	O
clones	O
by	O
applying	O
the	O
genetic	O
footprinting	O
procedure	O
outlined	O
in	O
Figure	O
S1	O
.	O

Among	O
the	O
18	O
suppressor	O
mutants	O
sampled	O
at	O
random	O
from	O
the	O
DeltayhjH	B-Protein
background	O
,	O
half	O
had	O
insertions	O
in	O
different	O
regions	O
of	O
ycgR	B-Protein
,	O
a	O
gene	O
encoding	O
a	O
protein	O
of	O
unknown	O
function	O
(	O
Figure	O
6D	O
)	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
a	O
recent	O
report	O
in	O
which	O
the	O
inactivation	O
of	O
ycgR	B-Protein
was	O
observed	O
to	O
improve	O
motility	O
of	O
yhjH	B-Protein
mutants	O
[	O
48	O
]	O
.	O

The	O
other	O
half	O
of	O
DeltayhjH	B-Protein
suppressor	O
mutations	O
were	O
found	O
to	O
contain	O
insertions	O
within	O
the	O
intergenic	O
region	O
between	O
the	O
divergently	O
transcribed	O
genes	O
yfgF	B-Protein
and	O
yfgG	B-Protein
,	O
which	O
encode	O
gene	O
products	O
of	O
unknown	O
function	O
.	O

P1	O
transduction	O
of	O
this	O
insertion	O
to	O
the	O
DeltayhjH	B-Protein
isogenic	O
background	O
confirmed	O
the	O
ability	O
of	O
the	O
insertion	O
to	O
suppress	O
the	O
motility	O
defect	O
(	O
unpublished	O
data	O
)	O
.	O

However	O
,	O
deletions	O
of	O
either	O
yfgF	B-Protein
or	O
yfgG	B-Protein
produced	O
no	O
measurable	O
difference	O
in	O
motility	O
in	O
the	O
DeltayhjH	B-Protein
background	O
(	O
Figure	O
S9	O
)	O
.	O

Conversely	O
,	O
overexpression	O
of	O
yfgF	B-Protein
(	O
but	O
not	O
yfgG	B-Protein
)	O
was	O
found	O
to	O
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	B-Protein
mutants	O
(	O
Figure	O
6E	O
)	O
.	O

Microarray	O
-	O
based	O
genetic	O
footprinting	O
of	O
the	O
entire	O
pool	O
of	O
mutants	O
extracted	O
from	O
the	O
motile	O
front	O
guided	O
the	O
identification	O
of	O
five	O
additional	O
suppressor	O
mutations	O
(	O
Figure	O
6F	O
;	O
Dataset	O
S11	O
)	O
.	O

Among	O
the	O
loci	O
that	O
partially	O
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	B-Protein
are	O
fliZ	B-Protein
(	O
a	O
gene	O
predicted	O
to	O
be	O
a	O
regulator	O
of	O
the	O
flagellum	O
-	O
specific	O
sigma	O
factor	O
sigma28	B-Protein
)	O
,	O
yfiR	B-Protein
(	O
a	O
gene	O
identified	O
in	O
the	O
selection	O
for	O
swarming	O
motility	O
defective	O
mutants	O
)	O
,	O
and	O
three	O
additional	O
genes	O
of	O
unknown	O
function	O
:	O
yjdA	B-Protein
,	O
yjcZ	B-Protein
,	O
and	O
yegE	B-Protein
.	O

We	O
hypothesize	O
that	O
mutations	O
partially	O
suppressing	O
the	O
chemotaxis	O
defect	O
of	O
DeltayhjH	B-Protein
mutants	O
do	O
so	O
by	O
correcting	O
the	O
severe	O
CCW	O
flagellar	O
rotation	O
bias	O
.	O

When	O
combined	O
in	O
the	O
same	O
background	O
,	O
these	O
mutations	O
may	O
bring	O
the	O
motor	O
bias	O
closer	O
to	O
the	O
optimal	O
operating	O
point	O
for	O
chemotaxis	O
,	O
either	O
by	O
having	O
an	O
opposing	O
effect	O
on	O
the	O
intracellular	O
concentration	O
of	O
signaling	O
molecules	O
known	O
to	O
affect	O
motility	O
(	O
discussed	O
in	O
the	O
next	O
section	O
)	O
or	O
by	O
an	O
unknown	O
mechanism	O
that	O
overrides	O
the	O
CCW	O
bias	O
.	O

Further	O
studies	O
are	O
underway	O
to	O
explore	O
the	O
functional	O
relationship	O
between	O
yhjH	B-Protein
and	O
these	O
suppressor	O
mutations	O
.	O

The	O
mechanisms	O
by	O
which	O
deletion	O
of	O
yegE	B-Protein
and	O
overexpression	O
of	O
yfgF	B-Protein
suppress	O
the	O
motility	O
defect	O
of	O
DeltayhjH	B-Protein
mutants	O
are	O
discussed	O
in	O
the	O
next	O
section	O
.	O

Suppressor	O
mutations	O
identified	O
in	O
the	O
Deltahns	B-Protein
background	O
are	O
shown	O
and	O
discussed	O
in	O
Figure	O
S8	O
,	O
and	O
the	O
microarray	O
results	O
can	O
be	O
found	O
in	O
Dataset	O
S12	O
.	O

The	O
Role	O
of	O
the	O
C	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
Second	O
-	O
Messenger	O
System	O
in	O
Swimming	O
and	O
Swarming	O
Motility	O

Based	O
on	O
sequence	O
homology	O
,	O
YhjH	B-Protein
,	O
YfgF	B-Protein
,	O
and	O
YegE	B-Protein
belong	O
to	O
the	O
newly	O
identified	O
and	O
highly	O
prevalent	O
family	O
of	O
proteins	O
that	O
function	O
in	O
the	O
turnover	O
of	O
bis	B-Chemical
-	I-Chemical
(	I-Chemical
3	I-Chemical
'	I-Chemical
-	I-Chemical
5	I-Chemical
'	I-Chemical
)	I-Chemical
-	I-Chemical
cyclic	I-Chemical
dimeric	I-Chemical
guanosine	I-Chemical
monophosphate	I-Chemical
(	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
)	O
,	O
which	O
is	O
a	O
second	O
messenger	O
involved	O
in	O
the	O
regulation	O
of	O
a	O
wide	O
variety	O
of	O
bacterial	O
behaviors	O
[	O
49	O
]	O
.	O

Synthesis	O
of	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
is	O
catalyzed	O
by	O
diguanylate	O
cyclases	O
(	O
DGC	O
)	O
and	O
its	O
degradation	O
is	O
regulated	O
by	O
phosphodiesterases	O
(	O
PDE	O
)	O
.	O

The	O
cyclase	O
and	O
phosphodiesterase	O
activities	O
have	O
been	O
attributed	O
to	O
GGDEF	B-Protein
and	O
EAL	B-Protein
protein	O
domains	O
,	O
respectively	O
[	O
50	O
,	O
51	O
]	O
,	O
and	O
the	O
activity	O
of	O
these	O
domains	O
is	O
known	O
to	O
have	O
opposite	O
effects	O
on	O
motility	O
[	O
52	O
]	O
.	O

YhjH	B-Protein
contains	O
an	O
EAL	B-Protein
domain	O
,	O
and	O
expression	O
of	O
this	O
protein	O
leads	O
to	O
the	O
degradation	O
of	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
and	O
enhanced	O
motility	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
[	O
52	O
]	O
.	O

Based	O
on	O
this	O
observation	O
and	O
because	O
EAL	B-Protein
domain	O
proteins	O
function	O
in	O
the	O
degradation	O
of	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
,	O
we	O
hypothesized	O
that	O
the	O
motility	O
defect	O
of	O
DeltayhjH	B-Protein
(	O
Figure	O
1C	O
)	O
is	O
a	O
result	O
of	O
increased	O
intracellular	O
levels	O
of	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
.	O

YegE	B-Protein
and	O
YfgF	B-Protein
both	O
contain	O
an	O
EAL	B-Protein
domain	O
C	O
-	O
terminal	O
to	O
a	O
GGDEF	B-Protein
domain	O
(	O
Figure	O
6G	O
)	O
.	O

The	O
presence	O
of	O
domains	O
of	O
opposing	O
activities	O
in	O
a	O
single	O
protein	O
complicates	O
functional	O
inferences	O
.	O

However	O
,	O
a	O
single	O
GGDEF	B-Protein
/	O
EAL	B-Protein
composite	O
protein	O
exhibiting	O
concomitant	O
DGC	O
and	O
PDE	O
activities	O
has	O
not	O
been	O
reported	O
.	O

In	O
addition	O
,	O
several	O
GGDEF	B-Protein
/	O
EAL	B-Protein
composite	O
proteins	O
were	O
found	O
to	O
exhibit	O
either	O
DGC	O
or	O
PDE	O
activity	O
[	O
53	O
,	O
54	O
]	O
.	O

Based	O
on	O
the	O
known	O
antagonistic	O
effects	O
of	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
on	O
motility	O
[	O
52	O
]	O
and	O
by	O
following	O
several	O
lines	O
of	O
reasoning	O
,	O
we	O
hypothesized	O
the	O
dominant	O
enzymatic	O
activities	O
of	O
the	O
GGDEF	B-Protein
and	O
EAL	B-Protein
domains	O
in	O
YfgF	B-Protein
and	O
YegE	B-Protein
.	O

We	O
argue	O
that	O
YfgF	B-Protein
has	O
an	O
active	O
EAL	B-Protein
domain	O
and	O
functions	O
as	O
a	O
PDE	O
based	O
on	O
three	O
observations	O
:	O
(	O
1	O
)	O
expression	O
of	O
this	O
gene	O
enhances	O
motility	O
of	O
the	O
DeltayhjH	B-Protein
strain	O
(	O
Figure	O
6E	O
)	O
;	O
(	O
2	O
)	O
the	O
amino	O
acid	O
sequence	O
of	O
YfgF	B-Protein
shows	O
similarity	O
to	O
enzymatically	O
active	O
EAL	B-Protein
domains	O
(	O
Figure	O
S10	O
)	O
;	O
and	O
(	O
3	O
)	O
the	O
amino	O
acid	O
sequence	O
lacks	O
a	O
complete	O
GGDEF	B-Protein
motif	O
needed	O
for	O
DGC	O
activity	O
(	O
data	O
not	O
shown	O
)	O
.	O

Likewise	O
,	O
three	O
observations	O
suggest	O
that	O
the	O
EAL	B-Protein
domain	O
in	O
YegE	B-Protein
is	O
inactive	O
and	O
that	O
this	O
protein	O
functions	O
primarily	O
as	O
a	O
DGC	O
:	O
(	O
1	O
)	O
deletion	O
of	O
YegE	B-Protein
enhances	O
motility	O
of	O
the	O
DeltayhjH	B-Protein
strain	O
(	O
Figure	O
6F	O
)	O
;	O
(	O
2	O
)	O
the	O
amino	O
acid	O
sequence	O
of	O
the	O
EAL	B-Protein
domain	O
in	O
YegE	B-Protein
is	O
not	O
consistent	O
with	O
an	O
enzymatically	O
active	O
form	O
(	O
Figure	O
S10	O
)	O
;	O
and	O
(	O
3	O
)	O
YegE	B-Protein
contains	O
an	O
intact	O
GGDEF	B-Protein
motif	O
(	O
data	O
not	O
shown	O
)	O
.	O

Based	O
on	O
these	O
observations	O
,	O
we	O
propose	O
that	O
deleting	O
yegE	B-Protein
and	O
over	O
-	O
expressing	O
yfgF	B-Protein
suppress	O
the	O
motility	O
defect	O
of	O
the	O
DeltayhjH	B-Protein
strain	O
by	O
reducing	O
the	O
intracellular	O
levels	O
of	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
(	O
Figure	O
7	O
)	O
.	O

Deletion	O
of	O
yegE	B-Protein
and	O
over	O
-	O
expression	O
of	O
yfgF	B-Protein
did	O
not	O
have	O
significant	O
effects	O
on	O
the	O
motility	O
of	O
the	O
wild	O
-	O
type	O
strain	O
(	O
unpublished	O
data	O
)	O
.	O

E	B-Organism
.	I-Organism
coli	I-Organism
has	O
19	O
genes	O
encoding	O
proteins	O
with	O
GGDEF	B-Protein
domains	O
[	O
55	O
]	O
.	O

If	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
levels	O
act	O
globally	O
and	O
can	O
influence	O
motility	O
,	O
then	O
insertions	O
in	O
many	O
of	O
the	O
genes	O
containing	O
active	O
GGDEF	B-Protein
domains	O
should	O
rescue	O
motility	O
in	O
the	O
DeltayhjH	B-Protein
double	O
mutant	O
library	O
.	O

However	O
,	O
the	O
results	O
of	O
the	O
genome	O
-	O
wide	O
screen	O
for	O
suppressors	O
of	O
the	O
DeltayhjH	B-Protein
motility	O
defect	O
reveals	O
that	O
this	O
is	O
not	O
the	O
case	O
(	O
Table	O
S2	O
)	O
.	O

These	O
observations	O
suggest	O
that	O
the	O
expression	O
and	O
/	O
or	O
enzymatic	O
activities	O
of	O
these	O
GGDEF	B-Protein
-	O
containing	O
proteins	O
may	O
be	O
under	O
precise	O
context	O
-	O
dependent	O
control	O
.	O

Alternatively	O
,	O
specificity	O
in	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
signaling	O
may	O
be	O
due	O
to	O
a	O
number	O
of	O
mechanisms	O
including	O
spatial	O
and	O
temporal	O
sequestration	O
,	O
microcompartmentalization	O
,	O
restricted	O
production	O
/	O
degradation	O
,	O
or	O
target	O
modification	O
[	O
56	O
]	O
.	O

The	O
manner	O
in	O
which	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
alters	O
motility	O
at	O
the	O
molecular	O
level	O
is	O
currently	O
unknown	O
.	O

However	O
,	O
it	O
has	O
been	O
reported	O
that	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
binds	O
to	O
the	O
PilZ	B-Protein
domain	O
of	O
the	O
aforementioned	O
YcgR	B-Protein
protein	O
[	O
48	O
]	O
.	O

It	O
is	O
hypothesized	O
that	O
YcgR	B-Protein
undergoes	O
a	O
conformational	O
change	O
upon	O
binding	O
to	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
,	O
and	O
that	O
the	O
YcgR	B-Protein
-	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
complex	O
impairs	O
motility	O
through	O
a	O
protein	O
-	O
protein	O
interaction	O
with	O
the	O
flagellar	O
motor	O
[	O
57	O
]	O
.	O

Such	O
an	O
interaction	O
may	O
explain	O
the	O
observed	O
rotational	O
bias	O
of	O
flagella	O
in	O
DeltayhjH	B-Protein
mutants	O
(	O
Figure	O
6B	O
)	O
and	O
is	O
in	O
agreement	O
with	O
our	O
finding	O
that	O
mutations	O
in	O
ycgR	B-Protein
strongly	O
suppress	O
the	O
motility	O
defects	O
of	O
DeltayhjH	B-Protein
mutants	O
(	O
Figure	O
6F	O
)	O
.	O

In	O
addition	O
to	O
its	O
effects	O
on	O
swimming	O
,	O
we	O
found	O
evidence	O
that	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
signaling	O
also	O
plays	O
a	O
role	O
in	O
swarming	O
motility	O
.	O

As	O
stated	O
previously	O
,	O
mutations	O
in	O
yfiR	B-Protein
strongly	O
abolish	O
swarming	O
motility	O
.	O

The	O
yfiR	B-Protein
gene	O
is	O
the	O
first	O
in	O
an	O
operon	O
that	O
also	O
contains	O
yfiN	B-Protein
and	O
yfiB	B-Protein
(	O
inset	O
of	O
Figure	O
7	O
)	O
.	O

The	O
arrangement	O
of	O
these	O
genes	O
in	O
an	O
operon	O
suggests	O
that	O
they	O
may	O
function	O
together	O
.	O

YfiR	B-Protein
is	O
predicted	O
to	O
be	O
a	O
periplasmic	O
protein	O
,	O
YfiB	B-Protein
shows	O
sequence	O
similarity	O
to	O
outer	O
-	O
membrane	O
porin	O
proteins	O
,	O
and	O
YfiN	B-Protein
is	O
a	O
predicted	O
inner	O
-	O
membrane	O
protein	O
with	O
GGDEF	B-Protein
and	O
HAMP	B-Protein
domains	O
.	O

We	O
found	O
that	O
deletion	O
of	O
yfiN	B-Protein
strongly	O
suppresses	O
the	O
swarming	O
defect	O
of	O
the	O
DeltayfiR	B-Protein
strain	O
,	O
indicating	O
that	O
yfiR	B-Protein
is	O
genetically	O
upstream	O
of	O
yfiN	B-Protein
,	O
and	O
that	O
YfiR	B-Protein
may	O
regulate	O
the	O
DGC	O
activity	O
of	O
YfiN	B-Protein
'	O
s	O
GGDEF	B-Protein
output	O
domain	O
by	O
interacting	O
with	O
the	O
HAMP	B-Protein
sensory	O
input	O
domain	O
(	O
Figure	O
7	O
)	O
.	O

Mutations	O
in	O
ycgR	B-Protein
were	O
also	O
found	O
to	O
suppress	O
the	O
swarming	O
defect	O
of	O
the	O
DeltayfiR	B-Protein
strain	O
(	O
unpublished	O
data	O
)	O
,	O
suggesting	O
that	O
YcgR	B-Protein
binds	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
to	O
affect	O
both	O
swimming	O
and	O
swarming	O
motility	O
.	O

The	O
observations	O
that	O
the	O
DeltayhjH	B-Protein
mutant	O
is	O
impaired	O
in	O
swimming	O
but	O
indistinguishable	O
from	O
the	O
wild	O
-	O
type	O
strain	O
in	O
swarming	O
,	O
while	O
in	O
contrast	O
the	O
DeltayfiR	B-Protein
strain	O
cannot	O
swarm	O
and	O
is	O
only	O
mildly	O
impaired	O
in	O
swimming	O
,	O
support	O
the	O
notion	O
that	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
signaling	O
pathways	O
are	O
temporally	O
and	O
/	O
or	O
spatially	O
separated	O
,	O
as	O
recently	O
suggested	O
by	O
others	O
[	O
58	O
,	O
59	O
]	O
.	O

Involvement	O
of	O
Type	O
1	O
Fimbriae	O
in	O
Swimming	O
Motility	O

The	O
abundance	O
of	O
fimE	B-Protein
and	O
fimB	B-Protein
mutants	O
in	O
the	O
enrichment	O
for	O
nonmotile	O
mutants	O
suggested	O
a	O
role	O
for	O
type	O
1	O
fimbriae	O
in	O
swimming	O
motility	O
.	O

These	O
genes	O
encode	O
site	O
-	O
specific	O
recombinases	O
that	O
catalyze	O
the	O
inversion	O
of	O
a	O
DNA	O
element	O
known	O
as	O
the	O
fim	O
switch	O
or	O
fimS	B-Protein
,	O
whose	O
orientation	O
controls	O
the	O
expression	O
of	O
fimbrial	O
structural	O
genes	O
[	O
60	O
]	O
.	O

Inversion	O
of	O
fimS	B-Protein
by	O
site	O
-	O
specific	O
recombinases	O
alternately	O
connects	O
and	O
disconnects	O
the	O
fimbrial	O
structural	O
genes	O
from	O
their	O
promoter	O
,	O
resulting	O
in	O
a	O
process	O
of	O
phase	O
variation	O
that	O
gives	O
rise	O
to	O
bacteria	O
in	O
either	O
the	O
fimbriate	O
(	O
phase	O
ON	O
)	O
or	O
afimbriate	O
(	O
phase	O
OFF	O
)	O
state	O
[	O
61	O
]	O
.	O

By	O
randomly	O
sampling	O
mutants	O
impaired	O
for	O
motility	O
and	O
sequencing	O
the	O
region	O
of	O
DNA	O
adjacent	O
to	O
the	O
transposon	O
,	O
we	O
identified	O
a	O
mutant	O
with	O
a	O
reduced	O
ability	O
to	O
swim	O
with	O
an	O
insertion	O
within	O
fimS	B-Protein
.	O

To	O
determine	O
the	O
nature	O
of	O
the	O
motility	O
defect	O
,	O
we	O
analyzed	O
the	O
fimS	B-Protein
mutant	O
by	O
transmission	O
electron	O
microscopy	O
.	O

The	O
fimS	B-Protein
mutant	O
exhibited	O
a	O
level	O
of	O
fimbriation	O
similar	O
to	O
fimB	B-Protein
-	O
fimE	B-Protein
-	O
double	O
mutants	O
locked	O
in	O
phase	O
ON	O
(	O
Figure	O
S11A	O
)	O
,	O
indicating	O
that	O
a	O
high	O
level	O
of	O
fimbriation	O
reduces	O
motility	O
in	O
semi	O
-	O
solid	O
agar	O
.	O

This	O
observation	O
is	O
confirmed	O
by	O
comparing	O
the	O
motility	O
of	O
the	O
fimS	B-Protein
mutant	O
to	O
phase	O
ON	O
fimB	B-Protein
-	O
fimE	B-Protein
-	O
double	O
mutants	O
(	O
Figure	O
S11B	O
)	O
.	O

We	O
found	O
that	O
swarming	O
was	O
not	O
impaired	O
in	O
either	O
the	O
fimS	B-Protein
mutant	O
or	O
the	O
mutants	O
with	O
fimbria	O
locked	O
in	O
phase	O
ON	O
,	O
indicating	O
that	O
fimbria	O
expression	O
does	O
not	O
interfere	O
with	O
swarming	O
motility	O
(	O
Figure	O
S11C	O
)	O
.	O

The	O
basis	O
for	O
motility	O
suppression	O
by	O
constitutive	O
fimbriae	O
expression	O
remains	O
unclear	O
;	O
however	O
,	O
we	O
observed	O
that	O
hyper	O
-	O
fimbriated	O
cells	O
tend	O
to	O
have	O
,	O
on	O
average	O
,	O
fewer	O
flagella	O
compared	O
to	O
their	O
afimbriated	O
counterparts	O
(	O
Figure	O
S11D	O
)	O
.	O

This	O
may	O
reflect	O
competing	O
demands	O
for	O
resources	O
and	O
/	O
or	O
surface	O
area	O
for	O
synthesis	O
and	O
assembly	O
of	O
these	O
extracellular	O
appendages	O
.	O

The	O
Genetic	O
Basis	O
of	O
Environmentally	O
Induced	O
Repression	O
of	O
Motility	O

Chemotaxis	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
is	O
strongly	O
inhibited	O
by	O
environmental	O
conditions	O
such	O
as	O
high	O
temperature	O
,	O
low	O
pH	O
,	O
and	O
high	O
osmolarity	O
[	O
62	O
-	O
64	O
]	O
.	O

Some	O
of	O
these	O
environmental	O
influences	O
may	O
be	O
due	O
to	O
direct	O
physicochemical	O
perturbations	O
to	O
chemotaxis	O
or	O
flagellar	O
function	O
.	O

Alternatively	O
,	O
these	O
signals	O
may	O
provide	O
crucial	O
information	O
about	O
the	O
cell	O
'	O
s	O
local	O
environment	O
,	O
influencing	O
chemotactic	O
behavior	O
through	O
upstream	O
regulatory	O
pathways	O
.	O

Consistent	O
with	O
this	O
picture	O
,	O
the	O
promoter	O
of	O
the	O
flhDC	B-Protein
operon	O
,	O
the	O
master	O
regulator	O
of	O
flagellar	O
gene	O
expression	O
,	O
is	O
one	O
of	O
the	O
most	O
highly	O
regulated	O
loci	O
in	O
the	O
genome	O
and	O
contains	O
many	O
transcription	O
-	O
factor	O
binding	O
sites	O
[	O
65	O
]	O
.	O

We	O
devised	O
a	O
simple	O
selection	O
strategy	O
to	O
identify	O
the	O
genetic	O
loci	O
that	O
contribute	O
to	O
environmentally	O
induced	O
variation	O
in	O
chemotactic	O
behavior	O
.	O

We	O
focused	O
on	O
inhibition	O
of	O
motility	O
by	O
high	O
osmolarity	O
(	O
0	O
.	O
5	O
M	O
NaCl	O
)	O
,	O
since	O
previous	O
evidence	O
suggested	O
that	O
this	O
environmental	O
condition	O
signals	O
to	O
the	O
flhDC	B-Protein
regulatory	O
region	O
[	O
66	O
]	O
.	O

We	O
reasoned	O
that	O
null	O
mutations	O
in	O
components	O
of	O
such	O
upstream	O
signaling	O
pathways	O
would	O
alleviate	O
repression	O
of	O
chemotaxis	O
under	O
high	O
[	O
NaCl	O
]	O
conditions	O
.	O

According	O
to	O
this	O
model	O
,	O
the	O
transposon	O
insertion	O
library	O
should	O
harbor	O
mutants	O
that	O
perform	O
chemotaxis	O
in	O
high	O
[	O
NaCl	O
]	O
as	O
well	O
as	O
wild	O
-	O
type	O
cells	O
do	O
under	O
low	O
[	O
NaCl	O
]	O
conditions	O
.	O

As	O
can	O
be	O
seen	O
in	O
Figure	O
S12A	O
,	O
this	O
is	O
in	O
fact	O
what	O
we	O
observe	O
since	O
,	O
during	O
the	O
same	O
time	O
interval	O
,	O
some	O
members	O
from	O
the	O
transposon	O
mutant	O
library	O
travel	O
significantly	O
further	O
away	O
from	O
the	O
site	O
of	O
inoculation	O
than	O
do	O
the	O
homogeneous	O
population	O
of	O
wild	O
-	O
type	O
cells	O
.	O

In	O
order	O
to	O
identify	O
the	O
mutations	O
associated	O
with	O
the	O
observed	O
alleviation	O
in	O
suppression	O
of	O
motility	O
under	O
high	O
[	O
NaCl	O
]	O
,	O
we	O
extracted	O
the	O
population	O
of	O
mutants	O
that	O
traveled	O
to	O
the	O
extreme	O
edge	O
of	O
the	O
chemotaxis	O
front	O
.	O

Microarray	O
-	O
based	O
genetic	O
footprinting	O
of	O
these	O
mutants	O
provided	O
quantitative	O
genome	O
-	O
wide	O
readout	O
of	O
the	O
population	O
(	O
Dataset	O
S13	O
)	O
.	O

The	O
selection	O
results	O
revealed	O
that	O
mutants	O
harboring	O
insertions	O
in	O
five	O
genes	O
(	O
ompR	B-Protein
,	O
envZ	B-Protein
,	O
znuA	B-Protein
,	O
znuC	B-Protein
,	O
and	O
yfiM	B-Protein
)	O
were	O
the	O
most	O
abundant	O
.	O

The	O
microarray	O
results	O
were	O
confirmed	O
by	O
showing	O
that	O
individual	O
strains	O
with	O
mutations	O
in	O
these	O
genes	O
showed	O
increased	O
motility	O
in	O
high	O
[	O
NaCl	O
]	O
relative	O
to	O
the	O
wild	O
-	O
type	O
strain	O
(	O
Figure	O
S12B	O
)	O
.	O

OmpR	B-Protein
and	O
EnvZ	B-Protein
are	O
well	O
-	O
characterized	O
members	O
of	O
the	O
two	O
-	O
component	O
osmoregulatory	O
system	O
(	O
Figure	O
S12C	O
)	O
.	O

EnvZ	B-Protein
is	O
the	O
sensor	O
kinase	O
that	O
phosphorylates	O
OmpR	B-Protein
,	O
a	O
DNA	O
-	O
binding	O
regulatory	O
protein	O
,	O
under	O
conditions	O
of	O
high	O
osmolarity	O
[	O
67	O
]	O
.	O

Our	O
finding	O
that	O
the	O
EnvZ	B-Protein
/	O
OmpR	B-Protein
signaling	O
pathway	O
mediates	O
motility	O
suppression	O
in	O
high	O
[	O
NaCl	O
]	O
is	O
consistent	O
with	O
previous	O
work	O
that	O
found	O
phosphorylated	O
OmpR	B-Protein
to	O
negatively	O
regulate	O
the	O
expression	O
of	O
flagella	O
by	O
interacting	O
with	O
the	O
promoter	O
region	O
of	O
flhDC	B-Protein
[	O
66	O
]	O
.	O

ZnuA	B-Protein
and	O
ZnuC	B-Protein
are	O
part	O
of	O
a	O
high	O
-	O
affinity	O
zinc	B-Chemical
uptake	O
system	O
.	O

The	O
role	O
of	O
yfiM	B-Protein
,	O
a	O
novel	O
uncharacterized	O
gene	O
that	O
shows	O
sequence	O
similarity	O
to	O
a	O
lipoprotein	O
,	O
is	O
not	O
clear	O
at	O
this	O
point	O
.	O

Ongoing	O
work	O
will	O
determine	O
how	O
the	O
gene	O
products	O
of	O
yfiM	B-Protein
,	O
znuA	B-Protein
,	O
and	O
znuC	B-Protein
contribute	O
to	O
this	O
signaling	O
pathway	O
,	O
either	O
through	O
Envz	B-Protein
/	O
OmpR	B-Protein
or	O
through	O
a	O
parallel	O
pathway	O
.	O

We	O
have	O
shown	O
that	O
the	O
limits	O
on	O
swimming	O
motility	O
under	O
nominally	O
extreme	O
conditions	O
can	O
be	O
regulated	O
by	O
"	O
interpretation	O
"	O
of	O
environmental	O
signals	O
rather	O
than	O
by	O
hard	O
physicochemical	O
constraints	O
on	O
energy	O
generation	O
or	O
mechanics	O
.	O

This	O
argues	O
for	O
a	O
more	O
nuanced	O
perspective	O
on	O
the	O
functional	O
constraints	O
influencing	O
bacterial	O
behavior	O
in	O
general	O
-	O
including	O
the	O
strong	O
coupling	O
between	O
behavior	O
and	O
environment	O
-	O
and	O
an	O
appreciation	O
of	O
the	O
rich	O
ecological	O
context	O
that	O
has	O
shaped	O
bacterial	O
behavior	O
on	O
geological	O
time	O
scales	O
.	O

Conclusions	O
and	O
Summary	O

Microbes	O
account	O
for	O
half	O
the	O
world	O
'	O
s	O
biomass	O
and	O
are	O
the	O
most	O
widely	O
distributed	O
organisms	O
on	O
the	O
planet	O
.	O

Yet	O
most	O
of	O
our	O
genetic	O
understanding	O
of	O
bacterial	O
behavior	O
comes	O
from	O
the	O
tiny	O
fraction	O
of	O
microbes	O
studied	O
in	O
the	O
laboratory	O
.	O

With	O
the	O
recent	O
advances	O
in	O
bacterial	O
whole	O
-	O
genome	O
sequencing	O
[	O
68	O
,	O
69	O
]	O
,	O
the	O
scientific	O
community	O
is	O
poised	O
to	O
take	O
systems	O
-	O
level	O
experimental	O
approaches	O
to	O
rapidly	O
reveal	O
novel	O
and	O
fundamental	O
insights	O
into	O
the	O
microbial	O
world	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
established	O
a	O
powerful	O
framework	O
for	O
the	O
efficient	O
and	O
comprehensive	O
identification	O
of	O
the	O
genetic	O
basis	O
of	O
complex	O
bacterial	O
behaviors	O
.	O

The	O
power	O
of	O
this	O
approach	O
lies	O
in	O
the	O
rapid	O
and	O
parallel	O
manner	O
in	O
which	O
positive	O
and	O
negative	O
genetic	O
contributions	O
can	O
be	O
mapped	O
to	O
any	O
phenotype	O
after	O
competitive	O
selection	O
.	O

We	O
demonstrated	O
this	O
approach	O
in	O
four	O
distinct	O
but	O
complementary	O
selections	O
to	O
reveal	O
the	O
genetic	O
basis	O
of	O
E	B-Organism
.	I-Organism
coli	I-Organism
motility	O
.	O

Using	O
this	O
framework	O
,	O
we	O
identified	O
greater	O
than	O
95	O
%	O
of	O
previously	O
known	O
flagellar	O
and	O
chemotaxis	O
genes	O
,	O
and	O
we	O
found	O
three	O
dozen	O
novel	O
contributors	O
to	O
motility	O
consisting	O
of	O
both	O
characterized	O
and	O
uncharacterized	O
genes	O
.	O

Although	O
similar	O
approaches	O
have	O
been	O
successfully	O
applied	O
to	O
the	O
study	O
of	O
pathogenicity	O
[	O
70	O
-	O
74	O
]	O
,	O
the	O
large	O
number	O
of	O
genes	O
reported	O
and	O
the	O
limited	O
analyses	O
of	O
individual	O
mutants	O
made	O
it	O
difficult	O
to	O
determine	O
whether	O
the	O
methods	O
employed	O
in	O
these	O
studies	O
could	O
detect	O
the	O
subtle	O
quantitative	O
differences	O
necessary	O
to	O
map	O
genetic	O
loci	O
with	O
high	O
sensitivity	O
and	O
specificity	O
.	O

In	O
this	O
study	O
,	O
we	O
confirmed	O
our	O
findings	O
by	O
functional	O
analyses	O
of	O
individual	O
mutants	O
,	O
which	O
revealed	O
high	O
levels	O
of	O
sensitivity	O
and	O
low	O
rates	O
of	O
false	O
positives	O
.	O

In	O
addition	O
,	O
we	O
have	O
shown	O
that	O
the	O
same	O
method	O
can	O
be	O
used	O
to	O
quickly	O
and	O
thoroughly	O
explore	O
the	O
genetic	O
interactions	O
between	O
a	O
single	O
locus	O
and	O
all	O
other	O
genetic	O
loci	O
in	O
the	O
genome	O
.	O

These	O
interactions	O
correspond	O
to	O
important	O
network	O
-	O
level	O
concepts	O
;	O
for	O
example	O
,	O
the	O
flow	O
of	O
information	O
within	O
signal	O
transduction	O
pathways	O
and	O
second	O
-	O
messenger	O
systems	O
such	O
as	O
c	B-Chemical
-	I-Chemical
di	I-Chemical
-	I-Chemical
GMP	I-Chemical
.	O

In	O
addition	O
to	O
identifying	O
gene	O
-	O
by	O
-	O
gene	O
interactions	O
,	O
we	O
have	O
shown	O
that	O
the	O
same	O
framework	O
can	O
be	O
used	O
to	O
reveal	O
gene	O
-	O
by	O
-	O
environment	O
interactions	O
that	O
are	O
crucial	O
for	O
understanding	O
function	O
within	O
the	O
rich	O
ecological	O
context	O
in	O
which	O
genetic	O
networks	O
have	O
evolved	O
.	O

Large	O
scale	O
variation	O
in	O
Enterococcus	B-Organism
faecalis	I-Organism
illustrated	O
by	O
the	O
genome	O
analysis	O
of	O
strain	O
OG1RF	B-Organism

A	O
comparison	O
of	O
two	O
strains	O
of	O
the	O
hospital	O
pathogen	O
Enterococcus	B-Organism
faecalis	I-Organism
suggests	O
that	O
mediators	O
of	O
virulence	O
differ	O
between	O
strains	O
and	O
that	O
virulence	O
does	O
not	O
depend	O
on	O
mobile	O
gene	O
elements	O

Background	O

Enterococci	B-Organism
have	O
emerged	O
over	O
the	O
past	O
few	O
decades	O
as	O
the	O
second	O
to	O
third	O
most	O
common	O
cause	O
of	O
nosocomial	O
infections	O
,	O
including	O
urinary	O
tract	O
and	O
soft	O
tissue	O
infections	O
,	O
bacteremia	O
,	O
and	O
endocarditis	O
[	O
1	O
-	O
3	O
]	O
.	O

They	O
are	O
well	O
equipped	O
to	O
thrive	O
in	O
environments	O
with	O
heavy	O
antibiotic	O
usage	O
due	O
to	O
both	O
their	O
intrinsic	O
resistance	O
to	O
antibiotics	O
and	O
their	O
talent	O
for	O
swapping	O
genetic	O
information	O
,	O
which	O
allows	O
them	O
to	O
gain	O
and	O
share	O
resistance	O
determinants	O
.	O

Entecococcal	O
infections	O
are	O
predominantly	O
caused	O
by	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
and	O
E	B-Organism
.	I-Organism
faecium	I-Organism
.	O

However	O
,	O
many	O
,	O
if	O
not	O
most	O
,	O
strains	O
of	O
these	O
species	O
are	O
harmless	O
commensals	O
,	O
with	O
some	O
enterococci	B-Organism
being	O
marketed	O
in	O
Europe	O
to	O
alleviate	O
symptoms	O
of	O
irritable	O
bowel	O
syndrome	O
and	O
recurrent	O
chronic	O
sinusitis	O
or	O
bronchitis	O
(	O
Cylactin	B-Organism
(	O
R	O
)	O
and	O
Fargo688	B-Organism
(	O
R	O
)	O
(	O
E	B-Organism
.	I-Organism
faecium	I-Organism
)	O
and	O
Symbioflor	B-Organism
1	I-Organism
(	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
)	O
)	O
.	O

To	O
differentiate	O
the	O
two	O
faces	O
of	O
this	O
organism	O
,	O
genome	O
-	O
wide	O
comparisons	O
are	O
necessary	O
.	O

Although	O
hundreds	O
of	O
microbial	O
genomes	O
have	O
been	O
sequenced	O
,	O
only	O
two	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
genomes	O
have	O
been	O
reported	O
(	O
V583	B-Organism
as	O
a	O
clinical	O
isolate	O
[	O
4	O
]	O
and	O
Symbioflor	B-Organism
1	I-Organism
as	O
a	O
commensal	O
isolate	O
[	O
5	O
]	O
)	O
,	O
but	O
only	O
the	O
V583	B-Organism
genome	O
has	O
been	O
made	O
publicly	O
available	O
.	O

In	O
this	O
strain	O
,	O
more	O
than	O
one	O
-	O
quarter	O
of	O
the	O
genome	O
is	O
mobile	O
DNA	O
,	O
more	O
than	O
any	O
other	O
sequenced	O
bacterial	O
genome	O
[	O
4	O
]	O
.	O

The	O
occurrence	O
of	O
multiple	O
antibiotic	O
resistance	O
determinants	O
in	O
V583	B-Organism
[	O
6	O
]	O
makes	O
it	O
difficult	O
to	O
manipulate	O
genetically	O
.	O

Moreover	O
,	O
the	O
vancomycin	B-Chemical
resistance	O
phenotype	O
makes	O
this	O
strain	O
more	O
of	O
a	O
risk	O
to	O
handle	O
in	O
the	O
laboratory	O
.	O

To	O
avoid	O
these	O
issues	O
,	O
most	O
laboratories	O
use	O
strain	O
OG1	B-Organism
or	O
its	O
close	O
derivatives	O
.	O

OG1	B-Organism
is	O
a	O
human	B-Organism
isolate	O
subsequently	O
shown	O
to	O
cause	O
dental	O
caries	O
in	O
rats	B-Organism
[	O
7	O
]	O
.	O

OG1RF	B-Organism
is	O
a	O
rifampicin	B-Chemical
and	O
fusidic	O
acid	O
resistant	O
derivative	O
of	O
OG1	B-Organism
[	O
8	O
,	O
9	O
]	O
.	O

By	O
pulsed	O
-	O
field	O
gel	O
electrophoresis	O
,	O
Murray	O
et	O
al	O
.	O

[	O
10	O
]	O
estimated	O
the	O
size	O
of	O
the	O
OG1RF	B-Organism
genome	O
as	O
2	O
,	O
825	O
kb	O
and	O
created	O
a	O
restriction	O
map	O
of	O
the	O
chromosome	O
.	O

Multilocus	O
sequence	O
typing	O
(	O
MLST	O
)	O
showed	O
that	O
OG1RF	B-Organism
is	O
clonally	O
distinct	O
from	O
V583	B-Organism
(	O
differs	O
in	O
six	O
out	O
of	O
seven	O
alleles	O
of	O
housekeeping	O
genes	O
)	O
[	O
11	O
]	O
and	O
characterization	O
of	O
regions	O
flanking	O
transposon	O
insertions	O
in	O
OG1RF	B-Organism
suggested	O
that	O
approximately	O
10	O
%	O
of	O
their	O
sequences	O
differed	O
[	O
12	O
]	O
.	O

OG1	B-Organism
and	O
its	O
derivatives	O
have	O
been	O
successfully	O
used	O
over	O
the	O
past	O
20	O
years	O
in	O
various	O
animal	O
models	O
,	O
starting	O
with	O
the	O
demonstration	O
that	O
it	O
can	O
cause	O
caries	O
in	O
germ	O
-	O
free	O
rats	B-Organism
[	O
7	O
]	O
,	O
and	O
later	O
to	O
characterize	O
factors	O
important	O
for	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
virulence	O
in	O
a	O
mouse	B-Organism
model	O
of	O
peritonitis	O
[	O
13	O
]	O
,	O
a	O
rabbit	B-Organism
model	O
of	O
endophthalmitis	O
[	O
14	O
]	O
,	O
a	O
rat	B-Organism
model	O
of	O
endocarditis	O
[	O
15	O
]	O
and	O
in	O
a	O
mouse	B-Organism
urinary	O
tract	O
infection	O
model	O
[	O
16	O
]	O
.	O

OG1RF	B-Organism
was	O
also	O
shown	O
to	O
be	O
as	O
virulent	O
as	O
V583	B-Organism
in	O
the	O
model	O
host	O
Caenorhabditis	B-Organism
elegans	I-Organism
[	O
17	O
]	O
.	O

In	O
addition	O
to	O
its	O
virulence	O
,	O
the	O
main	O
reasons	O
for	O
the	O
extensive	O
use	O
of	O
OG1RF	B-Organism
as	O
a	O
laboratory	O
strain	O
are	O
that	O
it	O
does	O
not	O
carry	O
plasmids	O
,	O
is	O
readily	O
transformable	O
by	O
electroporation	O
,	O
and	O
is	O
not	O
resistant	O
to	O
commonly	O
used	O
antibiotics	O
,	O
other	O
than	O
rifampicin	B-Chemical
and	O
fusidic	B-Chemical
acid	I-Chemical
.	O

These	O
resistances	O
were	O
serially	O
selected	O
in	O
OG1	B-Organism
to	O
provide	O
strain	O
markers	O
[	O
9	O
]	O
.	O

The	O
lack	O
of	O
resistance	O
to	O
common	O
antibiotics	O
facilitates	O
the	O
selection	O
of	O
plasmids	O
,	O
transposons	O
,	O
and	O
allelic	O
replacement	O
markers	O
introduced	O
into	O
the	O
strain	O
.	O

Numerous	O
factors	O
important	O
for	O
virulence	O
have	O
been	O
characterized	O
in	O
OG1RF	B-Organism
.	O

A	O
recently	O
described	O
example	O
are	O
the	O
Ebp	O
pili	O
,	O
whose	O
subunits	O
are	O
encoded	O
by	O
the	O
ebp	B-Regulon-operon
operon	O
[	O
18	O
]	O
and	O
whose	O
genes	O
are	O
regulated	O
by	O
EbpR	B-Protein
[	O
19	O
]	O
.	O

A	O
non	O
-	O
piliated	O
mutant	O
produces	O
less	O
biofilm	O
than	O
the	O
parent	O
strain	O
and	O
is	O
attenuated	O
in	O
a	O
rat	B-Organism
model	O
of	O
endocarditis	O
[	O
18	O
]	O
and	O
in	O
a	O
murine	B-Organism
urinary	O
tract	O
infection	O
model	O
[	O
16	O
]	O
.	O

Also	O
present	O
is	O
Ace	B-Protein
,	O
a	O
member	O
of	O
the	O
MSCRAMM	O
(	O
microbial	O
surface	O
component	O
recognizing	O
adhesive	O
matrix	O
molecules	O
)	O
family	O
.	O

The	O
ace	B-Protein
gene	O
,	O
like	O
the	O
ebp	B-Regulon-operon
locus	O
,	O
is	O
ubiquitous	O
in	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
and	O
it	O
occurs	O
in	O
at	O
least	O
four	O
different	O
forms	O
that	O
vary	O
in	O
the	O
number	O
of	O
repeats	O
of	O
the	O
B	O
domain	O
[	O
20	O
]	O
.	O

Ace	B-Protein
mediates	O
conditional	O
(	O
that	O
is	O
,	O
after	O
growth	O
at	O
46degreesC	O
or	O
in	O
the	O
presence	O
of	O
serum	O
or	O
collagen	O
)	O
adherence	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
to	O
collagen	O
type	O
IV	O
and	O
to	O
laminin	O
[	O
21	O
]	O
and	O
,	O
in	O
unpublished	O
data	O
,	O
influences	O
the	O
ability	O
of	O
OG1RF	B-Organism
to	O
cause	O
experimental	O
endocarditis	O
(	O
KV	O
Singh	O
and	O
BE	O
Murray	O
,	O
unpublished	O
observation	O
)	O
.	O

Finally	O
,	O
the	O
Fsr	B-Protein
system	O
,	O
a	O
major	O
positive	O
and	O
negative	O
transcriptional	O
regulator	O
in	O
OG1RF	B-Organism
[	O
22	O
]	O
,	O
affects	O
expression	O
of	O
several	O
virulence	O
factor	O
genes	O
,	O
including	O
gelE	B-Protein
,	O
which	O
encodes	O
gelatinase	O
[	O
23	O
]	O
,	O
and	O
contributes	O
to	O
infection	O
in	O
various	O
animal	O
models	O
[	O
15	O
,	O
24	O
]	O
.	O

The	O
distinct	O
MLST	O
profile	O
and	O
the	O
wide	O
range	O
of	O
phenotypic	O
and	O
genotypic	O
analyses	O
of	O
OG1RF	B-Organism
,	O
including	O
many	O
molecular	O
genetic	O
studies	O
and	O
experiments	O
in	O
various	O
animal	O
models	O
,	O
suggested	O
that	O
genomic	O
analysis	O
of	O
this	O
strain	O
would	O
prove	O
insightful	O
and	O
would	O
be	O
useful	O
to	O
future	O
studies	O
.	O

Thus	O
,	O
we	O
analyzed	O
the	O
sequence	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
OG1RF	I-Organism
.	O

This	O
revealed	O
approximately	O
232	O
kb	O
encoding	O
227	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
that	O
are	O
unique	O
to	O
this	O
important	O
strain	O
compared	O
to	O
V583	B-Organism
.	O

The	O
unique	O
regions	O
were	O
then	O
characterized	O
further	O
.	O

Results	O
and	O
discussion	O

General	O
genome	O
features	O
The	O
complete	O
circular	O
chromosome	O
of	O
OG1RF	B-Organism
was	O
found	O
to	O
be	O
2	O
,	O
739	O
,	O
625	O
bp	O
with	O
an	O
average	O
G	O
+	O
C	O
content	O
of	O
37	O
.	O
8	O
%	O
.	O

The	O
complete	O
OG1RF	B-Organism
sequence	O
was	O
obtained	O
using	O
three	O
independent	O
techniques	O
(	O
Solexa	O
,	O
the	O
454	O
,	O
and	O
Sanger	O
sequencing	O
technique	O
)	O
with	O
a	O
higher	O
than	O
classic	O
coverage	O
(	O
more	O
than	O
100	O
times	O
)	O
,	O
diminishing	O
the	O
likelihood	O
of	O
sequencing	O
-	O
related	O
frameshifts	O
,	O
base	O
errors	O
and	O
/	O
or	O
misassembly	O
.	O

A	O
comparison	O
of	O
our	O
assembly	O
of	O
the	O
closed	O
OG1RF	B-Organism
genome	O
with	O
the	O
restriction	O
map	O
of	O
OG1RF	B-Organism
published	O
by	O
Murray	O
et	O
al	O
.	O

[	O
10	O
]	O
showed	O
only	O
minor	O
variations	O
(	O
primarily	O
an	O
overestimation	O
of	O
30	O
kb	O
for	O
the	O
Sfi	B-Protein
I	I-Protein
fragment	O
E	O
,	O
540	O
kb	O
versus	O
509	O
kb	O
predicted	O
from	O
the	O
sequence	O
;	O
Figure	O
1	O
)	O
.	O

We	O
found	O
232	O
kb	O
of	O
OG1RF	B-Organism
unique	O
sequences	O
distributed	O
in	O
48	O
regions	O
ranging	O
from	O
101	O
bp	O
to	O
approximately	O
49	O
kb	O
in	O
length	O
(	O
Figure	O
1	O
;	O
Additional	O
data	O
file	O
1	O
)	O
.	O

Using	O
the	O
published	O
DNA	O
sequence	O
of	O
V583	B-Organism
as	O
reference	O
(	O
NC	O
_	O
004668	O
)	O
,	O
OG1RF	B-Organism
shares	O
2	O
,	O
474	O
ORFs	O
as	O
well	O
as	O
the	O
12	O
rRNA	O
genes	O
and	O
58	O
of	O
68	O
tRNA	O
genes	O
(	O
Table	O
1	O
)	O
.	O

The	O
10	O
missing	O
tRNA	O
are	O
localized	O
in	O
a	O
region	O
in	O
V583	B-Organism
that	O
has	O
been	O
replaced	O
in	O
OG1RF	B-Organism
by	O
a	O
49	O
kb	O
region	O
(	O
see	O
below	O
)	O
.	O

Surprisingly	O
,	O
the	O
genomes	O
align	O
syntenically	O
,	O
as	O
shown	O
in	O
Figure	O
2	O
,	O
despite	O
the	O
fact	O
that	O
25	O
%	O
of	O
the	O
V583	B-Organism
genome	O
is	O
composed	O
of	O
mobile	O
elements	O
.	O

Similarly	O
,	O
the	O
presence	O
of	O
OG1RF	B-Organism
-	O
unique	O
sequences	O
has	O
not	O
affected	O
the	O
overall	O
chromosomal	O
arrangement	O
.	O

Some	O
of	O
the	O
major	O
insertions	O
/	O
deletions	O
in	O
the	O
two	O
genomes	O
are	O
shown	O
in	O
Figure	O
2	O
,	O
such	O
as	O
the	O
absence	O
of	O
the	O
pathogenicity	O
island	O
(	O
PAI	O
)	O
in	O
OG1RF	B-Organism
and	O
the	O
presence	O
of	O
an	O
approximately	O
49	O
kb	O
fragment	O
unique	O
to	O
OG1RF	B-Organism
.	O

However	O
,	O
most	O
of	O
the	O
differences	O
are	O
small	O
and	O
cannot	O
be	O
visualized	O
in	O
this	O
figure	O
.	O

Overall	O
,	O
we	O
found	O
64	O
areas	O
of	O
divergence	O
between	O
the	O
genomes	O
that	O
can	O
be	O
divided	O
into	O
3	O
classes	O
:	O
an	O
additional	O
sequence	O
present	O
in	O
OG1RF	B-Organism
when	O
compared	O
with	O
V583	B-Organism
;	O
a	O
sequence	O
replacement	O
where	O
a	O
sequence	O
in	O
OG1RF	B-Organism
differs	O
from	O
the	O
sequence	O
in	O
V583	B-Organism
;	O
and	O
the	O
absence	O
of	O
a	O
sequence	O
from	O
OG1RF	B-Organism
when	O
compared	O
with	O
V583	B-Organism
.	O

CRISPR	O
loci	O

The	O
CRISPR	O
(	O
comprised	O
of	O
regularly	O
interspaced	O
short	O
palindromic	O
repeats	O
)	O
loci	O
encoded	O
by	O
some	O
bacterial	O
strains	O
is	O
a	O
recently	O
described	O
system	O
that	O
protects	O
cells	O
from	O
infection	O
with	O
bacteriophage	O
[	O
25	O
-	O
27	O
]	O
.	O

The	O
specificity	O
of	O
the	O
phage	O
resistance	O
conferred	O
by	O
the	O
CRISPR	O
elements	O
and	O
CRISPR	O
-	O
associated	O
genes	O
(	O
cas	O
genes	O
)	O
is	O
determined	O
by	O
spacer	O
-	O
phage	O
sequence	O
similarity	O
.	O

OG1RF	B-Organism
carries	O
two	O
CRISPR	O
elements	O
:	O
CRISPR1	O
(	O
between	O
the	O
OG1RF	B-Organism
homologue	O
of	O
EF0672	B-Protein
and	O
EF0673	B-Protein
)	O
and	O
CRISPR2	O
(	O
between	O
the	O
OG1RF	B-Organism
homologue	O
of	O
EF2062	B-Protein
and	O
EF2063	B-Protein
)	O
;	O
CRISPR1	O
is	O
linked	O
to	O
cas	O
-	O
like	O
genes	O
while	O
CRISPR2	O
is	O
not	O
(	O
Figure	O
3	O
)	O
.	O

Both	O
OG1RF	B-Organism
CRISPR	O
elements	O
are	O
composed	O
of	O
7	O
repeats	O
of	O
a	O
37	O
bp	O
palindromic	O
sequence	O
with	O
a	O
29	O
bp	O
spacer	O
.	O

None	O
of	O
the	O
29	O
bp	O
spacers	O
(	O
14	O
total	O
)	O
have	O
homology	O
to	O
any	O
sequences	O
in	O
GenBank	O
.	O

The	O
CRISPR1	O
-	O
associated	O
proteins	O
belong	O
to	O
the	O
Nmeni	O
subtype	O
[	O
28	O
]	O
.	O

Species	O
bearing	O
this	O
CRISPR	O
/	O
cas	O
subtype	O
have	O
so	O
far	O
been	O
found	O
exclusively	O
in	O
bacteria	O
that	O
are	O
vertebrate	O
pathogens	O
or	O
commensals	O
.	O

The	O
Nmeni	O
subtype	O
is	O
characterized	O
by	O
the	O
presence	O
of	O
four	O
specific	O
cas	O
genes	O
and	O
a	O
single	O
copy	O
of	O
the	O
repeat	O
that	O
is	O
upstream	O
of	O
the	O
first	O
gene	O
in	O
the	O
locus	O
.	O

The	O
four	O
cas	O
genes	O
encode	O
Cas	B-Protein
_	I-Protein
csn1	I-Protein
(	O
possible	O
endonuclease	O
)	O
,	O
Cas1	B-Protein
(	O
novel	O
nuclease	O
)	O
,	O
Cas2	B-Protein
(	O
conserved	O
hypothetical	O
protein	O
)	O
,	O
and	O
Cas	B-Protein
_	I-Protein
csn2	I-Protein
(	O
conserved	O
hypothetical	O
protein	O
)	O
.	O

The	O
repeat	O
upstream	O
of	O
cas	B-Protein
_	I-Protein
csn1	I-Protein
appears	O
to	O
have	O
degenerated	O
since	O
it	O
shares	O
only	O
23	O
bp	O
with	O
the	O
37	O
bp	O
repeat	O
cluster	O
downstream	O
of	O
the	O
last	O
gene	O
.	O

A	O
unique	O
feature	O
of	O
the	O
OG1RF	B-Organism
CRISPR1	O
locus	O
is	O
the	O
presence	O
of	O
a	O
gene	O
downstream	O
of	O
the	O
element	O
,	O
which	O
encodes	O
a	O
hypothetical	O
119	O
amino	O
acid	O
transmembrane	O
protein	O
.	O

The	O
presence	O
of	O
the	O
CRISPR	O
loci	O
among	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
strains	O
may	O
be	O
a	O
powerful	O
tool	O
to	O
avoid	O
the	O
load	O
of	O
prophage	O
replication	O
.	O

To	O
determine	O
the	O
distribution	O
of	O
the	O
CRISPR1	O
locus	O
in	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
strains	O
,	O
16	O
isolates	O
of	O
various	O
MLST	O
types	O
were	O
tested	O
for	O
the	O
presence	O
(	O
PCR	O
with	O
primers	O
specific	O
for	O
csn1	B-Protein
and	O
cas1	B-Protein
)	O
or	O
absence	O
(	O
PCR	O
with	O
primers	O
overlapping	O
the	O
junction	O
between	O
EF0672	B-Protein
and	O
EF0673	B-Protein
)	O
of	O
the	O
CRISPR1	O
locus	O
(	O
Table	O
2	O
)	O
.	O

Seven	O
strains	O
were	O
cas	O
positive	O
,	O
but	O
negative	O
for	O
the	O
junction	O
and	O
the	O
remaining	O
nine	O
were	O
positive	O
only	O
for	O
the	O
junction	O
.	O

This	O
indicates	O
that	O
the	O
location	O
of	O
the	O
CRISPR1	O
locus	O
appears	O
to	O
be	O
conserved	O
(	O
between	O
EF0672	B-Protein
and	O
EF0673	B-Protein
when	O
compared	O
with	O
the	O
V583	B-Organism
genome	O
)	O
.	O

Interestingly	O
,	O
the	O
two	O
vancomycin	B-Chemical
resistant	O
strains	O
tested	O
were	O
both	O
cas	O
negative	O
.	O

It	O
is	O
appealing	O
to	O
postulate	O
that	O
the	O
presence	O
of	O
the	O
CRISPR	O
locus	O
in	O
OG1RF	B-Organism
may	O
be	O
the	O
reason	O
for	O
the	O
absence	O
of	O
prophage	O
in	O
this	O
strain	O
.	O

A	O
14	O
.	O
8	O
kb	O
region	O
inserted	O
in	O
the	O
23	O
.	O
9	O
kb	O
region	O
containing	O
fsrA	B-Protein
and	O
fsrB	B-Protein

Nakayama	O
et	O
al	O
.	O

[	O
29	O
]	O
described	O
a	O
conserved	O
23	O
.	O
9	O
kb	O
chromosomal	O
deletion	O
when	O
comparing	O
fsrA	B-Protein
-	O
lacking	O
/	O
fsrC	B-Protein
+	O
/	O
gelE	B-Protein
+	O
strains	O
(	O
by	O
PCR	O
)	O
from	O
various	O
origins	O
with	O
V583	B-Organism
;	O
the	O
deleted	O
sequences	O
start	O
in	O
the	O
middle	O
of	O
EF1841	B-Protein
,	O
include	O
the	O
fsrAB	B-Protein
genes	O
and	O
end	O
in	O
the	O
middle	O
of	O
the	O
fsrC	B-Protein
gene	O
(	O
EF1820	B-Protein
)	O
.	O

Loss	O
of	O
the	O
fsr	O
regulatory	O
components	O
results	O
in	O
a	O
gelatinase	O
-	O
negative	O
phenotype	O
under	O
routine	O
test	O
conditions	O
despite	O
the	O
fact	O
that	O
these	O
strains	O
still	O
carry	O
the	O
gelE	B-Protein
gene	O
[	O
23	O
,	O
29	O
]	O
.	O

The	O
absence	O
/	O
presence	O
of	O
the	O
23	O
.	O
9	O
kb	O
region	O
,	O
from	O
EF1820	B-Protein
/	O
fsrC	B-Protein
to	O
EF1841	B-Protein
,	O
did	O
not	O
appear	O
to	O
correlate	O
with	O
the	O
clinical	O
origin	O
of	O
the	O
isolates	O
[	O
30	O
]	O
.	O

In	O
a	O
more	O
recent	O
analysis	O
of	O
relationships	O
between	O
various	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
strains	O
,	O
the	O
23	O
.	O
9	O
kb	O
region	O
was	O
not	O
detected	O
in	O
86	O
%	O
of	O
the	O
strains	O
of	O
the	O
clonal	O
complex	O
(	O
CC	O
)	O
2	O
,	O
58	O
%	O
of	O
the	O
CC9	B-Organism
strains	O
,	O
nor	O
in	O
any	O
of	O
the	O
CC8	B-Organism
strains	O
[	O
31	O
]	O
.	O

The	O
Symbioflor	B-Organism
1	I-Organism
strain	O
,	O
used	O
as	O
a	O
probiotic	O
,	O
is	O
one	O
representative	O
of	O
the	O
7	O
.	O
4	O
%	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
isolates	O
that	O
are	O
missing	O
the	O
gelE	B-Protein
gene	O
in	O
addition	O
to	O
the	O
23	O
.	O
9	O
kb	O
region	O
[	O
5	O
,	O
30	O
]	O
.	O

Our	O
analysis	O
of	O
this	O
area	O
in	O
OG1RF	B-Organism
revealed	O
the	O
presence	O
of	O
an	O
additional	O
14	O
.	O
8	O
kb	O
fragment	O
inserted	O
between	O
the	O
corresponding	O
EF1826	B-Protein
and	O
EF1827	B-Protein
of	O
OG1RF	B-Organism
(	O
confirmed	O
by	O
PCR	O
;	O
results	O
not	O
shown	O
)	O
.	O

In	O
OG1RF	B-Organism
,	O
this	O
14	O
.	O
8	O
kb	O
region	O
contains	O
two	O
loci	O
,	O
a	O
WxL	O
locus	O
(	O
described	O
below	O
)	O
and	O
a	O
seven	O
-	O
gene	O
locus	O
that	O
may	O
encode	O
a	O
possible	O
ABC	O
transporter	O
with	O
similarity	O
to	O
one	O
annotated	O
in	O
Pediococcus	B-Organism
pentosaceus	I-Organism
.	O

Components	O
of	O
the	O
cell	O
surface	O

It	O
has	O
been	O
shown	O
in	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
that	O
at	O
least	O
one	O
cell	O
surface	O
protein	O
(	O
Ace	B-Protein
)	O
is	O
subject	O
to	O
domain	O
variation	O
[	O
20	O
]	O
and	O
it	O
has	O
been	O
postulated	O
that	O
domain	O
variation	O
may	O
help	O
bacteria	O
escape	O
the	O
immune	O
system	O
.	O

We	O
found	O
more	O
polymorphisms	O
in	O
two	O
families	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
proteins	O
present	O
on	O
the	O
cell	O
surface	O
:	O
the	O
MSCRAMMs	O
and	O
the	O
WxL	O
domain	O
surface	O
proteins	O
.	O

The	O
MSCRAMMs	O
are	O
composed	O
of	O
two	O
large	O
regions	O
,	O
namely	O
,	O
the	O
non	O
-	O
repeat	O
A	O
region	O
(	O
which	O
is	O
usually	O
the	O
ligand	O
binding	O
region	O
for	O
extracellular	O
matrix	O
molecules	O
such	O
as	O
collagen	O
or	O
fibrinogen	O
)	O
and	O
the	O
B	O
region	O
(	O
which	O
typically	O
contains	O
repeated	O
sub	O
-	O
domains	O
)	O
.	O

The	O
B	O
region	O
of	O
Ace	B-Protein
contains	O
five	O
repeats	O
in	O
OG1RF	B-Organism
,	O
while	O
it	O
contains	O
only	O
four	O
in	O
V583	B-Organism
[	O
20	O
]	O
.	O

We	O
found	O
two	O
other	O
MSCRAMM	O
proteins	O
that	O
show	O
polymorphisms	O
in	O
the	O
number	O
of	O
their	O
B	O
repeats	O
.	O

OG1RF	B-Protein
_	I-Protein
0186	I-Protein
(	O
corresponding	O
to	O
EF2505	B-Protein
of	O
V583	B-Organism
)	O
has	O
four	O
repeats	O
compared	O
to	O
seven	O
in	O
V583	B-Organism
,	O
and	O
OG1RF	B-Protein
_	I-Protein
0165	I-Protein
(	O
corresponding	O
to	O
EF2224	B-Protein
of	O
V583	B-Organism
)	O
has	O
eight	O
repeats	O
compared	O
to	O
five	O
in	O
V583	B-Organism
.	O

It	O
has	O
been	O
proposed	O
that	O
the	O
repeats	O
are	O
used	O
as	O
a	O
stalk	O
that	O
projects	O
the	O
A	O
region	O
across	O
the	O
peptidoglycan	O
and	O
away	O
from	O
the	O
cell	O
surface	O
[	O
32	O
]	O
.	O

A	O
hypothesis	O
that	O
the	O
number	O
of	O
repeats	O
may	O
be	O
proportional	O
to	O
the	O
depth	O
of	O
the	O
peptidoglycan	O
has	O
been	O
proposed	O
[	O
32	O
]	O
.	O

However	O
,	O
OG1RF	B-Protein
_	I-Protein
0186	I-Protein
carries	O
fewer	O
repeats	O
than	O
EF2505	B-Protein
while	O
Ace	B-Protein
and	O
OG1RF	B-Protein
_	I-Protein
0165	I-Protein
carry	O
more	O
repeats	O
than	O
their	O
counterparts	O
in	O
V583	B-Organism
,	O
suggesting	O
that	O
our	O
observation	O
does	O
not	O
fit	O
this	O
hypothesis	O
or	O
that	O
the	O
peptidoglycan	O
depth	O
is	O
not	O
uniform	O
.	O

Apart	O
from	O
these	O
three	O
MSCRAMMs	O
with	O
B	O
-	O
repeat	O
polymorphisms	O
,	O
we	O
identified	O
two	O
unique	O
MSCRAMM	O
proteins	O
in	O
OG1RF	B-Organism
:	O
a	O
homologue	O
of	O
EF0089	B-Protein
(	O
OG1RF	B-Protein
_	I-Protein
0063	I-Protein
,	O
which	O
shares	O
48	O
%	O
similarity	O
)	O
and	O
a	O
homologue	O
of	O
EF1896	B-Protein
(	O
OG1RF	B-Protein
_	I-Protein
0039	I-Protein
,	O
which	O
shares	O
75	O
%	O
similarity	O
)	O
;	O
both	O
are	O
located	O
in	O
the	O
approximately	O
49	O
kb	O
region	O
unique	O
to	O
OG1RF	B-Organism
described	O
below	O
(	O
Figure	O
1	O
;	O
Additional	O
data	O
file	O
1	O
)	O
.	O

Another	O
family	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
surface	O
proteins	O
includes	O
the	O
newly	O
described	O
WxL	O
domain	O
surface	O
proteins	O
.	O

Siezen	O
et	O
al	O
.	O

[	O
33	O
]	O
reported	O
a	O
novel	O
gene	O
cluster	O
encoding	O
exclusively	O
cell	O
-	O
surface	O
proteins	O
that	O
is	O
conserved	O
in	O
a	O
subgroup	O
of	O
Gram	O
-	O
positive	O
bacteria	O
.	O

Each	O
gene	O
cluster	O
has	O
at	O
least	O
one	O
member	O
of	O
three	O
gene	O
families	O
:	O
a	O
gene	O
encoding	O
a	O
small	O
LPxTG	O
protein	O
(	O
approximately	O
120	O
amino	O
acids	O
)	O
;	O
a	O
gene	O
encoding	O
a	O
member	O
of	O
the	O
DUF916	O
transmembrane	O
protein	O
family	O
;	O
and	O
a	O
gene	O
encoding	O
a	O
WxL	O
domain	O
surface	O
protein	O
.	O

In	O
addition	O
,	O
members	O
of	O
these	O
gene	O
families	O
were	O
found	O
as	O
singletons	O
or	O
associated	O
with	O
genes	O
encoding	O
other	O
proteins	O
(	O
Additional	O
data	O
file	O
2	O
)	O
.	O

Recently	O
,	O
it	O
was	O
shown	O
that	O
the	O
WxL	O
domain	O
attaches	O
to	O
the	O
peptidoglycan	O
on	O
the	O
cell	O
surface	O
[	O
34	O
]	O
and	O
one	O
member	O
of	O
this	O
WxL	O
domain	O
family	O
,	O
the	O
homologue	O
of	O
EF2686	B-Protein
in	O
OG1RF	B-Organism
(	O
a	O
probable	O
internalin	O
protein	O
)	O
,	O
was	O
shown	O
to	O
be	O
important	O
for	O
virulence	O
in	O
a	O
mouse	B-Organism
peritonitis	O
model	O
and	O
is	O
required	O
for	O
dissemination	O
to	O
the	O
spleen	O
and	O
liver	O
[	O
35	O
]	O
.	O

OG1RF	B-Organism
shares	O
five	O
complete	O
WxL	O
loci	O
with	O
V583	B-Organism
(	O
EF0750	B-Protein
-	O
7	B-Protein
,	O
EF2682	B-Protein
-	O
6	B-Protein
,	O
EF2970	B-Protein
-	O
68	B-Protein
,	O
EF3181	B-Protein
-	O
8	B-Protein
,	O
and	O
EF3248	B-Protein
-	O
53	B-Protein
)	O
.	O

OG1RF	B-Organism
does	O
not	O
contain	O
homologues	O
of	O
EF2248	B-Protein
-	O
54	B-Protein
(	O
carrying	O
instead	O
the	O
iol	B-Regulon-operon
operon	O
)	O
,	O
though	O
it	O
has	O
a	O
novel	O
WxL	O
locus	O
within	O
the	O
14	O
.	O
8	O
kb	O
unique	O
region	O
upstream	O
of	O
the	O
fsr	B-Regulon-operon
locus	O
(	O
Additional	O
data	O
file	O
2	O
)	O
.	O

In	O
addition	O
to	O
the	O
variation	O
in	O
the	O
number	O
of	O
WxL	O
loci	O
,	O
we	O
also	O
observed	O
polymorphisms	O
in	O
six	O
of	O
the	O
WxL	O
domain	O
surface	O
proteins	O
.	O

For	O
example	O
,	O
OG1RF	B-Protein
_	I-Protein
0213	I-Protein
shares	O
88	O
%	O
similarity	O
with	O
EF3188	B-Organism
,	O
while	O
OG1RF	B-Protein
_	I-Protein
0224	I-Protein
,	O
OG1RF	B-Protein
_	I-Protein
0225	I-Protein
,	O
and	O
OG1RF	B-Protein
_	I-Protein
0227	I-Protein
share	O
64	O
-	O
68	O
%	O
similarity	O
with	O
their	O
V583	B-Organism
counterparts	O
,	O
EF3248	B-Protein
,	O
EF3250	B-Protein
,	O
and	O
EF3252	B-Protein
,	O
respectively	O
.	O

Also	O
,	O
in	O
place	O
of	O
EF3153	B-Protein
,	O
EF3154	B-Protein
,	O
and	O
EF3155	B-Protein
(	O
which	O
share	O
70	O
%	O
similarity	O
among	O
themselves	O
)	O
,	O
were	O
found	O
non	O
-	O
distantly	O
related	O
homologues	O
,	O
OG1RF	B-Protein
_	I-Protein
0209	I-Protein
and	O
OG1RF	B-Protein
_	I-Protein
0210	I-Protein
,	O
which	O
share	O
60	O
-	O
80	O
%	O
similarity	O
with	O
EF3153	B-Protein
,	O
EF3154	B-Protein
,	O
and	O
EF3155	B-Protein
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
while	O
several	O
of	O
these	O
WxL	O
loci	O
,	O
including	O
the	O
EF0750	B-Protein
and	O
EF3184	B-Protein
loci	O
,	O
were	O
present	O
by	O
hybridization	O
in	O
all	O
the	O
strains	O
(	O
clinical	O
or	O
food	O
isolates	O
)	O
tested	O
by	O
Lepage	O
et	O
al	O
.	O

[	O
36	O
]	O
,	O
other	O
loci	O
,	O
including	O
the	O
EF3153	B-Protein
and	O
EF3248	B-Protein
loci	O
,	O
were	O
not	O
detected	O
in	O
the	O
majority	O
of	O
these	O
strains	O
.	O

In	O
addition	O
,	O
it	O
appears	O
that	O
the	O
EF3248	B-Protein
locus	O
diverges	O
in	O
the	O
Symbioflor	B-Organism
1	I-Organism
strain	O
.	O

When	O
compared	O
to	O
V583	B-Organism
,	O
the	O
sequence	O
identity	O
in	O
this	O
area	O
between	O
the	O
two	O
strains	O
appears	O
to	O
be	O
as	O
low	O
as	O
75	O
%	O
(	O
depicted	O
in	O
Figure	O
2	O
from	O
reference	O
[	O
5	O
]	O
)	O
.	O

However	O
,	O
because	O
the	O
Symbioflor	B-Organism
1	I-Organism
genome	O
sequence	O
is	O
not	O
currently	O
available	O
,	O
it	O
was	O
not	O
possible	O
to	O
compare	O
their	O
respective	O
sequences	O
in	O
more	O
detail	O
.	O

Since	O
these	O
proteins	O
are	O
located	O
at	O
the	O
surface	O
of	O
the	O
cell	O
,	O
the	O
low	O
level	O
of	O
homology	O
shared	O
between	O
them	O
may	O
be	O
the	O
result	O
of	O
antigenic	O
variation	O
.	O

More	O
analyses	O
are	O
required	O
for	O
a	O
better	O
understanding	O
of	O
the	O
number	O
,	O
frequency	O
and	O
function	O
of	O
these	O
WxL	O
domain	O
proteins	O
and	O
their	O
possible	O
relationship	O
with	O
the	O
diversity	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
.	O

Finally	O
,	O
as	O
previously	O
found	O
using	O
PCR	O
,	O
the	O
cpsCDEFGHIJK	B-Protein
operon	O
capsule	O
polysaccharide	O
genes	O
[	O
37	O
]	O
were	O
confirmed	O
here	O
as	O
missing	O
,	O
although	O
OG1RF	B-Organism
carries	O
the	O
cpsA	B-Protein
and	O
cpsB	B-Protein
genes	O
,	O
which	O
were	O
proposed	O
to	O
be	O
essential	O
for	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
since	O
all	O
strains	O
tested	O
by	O
Hufnagel	O
et	O
al	O
.	O

[	O
37	O
]	O
carry	O
these	O
two	O
genes	O
.	O

In	O
OG1RF	B-Organism
,	O
the	O
region	O
that	O
would	O
encode	O
the	O
cps	B-Regulon-operon
operon	O
is	O
only	O
59	O
bp	O
in	O
length	O
and	O
has	O
no	O
homology	O
with	O
V583	B-Organism
.	O

Thus	O
,	O
while	O
V583	B-Organism
and	O
OG1RF	B-Organism
share	O
much	O
similarity	O
between	O
their	O
surface	O
components	O
,	O
there	O
are	O
unique	O
differences	O
that	O
could	O
potentially	O
be	O
important	O
in	O
affecting	O
the	O
behavior	O
of	O
the	O
strains	O
and	O
might	O
be	O
useful	O
for	O
strain	O
typing	O
.	O

Two	O
-	O
component	O
regulatory	O
systems	O

OG1RF	B-Organism
lacks	O
four	O
two	O
-	O
component	O
systems	O
found	O
in	O
V583	B-Organism
.	O

These	O
are	O
histidine	B-Protein
kinase	I-Protein
-	O
response	O
regulator	O
(	O
HK	B-Protein
-	O
RR	B-Protein
)	I-Protein
08	I-Protein
,	O
HK	B-Protein
-	O
RR12	B-Protein
located	O
in	O
the	O
PAI	O
,	O
HK	B-Protein
-	O
RR16	B-Protein
and	O
the	O
vanB	B-Protein
regulatory	O
system	O
HK	B-Protein
-	O
RR11	B-Protein
[	O
38	O
]	O
.	O

However	O
,	O
an	O
OG1RF	B-Organism
-	O
unique	O
two	O
-	O
component	O
system	O
with	O
high	O
homology	O
with	O
the	O
vanG	B-Protein
locus	O
was	O
found	O
at	O
the	O
location	O
corresponding	O
to	O
the	O
region	O
between	O
EF2860	B-Protein
and	O
EF2861	B-Protein
in	O
V583	B-Organism
(	O
Table	O
3	O
)	O
.	O

OG1RF	B-Protein
_	I-Protein
0193	I-Protein
shares	O
82	O
%	O
similarity	O
with	O
VanRG	B-Protein
and	O
81	O
%	O
similarity	O
with	O
VanRG2	B-Protein
.	O

Similarly	O
,	O
OG1RF	B-Protein
_	I-Protein
0192	I-Protein
shares	O
68	O
%	O
similarity	O
with	O
VanSG	B-Protein
and	O
VanSG2	B-Protein
.	O

A	O
gene	O
(	O
OG1RF	B-Protein
_	I-Protein
0191	I-Protein
)	O
encoding	O
an	O
M15	B-Protein
family	O
muramoyl	O
pentapeptide	O
carboxypeptidase	O
is	O
located	O
downstream	O
of	O
these	O
two	O
-	O
component	O
regulatory	O
genes	O
(	O
Figure	O
4a	O
)	O
.	O

The	O
predicted	O
carboxypeptidase	O
(	O
OG1RF	B-Protein
_	I-Protein
0191	I-Protein
)	O
shares	O
69	O
%	O
similarity	O
over	O
179	O
amino	O
acids	O
with	O
EF2297	B-Protein
,	O
a	O
membrane	O
-	O
associated	O
D	O
,	O
D	O
-	O
carboxypeptidase	O
encoded	O
by	O
the	O
vanB	B-Protein
operon	O
in	O
V583	B-Organism
.	O

However	O
,	O
OG1RF	B-Protein
_	I-Protein
0191	I-Protein
lacks	O
an	O
identifiable	O
transmembrane	O
domain	O
that	O
is	O
important	O
to	O
the	O
VanY	B-Protein
function	O
and	O
it	O
is	O
likely	O
,	O
therefore	O
,	O
that	O
this	O
protein	O
may	O
be	O
a	O
soluble	O
D	O
,	O
D	O
-	O
carboxypeptidase	O
/	O
transpeptidase	O
as	O
seen	O
in	O
Streptomyces	B-Organism
[	O
39	O
]	O
and	O
Actinomadura	B-Organism
[	O
40	O
]	O
,	O
and	O
thus	O
may	O
not	O
be	O
involved	O
in	O
peptidoglycan	O
metabolism	O
.	O

Consequently	O
,	O
it	O
seems	O
unlikely	O
that	O
this	O
operon	O
is	O
a	O
remnant	O
of	O
a	O
vancomycin	B-Chemical
resistance	O
operon	O
in	O
OG1RF	B-Organism
,	O
but	O
rather	O
part	O
of	O
a	O
still	O
unknown	O
regulatory	O
pathway	O
.	O

The	O
iol	B-Regulon-operon
operon	O

OG1RF	B-Organism
carries	O
an	O
iol	B-Regulon-operon
operon	O
while	O
V583	B-Organism
does	O
not	O
.	O

This	O
operon	O
encodes	O
the	O
factors	O
necessary	O
for	O
the	O
degradation	O
of	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
into	O
glyceraldehyde	B-Chemical
-	I-Chemical
3P	I-Chemical
.	O

Many	O
soil	O
and	O
plant	O
micro	O
-	O
organisms	O
,	O
including	O
Bacillus	B-Organism
subtilis	I-Organism
[	O
41	O
]	O
(	O
first	O
iol	B-Regulon-operon
operon	O
identified	O
)	O
,	O
Klebsiella	B-Organism
spp	O
.	O

[	O
42	O
]	O
,	O
and	O
cryptococci	O
[	O
43	O
]	O
,	O
have	O
been	O
reported	O
to	O
use	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
as	O
a	O
sole	O
carbon	B-Chemical
source	O
.	O

Myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
,	O
one	O
of	O
the	O
nine	O
isomers	O
of	O
the	O
inositol	B-Chemical
group	O
,	O
belongs	O
to	O
the	O
cyclitol	B-Chemical
group	O
and	O
is	O
abundant	O
in	O
nature	O
,	O
particularly	O
in	O
the	O
soil	O
.	O

The	O
OG1RF	B-Organism
iol	B-Regulon-operon
operon	O
appears	O
to	O
be	O
closely	O
related	O
to	O
ones	O
described	O
in	O
Clostridium	B-Organism
perfringens	I-Organism
[	O
44	O
]	O
and	O
Lactobacillus	B-Organism
casei	I-Organism
[	O
45	O
]	O
.	O

In	O
L	B-Organism
.	I-Organism
casei	I-Organism
,	O
the	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
operon	O
consists	O
of	O
ten	O
genes	O
with	O
an	O
upstream	O
divergent	O
regulator	O
gene	O
,	O
iolR	B-Protein
.	O

In	O
OG1RF	B-Organism
,	O
the	O
operon	O
appears	O
to	O
include	O
ten	O
genes	O
,	O
beginning	O
with	O
a	O
probable	O
transcriptional	O
regulator	O
(	O
helix	O
-	O
turn	O
-	O
helix	O
domain	O
protein	O
)	O
.	O

Also	O
,	O
the	O
OG1RF	B-Organism
operon	O
carries	O
two	O
copies	O
of	O
an	O
iolG	B-Protein
-	O
like	O
gene	O
,	O
which	O
encodes	O
inositol	B-Chemical
2	O
-	O
dehydrogenase	O
,	O
the	O
first	O
enzyme	O
of	O
the	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
degradation	O
pathway	O
(	O
Figure	O
5	O
)	O
.	O

However	O
,	O
the	O
order	O
of	O
the	O
genes	O
is	O
not	O
the	O
same	O
between	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
and	O
L	B-Organism
.	I-Organism
casei	I-Organism
.	O

In	O
addition	O
,	O
iolH	B-Protein
,	O
iolJ	B-Protein
and	O
iolK	B-Protein
,	O
present	O
in	O
L	B-Organism
.	I-Organism
casei	I-Organism
,	O
are	O
not	O
present	O
in	O
OG1RF	B-Organism
,	O
nor	O
are	O
iolH	B-Protein
and	O
iolK	B-Protein
present	O
in	O
the	O
C	B-Organism
.	I-Organism
perfringens	I-Organism
iol	B-Regulon-operon
operon	O
.	O

Yebra	O
et	O
al	O
.	O
reported	O
that	O
L	B-Organism
.	I-Organism
casei	I-Organism
was	O
the	O
sole	O
member	O
of	O
the	O
Lactobacillales	B-Organism
to	O
carry	O
a	O
functional	O
iol	B-Regulon-operon
operon	O
[	O
45	O
]	O
.	O

To	O
survey	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
,	O
also	O
a	O
member	O
of	O
this	O
order	O
,	O
for	O
the	O
presence	O
of	O
the	O
iol	B-Regulon-operon
operon	O
,	O
48	O
isolates	O
with	O
different	O
MLST	O
and	O
/	O
or	O
from	O
various	O
origins	O
(	O
including	O
OG1RF	B-Organism
and	O
V583	B-Organism
)	O
were	O
tested	O
for	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
fermentation	O
;	O
23	O
of	O
48	O
isolates	O
were	O
positive	O
.	O

In	O
addition	O
,	O
PCR	O
verified	O
the	O
presence	O
of	O
iolE	B-Protein
and	O
iolR	B-Protein
in	O
these	O
strains	O
and	O
in	O
one	O
negative	O
for	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
fermentation	O
,	O
indicating	O
that	O
the	O
iol	B-Regulon-operon
operon	O
is	O
not	O
unique	O
to	O
OG1RF	B-Organism
.	O

To	O
verify	O
that	O
the	O
iol	O
genes	O
are	O
responsible	O
for	O
the	O
fermentation	O
of	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
in	O
OG1RF	B-Organism
,	O
transposon	O
insertion	O
mutants	O
[	O
9	O
]	O
in	O
the	O
iolB	B-Protein
and	O
iolG2	B-Protein
genes	O
of	O
OG1RF	B-Organism
were	O
tested	O
.	O

Both	O
mutants	O
failed	O
to	O
ferment	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
(	O
data	O
not	O
shown	O
)	O
,	O
demonstrating	O
that	O
these	O
genes	O
are	O
essential	O
for	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
fermentation	O
.	O

To	O
investigate	O
whether	O
the	O
iol	B-Regulon-operon
operon	O
was	O
'	O
inserted	O
into	O
'	O
or	O
'	O
removed	O
from	O
'	O
a	O
putative	O
ancestral	O
strain	O
,	O
the	O
sequences	O
surrounding	O
the	O
iol	O
genes	O
were	O
examined	O
.	O

In	O
OG1RF	B-Organism
,	O
the	O
iol	B-Regulon-operon
operon	O
is	O
located	O
between	O
the	O
equivalent	O
of	O
EF2239	B-Protein
and	O
EF2352	B-Protein
when	O
compared	O
with	O
V583	B-Organism
.	O

In	O
V583	B-Organism
,	O
this	O
region	O
encodes	O
probable	O
prophage	O
proteins	O
and	O
carries	O
the	O
vanB	B-Protein
transposon	O
,	O
which	O
confers	O
vancomycin	B-Chemical
resistance	O
.	O

Since	O
we	O
did	O
not	O
identify	O
any	O
remnants	O
of	O
the	O
iol	B-Regulon-operon
operon	O
in	O
V583	B-Organism
,	O
it	O
would	O
appear	O
that	O
at	O
least	O
two	O
independent	O
events	O
at	O
the	O
same	O
location	O
differentiate	O
OG1RF	B-Organism
and	O
V583	B-Organism
,	O
suggesting	O
that	O
it	O
is	O
a	O
hot	O
region	O
for	O
rearrangement	O
.	O

This	O
region	O
between	O
EF2239	B-Protein
and	O
EF2352	B-Protein
(	O
111	O
Kb	O
)	O
is	O
also	O
missing	O
in	O
the	O
Symbioflor	B-Organism
1	I-Organism
strain	O
(	O
referred	O
to	O
as	O
gap	O
2	O
)	O
[	O
5	O
]	O
.	O

The	O
possible	O
junction	O
and	O
presence	O
of	O
unique	O
sequence	O
in	O
this	O
region	O
,	O
if	O
investigated	O
,	O
was	O
not	O
mentioned	O
in	O
the	O
publication	O
.	O

Nonetheless	O
,	O
preliminary	O
analysis	O
of	O
other	O
strains	O
'	O
genotypes	O
in	O
this	O
area	O
seemed	O
to	O
confirm	O
the	O
hypothesis	O
of	O
a	O
hot	O
region	O
for	O
rearrangement	O
(	O
data	O
not	O
shown	O
)	O
.	O

A	O
homologue	O
of	O
Tn916	B-Protein
in	O
OG1RF	B-Organism

An	O
analysis	O
of	O
the	O
G	O
+	O
C	O
content	O
of	O
OG1RF	B-Organism
unique	O
regions	O
revealed	O
several	O
loci	O
with	O
a	O
lower	O
G	O
+	O
C	O
content	O
than	O
the	O
37	O
.	O
8	O
%	O
average	O
content	O
of	O
OG1RF	B-Organism
.	O

One	O
of	O
these	O
is	O
an	O
approximately	O
49	O
kb	O
fragment	O
with	O
a	O
G	O
+	O
C	O
content	O
of	O
32	O
.	O
1	O
%	O
located	O
between	O
an	O
rRNA	B-Regulon-operon
operon	I-Regulon-operon
and	O
the	O
homologue	O
in	O
OG1RF	B-Organism
of	O
EF1053	B-Protein
,	O
replacing	O
10	O
tRNA	O
genes	O
present	O
in	O
V583	B-Organism
(	O
Figure	O
1	O
)	O
.	O

This	O
fragment	O
appears	O
to	O
be	O
a	O
patchwork	O
composed	O
of	O
hypothetical	O
genes	O
,	O
homologues	O
of	O
Tn916	B-Protein
-	O
associated	O
genes	O
and	O
homologues	O
of	O
genes	O
from	O
other	O
Gram	O
-	O
positive	O
organisms	O
,	O
including	O
Listeria	O
,	O
E	B-Organism
.	I-Organism
faecium	I-Organism
,	O
staphylococci	B-Organism
,	O
or	O
lactococci	B-Organism
(	O
Additional	O
data	O
file	O
1	O
)	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
this	O
region	O
contains	O
:	O
a	O
putative	O
adhesin	O
protein	O
gene	O
(	O
OG1RF	B-Protein
_	I-Protein
0039	I-Protein
)	O
at	O
one	O
end	O
of	O
the	O
fragment	O
;	O
homologues	O
of	O
14	O
Tn916	B-Protein
-	O
associated	O
genes	O
(	O
Tn916	B-Protein
_	I-Protein
2	I-Protein
to	O
Tn916	B-Protein
_	I-Protein
12	I-Protein
,	O
Tn916	B-Protein
_	I-Protein
18	I-Protein
and	O
Tn916	B-Protein
_	I-Protein
19	I-Protein
,	O
with	O
an	O
average	O
of	O
70	O
%	O
similarity	O
)	O
;	O
and	O
a	O
gene	O
encoding	O
a	O
putative	O
integrase	O
(	O
OG1RF	B-Protein
_	I-Protein
0088	I-Protein
)	O
at	O
the	O
other	O
end	O
-	O
these	O
three	O
features	O
are	O
also	O
present	O
in	O
Tn5386	B-Protein
in	O
E	B-Organism
.	I-Organism
faecium	I-Organism
D344R	I-Organism
[	O
46	O
]	O
.	O

However	O
,	O
the	O
approximately	O
49	O
kb	O
fragment	O
lacks	O
an	O
excisase	O
gene	O
and	O
the	O
probable	O
lantibiotic	O
ABC	O
transporter	O
genes	O
present	O
in	O
Tn5386	B-Protein
.	O

An	O
uninterrupted	O
competence	O
operon	O
in	O
OG1RF	B-Organism

OG1RF	B-Organism
contains	O
what	O
appears	O
to	O
be	O
an	O
intact	O
competence	O
operon	O
while	O
that	O
of	O
V583	B-Organism
appears	O
to	O
be	O
non	O
-	O
functional	O
.	O

This	O
operon	O
in	O
OG1RF	B-Organism
is	O
similar	O
to	O
a	O
nine	O
-	O
gene	O
operon	O
described	O
in	O
Streptococcus	B-Organism
mutans	I-Organism
[	O
47	O
]	O
,	O
as	O
shown	O
in	O
Figure	O
6	O
.	O

For	O
example	O
,	O
the	O
homologue	O
in	O
OG1RF	B-Organism
of	O
EF2046	B-Protein
shares	O
61	O
%	O
similarity	O
with	O
ComYA	B-Regulon-operon
and	O
the	O
OG1RF	B-Organism
homologue	O
of	O
EF2045	B-Protein
is	O
55	O
%	O
similar	O
to	O
ComYB	B-Regulon-operon
.	O

In	O
S	B-Organism
.	I-Organism
mutans	I-Organism
,	O
only	O
the	O
first	O
seven	O
genes	O
of	O
the	O
operon	O
are	O
essential	O
for	O
competence	O
[	O
47	O
]	O
.	O

In	O
V583	B-Organism
,	O
the	O
fourth	O
gene	O
of	O
this	O
operon	O
(	O
corresponding	O
to	O
OG1RF	B-Protein
_	I-Protein
0148	I-Protein
)	O
is	O
interrupted	O
by	O
phage	O
4	O
(	O
EF1896	B-Protein
-	O
EF2043	B-Protein
)	O
;	O
in	O
addition	O
,	O
EF1984	B-Protein
contains	O
a	O
premature	O
stop	O
codon	O
not	O
found	O
in	O
the	O
corresponding	O
gene	O
in	O
OG1RF	B-Organism
(	O
OG1RF	B-Protein
_	I-Protein
0228	I-Protein
)	O
.	O

Natural	O
competence	O
has	O
not	O
been	O
reported	O
for	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
.	O

To	O
assess	O
the	O
functionality	O
of	O
this	O
operon	O
in	O
OG1RF	B-Organism
,	O
we	O
evaluated	O
the	O
competence	O
of	O
cells	O
in	O
different	O
phases	O
of	O
growth	O
(	O
early	O
log	O
growth	O
to	O
stationary	O
phase	O
)	O
using	O
pAM401	O
[	O
48	O
]	O
and	O
pMSP3535VA	O
[	O
49	O
]	O
.	O

We	O
were	O
not	O
able	O
to	O
show	O
natural	O
competence	O
under	O
the	O
conditions	O
tested	O
.	O

We	O
have	O
also	O
noted	O
that	O
V583	B-Organism
is	O
less	O
transformable	O
by	O
electroporation	O
than	O
OG1RF	B-Organism
.	O

To	O
investigate	O
the	O
possibility	O
that	O
directly	O
or	O
indirectly	O
the	O
com	B-Regulon-operon
operon	O
might	O
be	O
responsible	O
for	O
this	O
phenotype	O
,	O
we	O
also	O
evaluated	O
transformability	O
by	O
electroporation	O
.	O

When	O
compared	O
with	O
OG1RF	B-Organism
,	O
transposon	O
mutants	O
[	O
12	O
]	O
in	O
the	O
OG1RF	B-Organism
equivalent	O
of	O
EF2045	B-Protein
(	O
encoding	O
the	O
comGB	B-Regulon-operon
homologue	O
)	O
and	O
in	O
the	O
OG1RF	B-Organism
equivalent	O
of	O
EF1986	B-Protein
(	O
encoding	O
the	O
comGF	B-Regulon-operon
homologue	O
)	O
showed	O
similar	O
levels	O
of	O
transformability	O
by	O
electroporation	O
(	O
data	O
not	O
shown	O
)	O
,	O
implying	O
that	O
the	O
difference	O
in	O
electroporation	O
efficiency	O
observed	O
between	O
OG1RF	B-Organism
and	O
V583	B-Organism
is	O
not	O
related	O
to	O
this	O
locus	O
.	O

In	O
Streptococcus	B-Organism
pneumoniae	I-Organism
[	O
50	O
]	O
,	O
the	O
competence	O
operon	O
is	O
tightly	O
regulated	O
by	O
a	O
quorum	O
sensing	O
two	O
-	O
component	O
system	O
(	O
ComDE	B-Regulon-operon
)	O
and	O
a	O
competence	B-Protein
-	I-Protein
stimulating	I-Protein
peptide	I-Protein
(	O
CSP	B-Protein
;	O
encoded	O
by	O
comC	B-Protein
)	O
.	O

We	O
did	O
not	O
find	O
any	O
homologues	O
of	O
CSP	B-Protein
in	O
OG1RF	B-Organism
.	O

Two	O
homologous	O
ComDE	B-Regulon-operon
sensor	O
histidine	O
kinase	O
/	O
response	O
regulators	O
were	O
found	O
in	O
OG1RF	B-Organism
,	O
one	O
of	O
which	O
is	O
FsrC	B-Protein
/	O
FsrA	B-Protein
.	O

Based	O
on	O
our	O
previous	O
microarray	O
data	O
,	O
the	O
Fsr	O
system	O
does	O
not	O
regulate	O
the	O
comY	B-Protein
operon	O
,	O
at	O
least	O
under	O
our	O
previously	O
used	O
conditions	O
(	O
mid	O
-	O
log	O
phase	O
growth	O
to	O
early	O
stationary	O
phase	O
in	O
brain	O
heart	O
infusion	O
(	O
BHI	O
)	O
)	O
[	O
22	O
]	O
.	O

The	O
other	O
ComDE	B-Regulon-operon
homology	O
is	O
that	O
with	O
a	O
two	O
-	O
component	O
system	O
unique	O
to	O
OG1RF	B-Organism
(	O
OG1RF	B-Protein
_	I-Protein
0199	I-Protein
and	O
OG1RF	B-Protein
_	I-Protein
0198	I-Protein
,	O
respectively	O
)	O
that	O
lies	O
on	O
a	O
4	O
,	O
706	O
bp	O
unique	O
fragment	O
that	O
maps	O
between	O
EF3114	B-Protein
and	O
EF3115	B-Protein
in	O
V583	B-Organism
.	O

This	O
fragment	O
also	O
carries	O
two	O
genes	O
(	O
OG1RF	B-Protein
_	I-Protein
0200	I-Protein
and	O
OG1RF	B-Protein
_	I-Protein
0201	I-Protein
)	O
encoding	O
homologues	O
of	O
the	O
YhaQ	B-Protein
and	O
YhaP	B-Protein
sodium	B-Chemical
efflux	O
ATP	B-Chemical
-	O
binding	O
cassette	O
efflux	O
/	O
transporter	O
proteins	O
(	O
Figure	O
4b	O
)	O
.	O

Although	O
they	O
are	O
potential	O
elements	O
of	O
a	O
secretion	O
apparatus	O
,	O
these	O
two	O
proteins	O
do	O
not	O
share	O
any	O
homology	O
at	O
the	O
protein	O
level	O
with	O
the	O
competence	O
secretion	O
apparatus	O
ComAB	B-Regulon-operon
of	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
[	O
51	O
]	O
nor	O
CslAB	B-Regulon-operon
from	O
S	B-Organism
.	I-Organism
mutans	I-Organism
[	O
52	O
]	O
.	O

Searching	O
for	O
a	O
possible	O
CSP	O
in	O
the	O
vicinity	O
of	O
these	O
genes	O
,	O
we	O
identified	O
a	O
small	O
ORF	O
encoding	O
50	O
amino	O
acids	O
between	O
yhaP	B-Protein
and	O
OG1RF199	B-Protein
and	O
another	O
encoding	O
20	O
amino	O
acids	O
downstream	O
of	O
OG1RF198	B-Protein
.	O

More	O
analysis	O
will	O
be	O
required	O
to	O
determine	O
if	O
there	O
are	O
conditions	O
in	O
which	O
the	O
OG1RF	B-Organism
com	B-Regulon-operon
operon	O
is	O
expressed	O
and	O
to	O
determine	O
whether	O
or	O
not	O
this	O
two	O
-	O
component	O
system	O
is	O
involved	O
in	O
competence	O
.	O

Limited	O
presence	O
of	O
mobile	O
elements	O

By	O
probing	O
a	O
microarray	O
of	O
the	O
V583	O
genome	O
and	O
plasmids	O
with	O
OG1RF	B-Organism
genomic	O
DNA	O
,	O
we	O
previously	O
estimated	O
that	O
only	O
75	O
%	O
of	O
V583	B-Organism
ORFs	O
were	O
also	O
present	O
in	O
OG1RF	B-Organism
[	O
22	O
]	O
.	O

Later	O
,	O
Aakra	O
et	O
al	O
.	O

[	O
53	O
]	O
compared	O
nine	O
strains	O
,	O
including	O
OG1RF	B-Organism
to	O
V583	B-Organism
,	O
using	O
comparative	O
genomic	O
hybridization	O
.	O

In	O
these	O
results	O
,	O
OG1RF	B-Organism
appears	O
to	O
carry	O
a	O
few	O
genes	O
included	O
in	O
the	O
PAI	O
,	O
and	O
a	O
few	O
prophage	O
genes	O
.	O

Using	O
the	O
complete	O
genome	O
sequence	O
,	O
we	O
have	O
now	O
found	O
that	O
OG1RF	B-Organism
lacks	O
639	O
genes	O
and	O
the	O
three	O
pTET	O
plasmids	O
described	O
in	O
V583	B-Organism
.	O

All	O
but	O
45	O
of	O
the	O
missing	O
genes	O
are	O
associated	O
with	O
putative	O
mobile	O
elements	O
,	O
such	O
as	O
the	O
entire	O
PAI	O
,	O
the	O
recently	O
described	O
phages	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6	O
,	O
and	O
7	O
[	O
31	O
]	O
,	O
and	O
the	O
approximately	O
111	O
kb	O
area	O
between	O
genes	O
EF2240	B-Protein
and	O
EF2351	B-Protein
(	O
including	O
the	O
vanB	B-Protein
transposon	O
)	O
present	O
in	O
V583	B-Organism
.	O

The	O
absence	O
of	O
these	O
elements	O
appears	O
also	O
to	O
be	O
a	O
characteristic	O
of	O
the	O
commensal	O
strain	O
Symbioflor	B-Organism
1	I-Organism
,	O
although	O
because	O
the	O
genome	O
was	O
not	O
completely	O
finished	O
,	O
the	O
possibility	O
remains	O
that	O
some	O
of	O
these	O
regions	O
were	O
not	O
sequenced	O
.	O

In	O
conclusion	O
,	O
other	O
than	O
the	O
approximately	O
49	O
kb	O
fragment	O
containing	O
a	O
Tn916	B-Protein
homologue	O
,	O
it	O
appears	O
that	O
OG1RF	B-Organism
has	O
only	O
one	O
additional	O
possible	O
mobile	O
element	O
derivative	O
,	O
namely	O
the	O
phage	O
2	O
proposed	O
to	O
be	O
part	O
of	O
the	O
core	O
genome	O
[	O
31	O
]	O
.	O

Fusidic	B-Chemical
acid	I-Chemical
and	O
rifampicin	B-Chemical
resistance	O

OG1RF	B-Organism
was	O
sequentially	O
selected	O
from	O
OG1	B-Organism
for	O
resistance	O
to	O
fusidic	B-Chemical
acid	I-Chemical
and	O
rifampicin	B-Chemical
[	O
9	O
]	O
.	O

The	O
mutation	O
leading	O
to	O
rifampicin	B-Chemical
resistance	O
was	O
identified	O
in	O
the	O
rpoB	B-Protein
gene	O
by	O
Ozawa	O
et	O
al	O
.	O

[	O
54	O
]	O
and	O
is	O
caused	O
by	O
the	O
A1467G	O
mutation	O
,	O
which	O
results	O
in	O
substitution	O
of	O
arginine	O
for	O
histidine	O
at	O
amino	O
acid	O
489	O
.	O

The	O
mutation	O
also	O
affected	O
the	O
clumping	O
phenotype	O
of	O
traA	B-Protein
mutants	O
and	O
this	O
effect	O
appears	O
to	O
be	O
specific	O
for	O
the	O
pAM373	O
system	O
[	O
54	O
]	O
.	O

All	O
of	O
the	O
other	O
22	O
differences	O
in	O
rpoB	B-Protein
between	O
OG1RF	B-Organism
and	O
V583	B-Organism
are	O
synonymous	O
.	O

Fusidic	B-Chemical
acid	I-Chemical
resistance	O
is	O
associated	O
with	O
mutation	O
(	O
s	O
)	O
in	O
the	O
fusA	B-Protein
gene	O
,	O
which	O
encodes	O
elongation	B-Protein
factor	I-Protein
G	I-Protein
.	O

We	O
compared	O
fusA	B-Protein
from	O
OG1RF	B-Organism
with	O
that	O
in	O
V583	B-Organism
and	O
identified	O
two	O
differences	O
(	O
C1368A	O
and	O
T1992C	O
)	O
.	O

The	O
mutation	O
T1992C	O
is	O
synonymous	O
,	O
while	O
the	O
mutation	O
C1368A	O
leads	O
to	O
the	O
presence	O
of	O
glutamine	O
(	O
histidine	O
in	O
V583	B-Organism
)	O
at	O
position	O
404	O
in	O
OG1RF	B-Organism
.	O

Mutations	O
in	O
this	O
region	O
have	O
been	O
associated	O
with	O
fusidic	B-Chemical
acid	I-Chemical
resistance	O
in	O
Staphylococcus	B-Organism
aureus	I-Organism
[	O
55	O
,	O
56	O
]	O
,	O
and	O
thus	O
the	O
C1368A	O
mutation	O
is	O
likely	O
the	O
cause	O
of	O
the	O
fusidic	B-Chemical
acid	I-Chemical
resistance	O
phenotype	O
in	O
OG1RF	B-Organism
.	O

Virulence	O
and	O
biofilm	O
comparisons	O
of	O
OG1RF	B-Organism
with	O
V583	B-Organism

When	O
compared	O
in	O
the	O
mouse	B-Organism
peritonitis	O
model	O
,	O
the	O
LD50	O
values	O
of	O
V583	B-Organism
in	O
different	O
determinations	O
were	O
lower	O
(	O
4	O
.	O
8	O
x	O
107	O
to	O
1	O
.	O
1	O
x	O
108	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
ml	O
)	O
than	O
the	O
LD50	O
values	O
of	O
OG1RF	B-Organism
(	O
1	O
.	O
2	O
x	O
108	O
to	O
4	O
.	O
8	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
.	O

However	O
,	O
at	O
comparable	O
inoculum	O
,	O
OG1RF	B-Organism
(	O
4	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
showed	O
more	O
rapid	O
mortality	O
versus	O
V583	B-Organism
(	O
5	O
x	O
108	O
CFU	O
/	O
ml	O
)	O
in	O
the	O
first	O
48	O
hours	O
(	O
P	O
=	O
0	O
.	O
0034	O
;	O
Additional	O
data	O
file	O
3	O
)	O
.	O

In	O
a	O
urinary	O
tract	O
infection	O
model	O
administering	O
mixed	O
equal	O
inocula	O
of	O
V583	B-Organism
and	O
OG1RF	B-Organism
,	O
OG1RF	B-Organism
significantly	O
outnumbered	O
V583	B-Organism
in	O
kidney	O
with	O
geometric	O
means	O
of	O
1	O
.	O
3	O
x	O
104	O
CFU	O
/	O
gm	O
for	O
OG1RF	B-Organism
versus	O
1	O
.	O
9	O
x	O
102	O
CFU	O
/	O
gm	O
for	O
V583	B-Organism
(	O
P	O
=	O
0	O
.	O
0005	O
)	O
;	O
in	O
urinary	O
bladder	O
homogenates	O
,	O
the	O
geometric	O
mean	O
CFU	O
/	O
gm	O
was	O
1	O
.	O
7	O
x	O
103	O
for	O
OG1RF	B-Organism
versus	O
6	O
.	O
6	O
x	O
101	O
for	O
V583	B-Organism
(	O
P	O
=	O
0	O
.	O
003	O
;	O
Figure	O
7a	O
)	O
.	O

Similarly	O
,	O
in	O
mono	O
-	O
infection	O
,	O
the	O
geometric	O
mean	O
CFU	O
/	O
gm	O
of	O
OG1RF	B-Organism
in	O
kidneys	O
was	O
9	O
.	O
4	O
x	O
103	O
versus	O
4	O
x	O
101	O
for	O
V583	B-Organism
(	O
P	O
=	O
0	O
.	O
0035	O
;	O
Figure	O
7b	O
)	O
.	O

We	O
also	O
found	O
that	O
OG1RF	B-Organism
produced	O
20	O
%	O
more	O
biofilm	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
than	O
V583	B-Organism
at	O
24	O
hours	O
(	O
results	O
not	O
shown	O
)	O
.	O

These	O
results	O
,	O
together	O
with	O
the	O
previous	O
results	O
in	O
C	B-Organism
.	I-Organism
elegans	I-Organism
[	O
17	O
]	O
,	O
demonstrate	O
that	O
OG1RF	B-Organism
,	O
although	O
lacking	O
what	O
was	O
thought	O
to	O
be	O
important	O
for	O
virulence	O
(	O
PAI	O
,	O
plasmids	O
,	O
prophages	O
)	O
,	O
is	O
as	O
pathogenic	O
as	O
V583	B-Organism
in	O
at	O
least	O
three	O
assays	O
.	O

Conclusion	O

E	B-Organism
.	I-Organism
faecalis	I-Organism
OG1RF	I-Organism
carries	O
a	O
number	O
of	O
unique	O
loci	O
compared	O
to	O
V583	B-Organism
.	O

Those	O
of	O
particular	O
interest	O
include	O
new	O
surface	O
proteins	O
(	O
MSCRAMMs	O
and	O
WxL	O
domain	O
proteins	O
)	O
,	O
an	O
operon	O
encoding	O
myo	B-Chemical
-	I-Chemical
inositol	I-Chemical
utilization	O
,	O
an	O
intact	O
competence	O
operon	O
,	O
and	O
two	O
CRISPR	O
elements	O
.	O

The	O
CRISPR	O
elements	O
may	O
be	O
of	O
particular	O
significance	O
when	O
one	O
considers	O
that	O
most	O
of	O
what	O
is	O
missing	O
from	O
OG1RF	B-Organism
compared	O
to	O
V583	B-Organism
consists	O
of	O
mobile	O
genetic	O
elements	O
(	O
MGEs	O
)	O
,	O
including	O
6	O
phages	O
or	O
remnants	O
thereof	O
.	O

The	O
presence	O
of	O
the	O
CRISPR	O
elements	O
in	O
OG1RF	B-Organism
provides	O
a	O
tantalizing	O
,	O
but	O
as	O
yet	O
unproven	O
,	O
explanation	O
for	O
the	O
discordance	O
in	O
the	O
number	O
of	O
mobile	O
elements	O
between	O
these	O
two	O
strains	O
.	O

The	O
acquisition	O
of	O
MGE	O
is	O
believed	O
to	O
be	O
an	O
important	O
mechanism	O
by	O
which	O
the	O
species	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
had	O
been	O
able	O
to	O
generate	O
genetic	O
diversity	O
and	O
,	O
thereby	O
,	O
highly	O
variable	O
phenotypes	O
[	O
4	O
]	O
.	O

It	O
has	O
been	O
proposed	O
that	O
the	O
ability	O
of	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
to	O
cause	O
healthcare	O
related	O
infections	O
is	O
associated	O
with	O
these	O
MGEs	O
[	O
4	O
,	O
5	O
]	O
.	O

This	O
hypothesis	O
was	O
supported	O
by	O
several	O
studies	O
that	O
have	O
highlighted	O
the	O
importance	O
of	O
virulence	O
determinants	O
carried	O
by	O
these	O
mobile	O
elements	O
,	O
such	O
as	O
cytolysin	O
[	O
57	O
]	O
by	O
the	O
PAI	O
.	O

However	O
,	O
more	O
recent	O
results	O
from	O
Aakra	O
et	O
al	O
.	O

[	O
53	O
]	O
and	O
Lepage	O
et	O
al	O
.	O

[	O
36	O
]	O
demonstrate	O
that	O
these	O
factors	O
may	O
be	O
present	O
in	O
harmless	O
strains	O
while	O
absent	O
in	O
clinical	O
isolates	O
,	O
indicating	O
that	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
virulence	O
is	O
not	O
dependent	O
on	O
any	O
single	O
virulence	O
factor	O
.	O

Indeed	O
,	O
few	O
studies	O
have	O
compared	O
the	O
virulence	O
pattern	O
of	O
strains	O
from	O
various	O
origins	O
.	O

The	O
increased	O
ability	O
of	O
OG1RF	B-Organism
to	O
infect	O
kidneys	O
and	O
to	O
produce	O
biofilm	O
,	O
despite	O
the	O
absence	O
of	O
MGEs	O
and	O
their	O
associated	O
virulence	O
factors	O
,	O
was	O
surprising	O
.	O

Different	O
possibilities	O
can	O
be	O
proposed	O
relating	O
to	O
the	O
factors	O
important	O
for	O
these	O
differences	O
in	O
enterococcal	O
infections	O
.	O

One	O
of	O
these	O
is	O
that	O
virulence	O
in	O
the	O
assays	O
used	O
may	O
be	O
linked	O
to	O
the	O
shared	O
core	O
genome	O
of	O
these	O
two	O
strains	O
,	O
with	O
the	O
differences	O
arising	O
from	O
the	O
unique	O
genes	O
.	O

On	O
the	O
other	O
hand	O
,	O
virulence	O
could	O
be	O
associated	O
primarily	O
with	O
the	O
genes	O
unique	O
to	O
each	O
strain	O
,	O
but	O
with	O
each	O
set	O
being	O
able	O
to	O
complement	O
the	O
absence	O
of	O
the	O
other	O
.	O

It	O
seems	O
most	O
likely	O
that	O
virulence	O
,	O
and	O
/	O
or	O
some	O
combination	O
of	O
virulence	O
and	O
fitness	O
,	O
is	O
caused	O
by	O
the	O
expression	O
of	O
a	O
mixture	O
of	O
both	O
the	O
core	O
and	O
unique	O
genes	O
.	O

It	O
is	O
also	O
important	O
to	O
remember	O
that	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
is	O
a	O
well	O
adapted	O
commensal	O
,	O
carrying	O
the	O
genes	O
necessary	O
to	O
survive	O
and	O
to	O
colonize	O
the	O
gut	O
,	O
and	O
that	O
a	O
subset	O
,	O
particularly	O
MLST	O
CC2	B-Organism
and	O
CC9	B-Organism
[	O
58	O
]	O
,	O
predominates	O
among	O
hospital	O
acquired	O
infections	O
.	O

It	O
may	O
be	O
that	O
these	O
clonal	O
complexes	O
are	O
not	O
more	O
virulent	O
per	O
se	O
,	O
as	O
defined	O
in	O
the	O
assays	O
described	O
here	O
,	O
but	O
rather	O
are	O
better	O
able	O
to	O
survive	O
and	O
/	O
or	O
colonize	O
hospitalized	O
patients	B-Organism
,	O
taking	O
advantage	O
of	O
factors	O
that	O
predispose	O
to	O
nosocomial	O
infections	O
such	O
as	O
urinary	O
or	O
venous	O
catheters	O
,	O
or	O
mucositis	O
,	O
among	O
others	O
.	O

Sequencing	O
of	O
more	O
E	B-Organism
.	I-Organism
faecalis	I-Organism
strains	O
may	O
facilitate	O
our	O
understanding	O
of	O
the	O
path	O
from	O
commensalism	O
to	O
pathogenicity	O
,	O
a	O
crucial	O
prerequisite	O
for	O
designing	O
therapeutic	O
interventions	O
directed	O
to	O
control	O
an	O
organism	O
that	O
is	O
already	O
resistant	O
to	O
a	O
large	O
spectrum	O
of	O
antibiotics	O
.	O

A	O
Naturally	O
Occurring	O
Mutation	O
in	O
ropB	B-Protein
Suppresses	O
SpeB	B-Protein
Expression	O
and	O
Reduces	O
M1T1	B-Organism
Group	O
A	O
Streptococcal	O
Systemic	O
Virulence	O

Epidemiological	O
studies	O
of	O
group	B-Organism
A	I-Organism
streptococcus	I-Organism
(	O
GAS	B-Organism
)	O
have	O
noted	O
an	O
inverse	O
relationship	O
between	O
SpeB	B-Protein
expression	O
and	O
invasive	O
disease	O
.	O

However	O
,	O
the	O
role	O
of	O
SpeB	B-Protein
in	O
the	O
course	O
of	O
infection	O
is	O
still	O
unclear	O
.	O

In	O
this	O
study	O
we	O
utilize	O
a	O
SpeB	B-Protein
-	O
negative	O
M1T1	O
clinical	O
isolate	O
,	O
5628	B-Organism
,	O
with	O
a	O
naturally	O
occurring	O
mutation	O
in	O
the	O
gene	O
encoding	O
the	O
regulator	O
RopB	B-Protein
,	O
to	O
elucidate	O
the	O
role	O
of	O
RopB	B-Protein
and	O
SpeB	B-Protein
in	O
systemic	O
virulence	O
.	O

Allelic	O
exchange	O
mutagenesis	O
was	O
used	O
to	O
replace	O
the	O
mutated	O
ropB	B-Protein
allele	O
in	O
5628	B-Organism
with	O
the	O
intact	O
allele	O
from	O
the	O
well	O
characterized	O
isolate	O
5448	B-Organism
.	O

The	O
inverse	O
allelic	O
exchange	O
was	O
also	O
performed	O
to	O
replace	O
the	O
intact	O
ropB	B-Protein
in	O
5448	B-Organism
with	O
the	O
mutated	O
allele	O
from	O
5628	B-Organism
.	O

An	O
intact	O
ropB	B-Protein
was	O
found	O
to	O
be	O
essential	O
for	O
SpeB	B-Protein
expression	O
.	O

While	O
the	O
ropB	B-Protein
mutation	O
was	O
shown	O
to	O
have	O
no	O
effect	O
on	O
hemolysis	O
of	O
RBC	O
'	O
s	O
,	O
extracellular	O
DNase	O
activity	O
or	O
survival	O
in	O
the	O
presence	O
of	O
neutrophils	O
,	O
strains	O
with	O
the	O
mutated	O
ropB	B-Protein
allele	O
were	O
less	O
virulent	O
in	O
murine	B-Organism
systemic	O
models	O
of	O
infection	O
.	O

An	O
isogenic	O
SpeB	B-Protein
knockout	O
strain	O
containing	O
an	O
intact	O
RopB	B-Protein
showed	O
similarly	O
reduced	O
virulence	O
.	O

Microarray	O
analysis	O
found	O
genes	O
of	O
the	O
SpeB	B-Protein
operon	O
to	O
be	O
the	O
primary	O
target	O
of	O
RopB	B-Protein
regulation	O
.	O

These	O
data	O
show	O
that	O
an	O
intact	O
RopB	B-Protein
and	O
efficient	O
SpeB	B-Protein
production	O
are	O
necessary	O
for	O
systemic	O
infection	O
with	O
GAS	B-Organism
.	O

Introduction	O

Streptococcus	B-Organism
pyogenes	I-Organism
(	O
group	B-Organism
A	I-Organism
streptococcus	I-Organism
;	O
GAS	B-Organism
)	O
is	O
a	O
Gram	O
-	O
positive	O
,	O
human	B-Organism
-	O
specific	O
pathogen	O
responsible	O
for	O
over	O
500	O
,	O
000	O
deaths	O
each	O
year	O
[	O
1	O
]	O
.	O

Severe	O
invasive	O
GAS	B-Organism
infections	O
such	O
as	O
necrotizing	O
fasciitis	O
account	O
for	O
approximately	O
30	O
%	O
of	O
these	O
deaths	O
,	O
and	O
the	O
incidence	O
of	O
such	O
acute	O
conditions	O
has	O
been	O
on	O
the	O
rise	O
since	O
the	O
mid	O
1980	O
'	O
s	O
[	O
2	O
]	O
.	O

This	O
resurgence	O
has	O
been	O
paralleled	O
by	O
the	O
emergence	O
of	O
a	O
globally	O
disseminated	O
GAS	B-Organism
cone	O
belonging	O
to	O
serotype	O
M1T1	B-Organism
[	O
3	O
]	O
-	O
[	O
5	O
]	O
.	O

While	O
the	O
M1T1	B-Organism
GAS	I-Organism
has	O
become	O
the	O
most	O
common	O
cause	O
of	O
streptococcal	O
pharyngitis	O
,	O
this	O
clone	O
is	O
also	O
overrepresented	O
in	O
cases	O
of	O
severe	O
invasive	O
disease	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Studies	O
of	O
M1T1	B-Organism
clinical	O
isolates	O
from	O
invasive	O
disease	O
cases	O
have	O
revealed	O
an	O
inverse	O
relationship	O
between	O
expression	O
of	O
the	O
extracellular	O
cysteine	O
protease	O
SpeB	B-Protein
and	O
clinical	O
severity	O
[	O
8	O
]	O
.	O

The	O
existence	O
of	O
a	O
SpeB	B-Protein
-	O
negative	O
invasive	O
phenotype	O
has	O
been	O
hypothesized	O
that	O
results	O
from	O
mutations	O
in	O
the	O
regulator	O
covR	B-Protein
/	O
S	B-Protein
[	O
9	O
]	O
.	O

SpeB	B-Protein
is	O
a	O
secreted	O
cysteine	O
protease	O
initially	O
expressed	O
as	O
40	O
kDa	O
zymogen	O
which	O
is	O
then	O
converted	O
to	O
the	O
28	O
kDa	O
active	O
form	O
by	O
autocatalytic	O
processing	O
[	O
10	O
]	O
.	O

SpeB	B-Protein
is	O
known	O
to	O
cleave	O
numerous	O
host	O
proteins	O
including	O
components	O
of	O
the	O
extracellular	O
matrix	O
,	O
cytokine	O
precursors	O
,	O
immunoglobulins	O
and	O
antimicrobial	O
peptides	O
[	O
11	O
]	O
-	O
[	O
13	O
]	O
,	O
which	O
could	O
interfere	O
with	O
host	O
immune	O
functions	O
.	O

However	O
,	O
SpeB	B-Protein
has	O
also	O
been	O
shown	O
to	O
cleave	O
a	O
range	O
of	O
GAS	B-Organism
proteins	O
such	O
as	O
the	O
fibrinogen	B-Protein
-	I-Protein
binding	I-Protein
M1	I-Protein
protein	I-Protein
[	O
14	O
]	O
,	O
[	O
15	O
]	O
,	O
various	O
superantigens	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
,	O
the	O
secreted	O
plasminogen	B-Protein
activator	I-Protein
streptokinase	I-Protein
[	O
18	O
]	O
as	O
well	O
as	O
the	O
DNase	O
Sda1	B-Protein
[	O
17	O
]	O
,	O
and	O
thus	O
possibly	O
interfere	O
with	O
the	O
proven	O
virulence	O
functions	O
of	O
these	O
bacterial	O
factors	O
.	O

The	O
precise	O
role	O
(	O
s	O
)	O
of	O
SpeB	B-Protein
throughout	O
the	O
course	O
of	O
infection	O
are	O
undoubtedly	O
complex	O
,	O
and	O
not	O
surprisingly	O
,	O
different	O
studies	O
using	O
different	O
in	O
vivo	O
animal	O
models	O
have	O
produced	O
seemingly	O
contradictory	O
results	O
[	O
19	O
]	O
-	O
[	O
21	O
]	O
.	O

In	O
this	O
study	O
we	O
examined	O
the	O
effect	O
of	O
a	O
natural	O
mutation	O
in	O
the	O
gene	O
encoding	O
the	O
regulator	O
RopB	B-Protein
(	O
also	O
known	O
as	O
Rgg	B-Protein
[	O
22	O
]	O
)	O
identified	O
in	O
a	O
SpeB	B-Protein
-	O
negative	O
GAS	O
clinical	O
isolate	O
.	O

RopB	B-Protein
is	O
a	O
GAS	B-Organism
transcriptional	O
regulator	O
that	O
has	O
been	O
shown	O
to	O
be	O
essential	O
for	O
expression	O
of	O
SpeB	B-Protein
and	O
binds	O
directly	O
to	O
the	O
promoter	O
region	O
of	O
speB	B-Protein
[	O
23	O
]	O
,	O
[	O
24	O
]	O
.	O

In	O
studies	O
performed	O
in	O
different	O
GAS	B-Organism
serotype	O
strains	O
,	O
RopB	B-Protein
has	O
variably	O
been	O
suggested	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
other	O
GAS	B-Organism
genes	O
including	O
those	O
associated	O
with	O
metabolism	O
of	O
non	O
-	O
glucose	O
carbohydrates	O
and	O
amino	O
acids	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
,	O
response	O
to	O
thermal	O
and	O
oxidative	O
stress	O
[	O
25	O
]	O
,	O
[	O
27	O
]	O
and	O
the	O
expression	O
of	O
virulence	O
factors	O
including	O
DNases	O
(	O
MF	B-Protein
-	I-Protein
1	I-Protein
and	O
MF	B-Protein
-	I-Protein
3	I-Protein
)	O
and	O
hemolysins	O
(	O
streptolysin	B-Protein
S	I-Protein
and	O
streptolysin	B-Protein
O	I-Protein
)	O
[	O
26	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
.	O

Subsequent	O
investigations	O
into	O
the	O
effect	O
of	O
RopB	B-Protein
on	O
virulence	O
have	O
yielded	O
differing	O
results	O
.	O

A	O
study	O
utilizing	O
a	O
zebrafish	B-Organism
intramuscular	O
infection	O
model	O
with	O
serotype	O
M5	B-Organism
GAS	I-Organism
showed	O
that	O
inactivation	O
of	O
RopB	B-Protein
resulted	O
in	O
decreased	O
virulence	O
[	O
30	O
]	O
,	O
whereas	O
a	O
study	O
utilizing	O
a	O
murine	B-Organism
intraperitoneal	O
infection	O
model	O
with	O
serotype	O
M49	B-Organism
GAS	I-Organism
showed	O
that	O
inactivation	O
of	O
RopB	B-Protein
resulted	O
in	O
increased	O
virulence	O
[	O
27	O
]	O
.	O

While	O
such	O
global	O
differences	O
in	O
virulence	O
effects	O
could	O
in	O
part	O
result	O
from	O
the	O
differing	O
animal	O
models	O
used	O
,	O
it	O
may	O
also	O
reflect	O
strain	O
-	O
specific	O
variation	O
in	O
the	O
RopB	B-Protein
regulon	O
.	O

For	O
example	O
,	O
separate	O
studies	O
have	O
shown	O
ropB	B-Protein
mutation	O
to	O
have	O
either	O
no	O
effect	O
on	O
hemolysis	O
and	O
DNase	O
activity	O
or	O
,	O
alternatively	O
,	O
to	O
increase	O
expression	O
of	O
hemolysin	O
and	O
DNase	O
-	O
encoding	O
genes	O
and	O
the	O
associated	O
phenotypic	O
activities	O
[	O
23	O
]	O
,	O
[	O
26	O
]	O
.	O

This	O
strain	O
-	O
specific	O
variation	O
is	O
highlighted	O
in	O
a	O
recent	O
work	O
by	O
Dmitriev	O
et	O
al	O
.	O

[	O
29	O
]	O
that	O
shows	O
inter	O
-	O
and	O
intra	O
-	O
serotypic	O
variation	O
in	O
the	O
transcriptome	O
of	O
ropB	B-Protein
mutant	O
GAS	O
,	O
with	O
only	O
members	O
of	O
the	O
SpeB	B-Protein
operon	O
being	O
commonly	O
regulated	O
in	O
all	O
strains	O
tested	O
.	O

It	O
is	O
in	O
the	O
light	O
of	O
the	O
current	O
uncertainty	O
surrounding	O
RopB	B-Protein
and	O
its	O
role	O
in	O
virulence	O
that	O
we	O
sought	O
to	O
investigate	O
the	O
role	O
of	O
this	O
transcriptional	O
regulator	O
in	O
the	O
serotype	O
M1T1	B-Organism
GAS	I-Organism
background	O
that	O
is	O
the	O
leading	O
agent	O
of	O
severe	O
human	B-Organism
infection	O
.	O

This	O
analysis	O
begins	O
with	O
a	O
naturally	O
-	O
occuring	O
mutation	O
in	O
ropB	B-Protein
identified	O
in	O
one	O
such	O
strain	O
.	O

Results	O

Sequence	O
analysis	O
of	O
clinical	O
isolate	O
5628	B-Organism
reveals	O
intact	O
speB	B-Protein
and	O
covR	B-Protein
/	O
S	B-Protein
but	O
mutation	O
in	O
ropB	B-Protein
M1T1	B-Organism
GAS	I-Organism
clinical	O
isolate	O
5628	B-Organism
was	O
found	O
on	O
screening	O
to	O
lack	O
SpeB	B-Protein
activity	O
by	O
azocasein	O
assay	O
.	O

DNA	O
sequencing	O
was	O
performed	O
using	O
primers	O
listed	O
in	O
Table	O
1	O
.	O

No	O
mutations	O
were	O
found	O
in	O
the	O
strain	O
5628	B-Organism
in	O
the	O
speB	B-Protein
gene	O
nor	O
in	O
the	O
covR	B-Protein
/	O
S	B-Protein
locus	O
,	O
which	O
has	O
been	O
previously	O
linked	O
to	O
loss	O
of	O
SpeB	B-Protein
expression	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
.	O

Further	O
sequencing	O
was	O
performed	O
on	O
the	O
previously	O
described	O
regulators	O
luxS	B-Protein
,	O
rofA	B-Protein
,	O
ropA	B-Protein
and	O
ropB	B-Protein
[	O
24	O
]	O
,	O
[	O
39	O
]	O
-	O
[	O
41	O
]	O
.	O

This	O
analysis	O
revealed	O
a	O
point	O
mutation	O
in	O
ropB	B-Protein
,	O
leading	O
to	O
truncation	O
of	O
RopB	B-Protein
at	O
amino	O
acid	O
170	O
of	O
the	O
280	O
amino	O
acid	O
protein	O
(	O
Fig	O
.	O
1A	O
)	O
.	O

The	O
truncation	O
of	O
RopB	B-Protein
suggested	O
that	O
this	O
may	O
be	O
the	O
cause	O
of	O
lack	O
of	O
SpeB	B-Protein
expression	O
in	O
this	O
strain	O
.	O

Repair	O
of	O
the	O
5628	B-Organism
ropB	B-Protein
allele	O
restores	O
SpeB	B-Protein
expression	O
and	O
activity	O

Western	O
blot	O
detected	O
SpeB	B-Protein
in	O
overnight	O
culture	O
supernatants	O
of	O
5628R	B-Organism
+	I-Organism
,	O
containing	O
the	O
intact	O
ropB	B-Protein
allele	O
,	O
but	O
not	O
in	O
the	O
clinical	O
isolate	O
5628	B-Organism
nor	O
the	O
isogenic	O
mutant	O
5628RDeltaSpeB	B-Protein
,	O
containing	O
the	O
intact	O
ropB	B-Protein
allele	O
but	O
lacking	O
speB	B-Protein
(	O
Fig	O
.	O
1B	O
)	O
.	O

This	O
expression	O
correlated	O
with	O
a	O
restoration	O
of	O
extracellular	O
protease	O
activity	O
as	O
detected	O
by	O
azocasein	O
degradation	O
assay	O
(	O
Fig	O
.	O
1C	O
)	O
.	O

Protease	O
activity	O
was	O
abrogated	O
by	O
the	O
addition	O
of	O
the	O
cysteine	O
protease	O
inhibitor	O
E64	O
.	O

These	O
data	O
demonstrated	O
that	O
the	O
ropB	B-Protein
point	O
mutation	O
was	O
indeed	O
responsible	O
for	O
the	O
lack	O
of	O
SpeB	B-Protein
expression	O
in	O
the	O
clinical	O
isolate	O
5628	B-Organism
.	O

RopB	B-Protein
mutation	O
does	O
not	O
affect	O
bacterial	O
growth	O
,	O
hemolysis	O
,	O
DNase	O
activity	O
or	O
resistance	O
to	O
neutrophil	O
killing	O

GAS	B-Organism
strain	I-Organism
5628	I-Organism
and	O
its	O
isogenic	O
mutants	O
5628R	B-Organism
+	I-Organism
and	O
5628RDeltaSpeB	B-Protein
were	O
grown	O
in	O
THB	O
,	O
and	O
the	O
OD600	O
was	O
measured	O
over	O
time	O
.	O

No	O
significant	O
difference	O
was	O
found	O
among	O
the	O
growth	O
rates	O
of	O
the	O
three	O
bacterial	O
strains	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Hemolysis	O
assays	O
were	O
performed	O
to	O
determine	O
the	O
effect	O
of	O
ropB	B-Protein
mutation	O
on	O
the	O
cytolytic	O
ability	O
of	O
GAS	B-Organism
.	O

No	O
significant	O
difference	O
was	O
seen	O
in	O
hemolytic	O
activity	O
among	O
strains	O
containing	O
the	O
WT	O
or	O
mutated	O
ropB	B-Protein
allele	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

Extracellular	O
DNase	O
activity	O
of	O
mid	O
-	O
log	O
phase	O
bacteria	O
and	O
GAS	B-Organism
resistance	O
to	O
neutrophil	O
killing	O
were	O
also	O
unaffected	O
by	O
mutation	O
in	O
ropB	B-Protein
(	O
Fig	O
.	O
2C	O
and	O
2D	O
)	O
.	O

SpeB	B-Protein
-	O
positive	O
bacteria	O
revert	O
to	O
a	O
SpeB	B-Protein
-	O
negative	O
phenotype	O
on	O
subcutaneous	O
infection	O

C57BL6	B-Organism
/	I-Organism
J	I-Organism
mice	I-Organism
were	O
subcutaneously	O
infected	O
with	O
the	O
SpeB	B-Protein
-	O
positive	O
strain	O
5628R	B-Organism
+	I-Organism
.	O

Three	O
days	O
post	O
-	O
infection	O
,	O
bacteria	O
were	O
recovered	O
from	O
the	O
lesion	O
and	O
screened	O
for	O
SpeB	B-Protein
status	O
using	O
the	O
skim	O
-	O
milk	O
agar	O
method	O
.	O

While	O
the	O
inoculum	O
was	O
100	O
%	O
SpeB	B-Protein
-	O
positive	O
,	O
bacterial	O
populations	O
recovered	O
from	O
the	O
lesions	O
of	O
individual	O
mice	B-Organism
were	O
found	O
to	O
be	O
2	O
%	O
,	O
4	O
%	O
,	O
6	O
%	O
,	O
8	O
%	O
,	O
and	O
24	O
%	O
SpeB	B-Protein
-	O
negative	O
.	O

Five	O
representative	O
colonies	O
were	O
picked	O
,	O
and	O
the	O
covR	B-Protein
/	O
S	B-Protein
locus	O
was	O
sequenced	O
in	O
each	O
of	O
them	O
.	O

All	O
colonies	O
sequenced	O
were	O
found	O
to	O
have	O
substitution	O
mutations	O
in	O
covR	B-Protein
/	O
S	B-Protein
resulting	O
in	O
truncation	O
of	O
CovS	B-Protein
.	O

This	O
finding	O
reveals	O
that	O
when	O
SpeB	B-Protein
-	O
negative	O
colonies	O
are	O
selected	O
for	O
in	O
vivo	O
,	O
this	O
selection	O
is	O
predominantly	O
a	O
phenomenon	O
associated	O
with	O
CovR	B-Protein
/	O
S	B-Protein
inactivation	O
.	O

The	O
ropB	B-Protein
mutation	O
of	O
strain	O
5628	B-Organism
was	O
not	O
recapitulated	O
on	O
passage	O
in	O
the	O
mouse	B-Organism
subcutaneous	O
infection	O
model	O
.	O

SpeB	B-Protein
is	O
the	O
principal	O
target	O
of	O
RopB	B-Protein
regulation	O
in	O
vivo	O

Microarray	O
analysis	O
was	O
performed	O
on	O
in	O
vivo	O
-	O
derived	O
RNA	O
from	O
the	O
well	O
characterized	O
GAS	B-Organism
strain	I-Organism
5448	I-Organism
and	O
its	O
derivative	O
5448R	B-Organism
-	I-Organism
,	O
containing	O
the	O
mutated	O
ropB	B-Protein
allele	O
from	O
5628	B-Organism
.	O

Fourty	O
-	O
seven	O
genes	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
and	O
52	O
genes	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
in	O
5448R	O
-	O
greater	O
than	O
2	O
-	O
fold	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
most	O
strongly	O
down	O
-	O
regulated	O
genes	O
in	O
5448R	B-Organism
-	I-Organism
are	O
members	O
of	O
the	O
SpeB	B-Protein
operon	O
,	O
as	O
would	O
be	O
expected	O
from	O
the	O
lack	O
of	O
SpeB	B-Protein
expression	O
and	O
activity	O
in	O
5628	B-Organism
(	O
Fig	O
.	O
3	O
)	O
.	O

In	O
addition	O
to	O
the	O
SpeB	B-Protein
operon	O
,	O
genes	O
of	O
the	O
streptolysin	B-Protein
S	I-Protein
operon	O
were	O
also	O
found	O
to	O
be	O
strongly	O
down	O
-	O
regulated	O
in	O
the	O
ropB	B-Protein
mutant	O
strain	O
.	O

Apart	O
from	O
the	O
gene	O
encoding	O
the	O
superantigen	O
SmeZ	B-Protein
,	O
there	O
was	O
an	O
absence	O
of	O
virulence	O
-	O
related	O
genes	O
found	O
to	O
be	O
strongly	O
up	O
-	O
regulated	O
in	O
the	O
strain	O
5448R	B-Organism
-	I-Organism
,	O
which	O
expressed	O
the	O
truncated	O
RopB	B-Protein
.	O

RopB	B-Protein
is	O
required	O
for	O
virulence	O
in	O
systemic	O
infection	O

To	O
determine	O
the	O
effect	O
of	O
ropB	B-Protein
mutation	O
on	O
virulence	O
,	O
C57BL6	B-Organism
/	I-Organism
J	I-Organism
mice	I-Organism
were	O
subjected	O
to	O
intraperitoneal	O
infection	O
with	O
mid	O
-	O
logarithmic	O
phase	O
bacteria	O
.	O

GAS	B-Organism
strain	I-Organism
5628R	I-Organism
+	I-Organism
expressing	O
a	O
full	O
length	O
RopB	B-Protein
showed	O
increased	O
virulence	O
compared	O
to	O
the	O
strain	O
5628	B-Organism
with	O
a	O
truncated	O
RopB	B-Protein
(	O
Figure	O
4A	O
)	O
.	O

Strain	O
5628RDeltaSpeB	B-Protein
containing	O
a	O
full	O
-	O
length	O
RopB	B-Protein
but	O
lacking	O
SpeB	B-Protein
also	O
showed	O
reduced	O
virulence	O
,	O
suggesting	O
that	O
the	O
reduced	O
virulence	O
of	O
5628	B-Organism
may	O
primarily	O
result	O
from	O
the	O
lack	O
of	O
SpeB	B-Protein
expression	O
in	O
this	O
strain	O
.	O

Virulence	O
was	O
also	O
examined	O
in	O
an	O
intravenous	O
model	O
of	O
systemic	O
infection	O
.	O

The	O
well	O
characterized	O
strain	O
5448	B-Organism
and	O
its	O
isogenic	O
mutant	O
5448R	B-Organism
-	I-Organism
,	O
containing	O
the	O
ropB	B-Protein
allele	O
from	O
5628	B-Organism
,	O
were	O
further	O
included	O
to	O
examine	O
the	O
effect	O
of	O
this	O
allelic	O
variation	O
in	O
a	O
well	O
-	O
characterized	O
virulent	O
strain	O
of	O
GAS	B-Organism
.	O

The	O
two	O
strains	O
containing	O
a	O
truncated	O
RopB	B-Protein
(	O
5628	B-Organism
and	O
5448R	B-Organism
-	I-Organism
)	O
demonstrated	O
similarly	O
reduced	O
virulence	O
compared	O
to	O
the	O
two	O
strains	O
containing	O
a	O
full	O
-	O
length	O
RopB	B-Protein
(	O
5628R	B-Organism
+	I-Organism
and	O
5448	B-Organism
)	O
(	O
Fig	O
.	O
4B	O
)	O
,	O
confirming	O
that	O
inactivation	O
of	O
RopB	B-Protein
results	O
in	O
decreased	O
virulence	O
in	O
systemic	O
infection	O
.	O

Discussion	O

The	O
cumulative	O
contribution	O
of	O
the	O
secreted	O
cysteine	O
protease	O
SpeB	B-Protein
to	O
the	O
pathogenesis	O
of	O
invasive	O
GAS	B-Organism
infection	O
is	O
at	O
present	O
unclear	O
,	O
and	O
studies	O
in	O
various	O
GAS	B-Organism
serotypes	O
and	O
animal	O
models	O
have	O
produced	O
varying	O
results	O
[	O
19	O
]	O
-	O
[	O
21	O
]	O
.	O

In	O
the	O
globally	O
-	O
disseminated	O
clonal	O
M1T1	B-Organism
serotype	O
associated	O
with	O
epidemic	O
invasive	O
GAS	B-Organism
infection	O
,	O
an	O
inverse	O
relationship	O
has	O
been	O
found	O
between	O
SpeB	B-Protein
activity	O
and	O
clinical	O
disease	O
severity	O
[	O
8	O
]	O
.	O

Recently	O
,	O
we	O
and	O
others	O
have	O
found	O
a	O
connection	O
between	O
inactivation	O
of	O
SpeB	B-Protein
through	O
mutation	O
in	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
covR	B-Protein
/	O
S	B-Protein
and	O
development	O
of	O
invasive	O
disease	O
in	O
the	O
murine	B-Organism
model	O
[	O
37	O
]	O
,	O
[	O
38	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
investigated	O
a	O
second	O
mechanism	O
of	O
inactivation	O
of	O
SpeB	B-Protein
,	O
namely	O
through	O
truncation	O
of	O
the	O
regulator	O
RopB	B-Protein
.	O

We	O
have	O
shown	O
that	O
in	O
M1T1	B-Organism
GAS	I-Organism
,	O
when	O
the	O
covR	B-Protein
/	O
S	B-Protein
locus	O
is	O
intact	O
and	O
DNase	O
Sda1	B-Protein
activity	O
is	O
unaffected	O
,	O
ropB	B-Protein
point	O
mutation	O
results	O
in	O
reduced	O
virulence	O
in	O
vivo	O
,	O
despite	O
inactivation	O
of	O
SpeB	B-Protein
activity	O
.	O

The	O
SpeB	B-Protein
-	O
negative	O
,	O
serotype	O
M1T1	O
clinical	O
isolate	O
5628	O
was	O
used	O
to	O
investigate	O
the	O
role	O
of	O
RopB	B-Protein
in	O
virulence	O
.	O

RopB	B-Protein
has	O
previously	O
been	O
shown	O
to	O
be	O
necessary	O
for	O
SpeB	B-Protein
production	O
[	O
23	O
]	O
,	O
[	O
24	O
]	O
as	O
well	O
as	O
regulation	O
of	O
other	O
GAS	B-Organism
virulence	O
factors	O
[	O
25	O
]	O
-	O
[	O
29	O
]	O
.	O

The	O
M1T1	B-Organism
strain	I-Organism
5628	I-Organism
contains	O
a	O
point	O
mutation	O
in	O
the	O
ropB	B-Protein
gene	O
that	O
results	O
in	O
a	O
truncation	O
of	O
the	O
last	O
110	O
amino	O
acids	O
of	O
the	O
280	O
amino	O
acid	O
protein	O
.	O

Restoration	O
of	O
full	O
-	O
length	O
RopB	B-Protein
in	O
5628R	B-Organism
+	I-Organism
resulted	O
in	O
gaining	O
SpeB	B-Protein
expression	O
,	O
but	O
did	O
not	O
result	O
in	O
changes	O
in	O
hemolysis	O
,	O
DNase	O
activity	O
or	O
resistance	O
to	O
killing	O
by	O
neutrophils	O
.	O

RopB	B-Protein
mutation	O
in	O
this	O
particular	O
strain	O
does	O
not	O
result	O
in	O
the	O
kind	O
of	O
global	O
phenotypic	O
change	O
found	O
with	O
covR	B-Protein
/	O
S	B-Protein
mutation	O
where	O
differential	O
expression	O
was	O
observed	O
of	O
multiple	O
genes	O
encoding	O
virulence	O
determinants	O
,	O
including	O
sic	B-Protein
,	O
ska	B-Protein
,	O
slo	B-Protein
,	O
speA	B-Protein
,	O
speJ	B-Protein
,	O
scpC	B-Protein
and	O
the	O
hyaluronic	B-Regulon-operon
acid	I-Regulon-operon
synthesis	I-Regulon-operon
operon	I-Regulon-operon
[	O
37	O
]	O
which	O
were	O
all	O
unaffected	O
in	O
the	O
ropB	B-Protein
mutant	O
examined	O
in	O
this	O
work	O
.	O

Recently	O
,	O
we	O
have	O
demonstrated	O
that	O
WT	O
,	O
SpeB	B-Protein
-	O
positive	O
bacteria	O
undergo	O
a	O
phase	O
-	O
shift	O
to	O
a	O
SpeB	B-Protein
-	O
negative	O
phenotype	O
after	O
subcutaneous	O
infection	O
of	O
mice	B-Organism
[	O
17	O
]	O
.	O

This	O
phase	O
switch	O
was	O
observed	O
to	O
be	O
the	O
result	O
of	O
mutations	O
in	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
covR	B-Protein
/	O
S	B-Protein
[	O
38	O
]	O
.	O

CovR	B-Protein
/	O
S	B-Protein
is	O
a	O
global	O
regulator	O
,	O
whose	O
inactivation	O
is	O
linked	O
to	O
an	O
invasive	O
phenotype	O
and	O
involves	O
up	O
-	O
regulation	O
of	O
many	O
genes	O
encoding	O
virulence	O
factors	O
such	O
as	O
streptodornase	B-Protein
,	O
streptokinase	B-Protein
,	O
streptolysin	B-Protein
O	I-Protein
,	O
streptococcal	O
inhibitor	O
of	O
complement	O
and	O
the	O
hyaluronic	B-Regulon-operon
acid	I-Regulon-operon
capsule	I-Regulon-operon
synthesis	I-Regulon-operon
operon	I-Regulon-operon
[	O
37	O
]	O
.	O

Of	O
the	O
down	O
-	O
regulated	O
genes	O
in	O
CovR	B-Protein
/	O
S	B-Protein
mutant	O
strains	O
,	O
SpeB	B-Protein
would	O
appear	O
to	O
be	O
one	O
of	O
the	O
most	O
important	O
due	O
to	O
its	O
ability	O
to	O
degrade	O
many	O
host	O
and	O
self	O
-	O
proteins	O
.	O

It	O
is	O
the	O
loss	O
of	O
SpeB	B-Protein
expression	O
in	O
these	O
mutant	O
bacteria	O
that	O
is	O
hypothesized	O
to	O
allow	O
the	O
invasive	O
spread	O
of	O
GAS	B-Organism
by	O
sparing	O
from	O
SpeB	B-Protein
degradation	O
self	O
-	O
proteins	O
involved	O
in	O
plasminogen	O
accumulation	O
and	O
activation	O
[	O
42	O
]	O
.	O

In	O
this	O
study	O
we	O
found	O
that	O
SpeB	B-Protein
-	O
positive	O
bacteria	O
with	O
a	O
restored	O
RopB	B-Protein
reverted	O
to	O
a	O
SpeB	B-Protein
-	O
negative	O
phenotype	O
on	O
subcutaneous	O
infection	O
.	O

Furthermore	O
,	O
the	O
switch	O
to	O
a	O
SpeB	B-Protein
-	O
negative	O
phenotype	O
appeared	O
to	O
occur	O
exclusively	O
through	O
mutations	O
in	O
covR	B-Protein
/	O
S	B-Protein
.	O

This	O
result	O
suggests	O
that	O
covR	B-Protein
/	O
S	B-Protein
mutations	O
are	O
the	O
predominant	O
method	O
of	O
phenotypic	O
switching	O
in	O
GAS	B-Organism
and	O
that	O
ropB	B-Protein
mutation	O
is	O
not	O
readily	O
selected	O
for	O
in	O
vivo	O
.	O

This	O
leads	O
to	O
the	O
conclusion	O
that	O
ropB	B-Protein
mutation	O
in	O
5628	B-Organism
does	O
not	O
represent	O
a	O
similar	O
mechanism	O
to	O
covR	B-Protein
/	O
S	B-Protein
mutation	O
and	O
may	O
(	O
a	O
)	O
be	O
an	O
incidental	O
occurrence	O
or	O
(	O
b	O
)	O
arise	O
secondary	O
to	O
different	O
selection	O
pressures	O
than	O
those	O
associated	O
with	O
the	O
shift	O
to	O
invasive	O
infection	O
.	O

Microarray	O
analysis	O
was	O
conducted	O
using	O
in	O
vivo	O
-	O
derived	O
RNA	O
,	O
since	O
the	O
transcriptome	O
of	O
bacteria	O
grown	O
in	O
vitro	O
may	O
differ	O
greatly	O
from	O
the	O
transcriptome	O
found	O
during	O
the	O
course	O
of	O
infection	O
.	O

Implantation	O
of	O
tissue	O
cages	O
allows	O
for	O
bacteria	O
to	O
be	O
grown	O
in	O
an	O
in	O
vivo	O
environment	O
for	O
24	O
hours	O
prior	O
to	O
recovery	O
and	O
RNA	O
extraction	O
.	O

The	O
microarray	O
data	O
showed	O
members	O
of	O
the	O
SpeB	B-Protein
operon	O
to	O
be	O
the	O
most	O
strongly	O
down	O
-	O
regulated	O
genes	O
following	O
inactivation	O
of	O
RopB	B-Protein
.	O

This	O
finding	O
supported	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
data	O
that	O
suggested	O
SpeB	B-Protein
is	O
the	O
main	O
target	O
of	O
RopB	B-Protein
regulation	O
in	O
this	O
strain	O
.	O

Virulence	O
studies	O
utilizing	O
systemic	O
models	O
of	O
infection	O
showed	O
that	O
a	O
full	O
-	O
length	O
RopB	B-Protein
was	O
required	O
for	O
virulence	O
.	O

The	O
clinical	O
isolate	O
5628	B-Organism
expressing	O
a	O
truncated	O
RopB	B-Protein
,	O
as	O
well	O
as	O
the	O
allelic	O
exchange	O
mutant	O
5448R	B-Organism
-	I-Organism
also	O
expressing	O
the	O
truncated	O
RopB	B-Protein
from	O
5628	B-Organism
,	O
showed	O
reduced	O
virulence	O
compared	O
to	O
strains	O
containing	O
a	O
full	O
-	O
length	O
RopB	B-Protein
.	O

These	O
data	O
illustrate	O
the	O
necessity	O
for	O
an	O
intact	O
RopB	B-Protein
for	O
full	O
virulence	O
in	O
vivo	O
.	O

In	O
addition	O
,	O
the	O
strain	O
5628RDeltaSpeB	B-Protein
expressing	O
an	O
intact	O
RopB	B-Protein
but	O
lacking	O
SpeB	B-Protein
showed	O
similarly	O
reduced	O
virulence	O
to	O
the	O
strain	O
with	O
a	O
truncated	O
RopB	B-Protein
.	O

While	O
the	O
down	O
-	O
regulation	O
of	O
the	O
streptolysin	B-Protein
S	I-Protein
operon	O
may	O
contribute	O
to	O
the	O
reduced	O
virulence	O
,	O
this	O
finding	O
implies	O
that	O
the	O
loss	O
of	O
SpeB	B-Protein
in	O
this	O
strain	O
is	O
the	O
main	O
cause	O
of	O
the	O
lack	O
of	O
virulence	O
exhibited	O
.	O

This	O
finding	O
leads	O
to	O
the	O
conclusion	O
that	O
inactivation	O
of	O
SpeB	B-Protein
alone	O
is	O
not	O
sufficient	O
to	O
initiate	O
invasive	O
disease	O
.	O

Moreover	O
,	O
these	O
data	O
suggest	O
that	O
SpeB	B-Protein
loss	O
,	O
only	O
in	O
the	O
context	O
of	O
mutation	O
of	O
the	O
covR	B-Protein
/	O
S	B-Protein
regulatory	O
circuit	O
,	O
promotes	O
invasion	O
.	O

Of	O
note	O
,	O
the	O
additional	O
virulence	O
factors	O
streptokinase	B-Protein
and	O
M1	B-Protein
protein	O
,	O
are	O
both	O
up	O
-	O
regulated	O
in	O
covR	B-Protein
/	O
S	B-Protein
mutant	O
M1T1	O
strains	O
[	O
37	O
]	O
,	O
but	O
not	O
in	O
the	O
ropB	B-Protein
mutant	O
under	O
investigation	O
in	O
this	O
study	O
.	O

Streptokinase	B-Protein
and	O
M1	B-Protein
protein	O
are	O
believed	O
to	O
play	O
a	O
role	O
in	O
the	O
accumulation	O
of	O
host	O
plasmin	O
at	O
the	O
GAS	B-Organism
cell	O
surface	O
,	O
a	O
process	O
which	O
is	O
thought	O
to	O
accentuate	O
invasive	O
disease	O
[	O
5	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

Together	O
these	O
data	O
provide	O
evidence	O
of	O
RopB	B-Protein
'	O
s	O
role	O
in	O
virulence	O
.	O

In	O
M1T1	B-Organism
GAS	I-Organism
,	O
an	O
intact	O
RopB	B-Protein
and	O
efficient	O
SpeB	B-Protein
production	O
are	O
necessary	O
for	O
systemic	O
infection	O
.	O

Global	O
Systems	O
-	O
Level	O
Analysis	O
of	O
Hfq	B-Protein
and	O
SmpB	B-Protein
Deletion	O
Mutants	O
in	O
Salmonella	B-Organism
:	O
Implications	O
for	O
Virulence	O
and	O
Global	O
Protein	O
Translation	O

Using	O
sample	O
-	O
matched	O
transcriptomics	O
and	O
proteomics	O
measurements	O
it	O
is	O
now	O
possible	O
to	O
begin	O
to	O
understand	O
the	O
impact	O
of	O
post	O
-	O
transcriptional	O
regulatory	O
programs	O
in	O
Enterobacteria	B-Organism
.	O

In	O
bacteria	O
post	O
-	O
transcriptional	O
regulation	O
is	O
mediated	O
by	O
relatively	O
few	O
identified	O
RNA	O
-	O
binding	O
protein	O
factors	O
including	O
CsrA	B-Protein
,	O
Hfq	B-Protein
and	O
SmpB	B-Protein
.	O

A	O
mutation	O
in	O
any	O
one	O
of	O
these	O
three	O
genes	O
,	O
csrA	B-Protein
,	O
hfq	B-Protein
,	O
and	O
smpB	B-Protein
,	O
in	O
Salmonella	B-Organism
is	O
attenuated	O
for	O
mouse	B-Organism
virulence	O
and	O
unable	O
to	O
survive	O
in	O
macrophages	O
.	O

CsrA	B-Protein
has	O
a	O
clearly	O
defined	O
specificity	O
based	O
on	O
binding	O
to	O
a	O
specific	O
mRNA	O
sequence	O
to	O
inhibit	O
translation	O
.	O

However	O
,	O
the	O
proteins	O
regulated	O
by	O
Hfq	B-Protein
and	O
SmpB	B-Protein
are	O
not	O
as	O
clearly	O
defined	O
.	O

Previous	O
work	O
identified	O
proteins	O
regulated	O
by	O
hfq	B-Protein
using	O
purification	O
of	O
the	O
RNA	O
-	O
protein	O
complex	O
with	O
direct	O
sequencing	O
of	O
the	O
bound	O
RNAs	O
and	O
found	O
binding	O
to	O
a	O
surprisingly	O
large	O
number	O
of	O
transcripts	O
.	O

In	O
this	O
report	O
we	O
have	O
used	O
global	O
proteomics	O
to	O
directly	O
identify	O
proteins	O
regulated	O
by	O
Hfq	B-Protein
or	O
SmpB	B-Protein
by	O
comparing	O
protein	O
abundance	O
in	O
the	O
parent	O
and	O
isogenic	O
hfq	B-Protein
or	O
smpB	B-Protein
mutant	O
.	O

From	O
these	O
same	O
samples	O
we	O
also	O
prepared	O
RNA	O
for	O
microarray	O
analysis	O
to	O
determine	O
if	O
alteration	O
of	O
protein	O
expression	O
was	O
mediated	O
post	O
-	O
transcriptionally	O
.	O

Samples	O
were	O
analyzed	O
from	O
bacteria	O
grown	O
under	O
four	O
different	O
conditions	O
;	O
two	O
laboratory	O
conditions	O
and	O
two	O
that	O
are	O
thought	O
to	O
mimic	O
the	O
intracellular	O
environment	O
.	O

We	O
show	O
that	O
mutants	O
of	O
hfq	B-Protein
and	O
smpB	B-Protein
directly	O
or	O
indirectly	O
modulate	O
at	O
least	O
20	O
%	O
and	O
4	O
%	O
of	O
all	O
possible	O
Salmonella	B-Organism
proteins	O
,	O
respectively	O
,	O
with	O
limited	O
correlation	O
between	O
transcription	O
and	O
protein	O
expression	O
.	O

These	O
proteins	O
represent	O
a	O
broad	O
spectrum	O
of	O
Salmonella	B-Organism
proteins	O
required	O
for	O
many	O
biological	O
processes	O
including	O
host	O
cell	O
invasion	O
,	O
motility	O
,	O
central	O
metabolism	O
,	O
LPS	B-Chemical
biosynthesis	O
,	O
two	O
-	O
component	O
regulatory	O
systems	O
,	O
and	O
fatty	O
acid	O
metabolism	O
.	O

Our	O
results	O
represent	O
one	O
of	O
the	O
first	O
global	O
analyses	O
of	O
post	O
-	O
transcriptional	O
regulons	O
in	O
any	O
organism	O
and	O
suggest	O
that	O
regulation	O
at	O
the	O
translational	O
level	O
is	O
widespread	O
and	O
plays	O
an	O
important	O
role	O
in	O
virulence	O
regulation	O
and	O
environmental	O
adaptation	O
for	O
Salmonella	B-Organism
.	O

Introduction	O

Post	O
-	O
transcriptional	O
regulation	O
of	O
gene	O
expression	O
by	O
small	O
noncoding	O
RNAs	O
(	O
sRNAs	O
)	O
is	O
widespread	O
in	O
both	O
prokaryotes	O
and	O
eukaryotes	O
and	O
has	O
only	O
recently	O
been	O
recognized	O
as	O
playing	O
a	O
prominent	O
role	O
in	O
the	O
regulation	O
of	O
cellular	O
processes	O
.	O

In	O
bacteria	O
,	O
regulatory	O
sRNAs	O
act	O
via	O
base	O
-	O
pairing	O
interactions	O
with	O
their	O
target	O
mRNAs	O
to	O
modulate	O
their	O
translation	O
and	O
/	O
or	O
decay	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
,	O
in	O
a	O
reaction	O
typically	O
dependent	O
on	O
the	O
RNA	O
-	O
binding	O
protein	O
Hfq	B-Protein
[	O
3	O
]	O
,	O
[	O
4	O
]	O
.	O

While	O
the	O
role	O
of	O
DNA	O
-	O
binding	O
proteins	O
,	O
particularly	O
transcription	O
factors	O
,	O
in	O
regulating	O
gene	O
expression	O
at	O
the	O
level	O
of	O
transcription	O
has	O
received	O
much	O
attention	O
,	O
how	O
RNA	O
-	O
binding	O
proteins	O
control	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
remains	O
unclear	O
.	O

The	O
RNA	O
-	O
binding	O
protein	O
Hfq	B-Protein
was	O
initially	O
shown	O
to	O
be	O
the	O
host	O
factor	O
required	O
for	O
replication	O
of	O
Qbeta	B-Organism
RNA	O
bacteriophage	O
[	O
5	O
]	O
and	O
is	O
a	O
member	O
of	O
the	O
Sm	O
protein	O
family	O
of	O
RNA	O
binding	O
proteins	O
that	O
also	O
include	O
eukaryotic	O
proteins	O
required	O
for	O
mRNA	O
splicing	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
.	O

Hfq	B-Protein
is	O
a	O
highly	O
conserved	O
protein	O
encoded	O
within	O
many	O
bacterial	O
genomes	O
and	O
at	O
least	O
one	O
archaeon	O
genome	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
.	O

In	O
bacteria	O
,	O
Hfq	B-Protein
functions	O
as	O
a	O
post	O
-	O
transcriptional	O
regulator	O
that	O
modulates	O
the	O
stability	O
and	O
translation	O
of	O
mRNAs	O
chiefly	O
by	O
facilitating	O
sRNA	O
-	O
mRNA	O
interactions	O
[	O
1	O
]	O
,	O
[	O
4	O
]	O
,	O
[	O
9	O
]	O
.	O

Its	O
broad	O
role	O
in	O
regulation	O
at	O
the	O
translational	O
level	O
has	O
recently	O
been	O
hinted	O
at	O
by	O
Sittka	O
and	O
co	O
-	O
workers	O
[	O
10	O
]	O
.	O

The	O
RNA	O
-	O
binding	O
protein	O
SmpB	B-Protein
specifically	O
interacts	O
with	O
the	O
sRNA	O
tmRNA	B-Protein
(	O
also	O
known	O
as	O
ssrA	B-Protein
and	O
10Sa	B-Protein
)	O
and	O
is	O
required	O
for	O
all	O
known	O
functions	O
of	O
tmRNA	B-Protein
[	O
11	O
]	O
.	O

Indeed	O
SmpB	B-Protein
deletion	O
mutants	O
have	O
been	O
observed	O
to	O
have	O
the	O
same	O
phenotype	O
as	O
tmRNA	B-Protein
deletion	O
mutants	O
[	O
11	O
]	O
.	O

tmRNA	B-Protein
is	O
found	O
in	O
a	O
wide	O
range	O
of	O
bacteria	O
and	O
in	O
the	O
mitochondria	O
of	O
some	O
eukaryotes	O
and	O
uniquely	O
exhibits	O
properties	O
of	O
both	O
tRNA	O
and	O
mRNA	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

tmRNA	B-Protein
functions	O
as	O
a	O
part	O
of	O
the	O
translational	O
quality	O
control	O
process	O
,	O
recognizing	O
and	O
binding	O
to	O
ribosomes	O
that	O
become	O
stalled	O
.	O

Once	O
bound	O
,	O
tmRNA	B-Protein
adds	O
a	O
peptide	O
tag	O
to	O
the	O
nascent	O
partially	O
synthesized	O
protein	O
chain	O
which	O
targets	O
it	O
for	O
degradation	O
by	O
C	O
-	O
terminal	O
-	O
specific	O
cellular	O
proteases	O
[	O
15	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
,	O
[	O
18	O
]	O
.	O

Usually	O
classified	O
as	O
a	O
housekeeping	O
or	O
repair	O
system	O
,	O
a	O
role	O
for	O
tmRNA	B-Protein
as	O
a	O
regulatory	O
sRNA	O
has	O
been	O
recently	O
suggested	O
.	O

Ranquet	O
and	O
Gottesman	O
[	O
19	O
]	O
report	O
that	O
the	O
sRNA	O
tmRNA	B-Protein
plays	O
a	O
regulatory	O
role	O
in	O
gene	O
expression	O
and	O
is	O
required	O
for	O
the	O
correct	O
high	O
-	O
level	O
translation	O
of	O
RpoS	B-Protein
.	O

Recent	O
reports	O
suggest	O
that	O
both	O
Hfq	B-Protein
and	O
SmpB	B-Protein
play	O
essential	O
roles	O
in	O
bacterial	O
pathogenesis	O
.	O

For	O
example	O
an	O
Deltahfq	B-Protein
mutant	O
derivative	O
in	O
the	O
pathogen	O
Salmonella	B-Organism
enterica	I-Organism
serovars	I-Organism
Typhimurium	I-Organism
(	O
Salmonella	B-Organism
Typhimurium	I-Organism
)	O
was	O
found	O
to	O
attenuate	O
virulence	O
in	O
mice	B-Organism
and	O
was	O
impaired	O
in	O
the	O
invasion	O
of	O
non	O
-	O
phagocytic	O
cells	O
[	O
20	O
]	O
.	O

Hfq	B-Protein
was	O
also	O
reported	O
to	O
be	O
essential	O
for	O
Vibrio	B-Organism
cholerae	I-Organism
virulence	O
,	O
with	O
sRNAs	O
in	O
conjunction	O
with	O
Hfq	B-Protein
suggested	O
as	O
likely	O
critical	O
regulators	O
of	O
Vibrio	B-Organism
cholerae	I-Organism
pathogenicity	O
[	O
21	O
]	O
.	O

Robertson	O
and	O
Roop	O
demonstrated	O
that	O
a	O
Brucella	O
abortus	O
Deltahfq	B-Protein
mutant	O
failed	O
to	O
replicate	O
in	O
cultured	O
murine	B-Organism
macrophages	O
,	O
and	O
displayed	O
attenuated	O
virulence	O
in	O
a	O
mouse	B-Organism
model	O
[	O
22	O
]	O
.	O

In	O
another	O
study	O
,	O
a	O
smpB	B-Protein
mutant	O
of	O
Salmonella	B-Organism
Typhimurium	I-Organism
exhibited	O
defects	O
in	O
intra	O
-	O
macrophage	O
survival	O
,	O
a	O
model	O
of	O
Salmonella	B-Organism
pathogenesis	O
[	O
23	O
]	O
.	O

More	O
recently	O
mutation	O
of	O
tmRNA	B-Protein
was	O
shown	O
to	O
be	O
responsible	O
for	O
a	O
marked	O
reduction	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
virulence	O
in	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	I-Organism
[	O
24	O
]	O
.	O

In	O
Yersinia	B-Organism
pseudotuberculosis	I-Organism
mutations	O
of	O
smpB	B-Protein
and	O
tmRNA	B-Protein
generated	O
a	O
bacterium	O
that	O
exhibited	O
defects	O
in	O
survival	O
and	O
replication	O
in	O
macrophages	O
and	O
was	O
avirulent	O
in	O
mice	B-Organism
[	O
25	O
]	O
.	O

Collectively	O
,	O
these	O
results	O
demonstrate	O
that	O
Hfq	B-Protein
and	O
SmpB	B-Protein
are	O
essential	O
for	O
regulating	O
virulence	O
by	O
controlling	O
translation	O
of	O
key	O
components	O
.	O

Identifying	O
what	O
proteins	O
are	O
actually	O
regulated	O
by	O
Hfq	B-Protein
and	O
SmpB	B-Protein
is	O
an	O
important	O
step	O
in	O
understanding	O
the	O
impact	O
of	O
post	O
-	O
transcriptional	O
gene	O
regulation	O
in	O
Enterobacteria	B-Organism
and	O
more	O
specifically	O
how	O
Hfq	B-Protein
and	O
SmpB	B-Protein
control	O
Salmonella	B-Organism
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
/	O
translational	O
level	O
and	O
the	O
role	O
that	O
this	O
may	O
play	O
in	O
Salmonella	B-Organism
pathogenesis	O
.	O

Towards	O
the	O
global	O
identification	O
of	O
Hfq	B-Protein
targets	O
,	O
previous	O
efforts	O
have	O
employed	O
a	O
combination	O
of	O
co	O
-	O
immunoprecipiatation	O
(	O
co	O
-	O
IP	O
)	O
and	O
or	O
microarray	O
analysis	O
.	O

Zhang	O
et	O
al	O
.	O

[	O
26	O
]	O
used	O
high	O
-	O
density	O
microarrays	O
to	O
detect	O
potential	O
targets	O
of	O
Hfq	B-Protein
co	O
-	O
immunoprecipitated	O
with	O
Hfq	B-Protein
-	O
specific	O
antibodies	O
.	O

In	O
a	O
recent	O
study	O
Sittka	O
et	O
al	O
.	O

[	O
10	O
]	O
used	O
high	O
-	O
throughput	O
pyrosequencing	O
(	O
HTPS	O
)	O
to	O
detect	O
potential	O
targets	O
of	O
an	O
epitope	O
tagged	O
-	O
Hfq	B-Protein
protein	O
co	O
-	O
immunoprecipitated	O
with	O
commercially	O
available	O
antibodies	O
,	O
overcoming	O
the	O
limitations	O
of	O
the	O
previous	O
strategy	O
;	O
the	O
need	O
for	O
custom	O
microarrays	O
and	O
specialized	O
antibodies	O
.	O

In	O
another	O
study	O
[	O
27	O
]	O
microarray	O
analysis	O
was	O
used	O
to	O
identify	O
changes	O
in	O
gene	O
expression	O
resulting	O
from	O
lack	O
of	O
Hfq	B-Protein
,	O
thus	O
providing	O
potential	O
new	O
target	O
genes	O
for	O
sRNA	O
regulation	O
.	O

While	O
co	O
-	O
immunoprecipiatation	O
has	O
proven	O
valuable	O
in	O
identifying	O
targets	O
of	O
Hfq	B-Protein
,	O
and	O
thus	O
targets	O
of	O
translational	O
regulation	O
,	O
one	O
possible	O
criticism	O
of	O
this	O
approach	O
is	O
that	O
the	O
RNA	O
co	O
-	O
immunoprecipitated	O
with	O
Hfq	B-Protein
may	O
be	O
brought	O
down	O
simply	O
because	O
Hfq	B-Protein
strongly	O
binds	O
to	O
RNA	O
molecules	O
and	O
that	O
the	O
binding	O
is	O
somewhat	O
non	O
-	O
specific	O
.	O

In	O
addition	O
,	O
it	O
is	O
clear	O
that	O
a	O
transcriptional	O
analysis	O
solely	O
can	O
not	O
distinguish	O
between	O
transcriptional	O
and	O
translational	O
/	O
post	O
-	O
transcriptional	O
regulatory	O
effects	O
.	O

Using	O
sample	O
-	O
matched	O
transcriptomics	O
and	O
proteomics	O
measurements	O
it	O
is	O
possible	O
to	O
accurately	O
characterize	O
on	O
a	O
global	O
scale	O
control	O
of	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
.	O

Here	O
,	O
we	O
performed	O
sample	O
-	O
matched	O
global	O
proteomics	O
and	O
transcriptional	O
analyses	O
together	O
with	O
cellular	O
assays	O
and	O
animal	O
studies	O
to	O
begin	O
to	O
understand	O
how	O
Hfq	B-Protein
and	O
SmpB	B-Protein
control	O
Salmonella	B-Organism
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
and	O
the	O
role	O
that	O
this	O
may	O
play	O
in	O
Salmonella	B-Organism
pathogenesis	O
.	O

Our	O
global	O
analyses	O
revealed	O
that	O
a	O
relatively	O
high	O
percentage	O
of	O
all	O
the	O
annotated	O
Salmonella	B-Organism
genes	O
(	O
>	O
20	O
%	O
)	O
are	O
regulated	O
post	O
-	O
transcriptionally	O
either	O
directly	O
or	O
indirectly	O
.	O

The	O
extent	O
of	O
global	O
regulation	O
of	O
translation	O
is	O
much	O
greater	O
than	O
previously	O
thought	O
[	O
10	O
]	O
,	O
with	O
profound	O
effects	O
in	O
all	O
stages	O
of	O
Salmonella	B-Organism
'	O
s	O
life	O
cycle	O
including	O
a	O
variety	O
of	O
house	O
keeping	O
pathways	O
and	O
known	O
and	O
novel	O
virulence	O
factors	O
,	O
in	O
part	O
explaining	O
the	O
requirement	O
of	O
both	O
translational	O
regulators	O
for	O
virulence	O
in	O
Salmonella	B-Organism
.	O

This	O
study	O
represents	O
one	O
of	O
the	O
first	O
comparative	O
global	O
analyses	O
of	O
post	O
-	O
transcriptional	O
regulation	O
in	O
any	O
organism	O
;	O
the	O
data	O
suggest	O
post	O
-	O
transcriptional	O
regulation	O
is	O
widespread	O
and	O
plays	O
an	O
important	O
role	O
in	O
virulence	O
regulation	O
and	O
environmental	O
adaptation	O
for	O
Salmonella	B-Organism
.	O

Results	O
and	O
Discussion	O

Construction	O
and	O
growth	O
characteristics	O
of	O
mutant	O
and	O
wildtype	O
Salmonella	B-Organism
Typhimurium	I-Organism
strains	O
Hfq	B-Protein
and	O
SmpB	B-Protein
are	O
essential	O
for	O
virulence	O
in	O
a	O
variety	O
of	O
pathogenic	O
bacteria	O
including	O
Salmonella	B-Organism
Typhimurium	I-Organism
[	O
20	O
]	O
,	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
,	O
[	O
25	O
]	O
.	O

To	O
address	O
the	O
role	O
of	O
Hfq	B-Protein
and	O
SmpB	B-Protein
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
pathogenesis	O
and	O
protein	O
synthesis	O
we	O
first	O
constructed	O
non	O
-	O
polar	O
deletion	O
mutations	O
of	O
the	O
hfq	B-Protein
and	O
smpB	B-Protein
genes	O
using	O
a	O
modified	O
pKD13	O
derivative	O
as	O
the	O
template	O
.	O

In	O
this	O
method	O
[	O
28	O
]	O
,	O
the	O
coding	O
region	O
between	O
the	O
initiation	O
methionine	O
and	O
the	O
last	O
seven	O
amino	O
acids	O
of	O
the	O
gene	O
was	O
replaced	O
with	O
an	O
inframe	O
"	O
scar	O
"	O
sequence	O
that	O
does	O
not	O
contain	O
any	O
stop	O
codons	O
.	O

Functional	O
disruption	O
of	O
the	O
hfq	B-Protein
and	O
smpB	B-Protein
mutant	O
derivatives	O
was	O
first	O
confirmed	O
by	O
PCR	O
analysis	O
after	O
which	O
the	O
mutants	O
were	O
P22	O
transduced	O
to	O
a	O
new	O
genetic	O
background	O
to	O
avoid	O
the	O
possibility	O
of	O
secondary	O
mutations	O
.	O

Mutants	O
that	O
lacked	O
either	O
of	O
these	O
proteins	O
showed	O
impaired	O
growth	O
phenotype	O
in	O
acidic	O
minimal	O
media	O
(	O
AMM	O
)	O
.	O

The	O
hfq	B-Protein
-	O
deficient	O
strain	O
also	O
exhibited	O
decreased	O
growth	O
rate	O
in	O
Luria	O
-	O
Bertani	O
(	O
LB	O
)	O
broth	O
(	O
Figure	O
S1	O
)	O
.	O

These	O
results	O
suggest	O
SmpB	B-Protein
and	O
Hfq	B-Protein
are	O
involved	O
in	O
broad	O
cellular	O
functions	O
,	O
including	O
growth	O
rate	O
regulation	O
.	O

Deltahfq	B-Protein
and	O
DeltasmpB	B-Protein
Salmonella	O
Typhimurium	O
mutant	O
strains	O
are	O
avirulent	O

To	O
directly	O
assess	O
the	O
role	O
of	O
Hfq	B-Protein
and	O
SmpB	B-Protein
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
pathogenesis	O
,	O
BALB	B-Organism
/	I-Organism
c	I-Organism
mice	I-Organism
were	O
infected	O
intraperitoneally	O
with	O
200	O
cfu	O
of	O
either	O
Deltahfq	B-Protein
mutant	O
strain	O
,	O
DeltasmpB	B-Protein
mutant	O
strain	O
or	O
wildtype	O
strain	O
and	O
monitored	O
for	O
21	O
days	O
(	O
Figure	O
1	O
)	O
.	O

The	O
absence	O
of	O
smpB	B-Protein
and	O
hfq	B-Protein
attenuated	O
Salmonella	B-Organism
virulence	O
;	O
mice	B-Organism
infected	O
with	O
the	O
DeltasmpB	B-Protein
mutant	O
strain	O
died	O
at	O
10	O
days	O
post	O
-	O
infection	O
while	O
mice	B-Organism
infected	O
with	O
the	O
Deltahfq	B-Protein
mutant	O
strain	O
were	O
fully	O
resistant	O
to	O
the	O
infection	O
.	O

Mice	B-Organism
infected	O
with	O
wildtype	O
strain	O
exhibited	O
typical	O
symptoms	O
of	O
infection	O
and	O
died	O
at	O
around	O
six	O
days	O
.	O

These	O
results	O
are	O
similar	O
to	O
those	O
in	O
previous	O
reports	O
[	O
20	O
]	O
,	O
[	O
23	O
]	O
.	O

Deltahfq	B-Protein
and	O
DeltasmpB	B-Protein
Salmonella	O
Typhimurium	O
mutant	O
strains	O
show	O
defects	O
in	O
intra	O
-	O
macrophage	O
proliferation	O

As	O
Salmonella	B-Organism
'	O
s	O
ability	O
to	O
replicate	O
within	O
macrophages	O
is	O
essential	O
for	O
its	O
virulence	O
[	O
29	O
]	O
,	O
we	O
examined	O
intracellular	O
replication	O
of	O
Deltahfq	B-Protein
and	O
DeltasmpB	B-Protein
Salmonella	O
Typhimurium	O
mutant	O
strains	O
within	O
the	O
macrophage	O
-	O
like	O
cell	O
line	O
RAW264	O
.	O
7	O
.	O

These	O
cells	O
were	O
infected	O
at	O
a	O
multiplicity	O
of	O
infection	O
(	O
m	O
.	O
o	O
.	O
i	O
.	O
)	O
of	O
about	O
1	O
bacteria	O
per	O
cell	O
with	O
stationary	O
phase	O
bacteria	O
grown	O
overnight	O
in	O
LB	O
broth	O
as	O
described	O
in	O
Materials	O
and	O
Methods	O
.	O

Extracellular	O
bacteria	O
were	O
removed	O
by	O
washing	O
and	O
treatment	O
with	O
gentamicin	O
.	O

After	O
infection	O
the	O
cells	O
were	O
lysed	O
at	O
various	O
times	O
by	O
rapid	O
resuspension	O
in	O
PBS	O
containing	O
1	O
%	O
Triton	O
X	O
-	O
100	O
.	O

Intracellular	O
survival	O
/	O
replication	O
results	O
(	O
Figure	O
2	O
)	O
are	O
consistent	O
with	O
earlier	O
reports	O
that	O
suggest	O
Deltahfq	B-Protein
and	O
DeltasmpB	B-Protein
Salmonella	O
Typhimurium	O
mutant	O
strains	O
are	O
essential	O
for	O
intra	O
-	O
macrophage	O
proliferation	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
,	O
[	O
25	O
]	O
.	O

Global	O
effects	O
of	O
Hfq	B-Protein
and	O
SmpB	B-Protein
mutation	O
on	O
Salmonella	B-Organism
Typhimurium	I-Organism
chromosome	O

LC	O
-	O
MS	O
-	O
based	O
proteomics	O
was	O
used	O
to	O
obtain	O
a	O
general	O
overview	O
of	O
the	O
effects	O
of	O
Hfq	B-Protein
and	O
SmpB	B-Protein
on	O
global	O
protein	O
translation	O
in	O
Salmonella	B-Organism
.	O

The	O
differences	O
in	O
protein	O
expression	O
between	O
parent	O
and	O
isogenic	O
mutant	O
was	O
assessed	O
via	O
hypothesis	O
testing	O
,	O
specifically	O
a	O
comprehensive	O
ANOVA	O
scheme	O
included	O
in	O
the	O
computer	O
program	O
DAnTE	O
[	O
30	O
]	O
.	O

Relative	O
changes	O
in	O
protein	O
abundance	O
between	O
DeltasmpB	B-Protein
or	O
Deltahfq	B-Protein
mutant	O
strains	O
and	O
a	O
wild	O
-	O
type	O
strain	O
were	O
evaluated	O
across	O
four	O
differing	O
growth	O
conditions	O
.	O

These	O
included	O
logarithmic	O
(	O
log	O
)	O
and	O
stationary	O
(	O
stat	O
)	O
phase	O
cultures	O
and	O
growth	O
in	O
two	O
variations	O
of	O
an	O
acidic	O
,	O
low	O
magnesium	B-Chemical
[	O
Mg2	B-Chemical
+	I-Chemical
]	O
minimal	O
media	O
(	O
AMM	O
)	O
,	O
to	O
approximate	O
conditions	O
encountered	O
in	O
the	O
hosts	O
'	O
s	O
phagocytes	O
(	O
Materials	O
and	O
Methods	O
)	O
.	O

Across	O
all	O
experimental	O
datasets	O
we	O
observed	O
a	O
total	O
of	O
1621	O
Salmonella	B-Organism
Typhimurium	I-Organism
proteins	O
(	O
Table	O
S1	O
)	O
,	O
corresponding	O
to	O
approximately36	O
%	O
coverage	O
of	O
predicted	O
protein	O
coding	O
regions	O
.	O

These	O
proteins	O
represent	O
a	O
broad	O
spectrum	O
of	O
gene	O
products	O
from	O
the	O
genetic	O
translation	O
(	O
Table	O
1	O
)	O
,	O
with	O
proteins	O
of	O
unknown	O
or	O
unclassified	O
function	O
representing	O
the	O
largest	O
functional	O
category	O
as	O
might	O
be	O
expected	O
.	O

Across	O
each	O
of	O
the	O
four	O
growth	O
conditions	O
examined	O
our	O
analysis	O
revealed	O
that	O
Hfq	B-Protein
had	O
a	O
far	O
more	O
significant	O
effect	O
on	O
the	O
Salmonella	B-Organism
Typhimurium	I-Organism
proteome	O
than	O
SmpB	B-Protein
.	O

Overall	O
,	O
in	O
comparison	O
to	O
expression	O
in	O
the	O
parent	O
strain	O
,	O
Hfq	B-Protein
and	O
SmpB	B-Protein
altered	O
,	O
approximately50	O
%	O
(	O
781proteins	O
)	O
and	O
approximately12	O
%	O
(	O
189	O
proteins	O
)	O
of	O
the	O
observed	O
proteome	O
(	O
1621	O
proteins	O
)	O
respectively	O
,	O
as	O
determined	O
by	O
an	O
ANOVA	O
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
using	O
the	O
computer	O
program	O
DAnTE	O
[	O
30	O
]	O
(	O
Table	O
S1	O
)	O
.	O

When	O
compared	O
to	O
the	O
entire	O
Salmonella	B-Organism
proteome	O
of	O
4450	O
annotated	O
open	O
reading	O
frames	O
(	O
orf	O
;	O
[	O
31	O
]	O
)	O
,	O
781	O
proteins	O
represents	O
approximately20	O
%	O
of	O
the	O
entire	O
Salmonella	B-Organism
genome	O
.	O

This	O
is	O
in	O
agreement	O
with	O
a	O
recent	O
study	O
that	O
found	O
that	O
Hfq	B-Protein
affects	O
18	O
%	O
of	O
the	O
Salmonella	B-Organism
genome	O
[	O
10	O
]	O
.	O

Considering	O
the	O
reported	O
pleitropic	O
nature	O
of	O
deletion	O
of	O
hfq	B-Protein
on	O
the	O
biology	O
of	O
Salmonella	B-Organism
Typhimurium	I-Organism
it	O
is	O
likely	O
that	O
a	O
proportion	O
of	O
the	O
changes	O
in	O
protein	O
abundances	O
maybe	O
a	O
non	O
-	O
specific	O
and	O
/	O
or	O
secondary	O
consequence	O
of	O
hfq	B-Protein
deletion	O
.	O

That	O
is	O
,	O
not	O
every	O
deregulated	O
protein	O
in	O
the	O
hfq	B-Protein
mutant	O
strain	O
is	O
necessarily	O
directly	O
regulated	O
by	O
Hfq	B-Protein
.	O

Indeed	O
analysis	O
of	O
the	O
correlation	O
between	O
Hfq	B-Protein
-	O
dependent	O
proteins	O
identified	O
in	O
this	O
study	O
and	O
Hfq	B-Protein
-	O
associated	O
mRNAs	O
identified	O
by	O
Sittka	O
et	O
al	O
.	O

[	O
10	O
]	O
showed	O
an	O
approximately	O
25	O
%	O
overlap	O
(	O
Table	O
S2	O
)	O
,	O
similar	O
to	O
the	O
approximately30	O
%	O
overlap	O
observed	O
between	O
data	O
from	O
a	O
transcriptional	O
analysis	O
of	O
an	O
Deltahfq	B-Protein
mutant	O
strain	O
and	O
data	O
from	O
a	O
co	O
-	O
IP	O
analysis	O
of	O
Hfq	B-Protein
-	O
associated	O
mRNAs	O
[	O
10	O
]	O
.	O

We	O
report	O
that	O
Hfq	B-Protein
directly	O
or	O
indirectly	O
modulates	O
approximately20	O
%	O
of	O
the	O
Salmonella	B-Organism
genome	O
.	O

However	O
this	O
most	O
likely	O
is	O
an	O
underestimate	O
of	O
the	O
true	O
number	O
of	O
proteins	O
that	O
are	O
regulated	O
by	O
Hfq	B-Protein
,	O
if	O
accurate	O
protein	O
identifications	O
could	O
be	O
made	O
for	O
the	O
remaining	O
2829	O
orfs	O
of	O
the	O
entire	O
Salmonella	B-Organism
proteome	O
(	O
4450	O
orfs	O
)	O
that	O
are	O
either	O
expressed	O
at	O
levels	O
too	O
low	O
to	O
be	O
detected	O
or	O
not	O
expressed	O
under	O
the	O
four	O
growth	O
conditions	O
employed	O
in	O
this	O
study	O
.	O

Considering	O
that	O
we	O
observe	O
36	O
%	O
(	O
1621	O
orfs	O
)	O
of	O
the	O
entire	O
Salmonella	B-Organism
proteome	O
(	O
4450	O
orfs	O
)	O
and	O
that	O
50	O
%	O
(	O
781	O
orfs	O
)	O
of	O
this	O
observed	O
proteome	O
(	O
1621	O
orfs	O
)	O
is	O
modulated	O
by	O
Hfq	B-Protein
,	O
it	O
would	O
be	O
expected	O
that	O
a	O
significant	O
portion	O
of	O
the	O
unobserved	O
Salmonella	B-Organism
proteome	O
(	O
2829	O
orfs	O
)	O
would	O
also	O
be	O
regulated	O
by	O
Hfq	B-Protein
,	O
thus	O
our	O
assertion	O
that	O
the	O
approximately20	O
%	O
value	O
may	O
very	O
well	O
represent	O
an	O
underestimation	O
.	O

Similarly	O
189	O
proteins	O
represents	O
approximately4	O
%	O
when	O
compared	O
to	O
all	O
annotated	O
orfs	O
but	O
again	O
this	O
is	O
likely	O
an	O
underestimate	O
of	O
proteins	O
regulated	O
by	O
SmpB	B-Protein
if	O
accurate	O
protein	O
identifications	O
could	O
be	O
made	O
for	O
the	O
remaining	O
2829	O
orfs	O
that	O
are	O
either	O
expressed	O
at	O
levels	O
too	O
low	O
to	O
be	O
detected	O
or	O
not	O
expressed	O
under	O
the	O
four	O
growth	O
conditions	O
employed	O
in	O
this	O
study	O
.	O

Classification	O
of	O
the	O
Salmonella	B-Organism
proteins	O
deregulated	O
by	O
either	O
Hfq	B-Protein
or	O
SmpB	B-Protein
by	O
the	O
J	O
.	O

Craig	O
Venter	O
Institute	O
(	O
JCVI	O
)	O
functional	O
categories	O
[	O
32	O
]	O
showed	O
that	O
Hfq	B-Protein
modulated	O
the	O
expression	O
of	O
>	O
/	O
=	O
40	O
%	O
of	O
the	O
observed	O
proteins	O
in	O
15	O
of	O
the	O
19	O
functional	O
categories	O
annotated	O
for	O
Salmonella	B-Organism
(	O
Table	O
1	O
)	O
.	O

The	O
"	O
Cellular	O
Processes	O
"	O
functional	O
category	O
represented	O
the	O
category	O
with	O
most	O
genes	O
impacted	O
by	O
Hfq	B-Protein
(	O
approximately63	O
%	O
)	O
.	O

This	O
category	O
encompasses	O
sub	O
-	O
categories	O
including	O
adaptations	O
to	O
atypical	O
conditions	O
,	O
cell	O
adhesion	O
,	O
pathogenesis	O
,	O
chemotaxis	O
and	O
motility	O
,	O
detoxification	O
,	O
toxin	O
production	O
and	O
resistance	O
,	O
DNA	O
transformation	O
and	O
cell	O
division	O
.	O

Translational	O
regulation	O
of	O
these	O
genes	O
permits	O
more	O
rapid	O
adaptation	O
than	O
would	O
be	O
required	O
if	O
the	O
genes	O
had	O
to	O
be	O
first	O
transcribed	O
.	O

This	O
observation	O
may	O
explain	O
the	O
acute	O
attenuation	O
in	O
virulence	O
observed	O
for	O
the	O
Deltahfq	B-Protein
mutant	O
as	O
well	O
as	O
the	O
previously	O
observed	O
invasion	O
and	O
motility	O
phenotypes	O
of	O
an	O
Deltahfq	B-Protein
mutant	O
[	O
10	O
]	O
,	O
[	O
20	O
]	O
.	O

We	O
validated	O
a	O
representative	O
set	O
of	O
proteins	O
by	O
comparing	O
our	O
results	O
with	O
published	O
results	O
.	O

Sittka	O
et	O
al	O
.	O

[	O
20	O
]	O
investigated	O
the	O
proteome	O
of	O
an	O
Deltahfq	B-Protein
mutant	O
strain	O
using	O
2D	O
gel	O
analysis	O
,	O
and	O
found	O
approximately70	O
differentially	O
expressed	O
proteins	O
in	O
early	O
stationary	O
phase	O
.	O

Across	O
all	O
growth	O
conditions	O
we	O
identified	O
67	O
of	O
the	O
approximately70	O
differentially	O
expressed	O
proteins	O
identified	O
in	O
that	O
study	O
.	O

Furthermore	O
51	O
of	O
the	O
approximately70	O
Hfq	B-Protein
-	O
dependent	O
proteins	O
identified	O
by	O
Sittka	O
et	O
al	O
.	O
were	O
also	O
found	O
to	O
be	O
differentially	O
expressed	O
in	O
the	O
present	O
study	O
.	O

The	O
direction	O
of	O
regulation	O
of	O
many	O
of	O
these	O
proteins	O
was	O
in	O
general	O
agreement	O
with	O
the	O
literature	O
including	O
OmpF	B-Protein
,	O
DppA	B-Protein
,	O
FliC	B-Protein
,	O
SurA	B-Protein
,	O
and	O
LuxS	B-Protein
as	O
shown	O
in	O
Table	O
S3	O
.	O

As	O
best	O
as	O
we	O
can	O
approximate	O
our	O
LB	O
Stat	O
growth	O
condition	O
would	O
most	O
closely	O
match	O
the	O
early	O
stationary	O
phase	O
growth	O
condition	O
described	O
by	O
Sittka	O
et	O
al	O
.	O

[	O
20	O
]	O
and	O
hence	O
one	O
would	O
expect	O
minimal	O
variability	O
in	O
a	O
cross	O
-	O
comparison	O
between	O
both	O
studies	O
under	O
these	O
two	O
growth	O
conditions	O
.	O

Indeed	O
the	O
direction	O
of	O
regulation	O
of	O
21	O
out	O
of	O
22	O
differentially	O
expressed	O
proteins	O
in	O
LB	O
Stat	O
growth	O
is	O
in	O
agreement	O
with	O
the	O
literature	O
providing	O
validation	O
.	O

The	O
exception	O
was	O
the	O
SPI	O
-	O
1	O
protein	O
SipA	B-Protein
under	O
LB	O
Stat	O
growth	O
conditions	O
.	O

However	O
under	O
SPI	O
-	O
1	O
inducing	O
conditions	O
(	O
LB	O
Log	O
)	O
regulation	O
of	O
SPI	O
-	O
1	O
proteins	O
by	O
Hfq	B-Protein
was	O
generally	O
consistent	O
with	O
the	O
literature	O
.	O

To	O
extend	O
our	O
validation	O
of	O
the	O
proteomics	O
results	O
we	O
also	O
directly	O
analyzed	O
protein	O
levels	O
by	O
Western	O
blot	O
analysis	O
of	O
selected	O
proteins	O
based	O
on	O
our	O
proteomics	O
results	O
.	O

Our	O
proteomics	O
results	O
showed	O
that	O
HtrA	B-Protein
protein	O
levels	O
were	O
strongly	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	B-Protein
mutant	O
relative	O
to	O
wildtype	O
in	O
LB	O
Log	O
,	O
while	O
OsmY	B-Protein
and	O
STM1513	B-Protein
were	O
strongly	O
down	O
-	O
regulated	O
in	O
the	O
Deltahfq	B-Protein
mutant	O
relative	O
to	O
wildtype	O
in	O
AMM	O
-	O
1	O
and	O
LB	O
Stat	O
respectively	O
.	O

Deletion	O
of	O
SmpB	B-Protein
resulted	O
in	O
a	O
significant	O
decrease	O
in	O
protein	O
expression	O
levels	O
of	O
FliC	B-Protein
under	O
LB	O
Log	O
and	O
a	O
significant	O
increase	O
in	O
the	O
protein	O
levels	O
of	O
YciF	B-Protein
in	O
AMM	O
-	O
2	O
.	O

Western	O
blot	O
analysis	O
of	O
the	O
relative	O
protein	O
levels	O
of	O
each	O
of	O
HtrA	B-Protein
,	O
OsmY	B-Protein
,	O
STM1513	B-Protein
,	O
FliC	B-Protein
,	O
and	O
YciF	B-Protein
(	O
Figure	O
S2	O
)	O
served	O
to	O
further	O
verify	O
our	O
global	O
proteomics	O
measurements	O
.	O

As	O
transcript	O
levels	O
are	O
often	O
equated	O
to	O
protein	O
expression	O
levels	O
,	O
it	O
was	O
of	O
particular	O
interest	O
to	O
determine	O
whether	O
genes	O
that	O
showed	O
significant	O
changes	O
in	O
protein	O
expression	O
also	O
exhibited	O
significant	O
changes	O
in	O
transcript	O
levels	O
.	O

Examination	O
of	O
transcript	O
levels	O
using	O
microarray	O
analysis	O
(	O
>	O
/	O
=	O
2	O
-	O
fold	O
change	O
)	O
revealed	O
a	O
more	O
modest	O
effect	O
on	O
Salmonella	B-Organism
transcription	O
,	O
with	O
approximately11	O
%	O
(	O
492	O
genes	O
)	O
and	O
approximately8	O
%	O
(	O
370	O
genes	O
)	O
of	O
the	O
Salmonella	B-Organism
Typhimurium	I-Organism
genome	O
(	O
4550	O
genes	O
;	O
[	O
31	O
]	O
)	O
under	O
control	O
of	O
Hfq	B-Protein
and	O
SmpB	B-Protein
,	O
respectively	O
(	O
Table	O
S4	O
)	O
.	O

The	O
result	O
for	O
hfq	B-Protein
transcriptional	O
analysis	O
is	O
in	O
general	O
agreement	O
with	O
previous	O
studies	O
for	O
Salmonella	B-Organism
[	O
10	O
]	O
and	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
[	O
33	O
]	O
where	O
approximately20	O
%	O
and	O
approximately15	O
%	O
of	O
all	O
genes	O
,	O
respectively	O
,	O
were	O
regulated	O
by	O
Hfq	B-Protein
,	O
but	O
slightly	O
higher	O
than	O
the	O
number	O
of	O
Hfq	B-Protein
-	O
dependent	O
genes	O
reported	O
for	O
E	B-Organism
.	I-Organism
coli	I-Organism
[	O
27	O
]	O
and	O
Vibrio	B-Organism
cholerae	I-Organism
[	O
21	O
]	O
,	O
approximately6	O
%	O
each	O
.	O

In	O
light	O
of	O
the	O
fact	O
that	O
these	O
studies	O
employed	O
varying	O
growth	O
conditions	O
it	O
is	O
not	O
possible	O
to	O
perform	O
a	O
rigorous	O
direct	O
comparison	O
across	O
these	O
diverse	O
datasets	O
.	O

However	O
it	O
is	O
worth	O
noting	O
that	O
our	O
observation	O
that	O
Hfq	B-Protein
strongly	O
regulates	O
flagellar	O
genes	O
and	O
SPI	O
-	O
1	O
TTSS	O
genes	O
,	O
discussed	O
below	O
,	O
is	O
consistent	O
with	O
previous	O
results	O
in	O
Salmonella	B-Organism
[	O
10	O
]	O
,	O
[	O
20	O
]	O
.	O

Overall	O
,	O
the	O
transcription	O
data	O
showed	O
fewer	O
discernable	O
patterns	O
of	O
regulation	O
by	O
Hfq	B-Protein
or	O
SmpB	B-Protein
relative	O
to	O
the	O
proteome	O
analysis	O
,	O
and	O
comparison	O
across	O
all	O
growth	O
conditions	O
revealed	O
little	O
overlap	O
in	O
proteins	O
and	O
transcripts	O
regulated	O
by	O
either	O
Hfq	B-Protein
or	O
SmpB	B-Protein
(	O
Figure	O
3	O
)	O
.	O

Of	O
the	O
781	O
proteins	O
and	O
492	O
transcripts	O
regulated	O
by	O
Hfq	B-Protein
,	O
113	O
genes	O
overlapped	O
both	O
sets	O
.	O

For	O
SmpB	B-Protein
-	O
regulated	O
proteins	O
(	O
189	O
)	O
and	O
transcripts	O
(	O
370	O
)	O
there	O
was	O
an	O
overlap	O
of	O
20	O
genes	O
.	O

Given	O
the	O
fact	O
that	O
the	O
present	O
study	O
specifically	O
examines	O
the	O
effects	O
of	O
two	O
translational	O
regulators	O
,	O
which	O
decouple	O
transcription	O
and	O
translation	O
,	O
a	O
lack	O
of	O
correlation	O
between	O
transcriptomics	O
and	O
proteomics	O
might	O
be	O
expected	O
.	O

Overall	O
Hfq	B-Protein
has	O
a	O
much	O
stronger	O
global	O
effect	O
on	O
Salmonella	B-Organism
protein	O
translation	O
than	O
SmpB	B-Protein
which	O
is	O
in	O
agreement	O
with	O
the	O
large	O
number	O
of	O
regulatory	O
sRNAs	O
that	O
serve	O
as	O
guides	O
for	O
Hfq	B-Protein
translational	O
modulation	O
as	O
opposed	O
to	O
the	O
single	O
regulatory	O
sRNA	O
(	O
i	O
.	O
e	O
.	O
tmRNA	B-Protein
)	O
that	O
requires	O
SmpB	B-Protein
for	O
activity	O
.	O

Hfq	B-Protein
control	O
of	O
biological	O
processes	O

While	O
the	O
role	O
of	O
Hfq	B-Protein
as	O
a	O
global	O
regulator	O
has	O
become	O
increasingly	O
appreciated	O
over	O
the	O
past	O
few	O
years	O
,	O
the	O
actual	O
extent	O
of	O
Hfq	B-Protein
regulation	O
of	O
translation	O
remains	O
unknown	O
.	O

We	O
observed	O
changes	O
in	O
expression	O
for	O
approximately50	O
%	O
of	O
the	O
observed	O
Salmonella	B-Organism
Typhimurium	I-Organism
proteome	O
based	O
on	O
an	O
ANOVA	B-Protein
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
(	O
Table	O
S1	B-Protein
)	O
.	O

The	O
proteins	O
affected	O
represent	O
a	O
broad	O
spectrum	O
of	O
Salmonella	B-Organism
proteins	O
required	O
for	O
many	O
biological	O
processes	O
including	O
general	O
metabolism	O
,	O
the	O
translational	O
machinery	O
,	O
stress	O
response	O
,	O
and	O
virulence	O
-	O
assocaited	O
processes	O
as	O
described	O
next	O
.	O

General	O
metabolism	O
Proteome	O
profiling	O
data	O
suggested	O
Hfq	B-Protein
regulates	O
nucleoside	O
(	O
DeoABC	B-Protein
)	O
and	O
nucleotide	O
metabolism	O
(	O
CarAB	B-Protein
,	O
PurUBCMHAD	B-Protein
,	O
Ndk	B-Protein
)	O
under	O
AMM	O
conditions	O
,	O
as	O
well	O
as	O
regulates	O
ribose	O
metabolism	O
and	O
transport	O
(	O
RbsABK	B-Protein
)	O
under	O
AMM	O
-	O
2	O
.	O

Hfq	B-Protein
also	O
appears	O
to	O
play	O
a	O
significant	O
role	O
in	O
central	O
metabolism	O
based	O
on	O
observed	O
differential	O
regulation	O
of	O
numerous	O
proteins	O
involved	O
in	O
glycolysis	O
/	O
gluconeogenesis	O
,	O
the	O
TCA	B-Chemical
pathway	O
,	O
pyruvate	B-Chemical
decarboxylation	O
and	O
the	O
pentose	O
phosphate	O
shunt	O
(	O
see	O
Table	O
S1	O
)	O
.	O

Other	O
metabolic	O
processes	O
regulated	O
by	O
Hfq	B-Protein
include	O
Fatty	O
acid	O
metabolism	O
(	O
FadA	B-Protein
,	O
FadB	B-Protein
,	O
FabA	B-Protein
,	O
FabZ	B-Protein
,	O
fbab	B-Protein
,	O
AccB	B-Protein
,	O
Acs	B-Protein
,	O
FabG	B-Protein
,	O
FabF	B-Protein
,	O
FabI	B-Protein
,	O
FabB	B-Protein
)	O
;	O
Arginine	O
catabolism	O
(	O
AstABCD	B-Protein
)	O
;	O
and	O
Propanoite	B-Chemical
catabolism	O
(	O
PrpBCDE	B-Protein
)	O
.	O

Examination	O
of	O
the	O
transcript	O
levels	O
of	O
the	O
corresponding	O
genes	O
showed	O
no	O
significant	O
change	O
in	O
mRNA	O
expression	O
levels	O
relative	O
to	O
wildtype	O
,	O
suggesting	O
that	O
Hfq	B-Protein
provides	O
most	O
of	O
the	O
control	O
of	O
these	O
pathways	O
for	O
the	O
growth	O
conditions	O
monitored	O
.	O

Translation	O

Hfq	B-Protein
also	O
appears	O
to	O
play	O
a	O
role	O
in	O
the	O
regulation	O
of	O
the	O
translational	O
machinery	O
itself	O
presumably	O
as	O
a	O
feedback	O
mechanism	O
to	O
maintain	O
tight	O
control	O
over	O
the	O
amount	O
of	O
ribosomal	O
synthesis	O
.	O

Several	O
ribosomal	O
proteins	O
including	O
RpsM	B-Protein
,	O
RpsG	B-Protein
,	O
RpmD	B-Protein
,	O
and	O
RplN	B-Protein
exhibited	O
a	O
marked	O
reduction	O
in	O
both	O
protein	O
and	O
mRNA	O
levels	O
in	O
the	O
Deltahfq	B-Protein
mutant	O
strain	O
compared	O
to	O
the	O
wildtype	O
under	O
LB	O
Stat	O
growth	O
condition	O
.	O

One	O
hallmark	O
of	O
growth	O
under	O
nutrient	O
poor	O
conditions	O
is	O
lower	O
expression	O
of	O
the	O
machinery	O
necessary	O
to	O
synthesize	O
proteins	O
,	O
including	O
tRNA	O
synthetases	O
and	O
other	O
factors	O
.	O

In	O
fact	O
all	O
of	O
the	O
aminoacyl	O
-	O
tRNA	O
synthetases	O
(	O
IleS	B-Protein
,	O
ProS	B-Protein
,	O
CysS	B-Protein
,	O
GlnS	B-Protein
,	O
AspS	B-Protein
,	O
ArgS	B-Protein
,	O
GltX	B-Protein
,	O
AlaS	B-Protein
,	O
TrpS	B-Protein
,	O
GlyS	B-Protein
,	O
GlyQ	B-Protein
)	O
observed	O
were	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	B-Protein
mutant	O
relative	O
to	O
the	O
wild	O
type	O
without	O
a	O
concurrent	O
change	O
in	O
transcription	O
.	O

This	O
suggests	O
that	O
Hfq	B-Protein
normally	O
represses	O
translation	O
of	O
these	O
genes	O
under	O
conditions	O
that	O
mimics	O
the	O
intracellular	O
environment	O
(	O
AMM	O
)	O
.	O

Stress	O
response	O

Hfq	B-Protein
was	O
observed	O
to	O
modulate	O
numerous	O
proteins	O
involved	O
in	O
envelope	O
stress	O
under	O
AMM	O
-	O
2	O
conditions	O
,	O
including	O
FkpA	B-Protein
,	O
SurA	B-Protein
,	O
HtrA	B-Protein
,	O
NlpB	B-Protein
,	O
NmpC	B-Protein
,	O
ClpA	B-Protein
,	O
SlyD	B-Protein
,	O
RseA	B-Protein
,	O
RseB	B-Protein
,	O
RpoE	B-Protein
,	O
OmpF	B-Protein
,	O
and	O
HtpG	B-Protein
,	O
which	O
were	O
all	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	B-Protein
mutant	O
strain	O
.	O

These	O
observations	O
are	O
in	O
agreement	O
with	O
the	O
recently	O
suggested	O
role	O
of	O
Hfq	B-Protein
in	O
envelope	O
stress	O
based	O
on	O
lacZ	B-Protein
translational	O
fusions	O
[	O
34	O
]	O
as	O
well	O
as	O
the	O
observation	O
that	O
rpoE	B-Protein
is	O
translationally	O
regulated	O
by	O
Hfq	B-Protein
[	O
10	O
]	O
.	O

Proteins	O
involved	O
in	O
oxidative	O
stress	O
(	O
NarY	B-Protein
,	O
Qor	B-Protein
,	O
Dps	B-Protein
,	O
WraB	B-Protein
,	O
OxyR	B-Protein
,	O
GrxA	B-Protein
,	O
Gor	B-Protein
,	O
GrxB	B-Protein
,	O
KatG	B-Protein
,	O
KatE	B-Protein
,	O
SodC	B-Protein
,	O
SodB	B-Protein
,	O
AhpF	B-Protein
)	O
;	O
acid	O
stress	O
(	O
CadA	B-Protein
)	O
;	O
and	O
starvation	O
(	O
SspA	B-Protein
,	O
SspB	B-Protein
)	O
were	O
all	O
also	O
differentially	O
regulated	O
by	O
Hfq	B-Protein
(	O
Table	O
S1	O
)	O
.	O

Collectively	O
,	O
these	O
results	O
point	O
to	O
a	O
central	O
role	O
for	O
Hfq	B-Protein
in	O
regulating	O
stress	O
response	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
.	O

Many	O
of	O
these	O
genes	O
are	O
required	O
for	O
virulence	O
as	O
discussed	O
in	O
more	O
detail	O
below	O
.	O

For	O
example	O
rpoE	B-Protein
has	O
been	O
shown	O
to	O
be	O
required	O
for	O
the	O
virulence	O
of	O
Salmonella	B-Organism
Typhimurium	I-Organism
[	O
35	O
]	O
.	O

Two	O
RpoE	B-Protein
-	O
regulated	O
genes	O
,	O
htrA	B-Protein
and	O
surA	B-Protein
,	O
have	O
also	O
been	O
shown	O
to	O
be	O
involved	O
in	O
Salmonella	B-Organism
virulence	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
,	O
[	O
37	O
]	O
.	O

The	O
OxyR	B-Protein
-	O
regulated	O
gene	O
dps	B-Protein
was	O
demonstrated	O
to	O
contribute	O
to	O
Salmonella	B-Organism
oxidative	O
stress	O
resistance	O
,	O
survival	O
in	O
macrophages	O
,	O
and	O
virulence	O
in	O
mice	B-Organism
[	O
38	O
]	O
.	O

Recent	O
studies	O
have	O
shown	O
the	O
periplasmic	O
Cu	B-Chemical
,	O
Zn	B-Chemical
-	O
superoxide	O
dismutase	O
sodC	B-Protein
to	O
contribute	O
to	O
Salmonella	B-Organism
virulence	O
in	O
mice	B-Organism
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

Virulence	O
-	O
associated	O

LPS	B-Chemical
(	O
lipopolysaccharide	B-Chemical
)	O
has	O
long	O
been	O
known	O
as	O
an	O
essential	O
component	O
of	O
virulence	O
of	O
Gram	O
negative	O
pathogens	O
and	O
,	O
more	O
recently	O
,	O
the	O
agonist	O
for	O
toll	O
like	O
receptor	O
4	O
.	O

Hfq	B-Protein
differentially	O
regulated	O
the	O
expression	O
of	O
several	O
proteins	O
involved	O
in	O
lipopolysaccharides	B-Chemical
(	O
LPS	B-Chemical
)	O
biosynthesis	O
in	O
acidic	O
minimal	O
media	O
.	O

LpxA	B-Protein
and	O
LpxD	B-Protein
involved	O
in	O
Lipid	O
A	O
synthesis	O
,	O
TolC	B-Protein
involved	O
in	O
LPS	O
Core	O
completion	O
,	O
as	O
well	O
as	O
proteins	O
involved	O
in	O
O	O
-	O
antigen	O
synthesis	O
(	O
RfbACKMGJU	B-Protein
)	O
,	O
appeared	O
as	O
up	O
-	O
regulated	O
in	O
the	O
Deltahfq	B-Protein
mutant	O
strain	O
suggesting	O
that	O
Hfq	B-Protein
may	O
normally	O
down	O
regulate	O
expression	O
within	O
the	O
host	O
.	O

Complementary	O
transcriptional	O
analysis	O
revealed	O
no	O
change	O
in	O
the	O
corresponding	O
mRNA	O
levels	O
relative	O
to	O
the	O
wildtype	O
.	O

Reduced	O
expression	O
of	O
LPS	B-Chemical
and	O
alterations	O
in	O
LPS	B-Chemical
modification	O
has	O
been	O
reported	O
for	O
intracellular	O
Salmonella	B-Organism
[	O
41	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
.	O

Our	O
results	O
suggest	O
Hfq	B-Protein
plays	O
a	O
role	O
in	O
the	O
post	O
-	O
transcriptional	O
regulation	O
of	O
several	O
two	O
component	O
systems	O
including	O
three	O
that	O
have	O
been	O
shown	O
to	O
be	O
essential	O
for	O
virulence	O
in	O
a	O
variety	O
of	O
animal	O
models	O
;	O
SsrA	B-Protein
/	O
B	B-Protein
,	O
PhoP	B-Protein
/	O
Q	B-Protein
,	O
and	O
OmpR	B-Protein
/	O
EnvZ	O
.	O

Two	O
component	O
systems	O
are	O
widespread	O
methods	O
of	O
sensing	O
external	O
conditions	O
and	O
responding	O
by	O
altering	O
gene	O
expression	O
in	O
prokaryotes	O
,	O
eukaryotes	O
and	O
archaea	O
.	O

Well	O
known	O
two	O
component	O
regulators	O
respond	O
to	O
osmolarity	O
,	O
nitrogen	B-Chemical
and	O
oxygen	B-Chemical
limitation	O
[	O
44	O
]	O
,	O
[	O
45	O
]	O
.	O

As	O
such	O
,	O
they	O
are	O
critical	O
to	O
the	O
ability	O
of	O
pathogenic	O
bacteria	O
to	O
adapt	O
and	O
survive	O
following	O
environmental	O
changes	O
.	O

In	O
addition	O
to	O
the	O
three	O
mentioned	O
above	O
Hfq	B-Protein
negatively	O
modulates	O
PhoB	B-Protein
involved	O
in	O
the	O
phosphate	B-Chemical
starvation	O
response	O
,	O
RstA	B-Protein
,	O
NarP	B-Protein
,	O
RcsB	B-Protein
,	O
BasR	B-Protein
,	O
and	O
CpxR	B-Protein
.	O

Microarray	O
analysis	O
showed	O
no	O
effect	O
on	O
transcription	O
of	O
these	O
genes	O
.	O

Salmonella	B-Organism
motility	O
enhances	O
cell	O
contact	O
thereby	O
increasing	O
host	O
cell	O
invasion	O
.	O

A	O
recent	O
study	O
showed	O
that	O
an	O
Deltahfq	B-Protein
mutant	O
that	O
was	O
non	O
-	O
motile	O
exhibited	O
an	O
invasion	O
defect	O
[	O
20	O
]	O
.	O

Analysis	O
of	O
protein	O
expression	O
in	O
the	O
Deltahfq	B-Protein
strain	O
showed	O
reduced	O
expression	O
of	O
SPI	O
-	O
1	O
TTSS	O
components	O
and	O
the	O
flagellar	O
subunit	O
protein	O
FliC	B-Protein
compared	O
to	O
the	O
wildtype	O
Salmonella	B-Organism
strain	O
.	O

Consistent	O
with	O
this	O
previous	O
study	O
,	O
we	O
observed	O
reduced	O
expression	O
of	O
SPI	O
-	O
1	O
invasion	O
proteins	O
and	O
numerous	O
motility	O
proteins	O
in	O
the	O
Deltahfq	B-Protein
mutant	O
strain	O
primarily	O
in	O
the	O
log	O
phase	O
growth	O
condition	O
compared	O
to	O
the	O
wildtype	O
strain	O
.	O

Among	O
the	O
SPI	O
-	O
1	O
invasion	O
proteins	O
were	O
PrgI	B-Protein
,	O
SptP	B-Protein
,	O
SipD	B-Protein
,	O
SicA	B-Protein
,	O
InvC	B-Protein
and	O
InvG	B-Protein
,	O
and	O
the	O
motility	O
proteins	O
FliC	B-Protein
,	O
FliT	B-Protein
,	O
FliB	B-Protein
,	O
CheZ	B-Protein
,	O
CheY	B-Protein
,	O
and	O
CheW	B-Protein
.	O

Microarray	O
results	O
revealed	O
a	O
reduction	O
in	O
mRNA	O
expression	O
of	O
the	O
SPI	O
-	O
1	O
TTSS	O
and	O
several	O
flagellar	O
proteins	O
,	O
including	O
FliC	B-Protein
,	O
FliO	B-Protein
,	O
and	O
FliN	B-Protein
grown	O
under	O
LB	O
Log	O
growth	O
conditions	O
.	O

This	O
reduction	O
in	O
mRNA	O
expression	O
suggests	O
that	O
Hfq	B-Protein
regulates	O
motility	O
and	O
invasion	O
at	O
the	O
transcription	O
level	O
,	O
presumably	O
by	O
modulating	O
one	O
of	O
the	O
upstream	O
regulators	O
.	O

Regulatory	O
elements	O
are	O
generally	O
not	O
made	O
at	O
high	O
levels	O
and	O
thus	O
difficult	O
to	O
identify	O
and	O
quantify	O
.	O

Analysis	O
of	O
our	O
data	O
however	O
demonstrated	O
the	O
upstream	O
regulator	O
for	O
motility	O
flgM	B-Protein
[	O
46	O
]	O
was	O
poorly	O
expressed	O
in	O
an	O
Deltahfq	B-Protein
mutant	O
.	O

Propanediol	B-Chemical
utilization	O
operon	O

The	O
cob	B-Regulon-operon
operon	I-Regulon-operon
is	O
required	O
for	O
the	O
de	O
novo	O
biosynthesis	O
of	O
vitamin	B-Chemical
B12	I-Chemical
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
.	O

Propanediol	B-Chemical
,	O
derived	O
from	O
rhamnose	B-Chemical
and	O
fucose	B-Chemical
catabolism	O
,	O
is	O
degraded	O
by	O
products	O
of	O
the	O
propanediol	B-Chemical
utilization	O
(	O
pdu	O
)	O
operon	O
(	O
immediately	O
adjacent	O
to	O
the	O
cob	B-Regulon-operon
operon	I-Regulon-operon
)	O
in	O
a	O
vitamin	B-Chemical
B12	I-Chemical
dependent	O
manner	O
.	O

This	O
allows	O
Salmonella	B-Organism
Typhimurium	I-Organism
to	O
grow	O
using	O
propanediol	B-Chemical
as	O
a	O
sole	O
carbon	B-Chemical
source	O
and	O
because	O
it	O
is	O
required	O
for	O
growth	O
in	O
macrophages	O
this	O
may	O
be	O
the	O
preferred	O
intracellular	O
metabolite	O
[	O
47	O
]	O
.	O

Results	O
from	O
our	O
proteomics	O
analysis	O
revealed	O
that	O
Hfq	B-Protein
regulates	O
the	O
cob	B-Regulon-operon
-	I-Regulon-operon
pdu	I-Regulon-operon
operon	I-Regulon-operon
in	O
AMM	O
-	O
2	O
(	O
Figure	O
4A	O
)	O
and	O
stationary	O
phase	O
(	O
Figure	O
4D	O
)	O
growth	O
conditions	O
,	O
with	O
several	O
products	O
of	O
the	O
cob	B-Regulon-operon
-	I-Regulon-operon
pdu	I-Regulon-operon
operon	I-Regulon-operon
exhibiting	O
increased	O
expression	O
compared	O
to	O
wild	O
type	O
.	O

Among	O
these	O
were	O
PduA	B-Protein
,	O
PduB	B-Protein
,	O
PduG	B-Protein
,	O
PduL	B-Protein
,	O
PduM	B-Protein
and	O
PduT	B-Protein
as	O
well	O
as	O
CobT	B-Protein
,	O
CbiH	B-Protein
,	O
CbiF	B-Protein
,	O
CbiC	B-Protein
,	O
and	O
CbiL	B-Protein
.	O

This	O
was	O
not	O
apparent	O
in	O
the	O
DeltasmpB	B-Protein
mutant	O
strain	O
in	O
which	O
cob	O
-	O
pdu	O
protein	O
levels	O
are	O
the	O
same	O
as	O
the	O
parent	O
(	O
Figure	O
4A	O
and	O
4D	O
)	O
.	O

Western	O
blot	O
analysis	O
of	O
PduA	B-Protein
and	O
PduE	B-Protein
relative	O
protein	O
levels	O
validated	O
results	O
from	O
the	O
proteomics	O
analysis	O
(	O
Figures	O
4B	O
,	O
4C	O
and	O
4E	O
,	O
4F	O
)	O
.	O

The	O
strong	O
regulation	O
of	O
Pdu	O
protein	O
expression	O
by	O
Hfq	B-Protein
suggests	O
the	O
pdu	B-Regulon-operon
operon	I-Regulon-operon
to	O
be	O
a	O
potential	O
target	O
of	O
sRNA	O
regulation	O
and	O
that	O
correct	O
coordinate	O
expression	O
may	O
be	O
essential	O
for	O
activity	O
.	O

Both	O
microarray	O
analysis	O
and	O
confirmative	O
qRT	O
-	O
PCR	O
assays	O
showed	O
that	O
RNA	O
levels	O
were	O
unchanged	O
for	O
pduA	B-Protein
and	O
pduE	B-Protein
genes	O
in	O
the	O
Deltahfq	B-Protein
mutant	O
strain	O
compared	O
to	O
the	O
wildtype	O
strain	O
(	O
Figure	O
5	O
)	O
,	O
thus	O
showing	O
that	O
Hfq	B-Protein
represses	O
translation	O
in	O
these	O
two	O
environmental	O
conditions	O
.	O

The	O
data	O
presented	O
here	O
suggests	O
Hfq	B-Protein
likely	O
plays	O
a	O
substantial	O
role	O
in	O
the	O
regulation	O
of	O
the	O
protein	O
expression	O
of	O
the	O
cob	B-Regulon-operon
-	I-Regulon-operon
pdu	I-Regulon-operon
operon	I-Regulon-operon
,	O
required	O
for	O
intra	O
-	O
macrophage	O
replication	O
[	O
47	O
]	O
,	O
via	O
post	O
-	O
transcriptional	O
regulatory	O
mechanisms	O
.	O

SmpB	B-Protein
control	O
of	O
biological	O
processes	O

SmpB	B-Protein
is	O
thought	O
to	O
be	O
limited	O
to	O
trans	O
-	O
translation	O
but	O
has	O
been	O
shown	O
to	O
increase	O
the	O
translation	O
of	O
a	O
single	O
protein	O
-	O
the	O
stationary	O
phase	O
sigma	O
factor	O
RpoS	B-Protein
[	O
19	O
]	O
.	O

The	O
normal	O
function	O
of	O
SmpB	B-Protein
is	O
in	O
quality	O
control	O
to	O
free	O
ribosomes	O
stalled	O
on	O
defective	O
mRNAs	O
[	O
11	O
]	O
,	O
[	O
16	O
]	O
.	O

However	O
,	O
results	O
from	O
our	O
global	O
proteomics	O
analysis	O
indicate	O
that	O
SmpB	B-Protein
directly	O
or	O
indirectly	O
modulates	O
the	O
expression	O
of	O
at	O
least	O
4	O
%	O
of	O
the	O
entire	O
Salmonella	B-Organism
Typhimurium	I-Organism
proteome	O
determined	O
from	O
ANOVA	O
analysis	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
(	O
Table	O
S1	O
)	O
.	O

The	O
majority	O
of	O
genes	O
encoding	O
these	O
proteins	O
showed	O
no	O
changes	O
in	O
mRNA	O
level	O
thus	O
it	O
is	O
interesting	O
to	O
speculate	O
an	O
additional	O
role	O
for	O
SmpB	B-Protein
as	O
a	O
general	O
post	O
-	O
transcriptional	O
/	O
translational	O
regulator	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
.	O

Few	O
of	O
the	O
genes	O
identified	O
are	O
regulated	O
by	O
RpoS	B-Protein
again	O
suggesting	O
that	O
this	O
is	O
a	O
direct	O
translational	O
effect	O
and	O
not	O
indirect	O
transcriptional	O
.	O

The	O
RpoS	B-Protein
regulon	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
has	O
been	O
initially	O
characterized	O
,	O
identifying	O
13	O
conserved	O
RpoS	B-Protein
-	O
regulated	O
genes	O
[	O
48	O
]	O
.	O

From	O
our	O
global	O
proteomics	O
analysis	O
we	O
were	O
able	O
to	O
observe	O
gene	O
products	O
for	O
8	O
of	O
the	O
13	O
conserved	O
RpoS	B-Protein
-	O
regulated	O
genes	O
,	O
of	O
which	O
only	O
a	O
single	O
protein	O
,	O
YciF	B-Protein
,	O
was	O
regulated	O
by	O
SmpB	B-Protein
.	O

We	O
note	O
however	O
that	O
a	O
more	O
detailed	O
and	O
rigorous	O
analysis	O
is	O
required	O
to	O
confirm	O
the	O
speculated	O
global	O
regulatory	O
role	O
of	O
SmpB	O
.	O

Examination	O
of	O
proteins	O
modulated	O
by	O
SmpB	B-Protein
revealed	O
a	O
number	O
of	O
SmpB	B-Protein
regulated	O
cellular	O
processes	O
.	O

SmpB	B-Protein
regulates	O
histidine	O
biosynthesis	O
in	O
AMM	O
-	O
1	O
,	O
affecting	O
HisDGCBHAF	B-Protein
.	O

Proteins	O
involved	O
in	O
motility	O
in	O
Salmonella	B-Organism
Typhimurium	I-Organism
also	O
showed	O
down	O
-	O
regulation	O
during	O
growth	O
in	O
LB	O
media	O
.	O

This	O
set	O
of	O
proteins	O
included	O
the	O
chemotaxis	O
proteins	O
CheZ	B-Protein
,	O
CheY	B-Protein
,	O
CheW	B-Protein
,	O
CheA	B-Protein
and	O
Tsr	B-Protein
as	O
well	O
as	O
the	O
flagellar	O
proteins	O
FliC	B-Protein
,	O
FliD	B-Protein
,	O
FliG	B-Protein
and	O
FljB	B-Protein
.	O

This	O
suggests	O
that	O
a	O
more	O
thorough	O
examination	O
of	O
the	O
role	O
of	O
SmpB	B-Protein
in	O
the	O
regulation	O
of	O
cell	O
motility	O
and	O
histidine	O
biosynthesis	O
is	O
warranted	O
.	O

Western	O
blot	O
analysis	O
of	O
FliC	B-Protein
relative	O
protein	O
levels	O
validated	O
results	O
from	O
the	O
proteomics	O
analysis	O
(	O
Figure	O
S2B	O
)	O
.	O

Proteins	O
co	O
-	O
regulated	O
by	O
Hfq	B-Protein
and	O
SmpB	B-Protein

We	O
were	O
interested	O
in	O
determining	O
whether	O
there	O
was	O
overlap	O
in	O
translational	O
regulation	O
between	O
Hfq	B-Protein
and	O
SmpB	B-Protein
i	O
.	O
e	O
.	O
,	O
the	O
extent	O
of	O
cross	O
-	O
talk	O
or	O
level	O
of	O
co	O
-	O
ordination	O
if	O
any	O
between	O
these	O
two	O
translational	O
regulators	O
(	O
Table	O
S1	O
)	O
.	O

For	O
example	O
it	O
was	O
possible	O
that	O
Hfq	B-Protein
directly	O
modulates	O
translation	O
of	O
smpB	B-Protein
and	O
therefore	O
all	O
of	O
the	O
effects	O
observed	O
for	O
smpB	B-Protein
could	O
be	O
related	O
to	O
Hfq	B-Protein
.	O

For	O
logarithmic	O
phase	O
growth	O
conditions	O
,	O
the	O
expression	O
pattern	O
of	O
242	O
proteins	O
appeared	O
to	O
exhibit	O
a	O
dependence	O
on	O
Hfq	B-Protein
,	O
while	O
37	O
proteins	O
exhibited	O
a	O
dependency	O
on	O
SmpB	B-Protein
.	O

Twenty	O
proteins	O
overlapped	O
both	O
sets	O
,	O
including	O
the	O
motility	O
proteins	O
FliC	B-Protein
,	O
CheA	B-Protein
,	O
CheZ	B-Protein
and	O
Tsr	B-Protein
.	O

Under	O
stationary	O
phase	O
growth	O
conditions	O
270	O
proteins	O
appeared	O
to	O
be	O
under	O
control	O
of	O
Hfq	B-Protein
and	O
27	O
proteins	O
under	O
control	O
of	O
SmpB	B-Protein
.	O

Nine	O
proteins	O
,	O
including	O
the	O
NADPH	B-Chemical
-	O
dependent	O
quinine	B-Chemical
oxidoreductase	O
Qor	B-Protein
,	O
TolC	B-Protein
involved	O
in	O
LPS	B-Chemical
biosynthesis	O
,	O
and	O
a	O
putative	O
hydrolase	O
YbeM	B-Protein
,	O
overlapped	O
.	O

Of	O
the	O
390	O
proteins	O
regulated	O
by	O
Hfq	B-Protein
and	O
50	O
proteins	O
regulated	O
by	O
SmpB	B-Protein
in	O
growth	O
in	O
AMM	O
-	O
2	O
,	O
15	O
proteins	O
were	O
co	O
-	O
regulated	O
by	O
both	O
Hfq	B-Protein
and	O
SmpB	B-Protein
,	O
including	O
the	O
invasion	O
protein	O
PrgI	B-Protein
,	O
MdoH	B-Protein
involved	O
in	O
the	O
synthesis	O
of	O
membrane	O
-	O
derived	O
oligosaccharide	O
,	O
and	O
a	O
putative	O
periplasmic	O
protein	O
CreA	B-Protein
.	O

Under	O
growth	O
in	O
AMM	O
-	O
1	O
267	O
proteins	O
appeared	O
regulated	O
by	O
Hfq	B-Protein
and	O
the	O
expression	O
pattern	O
of	O
86	O
proteins	O
exhibited	O
a	O
dependence	O
on	O
SmpB	B-Protein
.	O

Twenty	O
four	O
of	O
these	O
proteins	O
were	O
co	O
-	O
regulated	O
by	O
both	O
Hfq	B-Protein
and	O
SmpB	B-Protein
.	O

This	O
subset	O
included	O
a	O
putative	O
serine	O
/	O
threonine	O
protein	O
kinase	O
,	O
a	O
putative	O
intracellular	O
proteinase	O
YhbO	B-Protein
,	O
SrfJ	B-Protein
,	O
a	O
known	O
Salmonella	B-Organism
Typhimurium	I-Organism
virulence	O
protein	O
,	O
and	O
the	O
stress	O
protein	O
HtpG	B-Protein
.	O

These	O
results	O
also	O
confirm	O
that	O
there	O
is	O
no	O
direct	O
translational	O
control	O
of	O
smpB	B-Protein
by	O
Hfq	B-Protein
.	O

Summary	O

Post	O
-	O
transcriptional	O
regulation	O
has	O
not	O
been	O
directly	O
examined	O
on	O
a	O
global	O
scale	O
by	O
proteomic	O
methods	O
.	O

This	O
work	O
has	O
focused	O
on	O
two	O
translational	O
regulators	O
in	O
Salmonella	B-Organism
(	O
Hfq	B-Protein
and	O
SmpB	B-Protein
)	O
that	O
are	O
required	O
for	O
virulence	O
.	O

In	O
order	O
to	O
accurately	O
characterize	O
global	O
control	O
of	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
it	O
is	O
essential	O
to	O
measure	O
global	O
changes	O
in	O
both	O
transcript	O
and	O
protein	O
levels	O
.	O

We	O
performed	O
a	O
sample	O
-	O
matched	O
global	O
proteomics	O
and	O
transcriptional	O
analysis	O
to	O
examine	O
the	O
broad	O
impacts	O
of	O
deletion	O
mutants	O
of	O
hfq	B-Protein
and	O
smpB	B-Protein
on	O
global	O
protein	O
and	O
transcript	O
abundance	O
levels	O
to	O
begin	O
to	O
understand	O
how	O
Hfq	B-Protein
and	O
SmpB	B-Protein
mediate	O
the	O
control	O
of	O
global	O
gene	O
expression	O
at	O
the	O
post	O
-	O
transcriptional	O
level	O
.	O

Using	O
a	O
sample	O
-	O
matched	O
procedure	O
our	O
strategy	O
simultaneously	O
measures	O
changes	O
in	O
global	O
transcript	O
and	O
protein	O
abundance	O
levels	O
allowing	O
for	O
a	O
clear	O
distinction	O
between	O
the	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
effects	O
of	O
Hfq	B-Protein
or	O
SmpB	B-Protein
.	O

Furthermore	O
,	O
our	O
strategy	O
requires	O
no	O
tagging	O
and	O
or	O
isolation	O
of	O
Hfq	B-Protein
or	O
SmpB	B-Protein
precluding	O
the	O
possibility	O
of	O
spurious	O
results	O
introduced	O
by	O
tagging	O
and	O
or	O
co	O
-	O
immunoprecipitation	O
processes	O
.	O

Previous	O
attempts	O
to	O
identify	O
processes	O
/	O
targets	O
regulated	O
by	O
Hfq	B-Protein
,	O
and	O
thus	O
targets	O
of	O
sRNA	O
regulation	O
,	O
have	O
relied	O
on	O
transcript	O
-	O
centric	O
approaches	O
.	O

In	O
one	O
study	O
microarray	O
analysis	O
was	O
used	O
to	O
identify	O
changes	O
in	O
gene	O
expression	O
resulting	O
from	O
lack	O
of	O
Hfq	B-Protein
,	O
thus	O
providing	O
potential	O
new	O
target	O
genes	O
for	O
sRNA	O
regulation	O
[	O
27	O
]	O
.	O

High	O
-	O
density	O
oligonucleotide	O
microarrays	O
were	O
used	O
to	O
detect	O
sRNA	O
and	O
other	O
targets	O
of	O
Hfq	B-Protein
co	O
-	O
immunoprecipitated	O
with	O
Hfq	B-Protein
-	O
specific	O
antibodies	O
[	O
26	O
]	O
.	O

Most	O
recently	O
high	O
-	O
throughput	O
pyrosequencing	O
(	O
HTPS	O
)	O
was	O
used	O
to	O
detect	O
message	O
and	O
sRNA	O
bound	O
to	O
Hfq	B-Protein
following	O
immunoprecipitation	O
[	O
10	O
]	O
.	O

The	O
result	O
of	O
this	O
work	O
was	O
very	O
surprising	O
namely	O
that	O
Hfq	B-Protein
bound	O
to	O
20	O
%	O
of	O
all	O
Salmonella	B-Organism
mRNA	O
transcripts	O
and	O
at	O
least	O
64	O
small	O
RNA	O
molecules	O
.	O

One	O
possible	O
criticism	O
of	O
this	O
work	O
is	O
that	O
the	O
RNA	O
co	O
-	O
immunoprecipitated	O
with	O
Hfq	B-Protein
may	O
be	O
brought	O
down	O
simply	O
because	O
Hfq	B-Protein
strongly	O
binds	O
to	O
RNA	O
molecules	O
and	O
that	O
the	O
binding	O
is	O
somewhat	O
non	O
-	O
specific	O
.	O

Our	O
efforts	O
presented	O
here	O
support	O
the	O
conclusions	O
of	O
that	O
study	O
and	O
suggest	O
that	O
an	O
even	O
larger	O
number	O
of	O
Salmonella	B-Organism
proteins	O
are	O
translationally	O
regulated	O
than	O
the	O
20	O
%	O
suggested	O
by	O
these	O
authors	O
,	O
when	O
accessed	O
across	O
a	O
larger	O
number	O
of	O
growth	O
conditions	O
.	O

We	O
have	O
compared	O
wildtype	O
and	O
isogenic	O
hfq	B-Protein
and	O
smpB	B-Protein
derivatives	O
with	O
matched	O
samples	O
to	O
examine	O
both	O
transcription	O
and	O
translation	O
by	O
global	O
proteomics	O
.	O

There	O
were	O
some	O
cases	O
in	O
which	O
a	O
change	O
in	O
protein	O
level	O
could	O
be	O
related	O
to	O
a	O
change	O
in	O
transcription	O
but	O
this	O
was	O
the	O
exception	O
.	O

These	O
results	O
suggest	O
that	O
while	O
feedback	O
mechanisms	O
between	O
protein	O
abundance	O
and	O
transcript	O
levels	O
exist	O
,	O
the	O
majority	O
of	O
the	O
effects	O
observed	O
here	O
for	O
both	O
hfq	B-Protein
and	O
smpB	B-Protein
are	O
a	O
result	O
of	O
direct	O
modulation	O
of	O
post	O
-	O
transcriptional	O
events	O
.	O

These	O
results	O
have	O
been	O
validated	O
by	O
Western	O
blotting	O
to	O
a	O
number	O
of	O
proteins	O
.	O

The	O
amount	O
of	O
translational	O
regulation	O
varied	O
with	O
growth	O
conditions	O
.	O

During	O
growth	O
in	O
rich	O
media	O
approximately	O
14	O
%	O
of	O
all	O
proteins	O
observed	O
showed	O
differences	O
in	O
abundance	O
where	O
as	O
in	O
acidic	O
minimal	O
media	O
the	O
result	O
was	O
approximately21	O
%	O
.	O

Taking	O
into	O
account	O
all	O
growth	O
conditions	O
about	O
approximately50	O
%	O
of	O
all	O
observed	O
proteins	O
are	O
regulated	O
by	O
Hfq	B-Protein
an	O
astonishingly	O
high	O
number	O
.	O

These	O
results	O
may	O
explain	O
the	O
very	O
high	O
LD50	O
of	O
the	O
hfq	B-Protein
mutant	O
strain	O
(	O
>	O
109	O
i	O
.	O
p	O
.	O
)	O
and	O
its	O
growth	O
defect	O
even	O
in	O
rich	O
media	O
.	O

It	O
has	O
recently	O
been	O
shown	O
that	O
half	O
of	O
all	O
the	O
known	O
sRNAs	O
in	O
Salmonella	B-Organism
associate	O
with	O
Hfq	B-Protein
[	O
10	O
]	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
in	O
adaptive	O
evolution	O
experiments	O
using	O
a	O
chemostat	O
to	O
continuously	O
alter	O
grow	O
conditions	O
often	O
results	O
in	O
changes	O
in	O
Hfq	B-Protein
(	O
Bernard	O
Palsson	O
,	O
UCSD	O
,	O
personal	O
communication	O
)	O
.	O

It	O
has	O
long	O
been	O
known	O
that	O
many	O
proteins	O
are	O
transcriptionally	O
regulated	O
.	O

These	O
results	O
and	O
the	O
results	O
recently	O
described	O
by	O
Sittka	O
et	O
al	O
.	O

[	O
10	O
]	O
demonstrate	O
that	O
post	O
-	O
transcriptional	O
/	O
translational	O
regulation	O
plays	O
as	O
large	O
a	O
role	O
in	O
controlling	O
the	O
myriad	O
of	O
bacterial	O
processes	O
as	O
does	O
transcriptional	O
regulation	O
.	O

It	O
is	O
the	O
precisely	O
this	O
ability	O
to	O
rapidly	O
adjust	O
to	O
changing	O
conditions	O
in	O
less	O
time	O
than	O
it	O
takes	O
to	O
make	O
an	O
RNA	O
molecule	O
that	O
makes	O
this	O
a	O
pivotal	O
regulatory	O
process	O
.	O

Comparative	O
in	O
vivo	O
gene	O
expression	O
of	O
the	O
closely	O
related	O
bacteria	O
Photorhabdus	B-Organism
temperata	I-Organism
and	O
Xenorhabdus	B-Organism
koppenhoeferi	I-Organism
upon	O
infection	O
of	O
the	O
same	O
insect	O
host	O
,	O
Rhizotrogus	B-Organism
majalis	I-Organism

Background	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
are	O
Gram	O
-	O
negative	O
,	O
phylogenetically	O
related	O
,	O
enterobacteria	B-Organism
,	O
forming	O
mutualism	O
with	O
the	O
entomopathogenic	O
nematodes	O
Heterorhabditis	B-Organism
and	O
Steinernema	B-Organism
,	O
respectively	O
.	O

The	O
mutualistic	O
bacteria	O
living	O
in	O
the	O
intestines	O
of	O
the	O
nematode	O
infective	O
juveniles	O
are	O
pathogenic	O
to	O
the	O
insect	O
upon	O
release	O
by	O
the	O
nematodes	O
into	O
the	O
insect	O
hemolymph	O
.	O

Such	O
a	O
switch	O
needs	O
activation	O
of	O
genes	O
that	O
promote	O
bacterial	O
virulence	O
.	O

We	O
studied	O
in	O
vivo	O
gene	O
expression	O
in	O
Photorhabdus	B-Organism
temperata	I-Organism
and	O
Xenorhabdus	B-Organism
koppenhoeferi	I-Organism
upon	O
infection	O
of	O
the	O
white	O
grub	O
Rhizotrogus	B-Organism
majalis	I-Organism
using	O
selective	O
capture	O
of	O
transcribed	O
sequences	O
technique	O
.	O

Results	O
A	O
total	O
of	O
40	O
genes	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
39	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
were	O
found	O
to	O
be	O
upregulated	O
in	O
R	B-Organism
.	I-Organism
majalis	I-Organism
hemolymph	O
at	O
24	O
h	O
post	O
infection	O
.	O

Genomic	O
presence	O
or	O
upregulation	O
of	O
these	O
genes	O
specific	O
in	O
either	O
one	O
of	O
the	O
bacterium	O
was	O
confirmed	O
by	O
the	O
assay	O
of	O
comparative	O
hybridization	O
,	O
and	O
the	O
changes	O
of	O
randomly	O
selected	O
genes	O
were	O
further	O
validated	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
.	O

The	O
identified	O
genes	O
could	O
be	O
broadly	O
divided	O
into	O
seven	O
functional	O
groups	O
including	O
cell	O
surface	O
structure	O
,	O
regulation	O
,	O
virulence	O
and	O
secretion	O
,	O
stress	O
response	O
,	O
intracellular	O
metabolism	O
,	O
nutrient	O
scavenging	O
,	O
and	O
unknown	O
.	O

The	O
two	O
bacteria	O
shared	O
more	O
genes	O
in	O
stress	O
response	O
category	O
than	O
any	O
other	O
functional	O
group	O
.	O

More	O
than	O
60	O
%	O
of	O
the	O
identified	O
genes	O
were	O
uniquely	O
induced	O
in	O
either	O
bacterium	O
suggesting	O
vastly	O
different	O
molecular	O
mechanisms	O
of	O
pathogenicity	O
to	O
the	O
same	O
insect	O
host	O
.	O

In	O
P	B-Organism
.	I-Organism
temperata	I-Organism
lysR	B-Protein
gene	O
encoding	O
transcriptional	O
activator	O
was	O
induced	O
,	O
while	O
genes	O
yijC	B-Protein
and	O
rseA	B-Protein
encoding	O
transcriptional	O
repressors	O
were	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Lipopolysaccharide	B-Chemical
synthesis	O
gene	O
lpsE	B-Protein
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
but	O
not	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
.	O

Except	O
tcaC	B-Protein
and	O
hemolysin	O
related	O
genes	O
,	O
other	O
virulence	O
genes	O
were	O
different	O
between	O
the	O
two	O
bacteria	O
.	O

Genes	O
involved	O
in	O
TCA	B-Chemical
cycle	O
were	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
whereas	O
those	O
involved	O
in	O
glyoxylate	B-Chemical
pathway	O
were	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
suggesting	O
differences	O
in	O
metabolism	O
between	O
the	O
two	O
bacteria	O
in	O
the	O
same	O
insect	O
host	O
.	O

Upregulation	O
of	O
genes	O
encoding	O
different	O
types	O
of	O
nutrient	O
uptake	O
systems	O
further	O
emphasized	O
the	O
differences	O
in	O
nutritional	O
requirements	O
of	O
the	O
two	O
bacteria	O
in	O
the	O
same	O
insect	O
host	O
.	O

Photorhabdus	B-Organism
temperata	I-Organism
displayed	O
upregulation	O
of	O
genes	O
encoding	O
siderophore	O
-	O
dependent	O
iron	B-Chemical
uptake	O
system	O
,	O
but	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
upregulated	O
genes	O
encoding	O
siderophore	O
-	O
independent	O
ion	O
uptake	O
system	O
.	O

Photorhabdus	B-Organism
temperata	I-Organism
induced	O
genes	O
for	O
amino	O
acid	O
acquisition	O
but	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
upregulated	O
malF	B-Protein
gene	O
,	O
encoding	O
a	O
maltose	B-Chemical
uptake	O
system	O
.	O

Further	O
analyses	O
identified	O
possible	O
mechanistic	O
associations	O
between	O
the	O
identified	O
gene	O
products	O
in	O
metabolic	O
pathways	O
,	O
providing	O
an	O
interactive	O
model	O
of	O
pathogenesis	O
for	O
each	O
bacterium	O
species	O
.	O

Conclusion	O
This	O
study	O
identifies	O
set	O
of	O
genes	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
upon	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
,	O
and	O
highlights	O
differences	O
in	O
molecular	O
features	O
used	O
by	O
these	O
two	O
closely	O
related	O
bacteria	O
to	O
promote	O
their	O
pathogenicity	O
in	O
the	O
same	O
insect	O
host	O
.	O

Background	O

Entomopathogenic	O
Gram	O
-	O
negative	O
enterobacteria	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
form	O
symbioses	O
with	O
the	O
entomopathogenic	O
nematodes	O
Heterorhabditis	B-Organism
and	O
Steinernema	B-Organism
,	O
respectively	O
[	O
1	O
]	O
.	O

These	O
bacteria	O
not	O
only	O
have	O
similar	O
biology	O
but	O
are	O
also	O
phylogenetically	O
related	O
based	O
on	O
16s	O
rDNA	O
sequence	O
identities	O
[	O
2	O
]	O
.	O

They	O
naturally	O
colonize	O
intestines	O
of	O
the	O
nematode	O
infective	O
juveniles	O
which	O
invade	O
susceptible	O
insects	O
to	O
release	O
the	O
bacteria	O
into	O
the	O
hemolymph	O
.	O

The	O
bacteria	O
multiply	O
in	O
the	O
hemolymph	O
,	O
killing	O
the	O
insect	O
host	O
within	O
24	O
-	O
48	O
h	O
and	O
converting	O
the	O
cadaver	O
into	O
a	O
food	O
source	O
suitable	O
for	O
nematode	O
growth	O
and	O
reproduction	O
.	O

After	O
1	O
-	O
3	O
rounds	O
of	O
nematode	O
reproduction	O
,	O
the	O
bacteria	O
recolonize	O
the	O
emerging	O
infective	O
juveniles	O
ensuring	O
their	O
transmission	O
to	O
a	O
new	O
host	O
[	O
1	O
]	O
.	O

Available	O
evidence	O
suggests	O
that	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
encode	O
specific	O
factors	O
to	O
engage	O
in	O
a	O
pathogenic	O
relationship	O
with	O
the	O
insect	O
host	O
[	O
3	O
]	O
.	O

The	O
published	O
genome	O
sequence	O
of	O
Photorhabdus	B-Organism
luminescens	I-Organism
TT01	I-Organism
strain	O
indicates	O
that	O
virulence	O
genes	O
are	O
encoded	O
within	O
a	O
number	O
of	O
pathogenicity	O
islands	O
located	O
on	O
the	O
bacterial	O
chromosome	O
[	O
4	O
,	O
5	O
]	O
.	O

Besides	O
producing	O
toxins	O
to	O
cause	O
insect	O
death	O
,	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
have	O
to	O
first	O
evade	O
the	O
insect	O
'	O
s	O
immune	O
response	O
to	O
establish	O
a	O
successful	O
infection	O
.	O

The	O
two	O
bacteria	O
differ	O
in	O
mechanisms	O
by	O
which	O
they	O
evade	O
host	O
immune	O
responses	O
.	O

For	O
example	O
,	O
in	O
Photorhabdus	B-Organism
,	O
mutational	O
inactivation	O
of	O
phoP	B-Protein
gene	O
results	O
in	O
increased	O
sensitivity	O
to	O
insect	O
immune	O
response	O
and	O
decreased	O
virulence	O
towards	O
insects	O
[	O
6	O
,	O
7	O
]	O
,	O
while	O
in	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
,	O
phoPQ	B-Protein
mutants	O
are	O
more	O
susceptible	O
to	O
immune	O
response	O
but	O
are	O
fully	O
virulent	O
[	O
3	O
]	O
.	O

P	B-Organism
.	I-Organism
luminescens	I-Organism
produces	O
a	O
signaling	O
molecule	O
AI	B-Protein
-	I-Protein
2	I-Protein
to	O
resist	O
reactive	B-Chemical
oxygen	I-Chemical
species	I-Chemical
[	O
8	O
]	O
and	O
phenylpropanoid	O
chemical	O
ST	O
to	O
inhibit	O
the	O
activity	O
of	O
antimicrobial	O
enzyme	O
PO	O
and	O
formation	O
of	O
melanotic	O
nodules	O
[	O
9	O
]	O
,	O
but	O
the	O
strategy	O
used	O
by	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
appears	O
to	O
be	O
that	O
of	O
suppression	O
of	O
transcripts	O
involved	O
in	O
the	O
insect	O
immune	O
response	O
[	O
10	O
-	O
12	O
]	O
.	O

In	O
addition	O
,	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
encodes	O
a	O
type	O
III	O
secretion	O
system	O
and	O
one	O
of	O
the	O
effectors	O
,	O
LopT	B-Protein
,	O
suppresses	O
phagocytosis	O
and	O
reduces	O
nodulation	O
by	O
haemocytes	O
[	O
13	O
,	O
14	O
]	O
.	O

However	O
,	O
the	O
genomes	O
of	O
Xenorhabdus	B-Organism
bovienii	I-Organism
and	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
do	O
not	O
show	O
homologues	O
of	O
LopT	B-Protein
or	O
a	O
dedicated	O
type	O
III	O
secretion	O
system	O
[	O
3	O
]	O
,	O
and	O
Xenorhabdus	B-Organism
likely	O
uses	O
flagellar	O
regulatory	O
cascade	O
to	O
control	O
cellular	O
immunity	O
[	O
15	O
]	O
.	O

Despite	O
the	O
identification	O
of	O
the	O
above	O
regulatory	O
and	O
virulence	O
factors	O
from	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
,	O
the	O
full	O
profiles	O
of	O
genes	O
expressed	O
during	O
insect	O
infection	O
by	O
these	O
two	O
closely	O
related	O
bacteria	O
are	O
unknown	O
.	O

Munch	O
et	O
al	O
.	O

[	O
16	O
]	O
identified	O
29	O
promoters	O
induced	O
by	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
in	O
the	O
presence	O
of	O
isolated	O
Galleria	B-Organism
mellonella	I-Organism
homogenate	O
using	O
a	O
differential	O
fluorescence	O
induction	O
approach	O
.	O

However	O
,	O
treatment	O
with	O
insect	O
homogenate	O
might	O
neglect	O
physicochemical	O
parameters	O
as	O
inducers	O
which	O
could	O
result	O
in	O
different	O
sets	O
of	O
genes	O
being	O
upregulated	O
during	O
natural	O
infection	O
of	O
live	O
insects	O
.	O

We	O
used	O
selective	O
capture	O
of	O
transcribed	O
sequences	O
(	O
SCOTS	O
)	O
technique	O
to	O
study	O
in	O
vivo	O
gene	O
expression	O
in	O
Photorhabdus	B-Organism
temperata	I-Organism
(	O
associated	O
with	O
the	O
nematode	O
Heterorhabditis	B-Organism
bacteriophora	I-Organism
GPS11	I-Organism
)	O
and	O
Xenorhabdus	B-Organism
koppenhoeferi	I-Organism
(	O
associated	O
with	O
the	O
nematode	O
Steinernema	B-Organism
scarabaei	I-Organism
AMK001	I-Organism
)	O
during	O
infection	O
of	O
the	O
same	O
insect	O
host	O
Rhizotrogus	B-Organism
majalis	I-Organism
.	O

They	O
were	O
selected	O
according	O
to	O
their	O
distinct	O
pathogenicity	O
in	O
insects	O
of	O
the	O
family	O
of	O
Scarabaeidae	O
-	O
S	B-Organism
.	I-Organism
scarabaei	I-Organism
is	O
more	O
virulent	O
to	O
R	B-Organism
.	I-Organism
majalis	I-Organism
than	O
H	B-Organism
.	I-Organism
bacteriophora	I-Organism
.	O

However	O
,	O
unlike	O
their	O
nematode	O
partners	O
,	O
both	O
bacterial	O
species	O
are	O
highly	O
virulent	O
to	O
Rhizotrogus	B-Organism
majalis	I-Organism
.	O

In	O
addition	O
,	O
although	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
grows	O
slower	O
than	O
P	B-Organism
.	I-Organism
temperata	I-Organism
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
the	O
LD50	O
and	O
LT50	O
value	O
do	O
not	O
differ	O
between	O
these	O
two	O
bacteria	O
[	O
17	O
]	O
.	O

We	O
hypothesize	O
that	O
the	O
two	O
bacteria	O
species	O
will	O
use	O
both	O
common	O
and	O
distinct	O
molecular	O
mechanisms	O
during	O
infection	O
of	O
the	O
same	O
insect	O
host	O
.	O

Results	O

Isolation	O
of	O
bacterial	O
transcripts	O
induced	O
in	O
Rhizotrogus	B-Organism
majalis	I-Organism
To	O
isolate	O
bacterial	O
genes	O
induced	O
upon	O
infection	O
,	O
total	O
RNA	O
was	O
isolated	O
from	O
live	O
grubs	O
at	O
24	O
h	O
post	O
injection	O
with	O
P	B-Organism
.	I-Organism
temperata	I-Organism
or	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
as	O
well	O
as	O
from	O
48	O
h	O
log	O
-	O
phase	O
bacterial	O
cultures	O
grown	O
in	O
Brain	O
Heart	O
Infusion	O
(	O
BHI	O
)	O
broth	O
that	O
were	O
used	O
to	O
inject	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Random	O
-	O
primed	O
bacterial	O
cDNAs	O
were	O
normalized	O
by	O
hybridization	O
to	O
biotinylated	O
bacterial	O
genomic	O
DNA	O
that	O
had	O
been	O
blocked	O
beforehand	O
using	O
bacterial	O
ribosomal	O
RNA	O
operon	O
,	O
resulting	O
in	O
sampling	O
of	O
bacterial	O
mRNA	O
transcripts	O
apart	O
from	O
its	O
ribosomal	O
and	O
insect	O
transcripts	O
.	O

The	O
normalized	O
bacterial	O
cDNAs	O
representing	O
total	O
mRNA	O
transcripts	O
produced	O
by	O
bacteria	O
grown	O
in	O
vitro	O
or	O
within	O
the	O
infected	O
insects	O
were	O
named	O
as	O
normalized	O
in	O
vitro	O
and	O
in	O
vivo	O
cDNA	O
libraries	O
,	O
respectively	O
.	O

To	O
isolate	O
bacterial	O
mRNA	O
transcripts	O
preferentially	O
induced	O
during	O
infection	O
of	O
the	O
insect	O
compared	O
to	O
the	O
culture	O
,	O
normalized	O
in	O
vivo	O
cDNAs	O
were	O
enriched	O
by	O
hybridization	O
to	O
biotinylated	O
bacterial	O
genomic	O
DNA	O
that	O
had	O
been	O
pre	O
-	O
hybridized	O
with	O
rRNA	O
operon	O
and	O
in	O
vitro	O
normalized	O
cDNAs	O
.	O

The	O
enriched	O
cDNAs	O
representing	O
in	O
vivo	O
-	O
induced	O
genes	O
,	O
which	O
were	O
either	O
lower	O
in	O
abundance	O
or	O
absent	O
in	O
48	O
h	O
in	O
vitro	O
bacterial	O
cultures	O
were	O
then	O
cloned	O
into	O
a	O
TA	O
cloning	O
vector	O
to	O
construct	O
in	O
vivo	O
enriched	O
cDNA	O
libraries	O
.	O

A	O
total	O
of	O
384	O
clones	O
(	O
192	O
for	O
each	O
bacterium	O
)	O
derived	O
from	O
enriched	O
cDNA	O
libraries	O
were	O
randomly	O
picked	O
for	O
screening	O
.	O

Out	O
of	O
these	O
,	O
the	O
clones	O
(	O
150	O
for	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
140	O
for	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
)	O
that	O
showed	O
stronger	O
signal	O
upon	O
hybridization	O
with	O
in	O
vivo	O
-	O
derived	O
cDNAs	O
compared	O
to	O
in	O
vitro	O
-	O
derived	O
cDNAs	O
(	O
Fig	O
.	O
1	O
)	O
were	O
sequenced	O
and	O
analyzed	O
using	O
the	O
non	O
-	O
redundant	O
algorithms	O
of	O
BLAST	O
in	O
NCBI	O
and	O
database	O
of	O
Xenorhabdus	B-Organism
Genomes	I-Organism
.	O

These	O
sequenced	O
clones	O
were	O
therefore	O
considered	O
to	O
represent	O
reliable	O
transcripts	O
specifically	O
expressed	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
or	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
after	O
24	O
h	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Analysis	O
of	O
bacterial	O
genes	O
induced	O
in	O
Rhizotrogus	B-Organism
majalis	I-Organism

Most	O
identified	O
transcripts	O
were	O
either	O
similar	O
to	O
sequences	O
from	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
or	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
,	O
suggesting	O
that	O
bacterial	O
transcripts	O
were	O
successfully	O
enriched	O
from	O
the	O
infected	O
insects	O
.	O

For	O
both	O
bacteria	O
,	O
each	O
isolated	O
transcript	O
was	O
identified	O
at	O
least	O
twice	O
from	O
the	O
sequenced	O
clones	O
.	O

The	O
coverage	O
of	O
in	O
vivo	O
enriched	O
libraries	O
was	O
then	O
evaluated	O
using	O
Analytic	O
Rarefaction	O
according	O
to	O
the	O
redundancy	O
of	O
each	O
identical	O
transcript	O
in	O
the	O
sequenced	O
clones	O
.	O

As	O
indicated	O
by	O
the	O
rarefaction	O
curves	O
(	O
Fig	O
.	O
2	O
)	O
,	O
saturation	O
was	O
achieved	O
for	O
the	O
sequenced	O
clones	O
,	O
indicating	O
that	O
most	O
of	O
representative	O
genes	O
in	O
the	O
in	O
vivo	O
enriched	O
cDNA	O
libraries	O
were	O
identified	O
.	O

Totally	O
,	O
we	O
isolated	O
40	O
different	O
sequences	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
(	O
Table	O
1	O
)	O
and	O
39	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
(	O
Table	O
2	O
)	O
.	O

Based	O
on	O
homology	O
searches	O
,	O
the	O
genes	O
corresponding	O
to	O
distinct	O
sequences	O
could	O
be	O
divided	O
into	O
seven	O
functional	O
groups	O
:	O
cell	O
surface	O
structure	O
(	O
Class	O
I	O
)	O
,	O
intracellular	O
metabolism	O
(	O
Class	O
II	O
)	O
,	O
nutrient	O
scavenging	O
(	O
Class	O
III	O
)	O
,	O
regulation	O
(	O
Class	O
IV	O
)	O
,	O
stress	O
response	O
(	O
Class	O
V	O
)	O
,	O
virulence	O
(	O
Class	O
VI	O
)	O
and	O
uncharacterized	O
genes	O
(	O
Class	O
VII	O
)	O
.	O

Genes	O
involved	O
in	O
metabolism	O
constitute	O
about	O
25	O
%	O
to	O
33	O
%	O
of	O
the	O
total	O
number	O
of	O
in	O
vivo	O
-	O
induced	O
genes	O
(	O
Fig	O
.	O
3	O
)	O
,	O
showing	O
large	O
numbers	O
of	O
metabolic	O
changes	O
during	O
insect	O
infection	O
.	O

Semi	O
-	O
quantitative	O
reverse	O
transcriptase	O
PCR	O
performed	O
on	O
10	O
randomly	O
selected	O
identified	O
genes	O
(	O
five	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
:	O
cysK	B-Protein
,	O
fliA	B-Protein
,	O
lysR	B-Protein
,	O
pchC	B-Protein
and	O
pmt1	B-Protein
and	O
five	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
:	O
aceE	B-Protein
,	O
dacC	B-Protein
,	O
cobJ	B-Protein
,	O
malF	B-Protein
,	O
and	O
yijC	B-Protein
)	O
showed	O
that	O
these	O
genes	O
were	O
detectable	O
from	O
the	O
in	O
vivo	O
-	O
derived	O
cDNA	O
but	O
not	O
from	O
in	O
vitro	O
-	O
derived	O
cDNA	O
.	O

In	O
addition	O
,	O
18S	O
rRNA	O
gene	O
,	O
a	O
eukaryotic	O
housekeeping	O
gene	O
,	O
was	O
detected	O
in	O
the	O
in	O
vivo	O
cDNA	O
population	O
before	O
normalization	O
,	O
but	O
not	O
after	O
normalization	O
,	O
suggesting	O
that	O
bacterial	O
cDNAs	O
were	O
successfully	O
purified	O
from	O
the	O
insect	O
cDNAs	O
after	O
SCOTS	O
normalization	O
.	O

Also	O
gyrase	B-Protein
A	I-Protein
gene	O
,	O
a	O
prokaryotic	O
housekeeping	O
gene	O
,	O
was	O
not	O
detected	O
from	O
the	O
enriched	O
in	O
vivo	O
cDNAs	O
,	O
but	O
was	O
detected	O
in	O
all	O
other	O
cDNA	O
populations	O
including	O
in	O
vitro	O
and	O
in	O
vivo	O
cDNAs	O
before	O
and	O
after	O
normalization	O
,	O
indicating	O
that	O
only	O
differentially	O
expressed	O
genes	O
were	O
captured	O
after	O
enrichment	O
.	O

Identification	O
of	O
Photorhabdus	B-Organism
temperata	I-Organism
or	O
Xenorhabdus	B-Organism
koppenhoeferi	I-Organism
specific	O
genes	O

To	O
identify	O
genes	O
that	O
were	O
distinctive	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
or	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
genome	O
or	O
exclusively	O
induced	O
in	O
one	O
or	O
the	O
other	O
bacterium	O
,	O
comparative	O
hybridization	O
was	O
performed	O
based	O
upon	O
the	O
identified	O
genes	O
.	O

Twenty	O
nine	O
of	O
the	O
40	O
distinct	O
P	B-Organism
.	I-Organism
temperata	I-Organism
transcripts	O
have	O
similar	O
sequences	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
genome	O
,	O
thus	O
11	O
were	O
P	B-Organism
.	I-Organism
temperata	I-Organism
specific	O
;	O
30	O
of	O
the	O
39	O
distinct	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
transcripts	O
share	O
sequence	O
similarity	O
with	O
P	B-Organism
.	I-Organism
temperata	I-Organism
genome	O
,	O
thus	O
9	O
were	O
specific	O
to	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
(	O
Tables	O
1	O
and	O
2	O
)	O
.	O

Although	O
these	O
59	O
transcripts	O
(	O
29	O
+	O
30	O
)	O
corresponding	O
to	O
genes	O
present	O
in	O
the	O
genome	O
of	O
both	O
bacteria	O
,	O
21	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
22	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
were	O
identified	O
to	O
be	O
exclusively	O
induced	O
in	O
each	O
of	O
them	O
.	O

Only	O
a	O
small	O
number	O
of	O
transcripts	O
were	O
induced	O
in	O
both	O
bacteria	O
,	O
and	O
most	O
of	O
them	O
corresponded	O
to	O
genes	O
required	O
for	O
stress	O
response	O
.	O

Further	O
,	O
the	O
level	O
of	O
changes	O
in	O
the	O
transcripts	O
exclusively	O
induced	O
in	O
one	O
or	O
the	O
other	O
bacterium	O
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
was	O
determined	O
by	O
quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
on	O
following	O
representative	O
genes	O
:	O
cysK	B-Protein
,	O
def	B-Protein
,	O
dnaB	B-Protein
,	O
lysR	B-Protein
,	O
pchC	B-Protein
,	O
pckA	B-Protein
,	O
phoP	B-Protein
,	O
ptst1	B-Protein
,	O
sctL	B-Protein
,	O
selD	B-Protein
,	O
tolB	B-Protein
and	O
virB	B-Protein
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
and	O
aceK	B-Protein
,	O
clpP	B-Protein
,	O
cobJ	B-Protein
,	O
dacC	B-Protein
,	O
dld	B-Protein
,	O
malF	B-Protein
,	O
res	B-Protein
,	O
rtxC	B-Protein
,	O
tilS	B-Protein
,	O
virH	B-Protein
,	O
xhlA	B-Protein
,	O
and	O
xkst4	B-Protein
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

qRT	O
-	O
PCR	O
results	O
displayed	O
consistence	O
with	O
the	O
SCOTS	O
assay	O
.	O

Most	O
tested	O
genes	O
displayed	O
6	O
-	O
16	O
fold	O
induction	O
in	O
qRT	O
-	O
PCR	O
assays	O
,	O
and	O
a	O
few	O
genes	O
including	O
sctL	B-Protein
,	O
phoP	B-Protein
,	O
rtxC	B-Protein
and	O
clpP	B-Protein
exhibited	O
about	O
3	O
-	O
fold	O
induction	O
(	O
Fig	O
.	O
4	O
)	O
.	O

Analysis	O
of	O
biological	O
associations	O
of	O
in	O
vivo	O
-	O
induced	O
genes	O

To	O
understand	O
the	O
function	O
and	O
interactions	O
of	O
the	O
identified	O
gene	O
products	O
,	O
interactive	O
networks	O
were	O
built	O
to	O
provide	O
an	O
overview	O
of	O
how	O
gene	O
products	O
relate	O
to	O
each	O
other	O
by	O
leveraging	O
databases	O
of	O
published	O
literature	O
.	O

Using	O
PathwayStudio	O
(	O
Ariadne	O
,	O
Rockville	O
,	O
MD	O
,	O
USA	O
)	O
program	O
,	O
we	O
were	O
able	O
to	O
distill	O
all	O
published	O
information	O
about	O
biological	O
relationships	O
of	O
bacterial	O
homologs	O
of	O
the	O
identified	O
genes	O
.	O

Molecular	O
interactions	O
linking	O
each	O
identified	O
gene	O
product	O
in	O
terms	O
of	O
binding	O
,	O
direct	O
molecular	O
regulation	O
,	O
effects	O
on	O
expression	O
,	O
transportation	O
,	O
and	O
molecule	O
synthesis	O
were	O
elucidated	O
in	O
PathwayStudio	O
.	O

Based	O
on	O
this	O
analysis	O
,	O
the	O
biological	O
significance	O
of	O
each	O
gene	O
was	O
inferred	O
.	O

Linkage	O
between	O
proteins	O
shows	O
how	O
upregulated	O
genes	O
may	O
influence	O
other	O
genes	O
or	O
gene	O
products	O
.	O

For	O
example	O
,	O
gene	O
rpoB	B-Protein
,	O
induced	O
in	O
both	O
bacteria	O
,	O
interacts	O
with	O
many	O
gene	O
products	O
,	O
suggesting	O
its	O
overall	O
importance	O
during	O
insect	O
infection	O
(	O
see	O
Additional	O
files	O
1	O
and	O
2	O
)	O
.	O

Other	O
identified	O
genes	O
with	O
multiple	O
connections	O
to	O
different	O
gene	O
products	O
were	O
different	O
between	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
indicating	O
distinct	O
biological	O
processes	O
used	O
by	O
the	O
two	O
bacteria	O
for	O
insect	O
infection	O
.	O

Moreover	O
,	O
linkages	O
with	O
small	O
molecules	O
indicate	O
how	O
normal	O
functions	O
in	O
gene	O
regulation	O
networks	O
are	O
influenced	O
by	O
small	O
molecules	O
that	O
may	O
be	O
available	O
in	O
the	O
insect	O
body	O
.	O

For	O
example	O
,	O
regulation	O
of	O
genes	O
yncB	B-Protein
and	O
purH	B-Protein
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
are	O
influenced	O
by	O
aromatic	O
compounds	O
and	O
formate	B-Chemical
,	O
respectively	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

In	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
gene	O
trxB	B-Protein
is	O
influenced	O
by	O
arabinose	B-Chemical
and	O
selenium	B-Chemical
,	O
and	O
gene	O
znuA	B-Protein
is	O
influenced	O
by	O
etoposide	B-Chemical
(	O
see	O
Additional	O
file	O
2	O
)	O
.	O

Compared	O
to	O
the	O
biological	O
interactions	O
(	O
see	O
Additional	O
files	O
1	O
and	O
2	O
)	O
,	O
molecular	O
pathways	O
or	O
networks	O
in	O
which	O
identified	O
genes	O
link	O
to	O
each	O
other	O
were	O
further	O
illustrated	O
(	O
see	O
Additional	O
file	O
3	O
)	O
.	O

In	O
total	O
,	O
20	O
genes	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
18	O
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
(	O
see	O
Additional	O
file	O
3	O
)	O
were	O
found	O
to	O
be	O
part	O
of	O
the	O
dense	O
protein	O
interaction	O
networks	O
,	O
indicating	O
that	O
these	O
genes	O
may	O
act	O
in	O
concert	O
to	O
achieve	O
successful	O
infection	O
.	O

Some	O
products	O
encoded	O
by	O
induced	O
genes	O
were	O
found	O
to	O
interact	O
with	O
as	O
many	O
as	O
eight	O
other	O
gene	O
products	O
in	O
the	O
network	O
.	O

For	O
example	O
,	O
P	B-Organism
.	I-Organism
temperata	I-Organism
pckA	B-Protein
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
aceE	B-Protein
both	O
influence	O
8	O
other	O
genes	O
in	O
the	O
network	O
(	O
see	O
Additional	O
file	O
3	O
)	O
.	O

As	O
a	O
whole	O
,	O
the	O
protein	O
networks	O
of	O
the	O
identified	O
genes	O
were	O
different	O
for	O
the	O
two	O
bacteria	O
except	O
that	O
NAD	O
synthetase	O
gene	O
nadE	B-Protein
was	O
found	O
to	O
be	O
common	O
to	O
both	O
bacteria	O
.	O

Discussion	O

Our	O
gene	O
expression	O
data	O
reveal	O
similarities	O
and	O
differences	O
in	O
molecular	O
mechanisms	O
of	O
pathogenicity	O
by	O
the	O
two	O
bacteria	O
with	O
apparently	O
similar	O
biology	O
.	O

As	O
depicted	O
in	O
the	O
conceptual	O
molecular	O
model	O
(	O
Fig	O
.	O
5	O
)	O
,	O
apart	O
from	O
a	O
relatively	O
small	O
number	O
of	O
common	O
strategies	O
used	O
by	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
to	O
cause	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
,	O
most	O
upregulated	O
genes	O
were	O
different	O
between	O
the	O
two	O
bacteria	O
,	O
suggesting	O
vastly	O
different	O
pathways	O
to	O
bring	O
about	O
infection	O
of	O
the	O
same	O
insect	O
host	O
.	O

Genes	O
involved	O
in	O
cell	O
structure	O
modification	O
As	O
the	O
physical	O
contact	O
between	O
bacteria	O
and	O
their	O
host	O
is	O
accomplished	O
by	O
the	O
outer	O
surface	O
,	O
the	O
bacterial	O
cell	O
envelope	O
is	O
crucial	O
for	O
communication	O
and	O
interaction	O
with	O
host	O
cells	O
during	O
infection	O
.	O

Genes	O
involved	O
in	O
the	O
synthesis	O
of	O
outer	O
membrane	O
proteins	O
(	O
skp	B-Protein
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
ompF	B-Protein
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
)	O
and	O
flagella	O
(	O
fliA	B-Protein
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
fliM	B-Protein
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
)	O
were	O
induced	O
in	O
both	O
bacteria	O
,	O
indicating	O
the	O
importance	O
of	O
surface	O
proteins	O
in	O
this	O
bacteria	O
-	O
insect	O
interface	O
.	O

Outer	O
membrane	O
proteins	O
may	O
contribute	O
to	O
the	O
modulation	O
of	O
bacterial	O
cell	O
surface	O
properties	O
during	O
interaction	O
with	O
the	O
host	O
,	O
thus	O
playing	O
a	O
role	O
in	O
evading	O
host	O
immune	O
response	O
[	O
18	O
]	O
.	O

Flagellum	O
-	O
mediated	O
motility	O
may	O
provide	O
an	O
advantage	O
for	O
infection	O
by	O
attachment	O
to	O
the	O
host	O
surface	O
[	O
19	O
,	O
20	O
]	O
,	O
whereas	O
it	O
has	O
been	O
reported	O
in	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
that	O
the	O
expression	O
of	O
virulence	O
factors	O
is	O
not	O
controlled	O
by	O
the	O
regulation	O
of	O
flagella	O
motility	O
[	O
21	O
]	O
.	O

Gene	O
dacC	B-Protein
encoding	O
a	O
peptidoglycan	O
synthesis	O
enzyme	O
D	O
-	O
alanyl	O
-	O
D	O
-	O
alanine	O
carboxypeptidase	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
but	O
not	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
implying	O
that	O
peptidoglycan	O
undergoes	O
structural	O
alterations	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
that	O
probably	O
add	O
to	O
its	O
fitness	O
when	O
residing	O
in	O
the	O
host	O
.	O

As	O
a	O
well	O
-	O
defined	O
virulence	O
factor	O
playing	O
a	O
major	O
role	O
in	O
the	O
development	O
of	O
septicemia	O
[	O
22	O
]	O
,	O
lipopolysaccharide	B-Chemical
biosynthesis	O
gene	O
lpsE	B-Protein
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
but	O
not	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
which	O
may	O
explain	O
in	O
part	O
why	O
relatively	O
slower	O
growing	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
did	O
not	O
differ	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
in	O
virulence	O
to	O
R	B-Organism
.	I-Organism
majalis	I-Organism
in	O
our	O
previous	O
studies	O
[	O
17	O
]	O
.	O

Genes	O
involved	O
in	O
regulatory	O
networks	O

Facing	O
stimuli	O
,	O
different	O
regulatory	O
genes	O
were	O
upregulated	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
reflecting	O
their	O
unique	O
ability	O
to	O
respond	O
to	O
environmental	O
challenges	O
.	O

phoP	B-Protein
and	O
cpxR	B-Protein
genes	O
identified	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
encode	O
response	O
regulators	O
in	O
two	O
-	O
component	O
regulatory	O
systems	O
PhoPQ	B-Protein
and	O
CpxRA	B-Protein
,	O
respectively	O
[	O
23	O
,	O
24	O
]	O
.	O

PhoP	B-Protein
and	O
CpxR	B-Protein
are	O
dual	O
transcriptional	O
regulators	O
that	O
are	O
activated	O
in	O
response	O
to	O
environmental	O
stimuli	O
and	O
then	O
act	O
to	O
modulate	O
activity	O
of	O
other	O
genes	O
[	O
23	O
,	O
24	O
]	O
.	O

Responding	O
to	O
low	O
Mg2	B-Chemical
+	I-Chemical
levels	O
,	O
phoP	B-Protein
expression	O
is	O
auto	O
-	O
regulated	O
by	O
PhoP	B-Protein
and	O
PhoQ	B-Protein
proteins	O
and	O
phoQ	B-Protein
is	O
constitutive	O
[	O
25	O
]	O
.	O

Auto	O
-	O
regulation	O
of	O
phoP	B-Protein
likely	O
regulates	O
expression	O
of	O
other	O
genes	O
that	O
mediate	O
various	O
cellular	O
functions	O
such	O
as	O
LPS	B-Chemical
modification	O
,	O
cell	O
structure	O
[	O
26	O
]	O
,	O
and	O
type	O
III	O
secretion	O
systems	O
[	O
27	O
]	O
.	O

phoP	B-Protein
has	O
been	O
previously	O
identified	O
to	O
be	O
involved	O
in	O
virulence	O
as	O
mutational	O
inactivation	O
of	O
this	O
gene	O
rendered	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
avirulent	O
to	O
Spodoptera	B-Organism
littoralis	I-Organism
larvae	O
[	O
6	O
]	O
.	O

Similarly	O
,	O
the	O
regulatory	O
protein	O
CpxR	B-Protein
can	O
be	O
activated	O
in	O
response	O
to	O
signals	O
associated	O
with	O
growth	O
and	O
metabolic	O
pathways	O
[	O
28	O
]	O
.	O

By	O
sensing	O
cell	O
envelope	O
stress	O
CpxR	B-Protein
appears	O
to	O
control	O
expression	O
of	O
other	O
genes	O
involved	O
in	O
envelope	O
stress	O
response	O
,	O
secretion	O
,	O
motility	O
and	O
multidrug	O
resistance	O
[	O
29	O
]	O
.	O

Sometimes	O
,	O
CpxR	B-Protein
acts	O
to	O
modulate	O
other	O
transcriptional	O
factors	O
[	O
30	O
]	O
.	O

Although	O
there	O
is	O
no	O
evidence	O
showing	O
links	O
between	O
phoP	B-Protein
/	O
cpxR	B-Protein
and	O
other	O
isolated	O
genes	O
,	O
overexpression	O
of	O
these	O
two	O
response	O
regulator	O
genes	O
may	O
possibly	O
relate	O
to	O
genes	O
involved	O
in	O
stress	O
responses	O
(	O
gshB	B-Protein
,	O
gor	B-Protein
,	O
msrA	B-Protein
and	O
surA	B-Protein
)	O
,	O
cell	O
structure	O
(	O
skp	B-Protein
,	O
dacC	B-Protein
and	O
ompF	B-Protein
)	O
and	O
type	O
III	O
secretion	O
systems	O
(	O
sctL	B-Protein
)	O
identified	O
in	O
this	O
study	O
.	O

Further	O
,	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
lysR	B-Protein
gene	O
encoding	O
a	O
transcriptional	O
activator	O
protein	O
was	O
found	O
to	O
be	O
upregulated	O
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
,	O
while	O
two	O
genes	O
yijC	B-Protein
and	O
rseA	B-Protein
encoding	O
transcriptional	O
repressors	O
were	O
identified	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

The	O
pathway	O
network	O
analysis	O
indicates	O
that	O
the	O
product	O
of	O
yijC	B-Protein
may	O
function	O
as	O
a	O
repressor	O
to	O
potentially	O
control	O
the	O
expression	O
of	O
the	O
fabB	B-Protein
gene	O
,	O
which	O
in	O
turn	O
,	O
modulates	O
the	O
physical	O
properties	O
of	O
the	O
membrane	O
by	O
altering	O
the	O
level	O
of	O
unsaturated	O
fatty	O
acid	O
production	O
.	O

Besides	O
transcriptional	O
regulatory	O
genes	O
,	O
gene	O
tilS	B-Protein
,	O
encoding	O
a	O
putative	O
cell	O
cycle	O
protein	O
[	O
4	O
]	O
,	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Upregulation	O
of	O
distinct	O
regulatory	O
genes	O
in	O
these	O
two	O
bacteria	O
indicates	O
the	O
different	O
stress	O
response	O
mechanisms	O
between	O
the	O
bacterial	O
species	O
in	O
the	O
same	O
host	O
.	O

However	O
,	O
none	O
of	O
these	O
regulatory	O
factors	O
were	O
identified	O
in	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
exposed	O
to	O
G	B-Organism
.	I-Organism
mellonella	I-Organism
homogenate	O
in	O
a	O
previous	O
study	O
[	O
16	O
]	O
,	O
suggesting	O
that	O
regulation	O
of	O
these	O
factors	O
either	O
depends	O
on	O
host	O
(	O
R	B-Organism
.	I-Organism
majalis	I-Organism
not	O
G	B-Organism
.	I-Organism
mellonella	I-Organism
)	O
or	O
bacteria	O
themselves	O
.	O

Genes	O
involved	O
in	O
virulence	O
and	O
secretion	O

Identification	O
of	O
genes	O
encoding	O
hemolysin	B-Protein
related	O
proteins	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
(	O
fhaC	B-Protein
)	O
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
(	O
xhlA	B-Protein
)	O
may	O
suggest	O
their	O
role	O
in	O
dealing	O
with	O
the	O
insect	O
cellular	O
immune	O
response	O
and	O
iron	B-Chemical
scavenge	O
[	O
31	O
,	O
32	O
]	O
.	O

Subsequently	O
,	O
bacterial	O
virulence	O
factors	O
actively	O
contribute	O
to	O
a	O
successful	O
infection	O
by	O
colonization	O
of	O
and	O
toxicity	O
towards	O
the	O
insect	O
host	O
.	O

Among	O
the	O
virulence	O
genes	O
identified	O
in	O
this	O
study	O
,	O
tcaC	B-Protein
was	O
identified	O
to	O
be	O
induced	O
in	O
both	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

The	O
tca	O
gene	O
family	O
encodes	O
four	O
toxin	O
complexes	O
TcaA	B-Protein
,	O
TcaB	B-Protein
,	O
TcaC	B-Protein
and	O
TcaD	B-Protein
[	O
33	O
]	O
,	O
and	O
has	O
been	O
found	O
in	O
several	O
bacterial	O
pathogens	O
including	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
,	O
Yersinia	B-Organism
and	O
Xenorhabdus	B-Organism
[	O
34	O
]	O
.	O

Interestingly	O
,	O
Tca	O
toxin	O
encoding	O
genes	O
were	O
also	O
found	O
to	O
be	O
induced	O
in	O
a	O
related	O
species	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
treated	O
with	O
the	O
homogenate	O
of	O
G	B-Organism
.	I-Organism
mellonella	I-Organism
[	O
16	O
]	O
.	O

This	O
leads	O
us	O
to	O
speculate	O
that	O
TcaC	B-Protein
serves	O
as	O
either	O
an	O
activator	O
or	O
a	O
chaperone	O
in	O
secretion	O
of	O
toxin	O
complex	O
from	O
the	O
cell	O
as	O
proposed	O
by	O
ffrench	O
-	O
Constant	O
et	O
al	O
.	O

[	O
35	O
]	O
and	O
Waterfield	O
et	O
al	O
.	O

[	O
36	O
]	O
.	O

Induction	O
of	O
gene	O
pplA	B-Protein
,	O
encoding	O
a	O
phospholipase	O
,	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
is	O
expected	O
to	O
contribute	O
to	O
its	O
faster	O
growth	O
rate	O
[	O
37	O
]	O
compared	O
to	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
in	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Further	O
,	O
genes	O
encoding	O
components	O
of	O
different	O
types	O
of	O
secretion	O
machineries	O
were	O
isolated	O
in	O
this	O
study	O
.	O

Upregulation	O
of	O
gene	O
sctL	B-Protein
,	O
encoding	O
components	O
of	O
type	O
III	O
secretion	O
machinery	O
,	O
possibly	O
coordinates	O
protein	O
secretion	O
system	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
for	O
translocating	O
effector	O
molecules	O
across	O
the	O
bacterial	O
cell	O
envelope	O
into	O
host	O
cells	O
[	O
38	O
-	O
40	O
]	O
.	O

Unlike	O
Photorhabdus	B-Organism
,	O
the	O
genomes	O
of	O
Xenorhabdus	B-Organism
bovienii	I-Organism
and	O
X	B-Organism
.	I-Organism
nematophila	I-Organism
do	O
not	O
encode	O
homologues	O
of	O
a	O
dedicated	O
type	O
III	O
secretion	O
system	O
[	O
3	O
]	O
,	O
indicating	O
that	O
Xenorhabdus	B-Organism
likely	O
uses	O
different	O
effectors	O
or	O
secretion	O
systems	O
.	O

Notably	O
,	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
virH	B-Protein
with	O
sequence	O
similarity	O
to	O
a	O
gene	O
encoding	O
putative	O
toxin	O
secretion	O
transporter	O
in	O
Vibrio	B-Organism
cholera	I-Organism
,	O
was	O
upregulated	O
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

In	O
addition	O
,	O
several	O
other	O
genes	O
encoding	O
proteins	O
with	O
putative	O
virulence	O
functions	O
identified	O
in	O
this	O
study	O
may	O
represent	O
novel	O
toxin	O
candidates	O
involved	O
in	O
insect	O
infection	O
.	O

These	O
include	O
pmt1	B-Protein
,	O
toxC	B-Protein
and	O
virB	B-Protein
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
and	O
virH	B-Protein
from	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Differences	O
in	O
expression	O
of	O
virulence	O
and	O
secretion	O
related	O
genes	O
imply	O
the	O
differential	O
virulence	O
mechanisms	O
employed	O
by	O
the	O
two	O
bacteria	O
.	O

Genes	O
involved	O
in	O
adaptation	O
to	O
host	O
-	O
induced	O
stresses	O

Compared	O
to	O
all	O
other	O
functional	O
classes	O
,	O
more	O
stress	O
response	O
genes	O
were	O
identified	O
to	O
be	O
shared	O
by	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
suggesting	O
common	O
themes	O
in	O
adaptation	O
to	O
host	O
-	O
imposed	O
stresses	O
.	O

Upregulation	O
of	O
both	O
surA	B-Protein
and	O
uspB	B-Protein
in	O
both	O
bacteria	O
indicates	O
their	O
importance	O
in	O
bacterial	O
adaptation	O
to	O
global	O
stress	O
during	O
insect	O
infection	O
.	O

Gene	O
surA	B-Protein
is	O
important	O
for	O
bacterial	O
survival	O
during	O
infection	O
[	O
41	O
,	O
42	O
]	O
to	O
avoid	O
accumulation	O
of	O
non	O
-	O
native	O
protein	O
conformations	O
[	O
42	O
-	O
44	O
]	O
,	O
and	O
uspB	B-Protein
gene	O
product	O
is	O
usually	O
accumulated	O
in	O
the	O
stationary	O
phase	O
and	O
probably	O
important	O
for	O
ethanol	B-Chemical
stress	O
[	O
45	O
]	O
.	O

Similarly	O
,	O
induction	O
of	O
a	O
chaperone	O
protein	O
encoding	O
gene	O
dnaK	B-Protein
in	O
both	O
bacteria	O
may	O
picture	O
common	O
stress	O
responses	O
between	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
in	O
a	O
number	O
of	O
cellular	O
processes	O
including	O
rescue	O
of	O
misfolded	O
proteins	O
and	O
control	O
of	O
the	O
activity	O
of	O
folded	O
regulatory	O
proteins	O
[	O
46	O
]	O
.	O

The	O
glutathione	B-Chemical
synthetase	O
gene	O
gshB	B-Protein
which	O
mediates	O
condensation	O
of	O
gamma	O
-	O
glutamylcysteine	O
and	O
glycine	O
to	O
form	O
glutathione	B-Chemical
[	O
47	O
,	O
48	O
]	O
was	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
but	O
glutathione	B-Chemical
reductase	O
gene	O
gor	O
which	O
reduces	O
glutathione	B-Chemical
disulfide	I-Chemical
to	O
the	O
sulfhydryl	O
form	O
of	O
glutathione	B-Chemical
[	O
47	O
,	O
48	O
]	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Glutathione	B-Chemical
plays	O
a	O
major	O
role	O
in	O
protection	O
against	O
oxidative	O
stress	O
and	O
in	O
detoxification	O
of	O
hazardous	O
chemicals	O
or	O
heavy	O
metals	O
[	O
49	O
]	O
.	O

Thus	O
,	O
although	O
gshB	B-Protein
and	O
gor	B-Protein
corresponding	O
products	O
are	O
involved	O
in	O
different	O
glutathione	B-Chemical
biosynthesis	O
pathways	O
,	O
expression	O
of	O
these	O
two	O
genes	O
may	O
suggests	O
possible	O
role	O
of	O
detoxification	O
mechanism	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Further	O
,	O
as	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
bacteria	O
can	O
switch	O
their	O
phenotypes	O
upon	O
insect	O
infection	O
,	O
we	O
speculate	O
that	O
upregulation	O
of	O
transposase	O
genes	O
in	O
both	O
bacteria	O
may	O
contribute	O
to	O
genetic	O
variability	O
for	O
better	O
adaptation	O
and	O
survival	O
in	O
a	O
particular	O
niche	O
[	O
50	O
]	O
.	O

Apart	O
from	O
the	O
common	O
mechanisms	O
handling	O
stresses	O
,	O
gene	O
msrA	B-Protein
encoding	O
a	O
peptide	O
methionine	O
sulfoxide	O
reductase	O
was	O
unique	O
to	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

As	O
an	O
important	O
antioxidant	O
enzyme	O
,	O
peptide	O
methionine	O
sulfoxide	O
reductase	O
mediates	O
the	O
repair	O
of	O
proteins	O
damaged	O
by	O
sulfoxidation	O
of	O
methionine	O
residues	O
[	O
51	O
,	O
52	O
]	O
.	O

Products	O
of	O
msrA	B-Protein
are	O
found	O
to	O
interact	O
with	O
several	O
other	O
gene	O
products	O
(	O
see	O
Additional	O
file	O
2	O
)	O
,	O
also	O
suggesting	O
its	O
importance	O
during	O
insect	O
infection	O
.	O

Genes	O
involved	O
in	O
intracellular	O
metabolism	O

Induction	O
of	O
different	O
metabolism	O
genes	O
in	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
during	O
insect	O
infection	O
highlights	O
the	O
differences	O
in	O
metabolic	O
changes	O
between	O
the	O
two	O
bacteria	O
.	O

Three	O
genes	O
,	O
aceE	B-Protein
,	O
aceK	B-Protein
and	O
dld	B-Protein
,	O
whose	O
products	O
catalyze	O
subsequent	O
steps	O
of	O
the	O
glyoxylate	B-Chemical
pathway	O
[	O
53	O
]	O
,	O
were	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

In	O
contrast	O
,	O
two	O
genes	O
kdgK	B-Protein
and	O
pckA	B-Protein
involved	O
in	O
energy	O
metabolism	O
in	O
the	O
TCA	B-Chemical
cycle	O
were	O
upregulated	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
[	O
54	O
,	O
55	O
]	O
.	O

Genes	O
related	O
to	O
the	O
TCA	B-Chemical
cycle	O
have	O
been	O
also	O
found	O
to	O
be	O
induced	O
in	O
other	O
bacteria	O
upon	O
host	O
infection	O
,	O
for	O
example	O
in	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
in	O
the	O
presence	O
of	O
G	B-Organism
.	I-Organism
mellonella	I-Organism
homogenate	O
[	O
16	O
]	O
and	O
in	O
Vibrio	B-Organism
cholerae	I-Organism
upon	O
infection	O
of	O
infant	O
mice	B-Organism
[	O
56	O
,	O
57	O
]	O
.	O

Further	O
,	O
as	O
a	O
cofactor	O
in	O
the	O
metabolism	O
of	O
fatty	O
acids	O
and	O
leucine	O
,	O
biotin	B-Chemical
plays	O
a	O
role	O
in	O
TCA	B-Chemical
cycle	O
by	O
assisting	O
in	O
metabolic	O
reactions	O
and	O
helping	O
to	O
transfer	O
carbon	B-Chemical
dioxide	I-Chemical
[	O
58	O
]	O
.	O

Therefore	O
,	O
upregulation	O
of	O
bioB	B-Protein
encoding	O
a	O
biontin	O
synthetase	O
protein	O
further	O
suggests	O
that	O
TCA	B-Chemical
cycle	O
is	O
involved	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
.	O

Induction	O
of	O
different	O
amino	O
acid	O
biosynthetic	O
genes	O
may	O
suggest	O
the	O
differences	O
in	O
amino	O
acid	O
requirements	O
in	O
the	O
two	O
bacteria	O
during	O
infection	O
.	O

Induction	O
of	O
cysK	B-Protein
gene	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
suggests	O
that	O
cysteine	O
may	O
be	O
required	O
when	O
growing	O
in	O
the	O
insect	O
,	O
but	O
lysine	O
may	O
be	O
needed	O
for	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
as	O
lysC	B-Protein
gene	O
was	O
induced	O
.	O

Isolation	O
of	O
P	B-Organism
.	I-Organism
temperata	I-Organism
def	O
,	O
encoding	O
an	O
amino	O
acid	O
tRNA	O
synthesis	O
enzyme	O
N	O
-	O
formylmethionylaminoacyl	O
-	O
tRNA	O
deformylase	O
,	O
may	O
reflect	O
the	O
importance	O
of	O
specific	O
amino	O
acids	O
involved	O
in	O
the	O
translation	O
process	O
during	O
growth	O
in	O
the	O
insect	O
host	O
.	O

Indeed	O
,	O
the	O
pathway	O
analysis	O
reveals	O
that	O
def	O
gene	O
product	O
interacts	O
with	O
CysS	B-Protein
,	O
a	O
cysteinyl	O
-	O
tRNA	O
synthetase	O
(	O
see	O
Additional	O
file	O
1	O
)	O
,	O
also	O
suggesting	O
the	O
requirement	O
for	O
cysteine	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
during	O
infection	O
.	O

Genes	O
involved	O
in	O
protein	O
synthesis	O
and	O
degradation	O
can	O
also	O
be	O
distinguished	O
between	O
the	O
two	O
bacteria	O
.	O

A	O
protease	O
gene	O
,	O
clpP	B-Protein
,	O
involved	O
in	O
protein	O
degradation	O
,	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
upon	O
infection	O
.	O

In	O
fact	O
proteases	O
have	O
been	O
identified	O
as	O
virulence	O
factors	O
in	O
some	O
other	O
bacterial	O
pathogens	O
[	O
59	O
]	O
.	O

The	O
signal	O
peptidase	O
II	O
encoded	O
by	O
lspA	B-Protein
gene	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
belongs	O
to	O
a	O
class	O
of	O
aspartyl	O
proteases	O
.	O

Since	O
the	O
product	O
of	O
lspA	B-Protein
has	O
been	O
suggested	O
as	O
an	O
important	O
virulence	O
factor	O
operating	O
via	O
maturation	O
of	O
several	O
lipoproteins	O
[	O
60	O
]	O
,	O
we	O
postulate	O
that	O
the	O
product	O
of	O
lspA	B-Protein
may	O
play	O
a	O
pathological	O
role	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
by	O
cleaving	O
some	O
core	O
proteins	O
and	O
thus	O
influencing	O
bacterial	O
life	O
cycle	O
in	O
the	O
insect	O
host	O
.	O

Genes	O
involved	O
in	O
nutrient	O
scavenging	O

Induction	O
of	O
different	O
types	O
of	O
nutrient	O
uptake	O
systems	O
in	O
Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
further	O
emphasized	O
the	O
possible	O
differences	O
in	O
nutritional	O
requirements	O
of	O
the	O
two	O
bacteria	O
in	O
the	O
insect	O
host	O
.	O

Ion	B-Chemical
scavenging	O
systems	O
induced	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
are	O
completely	O
different	O
.	O

In	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
pchC	B-Protein
,	O
a	O
gene	O
involved	O
in	O
the	O
biogenesis	O
of	O
pyochelin	B-Chemical
type	O
of	O
siderophore	O
[	O
61	O
]	O
,	O
was	O
upregulated	O
indicating	O
the	O
importance	O
of	O
iron	B-Chemical
,	O
whereas	O
a	O
siderophore	O
-	O
independent	O
zinc	B-Chemical
ion	O
transport	O
system	O
encoded	O
by	O
gene	O
znuA	B-Protein
[	O
62	O
]	O
was	O
induced	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
indicating	O
the	O
importance	O
of	O
zinc	B-Chemical
.	O

Also	O
supported	O
by	O
the	O
pathway	O
analysis	O
,	O
product	O
of	O
glnD	B-Protein
identified	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
likely	O
controls	O
the	O
production	O
of	O
siderophore	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

In	O
addition	O
to	O
ion	O
scavenging	O
systems	O
,	O
artM	B-Protein
,	O
encoding	O
a	O
putative	O
ABC	O
amino	O
acid	O
transport	O
system	O
[	O
63	O
]	O
was	O
identified	O
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
,	O
but	O
not	O
in	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
.	O

Besides	O
transporting	O
L	O
-	O
arginine	O
across	O
the	O
inner	O
membrane	O
[	O
63	O
]	O
,	O
the	O
pathway	O
network	O
reveals	O
that	O
the	O
product	O
of	O
artM	B-Protein
participates	O
in	O
cystine	O
transport	O
(	O
see	O
Additional	O
file	O
1	O
)	O
,	O
suggesting	O
that	O
this	O
gene	O
may	O
also	O
mediate	O
cystine	O
amino	O
acid	O
acquisition	O
.	O

Upregulation	O
of	O
artM	B-Protein
in	O
P	B-Organism
.	I-Organism
temperata	I-Organism
also	O
suggests	O
that	O
amino	O
acids	O
may	O
be	O
available	O
for	O
uptake	O
in	O
the	O
insect	O
.	O

Similarly	O
,	O
it	O
has	O
been	O
discussed	O
previously	O
that	O
histidine	O
and	O
phosphatidylethanolamine	B-Chemical
,	O
the	O
possible	O
components	O
presented	O
in	O
the	O
insect	O
host	O
hemolymph	O
,	O
may	O
be	O
important	O
food	O
sources	O
used	O
by	O
P	B-Organism
.	I-Organism
luminescens	I-Organism
for	O
growth	O
within	O
the	O
insect	O
host	O
[	O
64	O
]	O
.	O

As	O
cysteine	O
synthesis	O
gene	O
cysK	B-Protein
was	O
also	O
identified	O
from	O
P	B-Organism
.	I-Organism
temperata	I-Organism
as	O
discussed	O
above	O
,	O
it	O
may	O
indicate	O
that	O
the	O
level	O
of	O
cysteine	O
either	O
synthesized	O
by	O
P	B-Organism
.	I-Organism
temperata	I-Organism
or	O
acquired	O
from	O
the	O
insect	O
host	O
is	O
not	O
sufficient	O
during	O
infection	O
.	O

Interestingly	O
,	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
seems	O
to	O
require	O
sugar	O
as	O
malF	B-Protein
gene	O
which	O
is	O
involved	O
in	O
uptake	O
for	O
maltose	B-Chemical
and	O
lactose	B-Chemical
was	O
upregulated	O
.	O

Further	O
,	O
P	B-Organism
.	I-Organism
temperata	I-Organism
but	O
not	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
induced	O
tolB	B-Protein
gene	O
that	O
encodes	O
a	O
Tol	O
protein	O
upon	O
insect	O
infection	O
.	O

As	O
a	O
periplasmic	B-Protein
protein	I-Protein
,	O
TolB	B-Protein
is	O
an	O
extra	O
member	O
in	O
the	O
Tol	O
system	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
Tol	O
system	O
stabilizes	O
the	O
outer	O
membrane	O
structure	O
and	O
mutations	O
in	O
Tol	O
encoding	O
genes	O
result	O
in	O
hypersensitivity	O
to	O
deleterious	O
agents	O
[	O
65	O
]	O
.	O

Despite	O
unknown	O
mechanistic	O
details	O
of	O
Tol	O
system	O
,	O
upregulation	O
of	O
P	B-Organism
.	I-Organism
temperata	I-Organism
tolB	B-Protein
gene	O
suggests	O
that	O
it	O
may	O
be	O
involved	O
in	O
importing	O
biomolecules	O
by	O
somehow	O
supplying	O
energy	O
or	O
transport	O
as	O
noted	O
by	O
Nikaido	O
[	O
66	O
]	O
in	O
other	O
bacteria	O
.	O

Genes	O
with	O
unknown	O
function	O

Ten	O
genes	O
encoding	O
products	O
with	O
unknown	O
functions	O
were	O
identified	O
to	O
be	O
upregulated	O
in	O
both	O
bacteria	O
during	O
infection	O
of	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

These	O
include	O
two	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
three	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
genes	O
which	O
show	O
sequence	O
similarity	O
to	O
genes	O
encoding	O
hypothetical	O
proteins	O
with	O
unknown	O
functions	O
,	O
and	O
two	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
three	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
sequences	O
that	O
exhibit	O
no	O
similarity	O
to	O
any	O
gene	O
or	O
gene	O
product	O
in	O
current	O
databases	O
.	O

These	O
unknown	O
genes	O
may	O
represent	O
novel	O
pathogenicity	O
factors	O
used	O
by	O
bacteria	O
during	O
insect	O
infection	O
and	O
thus	O
require	O
further	O
investigation	O
.	O

Conclusion	O

This	O
research	O
indicates	O
that	O
selective	O
capture	O
of	O
transcribed	O
sequences	O
(	O
SCOTS	O
)	O
is	O
a	O
powerful	O
technique	O
to	O
study	O
in	O
vivo	O
gene	O
expression	O
in	O
bacterial	O
pathogens	O
of	O
insects	O
.	O

Results	O
reveal	O
that	O
phylogenetically	O
related	O
bacteria	O
with	O
similar	O
biology	O
differ	O
dramatically	O
in	O
molecular	O
mechanisms	O
of	O
pathogenicity	O
in	O
the	O
same	O
host	O
.	O

Photorhabdus	B-Organism
and	O
Xenorhabdus	B-Organism
bacteria	O
appear	O
to	O
share	O
more	O
genes	O
in	O
host	O
-	O
induced	O
stress	O
protection	O
category	O
,	O
including	O
tolerance	O
against	O
universal	O
stresses	O
,	O
glutathione	B-Chemical
-	O
mediated	O
protection	O
against	O
oxidative	O
stress	O
,	O
and	O
protection	O
against	O
nucleic	O
acid	O
damage	O
,	O
compared	O
to	O
genes	O
in	O
all	O
other	O
categories	O
.	O

While	O
genes	O
encoding	O
TcaC	B-Protein
toxin	O
and	O
hemolysin	O
related	O
proteins	O
were	O
identified	O
to	O
be	O
induced	O
in	O
both	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
,	O
the	O
two	O
bacteria	O
seem	O
to	O
use	O
different	O
regulatory	O
genes	O
,	O
secretion	O
systems	O
and	O
virulence	O
factors	O
to	O
achieve	O
infection	O
of	O
the	O
same	O
insect	O
host	O
R	B-Organism
.	I-Organism
majalis	I-Organism
.	O

Further	O
,	O
P	B-Organism
.	I-Organism
temperata	I-Organism
and	O
X	B-Organism
.	I-Organism
koppenhoeferi	I-Organism
displayed	O
different	O
metabolic	O
adaptations	O
in	O
the	O
same	O
insect	O
host	O
as	O
reflected	O
by	O
the	O
high	O
proportion	O
of	O
identified	O
genes	O
involved	O
in	O
metabolism	O
.	O

Overall	O
,	O
this	O
study	O
provides	O
a	O
better	O
understanding	O
of	O
the	O
evolution	O
of	O
bacterial	O
pathogenesis	O
and	O
provides	O
molecular	O
targets	O
for	O
genetic	O
manipulation	O
of	O
these	O
economically	O
important	O
nematode	O
symbiotic	O
insect	O
pathogens	O
.	O

Transcriptional	O
profiling	O
of	O
Actinobacillus	B-Organism
pleuropneumoniae	I-Organism
during	O
the	O
acute	O
phase	O
of	O
a	O
natural	O
infection	O
in	O
pigs	B-Organism

Background	O
Actinobacillus	B-Organism
pleuropneumoniae	I-Organism
is	O
the	O
etiological	O
agent	O
of	O
porcine	O
pleuropneumonia	O
,	O
a	O
respiratory	O
disease	O
which	O
causes	O
great	O
economic	O
losses	O
worldwide	O
.	O

Many	O
virulence	O
factors	O
are	O
involved	O
in	O
the	O
pathogenesis	O
,	O
namely	O
capsular	O
polysaccharides	O
,	O
RTX	O
toxins	O
,	O
LPS	B-Chemical
and	O
many	O
iron	B-Chemical
acquisition	O
systems	O
.	O

In	O
order	O
to	O
identify	O
genes	O
that	O
are	O
expressed	O
in	O
vivo	O
during	O
a	O
natural	O
infection	O
,	O
we	O
undertook	O
transcript	O
profiling	O
experiments	O
with	O
an	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
DNA	O
microarray	O
,	O
after	O
recovery	O
of	O
bacterial	O
mRNAs	O
from	O
serotype	B-Organism
5b	I-Organism
-	O
infected	O
porcine	O
lungs	O
.	O

AppChip2	B-Organism
contains	O
2033	O
PCR	O
amplicons	O
based	O
on	O
the	O
genomic	O
sequence	O
of	O
App	B-Organism
serotype	I-Organism
5b	I-Organism
strain	I-Organism
L20	I-Organism
,	O
representing	O
more	O
than	O
95	O
%	O
of	O
ORFs	O
greater	O
than	O
160	O
bp	O
in	O
length	O
.	O

Results	O
Transcriptional	O
profiling	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
recovered	O
from	O
the	O
lung	O
of	O
a	O
pig	B-Organism
suffering	O
from	O
a	O
natural	O
infection	O
or	O
following	O
growth	O
of	O
the	O
bacterial	O
isolate	O
in	O
BHI	O
medium	O
was	O
performed	O
.	O

An	O
RNA	O
extraction	O
protocol	O
combining	O
beadbeating	O
and	O
hot	O
-	O
acid	O
-	O
phenol	O
was	O
developed	O
in	O
order	O
to	O
maximize	O
bacterial	O
mRNA	O
yields	O
and	O
quality	O
following	O
total	O
RNA	O
extraction	O
from	O
lung	O
lesions	O
.	O

Nearly	O
all	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
transcripts	O
could	O
be	O
detected	O
on	O
our	O
microarrays	O
,	O
and	O
150	O
genes	O
were	O
deemed	O
differentially	O
expressed	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
infection	O
.	O

Our	O
results	O
indicate	O
that	O
,	O
for	O
example	O
,	O
gene	O
apxIVA	B-Protein
from	O
an	O
operon	O
coding	O
for	O
RTX	O
toxin	O
ApxIV	B-Protein
is	O
highly	O
up	O
-	O
regulated	O
in	O
vivo	O
,	O
and	O
that	O
two	O
genes	O
from	O
the	O
operon	O
coding	O
for	O
type	O
IV	O
fimbriae	O
(	O
APL	B-Protein
_	I-Protein
0878	I-Protein
and	O
APL	B-Protein
_	I-Protein
0879	I-Protein
)	O
were	O
also	O
up	O
-	O
regulated	O
.	O

These	O
transcriptional	O
profiling	O
data	O
,	O
combined	O
with	O
previous	O
comparative	O
genomic	O
hybridizations	O
performed	O
by	O
our	O
group	O
,	O
revealed	O
that	O
66	O
out	O
of	O
the	O
72	O
up	O
-	O
regulated	O
genes	O
are	O
conserved	O
amongst	O
all	O
serotypes	O
and	O
that	O
3	O
of	O
them	O
code	O
for	O
products	O
that	O
are	O
predicted	O
outer	O
membrane	O
proteins	O
(	O
genes	O
irp	B-Protein
and	O
APL	B-Protein
_	I-Protein
0959	I-Protein
,	O
predicted	O
to	O
code	O
for	O
a	O
TonB	O
-	O
dependent	O
receptor	O
and	O
a	O
filamentous	B-Protein
hemagglutinin	I-Protein
/	O
adhesin	B-Protein
respectively	O
)	O
or	O
lipoproteins	O
(	O
gene	O
APL	B-Protein
_	I-Protein
0920	I-Protein
)	O
.	O

Only	O
4	O
of	O
72	O
up	O
-	O
regulated	O
genes	O
had	O
previously	O
been	O
identified	O
in	O
controled	O
experimental	O
infections	O
.	O

Conclusions	O
These	O
genes	O
that	O
we	O
have	O
identified	O
as	O
up	O
-	O
regulated	O
in	O
vivo	O
,	O
conserved	O
across	O
serotypes	O
and	O
coding	O
for	O
potential	O
outer	O
membrane	O
proteins	O
represent	O
potential	O
candidates	O
for	O
the	O
development	O
of	O
a	O
cross	O
-	O
protective	O
vaccine	O
against	O
porcine	O
pleuropneumonia	O
.	O

Background	O

Actinobacillus	B-Organism
pleuropneumoniae	I-Organism
is	O
the	O
causative	O
agent	O
of	O
porcine	O
pleuropneumonia	O
,	O
a	O
highly	O
contagious	O
respiratory	O
disease	O
that	O
causes	O
great	O
economic	O
losses	O
worldwide	O
[	O
1	O
]	O
.	O

Transmission	O
occurs	O
through	O
aerosol	O
or	O
close	O
contact	O
with	O
infected	O
animals	O
or	O
asymptomatic	O
carriers	O
,	O
and	O
can	O
affect	O
pigs	B-Organism
of	O
all	O
ages	O
[	O
2	O
]	O
.	O

In	O
the	O
acute	O
phase	O
,	O
the	O
disease	O
is	O
often	O
lethal	O
in	O
24	O
to	O
48	O
h	O
,	O
and	O
leads	O
to	O
the	O
formation	O
of	O
extensive	O
fibrinohemorrhagic	O
lung	O
lesions	O
.	O

Animals	O
that	O
survive	O
the	O
infection	O
often	O
become	O
healthy	O
carriers	O
,	O
and	O
develop	O
localized	O
necrotizing	O
lesions	O
associated	O
with	O
pleuritis	O
[	O
3	O
]	O
.	O

Fifteen	O
different	O
serotypes	O
can	O
be	O
identified	O
based	O
on	O
differences	O
in	O
capsular	O
polysaccharides	O
.	O

While	O
serotypes	O
1	O
to	O
12	O
and	O
15	O
usually	O
belong	O
to	O
biotype	O
1	O
,	O
which	O
contains	O
strains	O
that	O
are	O
NAD	O
-	O
dependent	O
,	O
serotypes	O
13	O
and	O
14	O
are	O
usually	O
NAD	O
-	O
independent	O
and	O
belong	O
to	O
biotype	O
2	O
[	O
4	O
]	O
.	O

However	O
,	O
biotype	O
2	O
variants	O
of	O
serotypes	O
2	O
,	O
4	O
,	O
7	O
and	O
9	O
have	O
been	O
reported	O
[	O
5	O
-	O
7	O
]	O
.	O

Despite	O
years	O
of	O
research	O
,	O
mechanisms	O
involved	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
pathogenicity	O
are	O
still	O
not	O
fully	O
understood	O
.	O

While	O
many	O
virulence	O
factors	O
have	O
been	O
identified	O
,	O
such	O
as	O
lipopolysaccharides	B-Chemical
,	O
capsular	O
polysaccharides	O
,	O
Apx	O
toxins	O
and	O
iron	B-Chemical
acquisition	O
systems	O
[	O
4	O
]	O
,	O
or	O
suggested	O
,	O
like	O
biofilm	O
formation	O
[	O
8	O
]	O
,	O
autotransporter	O
adhesin	B-Protein
[	O
9	O
]	O
and	O
autotransporter	O
protease	O
synthesis	O
[	O
10	O
]	O
,	O
very	O
little	O
is	O
known	O
about	O
the	O
overall	O
contribution	O
of	O
each	O
component	O
to	O
the	O
infection	O
process	O
.	O

In	O
order	O
to	O
gain	O
new	O
insight	O
into	O
the	O
disease	O
,	O
researchers	O
have	O
relied	O
on	O
techniques	O
that	O
allow	O
for	O
the	O
identification	O
of	O
genes	O
expressed	O
in	O
bacteria	O
during	O
infection	O
of	O
the	O
host	O
[	O
11	O
]	O
,	O
namely	O
In	O
Vivo	O
Expression	O
Technology	O
(	O
IVET	O
)	O
,	O
Signature	O
Tagged	O
Mutagenesis	O
(	O
STM	O
)	O
and	O
Selective	O
Capture	O
of	O
Transcribed	O
Sequences	O
(	O
SCOTS	O
)	O
.	O

First	O
,	O
an	O
IVET	O
experiment	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
led	O
to	O
the	O
identification	O
of	O
10	O
loci	O
(	O
termed	O
ivi	O
)	O
transcribed	O
in	O
vivo	O
[	O
12	O
]	O
and	O
highlighted	O
the	O
importance	O
of	O
genes	O
involved	O
in	O
branched	O
-	O
chain	O
amino	O
acid	O
(	O
BCAA	O
)	O
synthesis	O
[	O
13	O
,	O
14	O
]	O
.	O

Later	O
,	O
over	O
the	O
course	O
of	O
two	O
STM	O
experiments	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
nearly	O
3000	O
mutants	O
were	O
screened	O
in	O
vivo	O
[	O
15	O
,	O
16	O
]	O
.	O

Both	O
experiments	O
showed	O
that	O
iron	B-Chemical
acquisition	O
was	O
highly	O
important	O
for	O
the	O
virulence	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
with	O
the	O
identification	O
of	O
mutants	O
impaired	O
for	O
the	O
ExbB	B-Protein
-	O
ExbD	B-Protein
-	O
TonB	B-Protein
energy	O
-	O
transducing	O
system	O
.	O

The	O
study	O
by	O
Sheehan	O
et	O
al	O
[	O
16	O
]	O
,	O
lead	O
to	O
the	O
identification	O
of	O
a	O
second	O
set	O
of	O
exbB	B-Protein
-	O
exbD	B-Protein
-	O
tonB	B-Protein
genes	O
,	O
and	O
it	O
was	O
determined	O
that	O
inactivation	O
of	O
tonB2	B-Protein
and	O
not	O
tonB1	B-Protein
lead	O
to	O
attenuation	O
in	O
vivo	O
[	O
17	O
]	O
.	O

More	O
recently	O
,	O
SCOTS	B-Protein
experiments	O
were	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
at	O
two	O
different	O
stages	O
of	O
infection	O
:	O
at	O
the	O
end	O
of	O
the	O
acute	O
stage	O
,	O
in	O
necrotic	O
lung	O
tissues	O
(	O
7	O
days	O
post	O
-	O
infection	O
)	O
[	O
18	O
]	O
,	O
and	O
in	O
the	O
chronic	O
stage	O
(	O
21	O
days	O
post	O
-	O
infection	O
)	O
[	O
10	O
]	O
.	O

These	O
studies	O
demonstrated	O
the	O
importance	O
of	O
anaerobic	O
metabolism	O
and	O
HlyX	B-Protein
-	O
regulated	O
mechanisms	O
during	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
infection	O
in	O
the	O
lungs	O
,	O
and	O
led	O
to	O
the	O
identification	O
and	O
characterisation	O
of	O
a	O
maturation	O
autotransporter	O
protease	O
,	O
AasP	B-Protein
,	O
responsible	O
for	O
cleavage	O
and	O
release	O
of	O
fragments	O
of	O
OmlA	B-Protein
from	O
the	O
cell	O
surface	O
[	O
19	O
]	O
.	O

The	O
HlyX	B-Protein
regulon	O
was	O
characterized	O
recently	O
,	O
and	O
iron	B-Chemical
-	O
regulated	O
protein	O
B	O
(	O
FrpB	B-Protein
)	O
was	O
identified	O
as	O
a	O
potentially	O
important	O
virulence	O
factor	O
up	O
-	O
regulated	O
when	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
is	O
grown	O
in	O
oxygen	B-Chemical
-	O
deprived	O
environments	O
[	O
20	O
]	O
.	O

Although	O
these	O
in	O
vivo	O
studies	O
have	O
been	O
very	O
valuable	O
in	O
gaining	O
a	O
better	O
understanding	O
of	O
the	O
mechanisms	O
involved	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
pathogenesis	O
,	O
limitations	O
associated	O
with	O
the	O
techniques	O
used	O
lead	O
only	O
to	O
a	O
partial	O
overview	O
of	O
the	O
transcriptional	O
events	O
taking	O
place	O
in	O
vivo	O
.	O

DNA	O
microarrays	O
have	O
been	O
used	O
to	O
determine	O
the	O
complete	O
transcriptomic	O
profile	O
of	O
microorganisms	O
in	O
vitro	O
,	O
but	O
technical	O
drawbacks	O
that	O
are	O
associated	O
with	O
the	O
use	O
of	O
this	O
technique	O
in	O
vivo	O
,	O
such	O
as	O
the	O
qualitative	O
and	O
quantitative	O
recovery	O
of	O
bacterial	O
RNA	O
from	O
host	O
tissues	O
,	O
explain	O
why	O
the	O
use	O
of	O
this	O
technique	O
to	O
monitor	O
bacterial	O
infections	O
has	O
been	O
limited	O
[	O
21	O
]	O
.	O

While	O
various	O
cell	O
culture	O
,	O
ex	O
-	O
vivo	O
or	O
mouse	B-Organism
infection	O
models	O
have	O
been	O
used	O
,	O
in	O
vivo	O
experiments	O
can	O
provide	O
more	O
accurate	O
information	O
on	O
bacterial	O
adaptation	O
and	O
virulence	O
when	O
the	O
natural	O
host	O
is	O
studied	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
only	O
two	O
genome	O
-	O
wide	O
transcriptional	O
profiling	O
experiments	O
using	O
DNA	O
microarrays	O
have	O
been	O
conducted	O
with	O
bacterial	O
pathogens	O
in	O
their	O
natural	O
host	O
,	O
during	O
a	O
natural	O
infection	O
.	O

LaRocque	O
et	O
al	O
.	O
have	O
evaluated	O
the	O
transcriptome	O
of	O
Vibrio	B-Organism
cholerae	I-Organism
in	O
the	O
early	O
and	O
late	O
stages	O
of	O
the	O
disease	O
by	O
collecting	O
stools	O
of	O
naturally	O
infected	O
patients	B-Organism
[	O
22	O
]	O
.	O

Son	O
et	O
al	O
.	O
used	O
fresh	O
sputum	O
samples	O
from	O
a	O
patient	B-Organism
with	O
cystic	O
fibrosis	O
to	O
study	O
the	O
in	O
vivo	O
transcriptome	O
of	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
[	O
23	O
]	O
.	O

Additionally	O
,	O
Agarwal	O
et	O
al	O
.	O
used	O
a	O
custom	O
-	O
made	O
Fur	B-Protein
and	O
iron	B-Chemical
regulon	O
microarray	O
to	O
investigate	O
the	O
expression	O
of	O
these	O
genes	O
during	O
gonococcal	O
infection	O
in	O
women	B-Organism
[	O
24	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
conducted	O
in	O
vivo	O
transcript	O
profiling	O
with	O
DNA	O
microarrays	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
during	O
the	O
acute	O
phase	O
of	O
a	O
natural	O
infection	O
in	O
pigs	B-Organism
.	O

Our	O
results	O
indicate	O
that	O
150	O
genes	O
are	O
differentially	O
expressed	O
during	O
the	O
acute	O
phase	O
of	O
infection	O
in	O
the	O
host	O
.	O

Of	O
these	O
,	O
72	O
were	O
up	O
-	O
regulated	O
,	O
and	O
three	O
of	O
these	O
encode	O
lipoproteins	O
or	O
OMPs	O
that	O
are	O
well	O
-	O
conserved	O
among	O
strains	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

Results	O
and	O
discussion	O

Animal	O
samples	O
While	O
working	O
with	O
samples	O
from	O
commercial	O
herds	O
means	O
that	O
we	O
are	O
working	O
with	O
disease	O
cases	O
that	O
are	O
representative	O
of	O
what	O
is	O
really	O
happening	O
in	O
the	O
field	O
,	O
it	O
also	O
means	O
that	O
limited	O
amounts	O
of	O
material	O
is	O
available	O
.	O

During	O
the	O
course	O
of	O
our	O
experiments	O
,	O
we	O
were	O
able	O
to	O
collect	O
samples	O
from	O
three	O
different	O
animals	O
from	O
the	O
same	O
herd	O
,	O
before	O
antibiotherapy	O
was	O
undertaken	O
to	O
eradicate	O
the	O
infection	O
.	O

All	O
the	O
animals	O
that	O
were	O
sampled	O
had	O
presented	O
symptoms	O
of	O
the	O
disease	O
for	O
less	O
than	O
24	O
h	O
.	O

Two	O
animals	O
died	O
as	O
a	O
result	O
of	O
the	O
infection	O
,	O
and	O
were	O
sampled	O
a	O
few	O
hours	O
after	O
death	O
.	O

Those	O
samples	O
were	O
not	O
used	O
for	O
the	O
microarray	O
experiments	O
since	O
significant	O
transcriptomic	O
changes	O
might	O
have	O
occurred	O
between	O
the	O
time	O
of	O
death	O
and	O
the	O
time	O
of	O
sampling	O
.	O

However	O
,	O
preliminary	O
microscopic	O
observations	O
were	O
made	O
and	O
our	O
RNA	O
extraction	O
protocol	O
was	O
tested	O
with	O
those	O
samples	O
.	O

The	O
last	O
animal	O
was	O
euthanized	O
on	O
site	O
by	O
a	O
veterinarian	O
,	O
and	O
sampled	O
less	O
than	O
5	O
minutes	O
after	O
death	O
.	O

The	O
infectious	O
field	O
strain	O
was	O
isolated	O
from	O
this	O
animal	O
.	O

While	O
it	O
can	O
be	O
argued	O
that	O
different	O
animals	O
might	O
react	O
differently	O
to	O
an	O
infection	O
by	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
and	O
therefore	O
elicit	O
different	O
transcriptional	O
changes	O
in	O
the	O
pathogen	O
,	O
we	O
are	O
confident	O
that	O
the	O
results	O
that	O
were	O
obtained	O
reflect	O
accurately	O
the	O
conditions	O
encountered	O
by	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
in	O
its	O
natural	O
host	O
following	O
acute	O
infection	O
.	O

Macroscopic	O
and	O
microscopic	O
observations	O

Clinical	O
signs	O
and	O
macroscopic	O
and	O
microscopic	O
examinations	O
were	O
consistent	O
with	O
acute	O
porcine	O
pleuropneumonia	O
.	O

Clinical	O
signs	O
ranged	O
from	O
depression	O
to	O
respiratory	O
distress	O
,	O
while	O
macroscopic	O
observation	O
of	O
deceased	O
pigs	B-Organism
revealed	O
lobar	O
fibrinohemorrhagic	O
pleuropneumonia	O
,	O
along	O
with	O
necrotic	O
lesions	O
and	O
the	O
accumulation	O
of	O
bloody	O
fluid	O
in	O
the	O
thorax	O
.	O

On	O
microscopic	O
examination	O
,	O
multiple	O
pulmonary	O
necrotic	O
areas	O
surrounded	O
by	O
or	O
containing	O
oat	B-Organism
cells	O
were	O
present	O
,	O
as	O
well	O
as	O
fibrin	O
accumulation	O
in	O
the	O
alveolar	O
lumen	O
,	O
interlobular	O
septa	O
and	O
pleura	O
(	O
Figure	O
1	O
)	O
.	O

The	O
infectious	O
field	O
strain	O
that	O
was	O
isolated	O
from	O
the	O
lung	O
tissues	O
was	O
named	O
896	O
-	O
07	O
,	O
and	O
serotyping	O
analysis	O
showed	O
that	O
it	O
belongs	O
to	O
serotype	B-Organism
5b	I-Organism
,	O
one	O
of	O
the	O
most	O
prevalent	O
in	O
North	O
America	O
[	O
4	O
]	O
.	O

Comparative	O
genomic	O
hybridizations	O

CGH	O
experiments	O
conducted	O
previously	O
in	O
our	O
laboratory	O
have	O
shown	O
that	O
the	O
majority	O
of	O
genes	O
in	O
the	O
reference	O
5b	B-Organism
L20	I-Organism
strain	O
were	O
conserved	O
in	O
reference	O
strains	O
and	O
fresh	O
field	O
isolates	O
.	O

Conversely	O
,	O
205	O
genes	O
were	O
identified	O
as	O
divergent	O
in	O
at	O
least	O
one	O
strain	O
,	O
including	O
39	O
that	O
are	O
either	O
phage	O
or	O
transposon	O
related	O
out	O
of	O
the	O
2033	O
ORFs	O
represented	O
on	O
the	O
microarray	O
,	O
which	O
represents	O
10	O
.	O
1	O
%	O
of	O
divergent	O
genes	O
[	O
25	O
]	O
.	O

As	O
anticipated	O
,	O
clusters	O
of	O
genes	O
associated	O
with	O
LPS	O
/	O
capsule	O
biosynthesis	O
and	O
toxin	O
production	O
showed	O
variations	O
.	O

AppChip2	B-Organism
was	O
designed	O
using	O
the	O
complete	O
genome	O
sequence	O
from	O
the	O
serotype	B-Organism
5b	I-Organism
reference	I-Organism
strain	I-Organism
L20	I-Organism
.	O

In	O
order	O
to	O
validate	O
its	O
use	O
to	O
assess	O
transcriptomic	O
events	O
taking	O
place	O
with	O
our	O
infectious	O
field	O
strain	O
during	O
the	O
infection	O
,	O
we	O
first	O
used	O
it	O
to	O
analyze	O
the	O
gene	O
content	O
of	O
the	O
896	B-Organism
-	I-Organism
07	I-Organism
field	O
strain	O
.	O

The	O
CGH	O
data	O
obtained	O
with	O
strain	O
896	B-Organism
-	I-Organism
07	I-Organism
was	O
added	O
to	O
that	O
obtained	O
with	O
other	O
field	O
and	O
reference	O
strains	O
[	O
25	O
]	O
in	O
order	O
to	O
generate	O
a	O
strain	O
dendogram	O
(	O
Figure	O
2	O
)	O
.	O

Serotyping	O
data	O
correlates	O
well	O
with	O
genetic	O
data	O
since	O
strain	O
896	B-Organism
-	I-Organism
07	I-Organism
forms	O
a	O
cluster	O
with	O
the	O
serotype	B-Organism
5b	I-Organism
reference	I-Organism
strain	I-Organism
L20	I-Organism
.	O

The	O
same	O
clusters	O
as	O
those	O
observed	O
previously	O
could	O
be	O
found	O
in	O
our	O
dendrogram	O
[	O
25	O
]	O
.	O

Only	O
28	O
genes	O
were	O
identified	O
as	O
divergent	O
/	O
absent	O
in	O
our	O
field	O
strain	O
,	O
when	O
compared	O
to	O
the	O
reference	O
serotype	O
5b	B-Organism
L20	I-Organism
strain	O
(	O
Table	O
1	O
)	O
.	O

This	O
represents	O
only	O
1	O
.	O
43	O
%	O
of	O
all	O
the	O
genes	O
(	O
1954	O
)	O
that	O
are	O
represented	O
on	O
AppChip2	B-Organism
[	O
25	O
]	O
.	O

Out	O
of	O
these	O
28	O
genes	O
,	O
20	O
can	O
be	O
found	O
in	O
two	O
major	O
regions	O
of	O
the	O
genome	O
:	O
14	O
putative	O
ORFs	O
code	O
for	O
phage	O
structures	O
,	O
while	O
6	O
are	O
located	O
in	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
tight	O
adherence	O
(	O
tad	O
)	O
locus	O
.	O

In	O
Aggregatibacter	B-Organism
actinomycetemcomitans	I-Organism
,	O
a	O
close	O
relative	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
the	O
tad	O
locus	O
is	O
involved	O
in	O
adherence	O
to	O
biological	O
and	O
abiological	O
surfaces	O
[	O
26	O
]	O
.	O

In	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
genes	O
from	O
this	O
locus	O
were	O
shown	O
to	O
be	O
up	O
-	O
regulated	O
during	O
adhesion	O
to	O
lung	O
epithelial	O
cells	O
in	O
vitro	O
[	O
9	O
]	O
.	O

The	O
other	O
important	O
locus	O
for	O
gene	O
divergence	O
/	O
absence	O
was	O
composed	O
of	O
phage	O
-	O
related	O
features	O
,	O
and	O
these	O
were	O
shown	O
to	O
be	O
divergent	O
during	O
inter	O
and	O
intra	O
-	O
serotype	O
comparisons	O
in	O
previous	O
experiments	O
[	O
25	O
]	O
.	O

Some	O
genes	O
might	O
also	O
be	O
present	O
in	O
the	O
genome	O
of	O
strain	O
896	B-Organism
-	I-Organism
07	I-Organism
and	O
absent	O
in	O
reference	O
strain	O
L20	B-Organism
,	O
and	O
therefore	O
absent	O
on	O
AppChip2	B-Organism
.	O

RNA	O
extraction	O

Tissue	O
samples	O
were	O
taken	O
where	O
lung	O
lesions	O
were	O
present	O
to	O
ensure	O
that	O
bacterial	O
yields	O
would	O
be	O
optimal	O
.	O

A	O
beadbeating	O
step	O
was	O
performed	O
prior	O
to	O
a	O
standard	O
hot	O
acid	O
-	O
phenol	B-Chemical
-	O
chloroform	B-Chemical
RNA	O
extraction	O
protocol	O
to	O
extract	O
bacterial	O
RNA	O
from	O
infected	O
lung	O
tissues	O
.	O

Tissues	O
were	O
homogenized	O
with	O
1	O
.	O
0	O
mm	O
zirconia	B-Chemical
/	O
silica	B-Chemical
beads	O
to	O
release	O
but	O
not	O
lyse	O
bacterial	O
cells	O
from	O
the	O
tissue	O
.	O

This	O
size	O
of	O
beads	O
is	O
too	O
large	O
to	O
lyse	O
bacterial	O
cells	O
(	O
Biospec	O
,	O
personal	O
communication	O
)	O
.	O

Following	O
homogenization	O
,	O
serial	O
dilutions	O
of	O
the	O
resulting	O
supernatant	O
were	O
plated	O
in	O
order	O
to	O
determine	O
an	O
approximate	O
number	O
of	O
CFU	O
per	O
gram	O
of	O
tissue	O
.	O

Our	O
results	O
indicated	O
that	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
could	O
easily	O
be	O
isolated	O
in	O
pure	O
culture	O
from	O
lung	O
tissues	O
of	O
all	O
animals	O
,	O
and	O
that	O
the	O
number	O
of	O
CFU	O
varied	O
from	O
1	O
x	O
106	O
to	O
1	O
x	O
107	O
per	O
gram	O
of	O
infected	O
tissue	O
.	O

Centrifugation	O
of	O
homogenized	O
samples	O
enabled	O
the	O
removal	O
of	O
most	O
cellular	O
debris	O
and	O
the	O
recovery	O
of	O
bacteria	O
.	O

Approximately	O
20	O
to	O
45	O
mug	O
of	O
total	O
RNA	O
could	O
routinely	O
be	O
extracted	O
from	O
approximately	O
2	O
g	O
of	O
necrotic	O
lung	O
tissue	O
,	O
with	O
no	O
apparent	O
contamination	O
by	O
eukaryotic	O
RNA	O
,	O
as	O
observed	O
on	O
agarose	O
gel	O
when	O
using	O
bacterial	O
RNA	O
extracted	O
from	O
BHI	O
broth	O
and	O
eukaryotic	O
RNA	O
recovered	O
from	O
porcine	O
lung	O
epithelial	O
cells	O
(	O
SJPL	O
cell	O
line	O
)	O
[	O
27	O
]	O
as	O
on	O
-	O
gel	O
controls	O
(	O
data	O
not	O
shown	O
)	O
.	O

Nevertheless	O
,	O
the	O
MicrobENRICH	O
kit	O
was	O
still	O
used	O
to	O
remove	O
any	O
possible	O
trace	O
of	O
remaining	O
eukaryotic	O
RNA	O
,	O
and	O
treatments	O
with	O
TurboDNase	O
removed	O
traces	O
of	O
contaminating	O
DNA	O
.	O

No	O
trace	O
of	O
bacterial	O
or	O
host	O
DNA	O
could	O
be	O
detected	O
following	O
PCR	O
amplification	O
with	O
primers	O
for	O
gene	O
ompW	B-Protein
and	O
for	O
pig	B-Organism
mitochondrial	O
DNA	O
.	O

We	O
propose	O
that	O
this	O
combination	O
of	O
techniques	O
could	O
prove	O
useful	O
in	O
isolating	O
pathogens	O
from	O
other	O
tissues	O
as	O
well	O
.	O

In	O
vivo	O
transcript	O
profiling	O

Before	O
investigating	O
the	O
in	O
vivo	O
transcript	O
profile	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
we	O
used	O
self	O
-	O
self	O
hybridizations	O
in	O
order	O
to	O
quantifiy	O
the	O
dye	O
bias	O
effect	O
after	O
hybridization	O
on	O
AppChip2	B-Organism
.	O

Duplicate	O
experiments	O
showed	O
a	O
R2	O
correlation	O
factor	O
of	O
0	O
.	O
996	O
between	O
the	O
intensity	O
detected	O
for	O
the	O
Cy3	O
labelled	O
and	O
Cy5	O
labelled	O
probes	O
,	O
and	O
only	O
two	O
genes	O
seemed	O
to	O
qualify	O
as	O
obvious	O
outliers	O
(	O
data	O
not	O
shown	O
)	O
.	O

Both	O
genes	O
,	O
APL	B-Protein
_	I-Protein
1141	I-Protein
and	O
APL	B-Protein
_	I-Protein
0484	I-Protein
,	O
were	O
not	O
identified	O
as	O
differentially	O
expressed	O
during	O
the	O
course	O
of	O
a	O
natural	O
infection	O
.	O

While	O
designing	O
the	O
microarray	O
experiments	O
,	O
growth	O
in	O
BHI	O
medium	O
to	O
an	O
optical	O
density	O
of	O
0	O
.	O
3	O
at	O
a	O
600	O
nm	O
wavelenght	O
was	O
chosen	O
as	O
our	O
reference	O
condition	O
.	O

This	O
condition	O
was	O
not	O
only	O
chosen	O
for	O
practical	O
reasons	O
,	O
but	O
also	O
to	O
fulfill	O
two	O
precise	O
objectives	O
:	O
first	O
,	O
to	O
allow	O
for	O
the	O
identification	O
of	O
genes	O
that	O
,	O
while	O
important	O
to	O
the	O
infection	O
process	O
,	O
have	O
not	O
been	O
identified	O
previously	O
in	O
vitro	O
in	O
rich	O
medium	O
,	O
and	O
second	O
,	O
to	O
allow	O
comparison	O
of	O
the	O
results	O
obtained	O
in	O
vivo	O
to	O
those	O
obtained	O
in	O
our	O
laboratory	O
in	O
other	O
growth	O
conditions	O
by	O
keeping	O
the	O
same	O
reference	O
[	O
28	O
-	O
30	O
]	O
.	O

Working	O
with	O
a	O
limited	O
amount	O
of	O
biological	O
material	O
meant	O
that	O
only	O
one	O
time	O
-	O
point	O
in	O
the	O
infection	O
could	O
be	O
investigated	O
.	O

In	O
the	O
acute	O
stage	O
of	O
porcine	O
pleuropneumonia	O
,	O
bacteria	O
are	O
likely	O
in	O
the	O
exponential	O
phase	O
of	O
growth	O
.	O

This	O
is	O
also	O
the	O
case	O
in	O
the	O
control	O
condition	O
.	O

The	O
transcriptome	O
of	O
A	B-Organism
.	I-Organism
pleuropneumonia	I-Organism
is	O
certainly	O
very	O
different	O
when	O
the	O
infection	O
is	O
in	O
the	O
chronic	O
stage	O
.	O

Therefore	O
,	O
while	O
our	O
results	O
are	O
an	O
accurate	O
representation	O
of	O
the	O
transcriptomic	O
events	O
that	O
occur	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
infection	O
process	O
as	O
compared	O
to	O
those	O
occuring	O
in	O
vitro	O
in	O
a	O
rich	O
culture	O
medium	O
,	O
events	O
occuring	O
earlier	O
of	O
later	O
in	O
the	O
infection	O
process	O
cannot	O
be	O
inferred	O
.	O

In	O
vivo	O
transcript	O
profiling	O
experiments	O
were	O
performed	O
on	O
samples	O
from	O
three	O
different	O
lesion	O
sites	O
on	O
the	O
euthanized	O
pig	B-Organism
.	O

Since	O
this	O
pig	B-Organism
was	O
euthanized	O
on	O
site	O
by	O
a	O
veterinarian	O
,	O
the	O
time	O
laps	O
between	O
the	O
death	O
of	O
the	O
animal	O
and	O
tissue	O
sampling	O
was	O
kept	O
to	O
a	O
minimum	O
.	O

Following	O
microarray	O
hybridization	O
and	O
analysis	O
,	O
86	O
.	O
7	O
%	O
of	O
all	O
coding	O
sequences	O
included	O
on	O
AppChip2	B-Organism
could	O
be	O
detected	O
during	O
our	O
experiments	O
,	O
and	O
150	O
genes	O
were	O
significantly	O
differentially	O
expressed	O
in	O
vivo	O
when	O
their	O
level	O
of	O
expression	O
was	O
compared	O
to	O
that	O
seen	O
in	O
vitro	O
,	O
with	O
a	O
FDR	O
of	O
4	O
.	O
25	O
%	O
over	O
the	O
course	O
of	O
three	O
hybridizations	O
:	O
72	O
of	O
these	O
were	O
up	O
-	O
regulated	O
,	O
while	O
78	O
were	O
down	O
-	O
regulated	O
.	O

Functional	O
classification	O
of	O
these	O
genes	O
revealed	O
that	O
up	O
-	O
regulated	O
genes	O
mostly	O
belonged	O
to	O
the	O
"	O
Transport	O
and	O
Binding	O
Proteins	O
"	O
and	O
"	O
Energy	O
Metabolism	O
"	O
classes	O
,	O
with	O
respectively	O
17	O
and	O
14	O
genes	O
(	O
see	O
Additional	O
file	O
1	O
and	O
Figure	O
3	O
)	O
.	O

Repressed	O
genes	O
mostly	O
belonged	O
to	O
the	O
"	O
Protein	O
Synthesis	O
"	O
,	O
"	O
Energy	O
Metabolism	O
"	O
and	O
"	O
Cell	O
Envelope	O
"	O
functional	O
classes	O
.	O

A	O
large	O
number	O
of	O
genes	O
encoding	O
"	O
Hypothetical	O
/	O
Unknown	O
/	O
Unclassified	O
"	O
products	O
were	O
differentially	O
expressed	O
.	O

Only	O
ten	O
out	O
of	O
the	O
150	O
differentially	O
expressed	O
genes	O
(	O
8	O
.	O
2	O
%	O
)	O
could	O
be	O
found	O
in	O
the	O
list	O
of	O
divergent	O
or	O
highly	O
divergent	O
/	O
absent	O
genes	O
in	O
at	O
least	O
one	O
reference	O
strain	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
as	O
established	O
by	O
Goure	O
et	O
al	O
.	O

[	O
25	O
]	O
.	O

Three	O
of	O
these	O
are	O
involved	O
in	O
surface	O
structures	O
,	O
namely	O
LPS	O
and	O
capsule	O
,	O
biosynthesis	O
(	O
genes	O
kpsF	B-Protein
,	O
cps5b	B-Protein
and	O
cpxC	B-Protein
)	O
,	O
and	O
two	O
others	O
are	O
found	O
in	O
phage	O
-	O
associated	O
regions	O
(	O
APL	B-Protein
_	I-Protein
0512	I-Protein
and	O
APL	B-Protein
_	I-Protein
0524	I-Protein
)	O
.	O

Of	O
the	O
last	O
five	O
genes	O
,	O
four	O
are	O
divergent	O
in	O
only	O
one	O
strain	O
(	O
hktE	B-Protein
,	O
fur	B-Protein
,	O
phoR	B-Protein
and	O
hisH	B-Protein
,	O
respectively	O
in	O
reference	O
strains	O
from	O
serotypes	B-Organism
8	I-Organism
,	O
2	B-Organism
,	O
15	B-Organism
and	O
7	B-Organism
)	O
,	O
and	O
the	O
APL	B-Protein
_	I-Protein
0999	I-Protein
gene	O
codes	O
for	O
a	O
hypothetical	O
protein	O
that	O
is	O
divergent	O
in	O
serotype	B-Organism
2	I-Organism
,	O
7	B-Organism
-	O
11	B-Organism
and	O
14	B-Organism
reference	O
strains	O
.	O

a	O
)	O
Validation	O
of	O
microarray	O
results	O
by	O
qRT	O
-	O
PCR	O
In	O
order	O
to	O
confirm	O
results	O
obtained	O
using	O
the	O
AppChip2	B-Organism
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
microarray	O
,	O
eleven	O
genes	O
were	O
selected	O
for	O
qRT	O
-	O
PCR	O
analysis	O
.	O

Five	O
of	O
these	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
(	O
sohB	B-Protein
,	O
hbpA	B-Protein
,	O
kpsF	B-Protein
,	O
apxIVA	B-Protein
,	O
phoR	B-Protein
)	O
and	O
six	O
were	O
down	O
-	O
regulated	O
(	O
nlpI	B-Protein
,	O
visC	B-Protein
,	O
proQ	B-Protein
,	O
APL	B-Protein
_	I-Protein
1456	I-Protein
,	O
APL	B-Protein
_	I-Protein
1135	I-Protein
and	O
nusG	B-Protein
)	O
.	O

These	O
genes	O
represented	O
a	O
large	O
range	O
of	O
log2	O
ratio	O
values	O
.	O

In	O
all	O
cases	O
,	O
microarray	O
results	O
were	O
supported	O
by	O
those	O
obtained	O
by	O
qRT	O
-	O
PCR	O
:	O
all	O
genes	O
that	O
were	O
identified	O
as	O
up	O
-	O
regulated	O
using	O
the	O
AppChip2	B-Organism
also	O
showed	O
up	O
-	O
regulation	O
following	O
qRT	O
-	O
PCR	O
analysis	O
,	O
and	O
the	O
same	O
was	O
true	O
for	O
selected	O
down	O
-	O
regulated	O
genes	O
(	O
Figure	O
4	O
)	O
.	O

b	O
)	O
Comparison	O
with	O
other	O
in	O
vivo	O
studies	O

Among	O
previous	O
in	O
vivo	O
experiments	O
that	O
were	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
the	O
one	O
that	O
was	O
closest	O
to	O
ours	O
in	O
terms	O
of	O
experimental	O
conditions	O
and	O
results	O
was	O
by	O
Baltes	O
et	O
al	O
[	O
18	O
]	O
.	O

In	O
their	O
experiment	O
,	O
Selective	O
Capture	O
of	O
Transcribed	O
Sequences	O
(	O
SCOTS	O
)	O
was	O
performed	O
on	O
lung	O
tissues	O
after	O
a	O
7	O
day	O
infection	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
(	O
end	O
of	O
acute	O
phase	O
)	O
,	O
and	O
46	O
genes	O
were	O
identified	O
[	O
18	O
]	O
.	O

Of	O
the	O
150	O
differentially	O
expressed	O
genes	O
that	O
we	O
have	O
identified	O
(	O
see	O
Additional	O
file	O
1	O
)	O
,	O
15	O
were	O
also	O
identified	O
in	O
other	O
in	O
vivo	O
studies	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
(	O
Table	O
2	O
)	O
:	O
only	O
4	O
of	O
these	O
were	O
up	O
-	O
regulated	O
following	O
transcript	O
profiling	O
in	O
vivo	O
.	O

These	O
include	O
3	O
genes	O
already	O
identified	O
by	O
Baltes	O
et	O
al	O
.	O
using	O
SCOTS	O
at	O
the	O
end	O
of	O
the	O
acute	O
stage	O
of	O
the	O
disease	O
[	O
18	O
]	O
:	O
fucI	B-Protein
,	O
encoding	O
the	O
L	B-Chemical
-	I-Chemical
fucose	I-Chemical
isomerase	O
,	O
nrdD	B-Protein
,	O
encoding	O
an	O
anaerobic	B-Chemical
ribonucleoside	I-Chemical
triphosphate	I-Chemical
reductase	O
,	O
and	O
apxIVA	B-Protein
,	O
encoding	O
the	O
ApxIVA	B-Protein
toxin	O
structural	O
protein	O
.	O

The	O
latter	O
,	O
the	O
gene	O
encoding	O
the	O
recently	O
discovered	O
fourth	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
Apx	O
toxin	O
[	O
31	O
]	O
,	O
had	O
only	O
been	O
detected	O
in	O
vivo	O
[	O
32	O
-	O
34	O
]	O
until	O
it	O
was	O
discovered	O
recently	O
that	O
it	O
is	O
also	O
up	O
-	O
regulated	O
after	O
contact	O
with	O
broncho	O
-	O
alveolar	O
lavage	O
fluids	O
[	O
30	O
]	O
.	O

It	O
is	O
also	O
the	O
only	O
apx	O
gene	O
that	O
was	O
up	O
-	O
regulated	O
in	O
our	O
experiment	O
,	O
but	O
it	O
is	O
worth	O
noting	O
that	O
the	O
apxIBCD	B-Protein
and	O
apxIIAB	B-Protein
genes	O
,	O
although	O
not	O
differentially	O
expressed	O
,	O
were	O
all	O
actively	O
transcribed	O
in	O
vivo	O
.	O

Finally	O
,	O
the	O
last	O
gene	O
that	O
was	O
up	O
-	O
regulated	O
in	O
our	O
study	O
and	O
identified	O
in	O
another	O
in	O
vivo	O
study	O
is	O
nanE	B-Protein
,	O
which	O
codes	O
for	O
a	O
putative	O
N	B-Chemical
-	I-Chemical
acetylmannosamine	I-Chemical
-	I-Chemical
6	I-Chemical
-	I-Chemical
phosphate	I-Chemical
2	O
-	O
epimerase	O
,	O
an	O
enzyme	O
involved	O
in	O
the	O
use	O
of	O
N	B-Chemical
-	I-Chemical
acetylneuraminate	I-Chemical
and	O
N	B-Chemical
-	I-Chemical
acetylmannosamine	I-Chemical
as	O
carbon	B-Chemical
sources	O
[	O
35	O
]	O
.	O

The	O
differences	O
between	O
our	O
results	O
and	O
those	O
obtained	O
in	O
other	O
in	O
vivo	O
studies	O
can	O
be	O
easily	O
explained	O
:	O
while	O
the	O
second	O
SCOTS	O
experiment	O
was	O
conducted	O
with	O
animals	O
suffering	O
from	O
chronic	O
infections	O
[	O
10	O
]	O
,	O
a	O
condition	O
which	O
differs	O
greatly	O
from	O
our	O
field	O
case	O
,	O
the	O
STM	O
and	O
IVET	O
techniques	O
do	O
not	O
provide	O
a	O
"	O
snap	O
-	O
shot	O
"	O
of	O
the	O
transcriptome	O
at	O
a	O
precise	O
time	O
point	O
during	O
the	O
infection	O
process	O
.	O

While	O
STM	O
and	O
IVET	O
can	O
theoretically	O
provide	O
a	O
global	O
overview	O
of	O
transcriptomic	O
events	O
,	O
the	O
experiments	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
are	O
not	O
likely	O
to	O
have	O
achieved	O
this	O
goal	O
.	O

Only	O
800	O
mutants	O
were	O
screened	O
by	O
Fuller	O
et	O
al	O
.	O
with	O
IVET	O
[	O
12	O
]	O
,	O
well	O
short	O
of	O
the	O
approximately	O
2000	O
genes	O
of	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
genome	O
,	O
and	O
although	O
Sheehan	O
et	O
al	O
.	O
screened	O
2064	O
mutants	O
using	O
STM	O
[	O
16	O
]	O
,	O
the	O
authors	O
noted	O
that	O
both	O
their	O
STM	O
screen	O
and	O
the	O
previous	O
STM	O
experiment	O
by	O
Fuller	O
et	O
al	O
.	O

[	O
15	O
]	O
were	O
likely	O
not	O
saturating	O
.	O

STM	O
relies	O
on	O
transposon	O
mutagenesis	O
,	O
and	O
there	O
are	O
some	O
insertional	O
hot	O
spots	O
in	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
genome	O
[	O
16	O
]	O
.	O

We	O
also	O
compared	O
our	O
results	O
to	O
the	O
transcriptional	O
profile	O
of	O
a	O
virulent	O
strain	O
of	O
Pseudomonas	B-Organism
aeruginosa	I-Organism
,	O
another	O
lung	O
pathogen	O
,	O
isolated	O
from	O
a	O
chronically	O
infected	O
cystic	O
fibrosis	O
patient	B-Organism
[	O
23	O
]	O
.	O

There	O
were	O
no	O
striking	O
similarities	O
when	O
comparing	O
the	O
functions	O
of	O
differentially	O
expressed	O
genes	O
in	O
both	O
studies	O
.	O

Since	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
is	O
well	O
-	O
known	O
for	O
the	O
versatility	O
of	O
nutrients	O
it	O
can	O
use	O
for	O
growth	O
,	O
and	O
since	O
both	O
conditions	O
(	O
chronic	O
infection	O
vs	O
acute	O
infection	O
)	O
were	O
highly	O
different	O
,	O
this	O
was	O
to	O
be	O
expected	O
.	O

However	O
,	O
one	O
interesting	O
aspect	O
of	O
both	O
cases	O
was	O
the	O
list	O
of	O
genes	O
that	O
weren	O
'	O
t	O
up	O
-	O
regulated	O
as	O
predicted	O
.	O

As	O
with	O
Son	O
et	O
al	O
.	O
,	O
we	O
noticed	O
that	O
few	O
of	O
the	O
landmark	O
virulence	O
genes	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
were	O
up	O
-	O
regulated	O
in	O
vivo	O
.	O

Out	O
of	O
the	O
three	O
Apx	O
toxins	O
present	O
in	O
serotype	B-Organism
5b	I-Organism
,	O
only	O
the	O
gene	O
encoding	O
the	O
ApxIV	B-Protein
toxin	O
was	O
up	O
-	O
regulated	O
.	O

The	O
Hsf	B-Protein
autotransporter	O
homolog	O
,	O
thought	O
to	O
be	O
important	O
in	O
adhesion	O
processes	O
,	O
as	O
well	O
as	O
pga	O
genes	O
necessary	O
for	O
biofilm	O
formation	O
,	O
were	O
not	O
identified	O
either	O
.	O

Well	O
-	O
characterized	O
iron	O
acquisition	O
genes	O
such	O
as	O
those	O
coding	O
for	O
the	O
hemoglobin	O
receptor	O
HgbA	B-Protein
(	O
despite	O
the	O
important	O
hemorrhage	O
noticed	O
in	O
the	O
infected	O
lungs	O
)	O
and	O
the	O
genes	O
coding	O
for	O
transferrin	O
binding	O
proteins	O
TbpA	B-Protein
and	O
TbpB	B-Protein
did	O
no	O
show	O
differential	O
expression	O
,	O
nor	O
did	O
genes	O
involved	O
in	O
anaerobic	O
respiration	O
.	O

While	O
in	O
the	O
latter	O
case	O
it	O
can	O
be	O
argued	O
that	O
the	O
environmental	O
conditions	O
encountered	O
during	O
the	O
acute	O
infection	O
might	O
explain	O
why	O
differential	O
expression	O
of	O
these	O
gene	O
transcripts	O
was	O
not	O
observed	O
,	O
it	O
could	O
also	O
be	O
hypothesized	O
that	O
years	O
of	O
evolution	O
of	O
the	O
field	O
strain	O
in	O
nature	O
might	O
have	O
led	O
to	O
the	O
loss	O
of	O
some	O
regulatory	O
mechanisms	O
that	O
could	O
still	O
be	O
present	O
in	O
well	O
-	O
characterized	O
laboratory	O
strains	O
,	O
thereby	O
leading	O
to	O
the	O
constitutive	O
expression	O
of	O
some	O
important	O
virulence	O
genes	O
.	O

In	O
the	O
case	O
of	O
the	O
P	B-Organism
.	I-Organism
aeruginosa	I-Organism
clinical	O
isolate	O
,	O
it	O
was	O
shown	O
that	O
more	O
than	O
300	O
genes	O
had	O
higher	O
levels	O
of	O
constitutive	O
expression	O
in	O
the	O
clinical	O
isolate	O
than	O
in	O
a	O
well	O
-	O
characterised	O
reference	O
strain	O
,	O
therefore	O
showing	O
the	O
deregulation	O
of	O
several	O
pathways	O
[	O
23	O
]	O
.	O

Whether	O
this	O
is	O
also	O
the	O
case	O
for	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
will	O
have	O
to	O
be	O
assessed	O
.	O

c	O
)	O
Down	O
-	O
regulated	O
genes	O

Interestingly	O
,	O
genes	O
involved	O
in	O
protein	O
synthesis	O
were	O
down	O
-	O
regulated	O
in	O
vivo	O
towards	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
.	O

A	O
total	O
of	O
8	O
different	O
30S	O
or	O
50S	O
ribosomal	O
genes	O
showed	O
levels	O
of	O
down	O
-	O
regulation	O
ranging	O
from	O
-	O
1	O
.	O
59	O
to	O
-	O
3	O
.	O
97	O
fold	O
.	O

These	O
genes	O
are	O
scattered	O
in	O
the	O
L20	B-Organism
genome	O
,	O
but	O
all	O
their	O
respective	O
operonic	O
structures	O
are	O
well	O
conserved	O
when	O
compared	O
to	O
those	O
observed	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
[	O
36	O
]	O
.	O

Not	O
much	O
is	O
known	O
,	O
however	O
,	O
about	O
the	O
regulation	O
of	O
these	O
transcriptional	O
units	O
.	O

While	O
some	O
experimental	O
evidence	O
seems	O
to	O
indicate	O
that	O
rpsJ	B-Protein
could	O
be	O
activated	O
by	O
FNR	O
[	O
37	O
]	O
and	O
repressed	O
by	O
ArcA	B-Protein
[	O
38	O
]	O
,	O
rpsT	B-Protein
seems	O
to	O
be	O
repressed	O
by	O
FNR	O
[	O
37	O
]	O
.	O

Both	O
rpsK	B-Protein
and	O
rpsU	B-Protein
are	O
transcribed	O
from	O
sigma	O
70	O
promoters	O
,	O
which	O
is	O
the	O
main	O
sigma	O
factor	O
during	O
the	O
exponential	O
growth	O
phase	O
[	O
39	O
]	O
.	O

This	O
would	O
probably	O
indicate	O
that	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
has	O
a	O
slower	O
metabolism	O
and	O
replication	O
rate	O
in	O
vivo	O
than	O
when	O
it	O
is	O
growing	O
in	O
a	O
rich	O
culture	O
medium	O
.	O

Further	O
strengthening	O
this	O
hypothesis	O
is	O
the	O
fact	O
that	O
two	O
subunits	O
from	O
DNA	O
polymerase	O
III	O
(	O
dnaN	B-Protein
,	O
dnaX	B-Protein
)	O
,	O
which	O
is	O
the	O
primary	O
enzyme	O
for	O
replicative	O
DNA	O
functions	O
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
are	O
down	O
-	O
regulated	O
,	O
as	O
well	O
the	O
genes	O
coding	O
for	O
the	O
DNA	O
primase	O
(	O
dnaG	B-Protein
)	O
and	O
the	O
cell	O
division	O
protein	O
FtsX	B-Protein
.	O

With	O
regards	O
to	O
their	O
possible	O
involvement	O
in	O
virulence	O
processes	O
,	O
some	O
genes	O
that	O
were	O
down	O
-	O
regulated	O
were	O
of	O
particular	O
interest	O
.	O

The	O
Fur	B-Protein
transcriptional	O
regulator	O
,	O
which	O
represses	O
transcription	O
of	O
genes	O
associated	O
with	O
iron	B-Chemical
acquisition	O
[	O
40	O
]	O
,	O
showed	O
a	O
2	O
.	O
6	O
fold	O
down	O
-	O
regulation	O
in	O
transcription	O
.	O

In	O
bacteria	O
,	O
Fur	B-Protein
down	O
-	O
regulates	O
the	O
transcription	O
of	O
genes	O
involved	O
in	O
iron	B-Chemical
-	O
acquisition	O
and	O
iron	B-Chemical
homeostasis	O
in	O
bacterial	O
cells	O
,	O
and	O
its	O
action	O
is	O
directly	O
linked	O
to	O
the	O
amount	O
of	O
available	O
iron	B-Chemical
,	O
as	O
it	O
requires	O
Fe2	B-Chemical
+	I-Chemical
as	O
a	O
cofactor	O
[	O
41	O
]	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
Fur	B-Protein
also	O
regulates	O
its	O
own	O
level	O
of	O
expression	O
.	O

Iron	B-Chemical
restriction	O
if	O
often	O
thought	O
to	O
be	O
an	O
important	O
signal	O
for	O
bacteria	O
,	O
and	O
has	O
often	O
been	O
linked	O
with	O
the	O
expression	O
of	O
virulence	O
factors	O
such	O
as	O
toxins	O
[	O
42	O
]	O
.	O

Therefore	O
,	O
it	O
would	O
seem	O
that	O
the	O
in	O
vivo	O
environment	O
towards	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
pleuropneumonia	O
is	O
not	O
iron	B-Chemical
-	O
restricted	O
for	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

This	O
is	O
not	O
surprising	O
considering	O
that	O
there	O
is	O
extensive	O
hemorrhage	O
and	O
tissue	O
destruction	O
,	O
caused	O
most	O
probably	O
by	O
the	O
secretion	O
of	O
Apx	O
toxins	O
.	O

However	O
,	O
a	O
few	O
genes	O
involved	O
in	O
iron	B-Chemical
acquisition	O
,	O
namely	O
APL	B-Protein
_	I-Protein
0096	I-Protein
,	O
APL	B-Protein
_	I-Protein
0668	I-Protein
,	O
hbpA	B-Protein
and	O
irp	B-Protein
,	O
were	O
up	O
-	O
regulated	O
.	O

Since	O
these	O
genes	O
were	O
not	O
identified	O
in	O
a	O
previous	O
transcript	O
profiling	O
experiment	O
under	O
iron	B-Chemical
-	O
restricted	O
conditions	O
[	O
28	O
]	O
,	O
this	O
might	O
imply	O
that	O
they	O
are	O
not	O
regulated	O
by	O
Fur	B-Protein
.	O

The	O
hfq	B-Protein
gene	O
,	O
which	O
codes	O
for	O
a	O
protein	O
involved	O
in	O
RNA	O
molecule	O
stability	O
and	O
RNA	O
-	O
RNA	O
interactions	O
[	O
43	O
]	O
and	O
that	O
therefore	O
has	O
an	O
important	O
regulatory	O
function	O
,	O
was	O
also	O
down	O
-	O
regulated	O
.	O

Hfq	B-Protein
is	O
an	O
RNA	O
chaperone	O
that	O
acts	O
as	O
a	O
post	O
-	O
transcriptional	O
riboregulator	O
[	O
44	O
]	O
.	O

The	O
role	O
of	O
Hfq	B-Protein
,	O
a	O
Sm	O
-	O
like	O
protein	O
,	O
has	O
been	O
investigated	O
with	O
greater	O
interest	O
over	O
the	O
last	O
decade	O
since	O
it	O
was	O
shown	O
that	O
it	O
is	O
involved	O
in	O
the	O
function	O
of	O
small	O
RNAs	O
(	O
sRNAs	O
)	O
[	O
45	O
]	O
.	O

It	O
is	O
believed	O
to	O
form	O
a	O
complex	O
with	O
sRNAs	O
and	O
RNAse	B-Protein
E	I-Protein
,	O
thereby	O
targeting	O
mRNAs	O
that	O
are	O
recognized	O
by	O
sRNAs	O
for	O
degradation	O
.	O

The	O
fact	O
that	O
the	O
hfq	B-Protein
gene	O
is	O
down	O
-	O
regulated	O
in	O
vivo	O
at	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
could	O
lead	O
to	O
a	O
decline	O
of	O
the	O
activity	O
of	O
sRNAs	O
that	O
require	O
Hfq	B-Protein
to	O
function	O
properly	O
.	O

No	O
sRNAs	O
have	O
been	O
identified	O
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
yet	O
,	O
but	O
they	O
have	O
been	O
found	O
in	O
numerous	O
bacterial	O
pathogens	O
[	O
46	O
]	O
.	O

Also	O
of	O
interest	O
was	O
the	O
down	O
-	O
regulation	O
of	O
the	O
cps5b	B-Protein
(	O
-	O
2	O
.	O
21	O
fold	O
)	O
and	O
cpxC	B-Protein
(	O
-	O
1	O
.	O
82	O
fold	O
)	O
genes	O
,	O
involved	O
respectively	O
in	O
the	O
biosynthesis	O
of	O
capsular	O
polysaccharide	O
and	O
in	O
the	O
export	O
of	O
these	O
polysaccharides	O
.	O

Down	O
-	O
regulation	O
of	O
cpxABC	B-Protein
,	O
involved	O
in	O
capsule	O
biosynthesis	O
,	O
has	O
also	O
been	O
observed	O
during	O
planktonic	O
life	O
in	O
liquid	O
medium	O
in	O
contact	O
with	O
porcine	O
lung	O
epithelial	O
cells	O
[	O
9	O
]	O
.	O

The	O
down	O
-	O
regulation	O
of	O
genes	O
involved	O
in	O
capsule	O
synthesis	O
could	O
potentially	O
lead	O
to	O
the	O
production	O
of	O
a	O
thinner	O
capsule	O
on	O
the	O
surface	O
of	O
bacteria	O
,	O
thereby	O
unmasking	O
potential	O
adhesins	O
.	O

Indeed	O
,	O
an	O
acapsular	O
mutant	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
that	O
was	O
generated	O
in	O
our	O
laboratory	O
was	O
shown	O
to	O
adhere	O
more	O
strongly	O
to	O
frozen	O
porcine	O
tracheal	O
sections	O
than	O
the	O
capsulated	O
wild	O
-	O
type	O
strain	O
[	O
47	O
]	O
.	O

d	O
)	O
Up	O
-	O
regulated	O
genes	O

Numerous	O
genes	O
that	O
could	O
be	O
involved	O
in	O
the	O
progression	O
of	O
the	O
disease	O
were	O
identified	O
as	O
up	O
-	O
regulated	O
.	O

Gene	O
sohB	B-Protein
has	O
the	O
highest	O
observed	O
fold	O
change	O
(	O
5	O
.	O
39x	O
)	O
and	O
codes	O
for	O
a	O
putative	O
secreted	O
serine	O
protease	O
that	O
seems	O
to	O
be	O
well	O
conserved	O
in	O
other	O
pathogenic	O
bacteria	O
,	O
such	O
as	O
Haemophilus	B-Organism
parasuis	I-Organism
,	O
Neisseria	B-Organism
meningitidis	I-Organism
and	O
N	B-Organism
.	I-Organism
gonorrhoeae	I-Organism
.	O

In	O
the	O
lungs	O
,	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
causes	O
extensive	O
tissue	O
damage	O
that	O
could	O
result	O
from	O
the	O
combined	O
action	O
of	O
Apx	O
toxins	O
and	O
secreted	O
proteases	O
[	O
48	O
]	O
.	O

Adhesion	O
processes	O
are	O
essential	O
for	O
the	O
establishment	O
of	O
bacterial	O
infections	O
.	O

The	O
apf	O
promoter	O
was	O
shown	O
to	O
be	O
active	O
in	O
vitro	O
during	O
adhesion	O
experiments	O
to	O
primary	O
epithelial	O
cells	O
,	O
and	O
in	O
vivo	O
early	O
in	O
the	O
infection	O
process	O
[	O
49	O
]	O
.	O

Here	O
,	O
we	O
report	O
that	O
genes	O
apfB	B-Protein
and	O
apfC	B-Protein
,	O
coding	O
for	O
the	O
type	O
IV	O
pilin	O
biogenesis	O
proteins	O
ApfB	B-Protein
and	O
ApfC	B-Protein
,	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
during	O
natural	O
infection	O
by	O
an	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
isolate	O
.	O

Type	O
IV	O
fimbriae	O
,	O
although	O
primarily	O
involved	O
in	O
promoting	O
the	O
attachment	O
to	O
biotic	O
or	O
abiotic	O
surfaces	O
,	O
are	O
also	O
involved	O
in	O
many	O
other	O
processes	O
,	O
including	O
DNA	O
uptake	O
,	O
biofilm	O
formation	O
and	O
twitching	O
mobility	O
[	O
50	O
]	O
.	O

Interestingly	O
,	O
another	O
gene	O
that	O
could	O
share	O
similar	O
functions	O
was	O
also	O
up	O
-	O
regulated	O
.	O

APL	B-Protein
_	I-Protein
0220	I-Protein
codes	O
for	O
a	O
member	O
of	O
the	O
CscG	B-Protein
superfamily	O
of	O
proteins	O
involved	O
in	O
the	O
assembly	O
of	O
curli	O
fibers	O
.	O

Curli	O
fibers	O
are	O
important	O
for	O
biofilm	O
formation	O
in	O
numerous	O
pathogens	O
,	O
including	O
E	B-Organism
.	I-Organism
coli	I-Organism
and	O
Salmonella	B-Organism
enteritidis	I-Organism
,	O
and	O
are	O
involved	O
in	O
the	O
first	O
steps	O
of	O
attachment	O
.	O

Curli	O
-	O
deficient	O
strains	O
tend	O
to	O
form	O
flat	O
biofilms	O
[	O
51	O
]	O
.	O

CscG	B-Protein
is	O
the	O
outer	O
membrane	O
protein	O
that	O
is	O
responsible	O
for	O
the	O
secretion	O
of	O
the	O
curli	O
structural	O
subunits	O
,	O
and	O
the	O
cscG	B-Protein
gene	O
is	O
generally	O
found	O
within	O
an	O
operon	O
composed	O
of	O
the	O
genes	O
cscDEFG	B-Protein
.	O

In	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
L20	I-Organism
,	O
this	O
organization	O
is	O
not	O
respected	O
:	O
APL	B-Protein
_	I-Protein
0220	I-Protein
seems	O
to	O
form	O
an	O
operon	O
with	O
the	O
genes	O
APL	B-Protein
_	I-Protein
0221	I-Protein
and	O
APL	B-Protein
_	I-Protein
0222	I-Protein
.	O

Neither	O
of	O
these	O
two	O
other	O
genes	O
shares	O
homology	O
with	O
known	O
csc	O
genes	O
.	O

Finally	O
,	O
the	O
kpsF	B-Protein
gene	O
,	O
coding	O
for	O
an	O
arabinose	O
-	O
5	O
-	O
phosphate	O
isomerase	O
,	O
should	O
also	O
be	O
mentioned	O
since	O
it	O
is	O
involved	O
in	O
the	O
pathway	O
responsible	O
for	O
the	O
synthesis	O
of	O
2	B-Chemical
-	I-Chemical
keto	I-Chemical
-	I-Chemical
3deozyoctulosonic	I-Chemical
acid	I-Chemical
(	O
Kdo	B-Chemical
)	O
,	O
which	O
is	O
present	O
in	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
LPS	B-Chemical
core	O
oligosaccharide	O
[	O
52	O
]	O
and	O
capsule	O
of	O
serotype	B-Organism
5	I-Organism
[	O
53	O
]	O
.	O

Studies	O
in	O
our	O
laboratory	O
have	O
shown	O
that	O
it	O
is	O
the	O
core	O
oligosaccharide	O
that	O
is	O
responsible	O
for	O
the	O
previously	O
observed	O
LPS	B-Chemical
-	O
associated	O
adhesion	O
mechanism	O
[	O
54	O
,	O
55	O
]	O
.	O

Two	O
operon	O
structures	O
that	O
were	O
up	O
-	O
regulated	O
in	O
vivo	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
could	O
give	O
some	O
insight	O
into	O
the	O
environment	O
the	O
bacteria	O
encounters	O
in	O
the	O
host	O
,	O
and	O
are	O
the	O
main	O
reason	O
why	O
the	O
"	O
Transport	O
and	O
Binding	O
Protein	O
"	O
functional	O
class	O
is	O
so	O
prominently	O
represented	O
in	O
our	O
list	O
of	O
up	O
-	O
regulated	O
genes	O
.	O

Genes	O
from	O
the	O
maltose	B-Regulon-operon
operon	I-Regulon-operon
,	I-Regulon-operon
involved	O
in	O
the	O
uptake	O
and	O
catabolism	O
of	O
maltose	B-Chemical
[	O
56	O
]	O
,	O
were	O
up	O
-	O
regulated	O
:	O
the	O
genes	O
malP	B-Protein
,	O
malK	B-Protein
,	O
malF	O
,	O
malG	B-Protein
,	O
malQ	B-Protein
and	O
a	O
malM	B-Protein
homolog	O
(	O
APL	B-Protein
_	I-Protein
1234	I-Protein
)	O
were	O
actively	O
transcribed	O
in	O
the	O
host	O
(	O
average	O
fold	O
increase	O
of	O
3	O
.	O
1	O
)	O
,	O
and	O
gene	O
lamB1	B-Protein
,	O
which	O
codes	O
for	O
a	O
maltoporin	B-Protein
,	O
showed	O
a	O
5	O
.	O
14	O
fold	O
change	O
in	O
the	O
only	O
hybridization	O
in	O
which	O
the	O
reporter	O
wasn	O
'	O
t	O
manually	O
flagged	O
because	O
of	O
signal	O
saturation	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
the	O
mal	O
genes	O
are	O
essential	O
for	O
the	O
transport	O
and	O
utilization	O
of	O
maltose	B-Chemical
and	O
maltodextrin	B-Chemical
[	O
56	O
]	O
.	O

Although	O
it	O
is	O
not	O
known	O
whether	O
maltose	B-Chemical
or	O
maltodextrin	B-Chemical
are	O
readily	O
available	O
as	O
carbohydrate	O
sources	O
in	O
mammalian	O
lungs	O
,	O
it	O
was	O
previously	O
shown	O
that	O
maltodextrin	B-Chemical
utilization	O
is	O
important	O
for	O
the	O
colonization	O
of	O
the	O
oro	O
-	O
pharynx	O
in	O
Group	B-Organism
A	I-Organism
Streptococcus	I-Organism
[	O
57	O
,	O
58	O
]	O
.	O

It	O
was	O
also	O
recently	O
shown	O
that	O
catabolism	O
of	O
maltose	O
provides	O
a	O
competitive	O
advantage	O
to	O
pathogenic	O
and	O
commensal	O
E	B-Organism
.	I-Organism
coli	I-Organism
strains	O
in	O
the	O
gut	O
[	O
59	O
]	O
.	O

Meanwhile	O
,	O
genes	O
from	O
the	O
ula	O
operon	O
(	O
ulaDCAG	O
)	O
,	O
coding	O
for	O
a	O
PTS	O
transport	O
system	O
for	O
ascorbate	O
,	O
showed	O
an	O
average	O
fold	O
change	O
of	O
2	O
.	O
76	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
these	O
genes	O
are	O
responsible	O
for	O
the	O
transport	O
and	O
utilization	O
of	O
ascorbate	O
in	O
anaerobic	O
conditions	O
[	O
60	O
]	O
.	O

While	O
ascorbate	O
use	O
has	O
not	O
been	O
linked	O
to	O
bacterial	O
virulence	O
before	O
,	O
it	O
has	O
been	O
shown	O
on	O
multiple	O
occasions	O
that	O
genes	O
involved	O
in	O
anaerobic	O
metabolism	O
are	O
important	O
for	O
the	O
virulence	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
[	O
10	O
,	O
61	O
-	O
63	O
]	O
.	O

In	O
pigs	B-Organism
lungs	O
,	O
following	O
extensive	O
infection	O
and	O
tissue	O
destruction	O
,	O
the	O
bacteria	O
are	O
likely	O
to	O
face	O
oxygen	O
deprivation	O
.	O

A	O
few	O
other	O
genes	O
that	O
are	O
involved	O
in	O
anaerobic	O
metabolism	O
were	O
up	O
-	O
regulated	O
.	O

The	O
hybB	B-Protein
gene	O
codes	O
for	O
hydrogenase	B-Protein
2	I-Protein
,	O
a	O
nickel	O
-	O
containing	O
enzyme	O
thought	O
to	O
be	O
responsible	O
for	O
H2	O
-	O
dependent	O
reduction	O
of	O
quinone	O
under	O
anaerobic	O
conditions	O
[	O
64	O
]	O
.	O

The	O
phosphoenolpyruvate	B-Chemical
carboxylase	O
and	O
fumarate	B-Chemical
reductase	O
subunit	O
C	O
,	O
respectively	O
encoded	O
by	O
genes	O
pepC	B-Protein
and	O
frdC	B-Protein
,	O
are	O
also	O
required	O
during	O
anaerobic	O
growth	O
.	O

However	O
,	O
other	O
genes	O
related	O
to	O
anaerobic	O
metabolism	O
and	O
that	O
were	O
previously	O
shown	O
to	O
be	O
important	O
in	O
vivo	O
[	O
61	O
-	O
63	O
]	O
,	O
namely	O
dmsA	B-Protein
,	O
aspA	B-Protein
and	O
hlyX	B-Protein
,	O
were	O
not	O
found	O
in	O
our	O
list	O
of	O
differentially	O
expressed	O
genes	O
.	O

The	O
dmsA	B-Protein
gene	O
did	O
show	O
a	O
mean	O
fold	O
change	O
of	O
1	O
.	O
60	O
over	O
two	O
successful	O
hybridizations	O
,	O
but	O
hlyX	B-Protein
had	O
a	O
mean	O
fold	O
change	O
of	O
-	O
1	O
.	O
66	O
over	O
three	O
successful	O
hybridizations	O
.	O

However	O
,	O
neither	O
of	O
these	O
changes	O
were	O
deemed	O
statistically	O
significant	O
.	O

This	O
suggests	O
that	O
HlyX	B-Protein
is	O
probably	O
not	O
highly	O
expressed	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
caused	O
by	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

Accordingly	O
,	O
of	O
17	O
genes	O
in	O
our	O
list	O
that	O
were	O
previously	O
shown	O
to	O
be	O
up	O
-	O
regulated	O
directly	O
or	O
indirectly	O
by	O
HlyX	B-Protein
under	O
anaerobiosis	O
,	O
12	O
(	O
dnaX	B-Protein
,	O
visC	B-Protein
,	O
dsbC	B-Protein
,	O
mazG	B-Protein
,	O
amiB	B-Protein
,	O
cpxC	B-Protein
,	O
dacA	B-Protein
,	O
rpoZ	B-Protein
,	O
APL	B-Protein
_	I-Protein
0086	I-Protein
,	O
APL	B-Protein
_	I-Protein
1597	I-Protein
,	O
APL	B-Protein
_	I-Protein
1802	I-Protein
and	O
APL	B-Protein
_	I-Protein
2043	I-Protein
)	O
were	O
down	O
-	O
regulated	O
in	O
vivo	O
,	O
while	O
only	O
5	O
(	O
sohB	B-Protein
,	O
mglB	B-Protein
,	O
hybB	B-Protein
,	O
APL	B-Protein
_	I-Protein
0096	I-Protein
and	O
APL	B-Protein
_	I-Protein
0920	I-Protein
)	O
were	O
up	O
-	O
regulated	O
.	O

Two	O
genes	O
coding	O
for	O
proteins	O
with	O
regulatory	O
functions	O
were	O
found	O
to	O
be	O
up	O
-	O
regulated	O
.	O

The	O
phoR	B-Protein
gene	O
codes	O
for	O
the	O
phosphate	O
regulon	O
PhoR	B-Protein
sensing	O
protein	O
,	O
located	O
in	O
the	O
inner	O
membrane	O
.	O

In	O
E	B-Organism
.	I-Organism
coli	I-Organism
,	O
this	O
protein	O
is	O
part	O
of	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
that	O
responds	O
to	O
periplasmic	O
orthophosphate	O
concentration	O
variations	O
[	O
65	O
]	O
.	O

The	O
phosphate	B-Regulon-operon
regulon	I-Regulon-operon
in	O
E	B-Organism
.	I-Organism
coli	I-Organism
controls	O
the	O
expression	O
of	O
at	O
least	O
47	O
genes	O
,	O
and	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
virulence	O
.	O

Numerous	O
phoR	B-Protein
,	O
phoB	B-Protein
(	O
the	O
other	O
component	O
of	O
the	O
two	O
-	O
component	O
system	O
)	O
and	O
pts	O
(	O
the	O
phosphate	O
transport	O
genes	O
genetically	O
and	O
functionally	O
linked	O
to	O
phoBR	B-Protein
)	O
mutants	O
were	O
found	O
to	O
be	O
less	O
virulent	O
or	O
avirulent	O
when	O
compared	O
to	O
wild	O
-	O
type	O
strains	O
,	O
with	O
phenotypes	O
such	O
as	O
increased	O
sensitivity	O
to	O
serum	O
,	O
acidity	O
and	O
cationic	O
antimicrobial	O
peptides	O
[	O
66	O
]	O
and	O
reduced	O
colonization	O
[	O
67	O
]	O
.	O

A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
strain	I-Organism
L20	I-Organism
harbours	O
an	O
operon	O
composed	O
of	O
the	O
genes	O
ptsSCAB	B-Protein
-	O
phoBR	B-Protein
.	O

Although	O
only	O
phoR	B-Protein
was	O
deemed	O
significantly	O
up	O
-	O
regulated	O
,	O
all	O
other	O
genes	O
showed	O
levels	O
of	O
variations	O
ranging	O
from	O
a	O
1	O
.	O
5	O
-	O
to	O
2	O
-	O
fold	O
increase	O
.	O

Since	O
it	O
seems	O
unlikely	O
that	O
porcine	O
lungs	O
are	O
devoid	O
of	O
phosphate	O
,	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
PhoBR	B-Protein
system	O
might	O
be	O
important	O
in	O
order	O
to	O
adapt	O
correctly	O
to	O
changing	O
conditions	O
inside	O
the	O
host	O
.	O

Another	O
gene	O
coding	O
for	O
a	O
member	O
of	O
a	O
two	O
-	O
component	O
system	O
was	O
up	O
-	O
regulated	O
:	O
gene	O
APL	B-Protein
_	I-Protein
0628	I-Protein
codes	O
for	O
a	O
cpxA	B-Protein
homolog	O
.	O

In	O
different	O
EPEC	B-Organism
and	O
UPEC	B-Organism
strains	O
,	O
the	O
CpxAR	B-Protein
system	O
was	O
found	O
to	O
important	O
for	O
the	O
correct	O
folding	O
and	O
assembly	O
of	O
pili	O
subunits	O
[	O
68	O
-	O
70	O
]	O
.	O

However	O
,	O
the	O
L20	B-Organism
cpxA	B-Protein
homolog	O
seems	O
to	O
either	O
be	O
truncated	O
,	O
or	O
found	O
on	O
two	O
separate	O
gene	O
loci	O
.	O

This	O
seems	O
to	O
be	O
the	O
case	O
since	O
cpxA	B-Protein
is	O
found	O
down	O
-	O
stream	O
of	O
cpxR	B-Protein
(	O
APL	B-Protein
_	I-Protein
0629	I-Protein
)	O
,	O
and	O
gene	O
APL	B-Protein
_	I-Protein
0627	I-Protein
is	O
a	O
hypothetical	O
two	O
-	O
component	O
sensor	O
protein	O
with	O
a	O
histidine	O
-	O
kinase	O
domain	O
.	O

e	O
)	O
Up	O
-	O
regulated	O
genes	O
which	O
are	O
conserved	O
and	O
predicted	O
to	O
code	O
for	O
OMPs	O
or	O
lipoproteins	O

The	O
main	O
goal	O
of	O
our	O
experiment	O
was	O
to	O
identify	O
genes	O
that	O
were	O
expressed	O
in	O
vivo	O
during	O
infection	O
of	O
the	O
natural	O
host	O
.	O

We	O
were	O
also	O
interested	O
by	O
genes	O
showing	O
high	O
-	O
level	O
of	O
sequence	O
conservation	O
among	O
different	O
field	O
and	O
reference	O
strains	O
[	O
25	O
]	O
,	O
and	O
coding	O
for	O
proteins	O
predicted	O
to	O
localize	O
to	O
the	O
outer	O
membrane	O
[	O
71	O
]	O
.	O

Three	O
genes	O
satisfied	O
those	O
criteria	O
:	O
two	O
that	O
are	O
coding	O
for	O
outer	O
membrane	O
proteins	O
(	O
APL	B-Protein
_	I-Protein
0959	I-Protein
and	O
irp	B-Protein
)	O
,	O
and	O
one	O
coding	O
for	O
a	O
lipoprotein	O
(	O
APL	B-Protein
_	I-Protein
0920	I-Protein
)	O
(	O
see	O
Additional	O
file	O
1	O
)	O
.	O

The	O
irp	B-Protein
(	O
iron	B-Protein
responsive	I-Protein
protein	I-Protein
)	O
gene	O
codes	O
for	O
a	O
predicted	O
TonB	B-Protein
-	O
dependant	O
receptor	O
,	O
possibly	O
involved	O
in	O
hemin	O
transport	O
.	O

However	O
,	O
since	O
this	O
was	O
deduced	O
from	O
sequence	O
homologies	O
,	O
the	O
real	O
function	O
of	O
irp	B-Protein
in	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
cannot	O
be	O
reliably	O
inferred	O
,	O
but	O
it	O
is	O
conserved	O
in	O
various	O
bacterial	O
pathogens	O
.	O

Interestingly	O
,	O
the	O
irp	B-Protein
gene	O
is	O
located	O
directly	O
next	O
to	O
APL	B-Protein
_	I-Protein
0920	I-Protein
,	O
a	O
conserved	O
lipoprotein	O
in	O
the	O
L20	B-Organism
genome	O
although	O
they	O
are	O
transcribed	O
in	O
opposite	O
directions	O
.	O

The	O
protein	O
sequence	O
deduced	O
from	O
the	O
APL	B-Protein
_	I-Protein
0920	I-Protein
gene	O
sequence	O
is	O
present	O
in	O
all	O
sequenced	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
strains	O
and	O
in	O
Mannheimia	B-Organism
haemolytica	I-Organism
PHL213	I-Organism
,	O
but	O
no	O
other	O
strong	O
homologies	O
can	O
be	O
found	O
in	O
other	O
bacterial	O
species	O
.	O

The	O
APL	B-Protein
_	I-Protein
0959	I-Protein
gene	O
codes	O
for	O
a	O
hypothetical	O
hemagglutinin	B-Protein
/	O
hemolysin	B-Protein
-	O
like	O
outer	O
membrane	O
protein	O
.	O

The	O
protein	O
sequence	O
deduced	O
from	O
the	O
gene	O
sequence	O
shares	O
approximately	O
30	O
%	O
identity	O
with	O
different	O
large	O
sections	O
of	O
the	O
filamentous	O
hemagglitinin	B-Protein
/	O
adhesin	B-Protein
(	O
FhaB	B-Protein
)	O
from	O
bacteria	O
of	O
the	O
Bordetella	B-Organism
genus	O
,	O
which	O
also	O
colonize	O
the	O
respiratory	O
tract	O
of	O
various	O
mammalian	O
hosts	O
.	O

While	O
it	O
was	O
first	O
identified	O
for	O
its	O
hemagglutination	B-Protein
properties	O
[	O
72	O
]	O
,	O
FHA	O
can	O
bind	O
carbohydrates	O
,	O
heparan	B-Chemical
sulphate	I-Chemical
and	O
integrin	B-Protein
[	O
73	O
]	O
.	O

It	O
is	O
the	O
most	O
important	O
adhesin	B-Protein
in	O
B	B-Organism
.	I-Organism
pertussis	I-Organism
,	O
and	O
deletion	O
of	O
FHA	O
in	O
B	B-Organism
.	I-Organism
bronchiseptica	I-Organism
,	O
another	O
important	O
swine	B-Organism
respiratory	O
pathogen	O
,	O
caused	O
lower	O
colonization	O
than	O
the	O
wild	O
-	O
type	O
strain	O
at	O
all	O
respiratory	O
tract	O
sites	O
tested	O
with	O
was	O
unable	O
to	O
cause	O
disease	O
[	O
74	O
]	O
.	O

The	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
FHA	O
homolog	O
is	O
conserved	O
amongst	O
all	O
field	O
and	O
reference	O
strains	O
previously	O
tested	O
[	O
25	O
]	O
,	O
and	O
was	O
predicted	O
to	O
locate	O
to	O
the	O
outer	O
membrane	O
[	O
71	O
]	O
.	O

In	O
B	B-Organism
.	I-Organism
bronchiseptica	I-Organism
,	O
FhaB	B-Protein
is	O
believed	O
to	O
be	O
important	O
early	O
in	O
the	O
infection	O
process	O
in	O
order	O
to	O
allow	O
colonization	O
of	O
the	O
ciliated	O
epithelial	O
cells	O
of	O
the	O
upper	O
respiratory	O
tract	O
.	O

In	O
Histophilus	B-Organism
somni	I-Organism
,	O
the	O
FhaB	B-Protein
homolog	O
is	O
thought	O
to	O
also	O
have	O
an	O
important	O
role	O
in	O
biofilm	O
formation	O
in	O
cases	O
of	O
myocarditis	O
caused	O
by	O
this	O
micro	O
-	O
organism	O
[	O
75	O
]	O
.	O

Up	O
-	O
regulation	O
of	O
the	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
fhaB	B-Protein
homolog	O
during	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
hints	O
at	O
a	O
similar	O
role	O
for	O
this	O
adhesin	O
in	O
the	O
establishment	O
of	O
pleuropneumonia	O
.	O

Surprisingly	O
,	O
this	O
gene	O
was	O
not	O
identified	O
as	O
up	O
-	O
regulated	O
in	O
previous	O
adhesion	O
experiments	O
performed	O
in	O
our	O
lab	O
[	O
9	O
]	O
,	O
and	O
it	O
even	O
showed	O
a	O
slight	O
,	O
although	O
not	O
significant	O
,	O
down	O
-	O
regulation	O
when	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
adhered	O
to	O
immortalized	O
lung	O
epithelial	O
cells	O
.	O

This	O
can	O
either	O
reflect	O
differences	O
in	O
regulatory	O
events	O
between	O
a	O
freshly	O
isolated	O
field	O
strain	O
and	O
a	O
well	O
-	O
conserved	O
and	O
characterized	O
laboratory	O
strain	O
,	O
or	O
simply	O
that	O
in	O
vitro	O
experiments	O
,	O
however	O
carefully	O
designed	O
they	O
may	O
be	O
,	O
can	O
never	O
really	O
completely	O
reproduce	O
complex	O
in	O
vivo	O
environments	O
.	O

Despite	O
years	O
of	O
research	O
,	O
an	O
efficient	O
cross	O
-	O
serotype	O
vaccine	O
that	O
can	O
prevent	O
porcine	O
pleuropneumonia	O
has	O
yet	O
to	O
be	O
successfully	O
produced	O
.	O

To	O
generate	O
a	O
vaccine	O
that	O
provides	O
good	O
cross	O
-	O
serotype	O
protection	O
against	O
porcine	O
pleuropneumonia	O
,	O
one	O
would	O
most	O
probably	O
have	O
to	O
include	O
antigens	O
that	O
are	O
conserved	O
amongst	O
all	O
serotypes	O
that	O
the	O
host	O
could	O
encounter	O
and	O
be	O
surface	O
-	O
exposed	O
.	O

The	O
three	O
proteins	O
that	O
are	O
encoded	O
by	O
genes	O
fhaB	B-Protein
,	O
irp	B-Protein
and	O
APL	B-Protein
_	I-Protein
0920	I-Protein
have	O
all	O
these	O
features	O
,	O
and	O
might	O
therefore	O
represent	O
good	O
candidates	O
to	O
include	O
in	O
future	O
cross	O
-	O
serotype	O
vaccines	O
against	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

FHA	O
of	O
B	B-Organism
.	I-Organism
pertussis	I-Organism
is	O
present	O
in	O
various	O
combined	O
diphteria	O
-	O
tetanus	O
-	O
pertussis	O
(	O
dTpa	O
)	O
acellular	O
vaccines	O
.	O

These	O
vaccines	O
have	O
been	O
successfully	O
used	O
to	O
prevent	O
whopping	O
cough	O
and	O
have	O
contributed	O
to	O
a	O
considerable	O
decrease	O
in	O
the	O
number	O
of	O
cases	O
registered	O
per	O
year	O
[	O
76	O
]	O
.	O

Thus	O
the	O
A	B-Organism
.	I-Organism
pleuropneumonie	I-Organism
FhaB	B-Protein
homolog	O
represents	O
an	O
excellent	O
candidate	O
to	O
include	O
in	O
a	O
future	O
pleuropneumonia	O
vaccine	O
that	O
could	O
actually	O
lead	O
to	O
efficient	O
protection	O
against	O
this	O
important	O
swine	B-Organism
pathogen	O
.	O

Conclusions	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
study	O
represents	O
the	O
first	O
and	O
only	O
genome	O
-	O
wide	O
in	O
vivo	O
gene	O
expression	O
experiment	O
to	O
be	O
conducted	O
with	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
in	O
its	O
natural	O
host	O
,	O
the	O
pig	B-Organism
,	O
following	O
a	O
natural	O
infection	O
.	O

Of	O
the	O
150	O
genes	O
that	O
we	O
could	O
identify	O
as	O
differentially	O
expressed	O
,	O
72	O
showed	O
greater	O
levels	O
of	O
expression	O
in	O
vivo	O
at	O
the	O
end	O
of	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
than	O
in	O
a	O
rich	O
culture	O
medium	O
,	O
while	O
78	O
were	O
repressed	O
.	O

By	O
comparing	O
our	O
results	O
to	O
those	O
obtained	O
following	O
comparative	O
genomics	O
and	O
proteomics	O
experiments	O
,	O
we	O
were	O
able	O
to	O
identify	O
three	O
genes	O
that	O
were	O
conserved	O
in	O
tested	O
reference	O
strains	O
and	O
in	O
fresh	O
field	O
isolates	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
,	O
and	O
these	O
were	O
also	O
predicted	O
to	O
code	O
for	O
outer	O
membrane	O
proteins	O
or	O
lipoproteins	O
.	O

These	O
three	O
genes	O
,	O
namely	O
fhaB	B-Protein
(	O
APL	B-Protein
_	I-Protein
0959	I-Protein
)	O
,	O
irp	B-Protein
(	O
APL	B-Protein
_	I-Protein
0919	I-Protein
)	O
and	O
APL	B-Protein
_	I-Protein
0920	I-Protein
,	O
could	O
all	O
represent	O
excellent	O
candidates	O
for	O
the	O
development	O
of	O
a	O
protective	O
cross	O
-	O
serotype	O
subunit	O
vaccine	O
against	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
.	O

While	O
our	O
results	O
can	O
help	O
decipher	O
some	O
of	O
the	O
adaptations	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
has	O
to	O
make	O
once	O
it	O
infects	O
the	O
host	O
,	O
much	O
more	O
research	O
is	O
necessary	O
in	O
order	O
to	O
understand	O
the	O
whole	O
picture	O
of	O
the	O
disease	O
.	O

The	O
acute	O
stage	O
and	O
the	O
chronic	O
stage	O
of	O
the	O
disease	O
are	O
probably	O
highly	O
different	O
conditions	O
,	O
and	O
it	O
would	O
be	O
interesting	O
in	O
future	O
works	O
to	O
compare	O
our	O
present	O
data	O
with	O
the	O
transcriptomic	O
profile	O
of	O
A	B-Organism
.	I-Organism
pleuropneumoniae	I-Organism
during	O
a	O
chronic	O
infection	O
.	O

Identification	O
of	O
the	O
Regulatory	O
Logic	O
Controlling	O
Salmonella	B-Organism
Pathoadaptation	O
by	O
the	O
SsrA	B-Protein
-	O
SsrB	B-Protein
Two	O
-	O
Component	O
System	O

Sequence	O
data	O
from	O
the	O
past	O
decade	O
has	O
laid	O
bare	O
the	O
significance	O
of	O
horizontal	O
gene	O
transfer	O
in	O
creating	O
genetic	O
diversity	O
in	O
the	O
bacterial	O
world	O
.	O

Regulatory	O
evolution	O
,	O
in	O
which	O
non	O
-	O
coding	O
DNA	O
is	O
mutated	O
to	O
create	O
new	O
regulatory	O
nodes	O
,	O
also	O
contributes	O
to	O
this	O
diversity	O
to	O
allow	O
niche	O
adaptation	O
and	O
the	O
evolution	O
of	O
pathogenesis	O
.	O

To	O
survive	O
in	O
the	O
host	O
environment	O
,	O
Salmonella	B-Organism
enterica	I-Organism
uses	O
a	O
type	O
III	O
secretion	O
system	O
and	O
effector	O
proteins	O
,	O
which	O
are	O
activated	O
by	O
the	O
SsrA	B-Protein
-	O
SsrB	B-Protein
two	O
-	O
component	O
system	O
in	O
response	O
to	O
the	O
host	O
environment	O
.	O

To	O
better	O
understand	O
the	O
phenomenon	O
of	O
regulatory	O
evolution	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
,	O
we	O
defined	O
the	O
SsrB	B-Protein
regulon	O
and	O
asked	O
how	O
this	O
transcription	O
factor	O
interacts	O
with	O
the	O
cis	O
-	O
regulatory	O
region	O
of	O
target	O
genes	O
.	O

Using	O
ChIP	O
-	O
on	O
-	O
chip	O
,	O
cDNA	O
hybridization	O
,	O
and	O
comparative	O
genomics	O
analyses	O
,	O
we	O
describe	O
the	O
SsrB	B-Protein
-	O
dependent	O
regulon	O
of	O
ancestral	O
and	O
horizontally	O
acquired	O
genes	O
.	O

Further	O
,	O
we	O
used	O
a	O
genetic	O
screen	O
and	O
computational	O
analyses	O
integrating	O
experimental	O
data	O
from	O
S	B-Organism
.	I-Organism
enterica	I-Organism
and	O
sequence	O
data	O
from	O
an	O
orthologous	O
regulatory	O
system	O
in	O
the	O
insect	O
endosymbiont	O
,	O
Sodalis	B-Organism
glossinidius	I-Organism
,	O
to	O
identify	O
the	O
conserved	O
yet	O
flexible	O
palindrome	O
sequence	O
that	O
defines	O
DNA	O
recognition	O
by	O
SsrB	B-Protein
.	O

Mutational	O
analysis	O
of	O
a	O
representative	O
promoter	O
validated	O
this	O
palindrome	O
as	O
the	O
minimal	O
architecture	O
needed	O
for	O
regulatory	O
input	O
by	O
SsrB	B-Protein
.	O

These	O
data	O
provide	O
a	O
high	O
-	O
resolution	O
map	O
of	O
a	O
regulatory	O
network	O
and	O
the	O
underlying	O
logic	O
enabling	O
pathogen	O
adaptation	O
to	O
a	O
host	O
.	O

Introduction	O

Precise	O
gene	O
regulation	O
is	O
crucial	O
to	O
the	O
successful	O
activation	O
and	O
execution	O
of	O
virulence	O
programs	O
for	O
all	O
pathogenic	O
organisms	O
.	O

The	O
acquisition	O
of	O
genes	O
through	O
horizontal	O
gene	O
transfer	O
,	O
a	O
widespread	O
means	O
of	O
bacterial	O
evolution	O
[	O
1	O
]	O
,	O
requires	O
a	O
process	O
to	O
integrate	O
new	O
coding	O
sequence	O
into	O
pre	O
-	O
existing	O
regulatory	O
circuitry	O
.	O

Silencing	O
of	O
horizontally	O
-	O
acquired	O
genes	O
by	O
DNA	O
binding	O
proteins	O
like	O
H	B-Protein
-	I-Protein
NS	I-Protein
is	O
one	O
way	O
some	O
incoming	O
genes	O
are	O
initially	O
controlled	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
,	O
which	O
can	O
then	O
be	O
subject	O
to	O
regulatory	O
evolution	O
by	O
mutating	O
cis	O
-	O
regulatory	O
operator	O
regions	O
to	O
select	O
for	O
optional	O
gene	O
expression	O
.	O

The	O
eventual	O
promoter	O
architecture	O
selected	O
to	O
deploy	O
virulence	O
genes	O
is	O
often	O
modular	O
and	O
should	O
reflect	O
a	O
design	O
that	O
maximizes	O
organismal	O
fitness	O
while	O
limiting	O
fitness	O
trade	O
-	O
offs	O
and	O
antagonistic	O
pleiotropy	O
[	O
4	O
]	O
.	O

Both	O
simulated	O
[	O
5	O
]	O
and	O
functional	O
experiments	O
[	O
6	O
]	O
,	O
[	O
7	O
]	O
show	O
that	O
mutation	O
of	O
cis	O
-	O
regulatory	O
sequences	O
can	O
be	O
rapid	O
,	O
and	O
that	O
plasticity	O
-	O
the	O
degree	O
to	O
which	O
regulatory	O
mutation	O
can	O
perturb	O
the	O
larger	O
gene	O
network	O
-	O
can	O
be	O
well	O
tolerated	O
in	O
bacterial	O
systems	O
.	O

Promoter	O
architectures	O
that	O
control	O
quantitative	O
traits	O
such	O
as	O
bacterial	O
virulence	O
are	O
,	O
in	O
fact	O
,	O
modular	O
and	O
evolvable	O
[	O
8	O
]	O
.	O

For	O
instance	O
,	O
Salmonella	B-Organism
enterica	I-Organism
has	O
a	O
multi	O
-	O
faceted	O
pathogenic	O
strategy	O
fine	O
-	O
tuned	O
by	O
several	O
transcriptional	O
regulators	O
.	O

Intracellular	O
survival	O
and	O
persistence	O
of	O
Salmonella	B-Organism
requires	O
a	O
type	O
III	O
secretion	O
system	O
(	O
T3SS	O
)	O
encoded	O
in	O
a	O
horizontally	O
-	O
acquired	O
genomic	O
island	O
called	O
Salmonella	B-Organism
Pathogenicity	O
Island	O
-	O
2	O
(	O
SPI	O
-	O
2	O
)	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

T3SS	O
are	O
complex	O
secretion	O
machines	O
that	O
deliver	O
bacterial	O
effector	O
proteins	O
directly	O
into	O
host	O
cells	O
through	O
an	O
injectisome	O
during	O
infection	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
.	O

Several	O
ancestral	O
regulators	O
control	O
the	O
genes	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
including	O
the	O
two	O
-	O
component	O
systems	O
EnvZ	B-Protein
-	O
OmpR	B-Protein
and	O
PhoQ	B-Protein
-	O
PhoP	B-Protein
,	O
and	O
the	O
regulatory	O
protein	O
SlyA	B-Protein
[	O
13	O
]	O
.	O

SsrA	B-Protein
-	O
SsrB	B-Protein
is	O
another	O
two	O
-	O
component	O
regulatory	O
system	O
co	O
-	O
inherited	O
by	O
genetic	O
linkage	O
with	O
the	O
SPI	O
-	O
2	O
locus	O
that	O
is	O
essential	O
for	O
gene	O
expression	O
in	O
SPI	O
-	O
2	O
[	O
14	O
]	O
-	O
[	O
16	O
]	O
.	O

SsrA	B-Protein
is	O
a	O
sensor	O
kinase	O
activated	O
in	O
the	O
host	O
environment	O
that	O
phosphorylates	O
the	O
SsrB	B-Protein
response	O
regulator	O
to	O
create	O
an	O
active	O
transcription	O
factor	O
needed	O
for	O
spatiotemporal	O
control	O
of	O
virulence	O
genes	O
[	O
13	O
]	O
,	O
[	O
17	O
]	O
.	O

In	O
the	O
Salmonella	B-Organism
genus	O
,	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
is	O
found	O
only	O
in	O
pathogenic	O
serotypes	O
of	O
Salmonella	B-Organism
enterica	I-Organism
that	O
infect	O
warm	O
-	O
blooded	O
animals	O
and	O
is	O
absent	O
from	O
Salmonella	B-Organism
bongori	I-Organism
,	O
which	O
colonizes	O
cold	O
-	O
blooded	O
animals	O
[	O
18	O
]	O
.	O

It	O
is	O
generally	O
accepted	O
that	O
SPI	O
-	O
2	O
was	O
acquired	O
by	O
Salmonella	B-Organism
enterica	I-Organism
after	O
divergence	O
from	O
S	B-Organism
.	I-Organism
bongori	I-Organism
,	O
providing	O
a	O
useful	O
pedigree	O
to	O
study	O
regulatory	O
evolution	O
influenced	O
by	O
SsrB	B-Protein
.	O

We	O
recently	O
demonstrated	O
the	O
evolutionary	O
significance	O
of	O
cis	O
-	O
regulatory	O
mutations	O
for	O
pathoadaptation	O
of	O
Salmonella	B-Organism
enterica	I-Organism
serovar	I-Organism
Typhimurium	I-Organism
(	O
S	B-Organism
.	I-Organism
Typhimurium	I-Organism
)	O
to	O
an	O
animal	O
host	O
[	O
19	O
]	O
.	O

Our	O
focus	O
was	O
on	O
SsrB	B-Protein
because	O
of	O
its	O
broad	O
conservation	O
among	O
the	O
pathogenic	O
Salmonellae	B-Organism
and	O
its	O
essentiality	O
for	O
animal	O
infection	O
,	O
suggesting	O
it	O
coordinates	O
fundamental	O
aspects	O
of	O
Salmonella	B-Organism
pathogenesis	O
beyond	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
.	O

In	O
this	O
study	O
we	O
investigated	O
how	O
regulatory	O
evolution	O
assimilates	O
horizontally	O
acquired	O
and	O
ancestral	O
genes	O
into	O
the	O
SsrB	B-Protein
regulon	O
on	O
a	O
genome	O
-	O
wide	O
scale	O
using	O
an	O
integrated	O
set	O
of	O
experimental	O
methods	O
.	O

Combining	O
our	O
data	O
with	O
previous	O
biochemical	O
work	O
,	O
along	O
with	O
comparative	O
genomic	O
analyses	O
with	O
an	O
orthologous	O
T3SS	O
-	O
encoding	O
genomic	O
island	O
in	O
the	O
tsetse	O
fly	O
endosymbiont	O
,	O
Sodalis	B-Organism
glossinidius	I-Organism
,	O
we	O
reveal	O
the	O
flexible	O
DNA	O
palindrome	O
that	O
distributes	O
SsrB	B-Protein
in	O
the	O
genome	O
to	O
influence	O
transcriptional	O
activation	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
and	O
almost	O
all	O
of	O
its	O
accessory	O
effector	O
proteins	O
.	O

Our	O
data	O
uncovers	O
the	O
principal	O
SsrB	B-Protein
circuitry	O
that	O
appears	O
to	O
have	O
been	O
conserved	O
to	O
support	O
multiple	O
bacterial	O
lifestyles	O
,	O
including	O
parasitic	O
and	O
mutualist	O
symbioses	O
.	O

Results	O

Transcriptional	O
profiling	O
of	O
an	O
ssrB	B-Protein
mutant	O
To	O
begin	O
to	O
understand	O
regulatory	O
evolution	O
and	O
network	O
expansion	O
of	O
the	O
SsrB	B-Protein
response	O
regulator	O
,	O
we	O
profiled	O
the	O
transcriptome	O
of	O
an	O
ssrB	B-Protein
mutant	O
and	O
compared	O
it	O
to	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
wild	O
-	O
type	O
cells	O
grown	O
in	O
an	O
acidic	O
minimal	O
medium	O
that	O
activates	O
the	O
SsrA	B-Protein
-	O
SsrB	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
[	O
20	O
]	O
.	O

We	O
identified	O
133	O
genes	O
that	O
were	O
significantly	O
down	O
-	O
regulated	O
in	O
the	O
ssrB	B-Protein
mutant	O
[	O
z	O
<	O
-	O
1	O
.	O
96	O
]	O
[	O
21	O
]	O
(	O
Table	O
1	O
)	O
.	O

This	O
included	O
almost	O
all	O
genes	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
as	O
well	O
as	O
effector	O
genes	O
encoded	O
throughout	O
the	O
genome	O
(	O
Dataset	O
S1	O
)	O
.	O

Next	O
,	O
we	O
performed	O
a	O
Clusters	O
of	O
Orthologous	O
Groups	O
(	O
COG	O
)	O
analysis	O
[	O
22	O
]	O
on	O
the	O
118	O
genes	O
that	O
had	O
an	O
ortholog	O
in	O
the	O
annotated	O
genome	O
of	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
strain	I-Organism
LT2	I-Organism
[	O
23	O
]	O
.	O

Among	O
these	O
,	O
45	O
genes	O
lacked	O
a	O
functional	O
COG	O
assignment	O
and	O
the	O
73	O
remaining	O
genes	O
were	O
distributed	O
among	O
86	O
COGs	O
(	O
Figure	O
1	O
)	O
.	O

The	O
majority	O
of	O
functions	O
in	O
the	O
latter	O
groups	O
are	O
in	O
transport	O
,	O
secretion	O
,	O
and	O
trafficking	O
of	O
cellular	O
components	O
in	O
addition	O
to	O
protein	O
and	O
membrane	O
modification	O
.	O

The	O
SsrA	B-Protein
-	O
SsrB	B-Protein
system	O
was	O
acquired	O
by	O
horizontal	O
gene	O
transfer	O
into	O
the	O
S	B-Organism
.	I-Organism
enterica	I-Organism
species	O
after	O
divergence	O
from	O
what	O
is	O
now	O
extant	O
S	B-Organism
.	I-Organism
bongori	I-Organism
.	O

As	O
such	O
,	O
S	B-Organism
.	I-Organism
bongori	I-Organism
has	O
evolved	O
in	O
the	O
absence	O
of	O
SsrA	B-Protein
-	O
SsrB	B-Protein
and	O
its	O
regulatory	O
architecture	O
has	O
not	O
been	O
influenced	O
by	O
it	O
.	O

Orthologous	O
genes	O
ancestral	O
to	O
both	O
species	O
but	O
regulated	O
by	O
SsrB	B-Protein
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
provide	O
evidence	O
for	O
network	O
expansion	O
and	O
regulatory	O
evolution	O
that	O
we	O
previously	O
showed	O
can	O
be	O
mapped	O
to	O
a	O
single	O
cis	O
-	O
input	O
location	O
by	O
using	O
functional	O
and	O
comparative	O
genomics	O
[	O
19	O
]	O
.	O

To	O
expand	O
on	O
this	O
,	O
we	O
used	O
a	O
reciprocal	O
BLAST	O
-	O
based	O
analysis	O
and	O
identified	O
47	O
orthologs	O
in	O
S	B-Organism
.	I-Organism
bongori	I-Organism
among	O
the	O
133	O
genes	O
whose	O
transcription	O
was	O
down	O
-	O
regulated	O
in	O
an	O
ssrB	B-Protein
mutant	O
(	O
Table	O
1	O
)	O
.	O

In	O
DeltassrB	B-Protein
cells	O
,	O
the	O
mean	O
fold	O
-	O
change	O
of	O
the	O
orthologous	O
genes	O
(	O
-	O
6	O
.	O
1	O
-	O
fold	O
)	O
was	O
subtler	O
than	O
for	O
the	O
S	B-Organism
.	I-Organism
enterica	I-Organism
-	O
specific	O
gene	O
set	O
(	O
mean	O
-	O
21	O
.	O
2	O
-	O
fold	O
)	O
,	O
which	O
included	O
the	O
T3SS	O
and	O
associated	O
effector	O
genes	O
(	O
Dataset	O
S1	O
)	O
.	O

We	O
also	O
determined	O
the	O
distribution	O
of	O
down	O
-	O
regulated	O
genes	O
among	O
genomic	O
islands	O
[	O
24	O
]	O
,	O
including	O
prophages	O
,	O
pathogenicity	O
islands	O
(	O
SPI	O
-	O
islands	O
)	O
and	O
additional	O
regions	O
of	O
difference	O
(	O
ROD	O
)	O
between	O
S	B-Organism
.	I-Organism
enterica	I-Organism
and	O
S	B-Organism
.	I-Organism
bongori	I-Organism
(	O
Dataset	O
S2	O
)	O
.	O

For	O
this	O
we	O
used	O
a	O
BLAST	O
-	O
based	O
comparison	O
of	O
genome	O
-	O
wide	O
synteny	O
between	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
and	O
S	B-Organism
.	I-Organism
bongori	I-Organism
and	O
identified	O
50	O
ROD	O
that	O
included	O
17	O
previously	O
reported	O
SPI	O
-	O
islands	O
and	O
prophages	O
.	O

Of	O
the	O
133	O
down	O
-	O
regulated	O
genes	O
identified	O
,	O
56	O
were	O
present	O
within	O
genomic	O
islands	O
(	O
Table	O
1	O
)	O
,	O
with	O
a	O
mean	O
change	O
in	O
gene	O
expression	O
of	O
-	O
25	O
.	O
3	O
-	O
fold	O
in	O
DeltassrB	B-Protein
cells	O
.	O

Genome	O
-	O
wide	O
SsrB	B-Protein
interactions	O

To	O
examine	O
SsrB	B-Protein
allocation	O
on	O
the	O
chromosome	O
in	O
vivo	O
,	O
we	O
isolated	O
functional	O
SsrB	B-Protein
-	O
DNA	O
interactions	O
using	O
chromatin	O
immunoprecipitation	O
and	O
examined	O
the	O
bound	O
DNA	O
by	O
chip	O
analysis	O
(	O
ChIP	O
-	O
on	O
-	O
chip	O
)	O
using	O
an	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
SL1344	I-Organism
array	O
containing	O
44	O
,	O
021	O
probes	O
.	O

With	O
this	O
method	O
,	O
we	O
identified	O
256	O
significant	O
interaction	O
peaks	O
distributed	O
throughout	O
the	O
genome	O
that	O
were	O
enriched	O
under	O
SsrB	B-Protein
-	O
activating	O
conditions	O
and	O
with	O
interaction	O
scores	O
three	O
standard	O
deviations	O
greater	O
than	O
the	O
mean	O
probe	O
score	O
(	O
Figure	O
2A	O
and	O
Table	O
1	O
)	O
.	O

Of	O
these	O
256	O
peaks	O
,	O
126	O
(	O
49	O
%	O
)	O
occurred	O
within	O
coding	O
regions	O
of	O
genes	O
(	O
CDS	O
)	O
and	O
130	O
(	O
51	O
%	O
)	O
were	O
in	O
intergenic	O
regions	O
(	O
IGR	O
)	O
.	O

Given	O
the	O
strong	O
influence	O
of	O
SsrB	B-Protein
on	O
horizontally	O
acquired	O
genes	O
(	O
Table	O
1	O
)	O
,	O
we	O
plotted	O
the	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
against	O
all	O
genomic	O
islands	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
SL1344	I-Organism
.	O

From	O
this	O
analysis	O
,	O
62	O
of	O
256	O
SsrB	B-Protein
binding	O
peaks	O
(	O
24	O
.	O
3	O
%	O
)	O
occurred	O
within	O
genomic	O
islands	O
(	O
Figure	O
2B	O
)	O
.	O

SsrB	B-Protein
ChIP	O
peaks	O
were	O
observed	O
upstream	O
of	O
previously	O
identified	O
SsrB	B-Protein
regulated	O
genes	O
indicating	O
that	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
captured	O
functional	O
interactions	O
(	O
Dataset	O
S3	O
)	O
.	O

To	O
generate	O
a	O
consensus	O
set	O
of	O
SsrB	B-Protein
regulated	O
genes	O
,	O
we	O
performed	O
an	O
analysis	O
to	O
identify	O
operons	O
in	O
the	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
SL1344	I-Organism
genome	O
that	O
encoded	O
at	O
least	O
one	O
gene	O
down	O
-	O
regulated	O
in	O
DeltassrB	B-Protein
cells	O
and	O
that	O
possessed	O
an	O
SsrB	B-Protein
binding	O
peak	O
in	O
the	O
upstream	O
regulatory	O
region	O
as	O
defined	O
by	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
analysis	O
.	O

From	O
this	O
,	O
the	O
133	O
down	O
-	O
regulated	O
genes	O
mapped	O
to	O
86	O
operons	O
,	O
49	O
of	O
which	O
had	O
an	O
SsrB	B-Protein
interaction	O
upstream	O
or	O
within	O
the	O
first	O
gene	O
of	O
the	O
operon	O
(	O
Table	O
2	O
)	O
.	O

This	O
analysis	O
captured	O
all	O
five	O
reported	O
operons	O
in	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O
in	O
addition	O
to	O
ten	O
operons	O
outside	O
of	O
this	O
island	O
that	O
encode	O
SPI	O
-	O
2	O
translocated	O
effectors	O
.	O

SsrB	B-Protein
binds	O
to	O
six	O
promoters	O
within	O
the	O
SPI	O
-	O
2	O
genomic	O
island	O

In	O
order	O
to	O
rigorously	O
evaluate	O
our	O
genome	O
-	O
wide	O
functional	O
genomics	O
data	O
,	O
we	O
compared	O
it	O
against	O
traditional	O
biochemical	O
experiments	O
describing	O
SsrB	B-Protein
-	O
DNA	O
interactions	O
at	O
the	O
SPI	O
-	O
2	O
locus	O
.	O

Previous	O
data	O
reported	O
SsrB	B-Protein
footprints	O
upstream	O
of	O
6	O
genes	O
in	O
SPI	O
-	O
2	O
:	O
ssrA	B-Protein
,	O
ssrB	B-Protein
,	O
ssaB	B-Protein
,	O
sseA	B-Protein
,	O
ssaG	B-Protein
,	O
and	O
ssaM	B-Protein
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

Our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
showed	O
discrete	O
SsrB	B-Protein
binding	O
at	O
all	O
of	O
these	O
promoters	O
except	O
for	O
the	O
promoter	O
reported	O
to	O
be	O
between	O
ssrA	B-Protein
and	O
ssrB	B-Protein
[	O
25	O
]	O
(	O
Figure	O
3	O
)	O
.	O

We	O
attempted	O
to	O
verify	O
functional	O
activity	O
at	O
this	O
site	O
,	O
but	O
could	O
not	O
using	O
transcriptional	O
fusions	O
(	O
data	O
not	O
shown	O
)	O
.	O

Our	O
data	O
also	O
identified	O
three	O
additional	O
SsrB	B-Protein
binding	O
peaks	O
upstream	O
of	O
sseA	B-Protein
,	O
within	O
the	O
CDS	O
of	O
ssaJ	B-Protein
,	O
and	O
in	O
the	O
IGR	O
upstream	O
of	O
ssaR	B-Protein
(	O
Figure	O
3	O
)	O
.	O

Functional	O
interactions	O
were	O
confirmed	O
for	O
sseA	B-Protein
and	O
ssaR	B-Protein
in	O
subsequent	O
reporter	O
experiments	O
described	O
below	O
.	O

Identification	O
of	O
a	O
functional	O
DNA	O
element	O
for	O
SsrB	B-Protein
binding	O

Previous	O
attempts	O
by	O
others	O
to	O
identify	O
a	O
conserved	O
SsrB	B-Protein
DNA	O
recognition	O
motif	O
have	O
been	O
unsuccessful	O
.	O

To	O
overcome	O
this	O
,	O
we	O
employed	O
a	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
originally	O
developed	O
to	O
define	O
binding	O
site	O
preferences	O
for	O
eukaryotic	O
transcription	O
factors	O
[	O
27	O
]	O
.	O

We	O
fused	O
the	O
DNA	O
binding	O
domain	O
of	O
SsrB	B-Protein
(	O
SsrBc	B-Protein
)	O
to	O
the	O
alpha	O
-	O
subunit	O
of	O
RNA	O
polymerase	O
and	O
screened	O
a	O
prey	O
library	O
of	O
approximately108	O
DNA	O
molecules	O
previously	O
counter	O
-	O
selected	O
against	O
self	O
-	O
activation	O
(	O
Figure	O
4A	O
)	O
.	O

We	O
used	O
the	O
PhoP	B-Protein
response	O
regulator	O
from	O
E	B-Organism
.	I-Organism
coli	I-Organism
as	O
a	O
control	O
because	O
a	O
DNA	O
recognition	O
sequence	O
for	O
it	O
was	O
known	O
[	O
28	O
]	O
.	O

Bait	O
-	O
prey	O
combinations	O
surviving	O
selection	O
on	O
medium	O
lacking	O
histidine	O
were	O
purified	O
,	O
and	O
preys	O
were	O
sequenced	O
and	O
analyzed	O
using	O
the	O
motif	O
-	O
finding	O
program	O
MEME	O
[	O
29	O
]	O
.	O

From	O
189	O
unique	O
sequences	O
isolated	O
for	O
SsrBc	B-Protein
,	O
over	O
80	O
%	O
contained	O
a	O
degenerate	O
consensus	O
motif	O
,	O
mCCyTA	O
(	O
Figure	O
4B	O
)	O
.	O

In	O
control	O
screens	O
with	O
the	O
PhoP	B-Protein
-	O
alphaNTD	B-Protein
fusion	O
,	O
the	O
PhoP	B-Protein
box	O
sequence	O
(	O
G	O
/	O
T	O
)	O
GTTTA	O
was	O
identified	O
in	O
11	O
%	O
of	O
sequenced	O
preys	O
(	O
12	O
/	O
109	O
,	O
data	O
not	O
shown	O
)	O
but	O
this	O
sequence	O
was	O
never	O
captured	O
by	O
SsrB	B-Protein
-	O
alphaNTD	B-Protein
and	O
vice	O
versa	O
,	O
demonstrating	O
specificity	O
of	O
the	O
bacterial	O
one	O
-	O
hybrid	O
system	O
for	O
prokaryotic	O
regulatory	O
proteins	O
.	O

Next	O
,	O
we	O
examined	O
our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
for	O
the	O
presence	O
of	O
a	O
conserved	O
regulatory	O
motif	O
.	O

We	O
extracted	O
sequence	O
data	O
from	O
the	O
local	O
maxima	O
of	O
the	O
256	O
binding	O
peaks	O
and	O
analyzed	O
the	O
sequences	O
with	O
the	O
computational	O
program	O
MDscan	O
[	O
30	O
]	O
.	O

Using	O
the	O
highest	O
-	O
ranking	O
probes	O
to	O
generate	O
an	O
initial	O
prediction	O
followed	O
by	O
lower	O
-	O
ranking	O
probes	O
for	O
refinement	O
,	O
this	O
analysis	O
identified	O
motifs	O
that	O
represented	O
either	O
the	O
forward	O
or	O
the	O
reverse	O
complement	O
of	O
the	O
consensus	O
sequence	O
ACmTTA	O
,	O
which	O
shares	O
consensus	O
with	O
the	O
motif	O
identified	O
in	O
the	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
(	O
Figure	O
4B	O
)	O
.	O

We	O
identified	O
variations	O
of	O
this	O
motif	O
within	O
footprinted	O
regions	O
of	O
SsrB	B-Protein
-	O
regulated	O
promoters	O
[	O
25	O
]	O
,	O
,	O
however	O
sequence	O
degeneracy	O
made	O
it	O
difficult	O
to	O
precisely	O
map	O
the	O
input	O
functions	O
.	O

Identification	O
of	O
a	O
functional	O
DNA	O
palindrome	O
conserved	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
SPI	O
-	O
2	O
and	O
the	O
Sodalis	B-Organism
glossinidius	I-Organism
SSR	O
-	O
3	O
region	O

The	O
analysis	O
of	O
regulatory	O
evolution	O
is	O
particularly	O
challenging	O
because	O
it	O
is	O
difficult	O
to	O
distinguish	O
neutral	O
stochastic	O
change	O
from	O
functional	O
divergence	O
.	O

To	O
solve	O
this	O
problem	O
in	O
the	O
context	O
of	O
mapping	O
the	O
SsrB	B-Protein
binding	O
element	O
,	O
we	O
used	O
comparative	O
genomics	O
to	O
search	O
for	O
conserved	O
promoter	O
architecture	O
in	O
another	O
organism	O
with	O
a	O
similar	O
genomic	O
island	O
to	O
Salmonella	B-Organism
SPI	O
-	O
2	O
.	O

The	O
tsetse	O
fly	O
endosymbiont	O
Sodalis	B-Organism
glossinidius	I-Organism
contains	O
the	O
Sodalis	B-Organism
Symbiosis	O
Region	O
-	O
3	O
(	O
SSR	O
-	O
3	O
)	O
that	O
is	O
similar	O
in	O
content	O
and	O
synteny	O
with	O
the	O
S	B-Organism
.	I-Organism
enterica	I-Organism
SPI	O
-	O
2	O
locus	O
[	O
31	O
]	O
.	O

Gene	O
conservation	O
includes	O
the	O
entire	O
T3SS	O
structural	O
module	O
extending	O
to	O
the	O
regulatory	O
genes	O
ssrA	B-Protein
-	O
ssrB	B-Protein
and	O
all	O
other	O
genes	O
except	O
the	O
effectors	O
sseF	B-Protein
and	O
sseG	B-Protein
,	O
which	O
are	O
not	O
present	O
in	O
Sodalis	B-Organism
SSR	O
-	O
3	O
.	O

We	O
aligned	O
the	O
sequences	O
of	O
the	O
five	O
mapped	O
promoters	O
in	O
SPI	O
-	O
2	O
with	O
the	O
orthologous	O
SSR	O
-	O
3	O
regions	O
to	O
identify	O
local	O
conservation	O
.	O

Highly	O
conserved	O
sites	O
within	O
the	O
promoters	O
were	O
restricted	O
to	O
regions	O
previously	O
footprinted	O
by	O
SsrB	B-Protein
[	O
25	O
]	O
,	O
[	O
26	O
]	O
,	O
whereas	O
adjacent	O
sequence	O
showed	O
substantial	O
drift	O
(	O
Figure	O
4C	O
)	O
.	O

Within	O
the	O
conserved	O
sites	O
we	O
identified	O
a	O
heptameric	O
sequence	O
in	O
7	O
-	O
4	O
-	O
7	O
tail	O
-	O
to	O
-	O
tail	O
architecture	O
that	O
created	O
an	O
18	O
-	O
bp	O
degenerate	O
palindrome	O
.	O

This	O
palindrome	O
was	O
found	O
in	O
all	O
SPI	O
-	O
2	O
and	O
SSR	O
-	O
3	O
T3SS	O
promoters	O
with	O
the	O
exception	O
of	O
the	O
sseA	B-Protein
promoter	O
that	O
had	O
only	O
one	O
reasonably	O
well	O
-	O
conserved	O
heptamer	O
in	O
the	O
footprinted	O
region	O
(	O
Figure	O
4C	O
and	O
Figure	O
S1	O
)	O
.	O

Interestingly	O
,	O
two	O
copies	O
of	O
the	O
palindrome	O
occur	O
upstream	O
of	O
the	O
ssrA	B-Protein
-	O
ssrB	B-Protein
operon	O
in	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
within	O
the	O
same	O
footprint	O
,	O
and	O
the	O
conservation	O
of	O
either	O
site	O
in	O
Sodalis	B-Organism
was	O
weak	O
.	O

Evaluation	O
of	O
the	O
heptamer	O
motif	O
in	O
the	O
palindrome	O
showed	O
high	O
similarity	O
to	O
the	O
motifs	O
identified	O
by	O
the	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
and	O
the	O
ChIP	O
-	O
on	O
-	O
chip	O
experiments	O
(	O
Figure	O
4B	O
and	O
4D	O
)	O
,	O
giving	O
us	O
confidence	O
that	O
we	O
had	O
identified	O
the	O
major	O
recognition	O
module	O
for	O
transcriptional	O
input	O
by	O
SsrB	B-Protein
.	O

In	O
accord	O
with	O
a	O
previous	O
observation	O
[	O
26	O
]	O
,	O
there	O
was	O
not	O
a	O
strict	O
requirement	O
in	O
the	O
spacing	O
between	O
the	O
SsrB	B-Protein
binding	O
site	O
and	O
the	O
downstream	O
transcriptional	O
start	O
site	O
.	O

SsrB	B-Protein
directs	O
transcriptional	O
input	O
using	O
a	O
flexible	O
palindrome	O
architecture	O

The	O
presence	O
of	O
a	O
conserved	O
palindrome	O
sequence	O
in	O
SPI	O
-	O
2	O
promoters	O
and	O
in	O
related	O
sequences	O
from	O
the	O
endosymbiont	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
suggested	O
that	O
regulatory	O
input	O
by	O
SsrB	B-Protein
was	O
through	O
a	O
palindrome	O
sequence	O
architecture	O
.	O

However	O
,	O
other	O
lines	O
of	O
evidence	O
suggested	O
that	O
the	O
recognition	O
site	O
architecture	O
was	O
flexible	O
in	O
nature	O
:	O
(	O
i	O
)	O
our	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
isolated	O
functional	O
single	O
hexamer	O
sequences	O
,	O
(	O
ii	O
)	O
the	O
SsrB	B-Protein
footprint	O
at	O
the	O
naturally	O
evolved	O
sseA	B-Protein
promoter	O
within	O
SPI	O
-	O
2	O
[	O
26	O
]	O
contained	O
only	O
one	O
reasonably	O
well	O
-	O
conserved	O
heptamer	O
,	O
and	O
(	O
iii	O
)	O
degenerate	O
or	O
non	O
-	O
ideal	O
palindromes	O
exist	O
in	O
the	O
genome	O
.	O

In	O
order	O
to	O
deconstruct	O
this	O
architecture	O
,	O
we	O
designed	O
a	O
set	O
of	O
experiments	O
to	O
test	O
the	O
palindrome	O
'	O
s	O
tolerance	O
to	O
mutation	O
.	O

We	O
chose	O
the	O
ssaG	B-Protein
promoter	O
for	O
these	O
experiments	O
because	O
16	O
of	O
18	O
bases	O
were	O
identical	O
between	O
SPI	O
-	O
2	O
and	O
SSR	O
-	O
3	O
from	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
,	O
differing	O
only	O
in	O
the	O
4	O
-	O
bp	O
spacer	O
between	O
heptamers	O
(	O
Figure	O
4C	O
)	O
.	O

We	O
mutated	O
the	O
palindrome	O
in	O
a	O
series	O
of	O
transcriptional	O
reporters	O
that	O
were	O
otherwise	O
identical	O
to	O
the	O
evolved	O
ssaG	B-Protein
promoter	O
(	O
Figure	O
5A	O
)	O
and	O
promoter	O
activity	O
was	O
compared	O
to	O
that	O
of	O
a	O
wild	O
-	O
type	O
palindrome	O
sequence	O
.	O

Variants	O
in	O
which	O
the	O
first	O
half	O
-	O
site	O
(	O
7	O
'	O
)	O
or	O
second	O
half	O
-	O
site	O
(	O
7	O
'	O
'	O
)	O
was	O
deleted	O
produced	O
similar	O
transcriptional	O
activity	O
to	O
the	O
wild	O
-	O
type	O
palindrome	O
,	O
verifying	O
that	O
a	O
single	O
well	O
-	O
conserved	O
heptamer	O
is	O
sufficient	O
for	O
transcriptional	O
input	O
under	O
these	O
experimental	O
conditions	O
(	O
Figure	O
5B	O
)	O
.	O

Deletion	O
of	O
the	O
4	O
-	O
bp	O
spacer	O
sequence	O
between	O
the	O
heptamers	O
-	O
the	O
most	O
degenerate	O
element	O
of	O
the	O
palindrome	O
-	O
also	O
generated	O
wild	O
-	O
type	O
promoter	O
activity	O
.	O

However	O
,	O
the	O
orientation	O
of	O
individual	O
heptamers	O
was	O
essential	O
for	O
transcriptional	O
input	O
since	O
rewiring	O
the	O
palindrome	O
in	O
any	O
head	O
-	O
to	O
-	O
head	O
orientation	O
produced	O
negligible	O
promoter	O
activity	O
.	O

However	O
,	O
if	O
the	O
two	O
half	O
sites	O
were	O
swapped	O
front	O
-	O
to	O
-	O
back	O
so	O
that	O
they	O
maintained	O
tail	O
-	O
to	O
-	O
tail	O
orientation	O
(	O
construct	O
labelled	O
"	O
Reverse	O
"	O
in	O
Figure	O
5	O
)	O
,	O
wild	O
-	O
type	O
promoter	O
activity	O
was	O
restored	O
.	O

Precise	O
deletion	O
of	O
the	O
entire	O
18	O
-	O
bp	O
palindrome	O
lead	O
to	O
approximately10	O
%	O
residual	O
activity	O
in	O
wild	O
-	O
type	O
cells	O
,	O
which	O
was	O
reduced	O
to	O
less	O
than	O
1	O
%	O
in	O
an	O
ssrB	B-Protein
mutant	O
(	O
Figure	O
5C	O
)	O
.	O

To	O
determine	O
whether	O
the	O
remaining	O
10	O
%	O
transcriptional	O
activity	O
was	O
a	O
result	O
of	O
an	O
SsrB	B-Protein
-	O
dependent	O
feed	O
-	O
forward	O
mechanism	O
or	O
transcriptional	O
read	O
-	O
through	O
of	O
our	O
chromosomally	O
integrated	O
reporter	O
,	O
we	O
constructed	O
an	O
ectopic	O
deletion	O
reporter	O
.	O

Assessment	O
of	O
reporter	O
activity	O
for	O
this	O
construct	O
in	O
addition	O
to	O
wild	O
-	O
type	O
constructs	O
in	O
wild	O
-	O
type	O
and	O
ssrB	B-Protein
mutant	O
backgrounds	O
showed	O
a	O
similar	O
level	O
of	O
activity	O
to	O
the	O
ssrB	B-Protein
mutant	O
(	O
Figure	O
5D	O
)	O
.	O

The	O
results	O
for	O
the	O
half	O
-	O
site	O
deletion	O
constructs	O
,	O
which	O
retained	O
activity	O
similar	O
to	O
wild	O
type	O
,	O
were	O
unexpected	O
.	O

Therefore	O
,	O
we	O
compared	O
the	O
sequences	O
generated	O
upon	O
mutation	O
against	O
a	O
consensus	O
palindrome	O
matrix	O
generated	O
from	O
all	O
SPI	O
-	O
2	O
and	O
other	O
identified	O
putative	O
elements	O
.	O

The	O
7	O
'	O
-	O
4	O
-	O
X	O
,	O
X	O
-	O
4	O
-	O
7	O
'	O
'	O
and	O
7	O
'	O
-	O
X	O
-	O
7	O
'	O
'	O
mutations	O
introduced	O
a	O
number	O
of	O
base	O
transitions	O
and	O
transversions	O
never	O
occurring	O
in	O
the	O
matrix	O
,	O
however	O
the	O
modified	O
7	O
base	O
pair	O
heptamer	O
retained	O
4	O
-	O
5	O
naturally	O
-	O
occurring	O
bases	O
along	O
with	O
the	O
unchanged	O
wild	O
-	O
type	O
sequence	O
in	O
the	O
other	O
heptamer	O
(	O
Figure	O
S2	O
)	O
.	O

The	O
possibility	O
existed	O
that	O
this	O
modified	O
heptamer	O
,	O
although	O
now	O
weaker	O
in	O
consensus	O
,	O
could	O
still	O
be	O
sufficient	O
for	O
recruitment	O
of	O
a	O
functional	O
form	O
of	O
SsrB	B-Protein
when	O
paired	O
with	O
the	O
other	O
wild	O
-	O
type	O
heptamer	O
.	O

To	O
test	O
this	O
,	O
we	O
created	O
an	O
additional	O
ectopic	O
transcriptional	O
fusion	O
construct	O
in	O
which	O
the	O
left	O
half	O
(	O
7	O
'	O
)	O
of	O
the	O
palindrome	O
was	O
mutated	O
to	O
bases	O
never	O
occurring	O
in	O
the	O
consensus	O
matrix	O
.	O

When	O
tested	O
in	O
promoter	O
activity	O
experiments	O
,	O
this	O
reporter	O
was	O
unable	O
to	O
activate	O
transcription	O
and	O
was	O
identical	O
to	O
the	O
X	O
-	O
X	O
-	O
X	O
mutant	O
construct	O
(	O
Figure	O
5D	O
)	O
.	O

Salmonella	O
SsrB	B-Protein
and	O
the	O
Sodalis	B-Organism
ortholog	O
(	O
SG1279	B-Protein
)	O
are	O
69	O
%	O
identical	O
and	O
81	O
%	O
similar	O
at	O
the	O
amino	O
acid	O
level	O
.	O

All	O
of	O
the	O
critical	O
residues	O
in	O
the	O
dimerization	O
helix	O
and	O
HTH	O
motif	O
required	O
for	O
specific	O
transcriptional	O
activity	O
by	O
SsrB	B-Protein
[	O
32	O
]	O
are	O
conserved	O
in	O
the	O
Sodalis	B-Organism
ortholog	O
(	O
Figure	O
S3	O
)	O
.	O

To	O
demonstrate	O
a	O
functional	O
role	O
for	O
the	O
palindrome	O
identified	O
in	O
Sodalis	B-Organism
,	O
we	O
engineered	O
luciferase	O
transcriptional	O
reporters	O
that	O
either	O
contained	O
(	O
7	O
'	O
-	O
4	O
-	O
7	O
'	O
'	O
)	O
or	O
lacked	O
(	O
X	O
-	O
X	O
-	O
X	O
)	O
the	O
identified	O
palindrome	O
from	O
the	O
Sodalis	B-Organism
SG1292	B-Protein
promoter	O
(	O
ssaG	B-Protein
ortholog	O
)	O
and	O
transformed	O
them	O
into	O
wild	O
-	O
type	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
and	O
an	O
ssrB	B-Protein
mutant	O
.	O

The	O
transcriptional	O
activity	O
from	O
a	O
wild	O
-	O
type	O
Sodalis	B-Organism
palindrome	O
sequence	O
was	O
high	O
,	O
but	O
was	O
completely	O
abolished	O
in	O
an	O
ssrB	B-Protein
mutant	O
and	O
in	O
experiments	O
where	O
only	O
the	O
palindrome	O
sequence	O
was	O
precisely	O
deleted	O
(	O
Figure	O
5D	O
)	O
.	O

These	O
experiments	O
demonstrated	O
a	O
functional	O
role	O
for	O
the	O
conserved	O
palindrome	O
in	O
Sodalis	B-Organism
and	O
the	O
requirement	O
for	O
SsrB	B-Protein
for	O
transcriptional	O
activation	O
.	O

Regulatory	O
evolution	O
of	O
the	O
SPI	O
-	O
2	O
T3SS	O
effector	O
repertoire	O

The	O
above	O
results	O
identified	O
the	O
conserved	O
,	O
yet	O
flexible	O
,	O
palindrome	O
sequence	O
defining	O
DNA	O
recognition	O
by	O
SsrB	B-Protein
.	O

To	O
examine	O
the	O
extent	O
to	O
which	O
regulatory	O
evolution	O
has	O
been	O
selective	O
for	O
this	O
genetic	O
architecture	O
,	O
we	O
created	O
a	O
position	O
weight	O
matrix	O
(	O
PWM	O
)	O
for	O
the	O
five	O
strongest	O
palindrome	O
sites	O
in	O
SPI	O
-	O
2	O
and	O
the	O
orthologous	O
sites	O
in	O
Sodalis	B-Organism
SSR	O
-	O
3	O
.	O

We	O
then	O
searched	O
for	O
representative	O
candidates	O
of	O
this	O
motif	O
in	O
the	O
S	B-Organism
.	I-Organism

Typhimurium	B-Organism
genome	O
using	O
the	O
simple	O
scoring	O
algorithm	O
MotifLocator	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

This	O
analysis	O
recovered	O
the	O
motifs	O
upstream	O
of	O
ssaB	B-Protein
,	O
ssaG	B-Protein
,	O
ssaM	B-Protein
,	O
and	O
ssaR	B-Protein
that	O
were	O
used	O
to	O
generate	O
the	O
PWM	O
.	O

The	O
palindrome	O
in	O
the	O
ssrA	B-Protein
promoter	O
was	O
not	O
used	O
to	O
create	O
the	O
PWM	O
due	O
to	O
its	O
weaker	O
consensus	O
in	O
the	O
left	O
heptamer	O
,	O
however	O
,	O
it	O
was	O
recovered	O
in	O
the	O
computational	O
analysis	O
in	O
a	O
second	O
group	O
of	O
lower	O
-	O
scoring	O
motifs	O
(	O
Figure	O
6A	O
)	O
.	O

We	O
identified	O
24	O
palindromes	O
co	O
-	O
occurring	O
with	O
ChIP	O
-	O
on	O
-	O
chip	O
peaks	O
upstream	O
of	O
24	O
different	O
SsrB	B-Protein
-	O
regulated	O
genes	O
or	O
operons	O
.	O

Applying	O
a	O
stringent	O
threshold	O
to	O
the	O
output	O
allowed	O
us	O
to	O
identify	O
two	O
groups	O
-	O
genes	O
with	O
high	O
-	O
scoring	O
upstream	O
palindromes	O
(	O
ssaB	B-Protein
,	O
ssaG	B-Protein
,	O
ssaM	B-Protein
,	O
ssaR	B-Protein
,	O
sopD2	B-Protein
,	O
sifA	B-Protein
,	O
sifB	B-Protein
,	O
sseK2	B-Protein
,	O
sseK3	B-Protein
,	O
sseL	B-Protein
,	O
sseA	B-Protein
'	O
,	O
steC	B-Protein
,	O
and	O
srcA	B-Protein
)	O
and	O
those	O
with	O
medium	O
-	O
scoring	O
palindromes	O
(	O
0	O
.	O
7	O
-	O
0	O
.	O
8	O
threshold	O
;	O
ssrA	B-Protein
,	O
STM1633	B-Protein
,	O
sseI	B-Protein
,	O
slrP	B-Protein
sspH2	B-Protein
,	O
pipB	B-Protein
,	O
sseJ	B-Protein
,	O
pipB2	B-Protein
,	O
srfN	B-Protein
,	O
sseA	B-Protein
and	O
steB	B-Protein
)	O
(	O
Figure	O
6A	O
and	O
Dataset	O
S4	O
)	O
(	O
sseA	B-Protein
'	O
denotes	O
the	O
SsrB	B-Protein
palindrome	O
sequence	O
upstream	O
of	O
sseA	B-Protein
that	O
falls	O
within	O
the	O
ssaE	B-Protein
CDS	O
,	O
while	O
sseA	B-Protein
refers	O
to	O
the	O
SsrB	B-Protein
-	O
footprinted	O
IGR	O
site	O
with	O
only	O
one	O
conserved	O
heptamer	O
defined	O
in	O
Figure	O
4C	O
)	O
.	O

Remarkably	O
,	O
this	O
accounted	O
for	O
17	O
of	O
22	O
SL1344	O
genome	O
-	O
encoded	O
effectors	O
translocated	O
by	O
the	O
SPI	O
-	O
2	O
-	O
encoded	O
T3SS	O
(	O
exceptions	O
are	O
chromosomal	O
steA	B-Protein
,	O
gogB	B-Protein
,	O
and	O
sseK	B-Protein
,	O
and	O
plasmid	O
-	O
encoded	O
spvB	B-Protein
and	O
spvC	B-Protein
)	O
.	O

These	O
genes	O
either	O
lacked	O
an	O
upstream	O
ChIP	O
peak	O
above	O
our	O
3	O
-	O
standard	O
deviation	O
cut	O
-	O
off	O
(	O
sseK	B-Protein
)	O
or	O
had	O
such	O
a	O
peak	O
but	O
did	O
not	O
reach	O
statistical	O
significance	O
in	O
our	O
transcriptional	O
profiling	O
experiments	O
(	O
steA	B-Protein
,	O
gogB	B-Protein
)	O
.	O

Our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
revealed	O
three	O
additional	O
strong	O
SsrB	B-Protein
binding	O
peaks	O
within	O
SPI	O
-	O
2	O
:	O
one	O
in	O
the	O
IGR	O
directly	O
upstream	O
of	O
ssaR	B-Protein
,	O
a	O
second	O
within	O
the	O
CDS	O
for	O
ssaJ	B-Protein
,	O
and	O
a	O
third	O
within	O
the	O
CDS	O
for	O
ssaE	B-Protein
that	O
would	O
be	O
predicted	O
to	O
influence	O
transcription	O
of	O
the	O
downstream	O
effector	O
/	O
chaperone	O
operon	O
beginning	O
with	O
sseA	B-Protein
.	O

The	O
analysis	O
described	O
above	O
recovered	O
SsrB	B-Protein
palindrome	O
sequences	O
at	O
the	O
sseA	B-Protein
'	O
and	O
ssaR	B-Protein
locations	O
prompting	O
further	O
validation	O
of	O
these	O
sites	O
.	O

No	O
palindrome	O
was	O
identified	O
for	O
the	O
ssaJ	B-Protein
interaction	O
peak	O
and	O
so	O
further	O
characterization	O
was	O
not	O
pursued	O
.	O

For	O
the	O
IGR	O
palindrome	O
upstream	O
of	O
ssaR	B-Protein
,	O
we	O
tested	O
both	O
a	O
chromosome	O
-	O
integrated	O
transcriptional	O
fusion	O
and	O
an	O
autonomous	O
episomal	O
reporter	O
.	O

In	O
wild	O
-	O
type	O
cells	O
these	O
reporters	O
were	O
as	O
active	O
as	O
other	O
SPI	O
-	O
2	O
promoters	O
,	O
whereas	O
promoter	O
activity	O
was	O
abrogated	O
in	O
DeltassrB	B-Protein
cells	O
,	O
implicating	O
this	O
IGR	O
as	O
a	O
functional	O
promoter	O
for	O
ssaR	B-Protein
(	O
Figure	O
6B	O
and	O
Figure	O
S4	O
)	O
.	O

We	O
next	O
tested	O
the	O
function	O
of	O
the	O
intragenic	O
palindrome	O
within	O
ssaE	B-Protein
(	O
sseA	B-Protein
'	O
)	O
.	O

For	O
this	O
,	O
we	O
constructed	O
a	O
single	O
-	O
copy	O
transcriptional	O
reporter	O
that	O
either	O
contained	O
(	O
WT	O
PsseA	B-Protein
)	O
or	O
lacked	O
(	O
PsseA	B-Protein
del	O
)	O
the	O
single	O
heptamer	O
site	O
in	O
the	O
sseA	B-Protein
IGR	O
and	O
integrated	O
this	O
reporter	O
into	O
wild	O
-	O
type	O
cells	O
and	O
mutants	O
lacking	O
either	O
ssrB	B-Protein
or	O
the	O
ssaE	B-Protein
coding	O
sequence	O
that	O
removed	O
the	O
high	O
-	O
scoring	O
intragenic	O
palindrome	O
sseA	B-Protein
'	O
.	O

These	O
experiments	O
showed	O
that	O
the	O
sseA	B-Protein
'	O
sequence	O
contributes	O
approximately	O
75	O
%	O
of	O
transcriptional	O
output	O
at	O
the	O
sseA	B-Protein
promoter	O
(	O
Figure	O
6C	O
)	O
,	O
since	O
deleting	O
the	O
single	O
heptamer	O
in	O
the	O
sseA	B-Protein
IGR	O
had	O
little	O
effect	O
on	O
transcriptional	O
output	O
in	O
any	O
of	O
the	O
strain	O
backgrounds	O
.	O

These	O
reporter	O
data	O
are	O
in	O
line	O
with	O
the	O
respective	O
binding	O
scores	O
for	O
the	O
ChIP	O
-	O
on	O
-	O
chip	O
interaction	O
peaks	O
(	O
Figure	O
3	O
)	O
and	O
the	O
sequence	O
similarity	O
for	O
these	O
elements	O
with	O
respect	O
to	O
the	O
consensus	O
palindrome	O
(	O
Figure	O
6A	O
and	O
Figure	O
4D	O
)	O
.	O

Together	O
,	O
these	O
data	O
provide	O
compelling	O
evidence	O
for	O
the	O
identity	O
of	O
the	O
DNA	O
recognition	O
element	O
that	O
has	O
been	O
selected	O
through	O
evolution	O
to	O
co	O
-	O
regulate	O
an	O
SsrB	B-Protein
-	O
dependent	O
gene	O
program	O
involved	O
in	O
adaptation	O
to	O
a	O
host	O
.	O

Discussion	O

Horizontal	O
gene	O
transfer	O
is	O
a	O
well	O
-	O
recognized	O
mechanism	O
of	O
bacterial	O
evolution	O
that	O
gives	O
rise	O
to	O
new	O
phenotypes	O
due	O
to	O
the	O
coordinated	O
expression	O
of	O
novel	O
genetic	O
components	O
[	O
1	O
]	O
.	O

A	O
good	O
example	O
of	O
this	O
is	O
acquisition	O
of	O
type	O
III	O
secretion	O
by	O
mutualists	O
and	O
pathogenic	O
bacteria	O
enabling	O
new	O
colonization	O
strategies	O
within	O
a	O
host	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

Evolved	O
changes	O
to	O
regulatory	O
circuitry	O
can	O
also	O
give	O
rise	O
to	O
phenotypic	O
diversity	O
at	O
the	O
species	O
level	O
[	O
19	O
]	O
.	O

In	O
both	O
cases	O
,	O
regulatory	O
evolution	O
is	O
required	O
to	O
correctly	O
deploy	O
gene	O
products	O
during	O
infection	O
,	O
yet	O
the	O
extent	O
to	O
which	O
regulatory	O
evolution	O
contributes	O
to	O
pathogenic	O
adaptation	O
is	O
only	O
beginning	O
to	O
be	O
realized	O
[	O
8	O
]	O
.	O

The	O
SsrA	B-Protein
-	O
SsrB	B-Protein
two	O
-	O
component	O
regulatory	O
system	O
in	O
S	B-Organism
.	I-Organism
enterica	I-Organism
has	O
been	O
the	O
focus	O
of	O
our	O
efforts	O
to	O
understand	O
the	O
significance	O
of	O
regulatory	O
evolution	O
for	O
pathogenic	O
adaptation	O
.	O

This	O
regulatory	O
system	O
was	O
co	O
-	O
acquired	O
with	O
a	O
T3SS	O
encoded	O
in	O
the	O
SPI	O
-	O
2	O
pathogenicity	O
island	O
and	O
likely	O
contributed	O
to	O
immediate	O
and	O
gradual	O
phenotypic	O
diversity	O
as	O
new	O
regulatory	O
nodes	O
were	O
explored	O
and	O
acted	O
upon	O
by	O
natural	O
selection	O
.	O

Extensive	O
work	O
has	O
been	O
reported	O
on	O
the	O
characterization	O
of	O
SsrB	B-Protein
dependent	O
genes	O
,	O
including	O
functional	O
evaluation	O
of	O
genes	O
encoded	O
within	O
SPI	O
-	O
2	O
in	O
addition	O
to	O
genome	O
-	O
wide	O
transcriptional	O
studies	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O

In	O
this	O
study	O
we	O
identified	O
genes	O
co	O
-	O
expressed	O
under	O
SsrB	B-Protein
-	O
inducing	O
conditions	O
and	O
found	O
those	O
with	O
strong	O
levels	O
of	O
expression	O
localized	O
predominantly	O
to	O
mobile	O
genetic	O
elements	O
,	O
recently	O
acquired	O
genomic	O
islands	O
or	O
other	O
annotated	O
islands	O
.	O

We	O
also	O
identified	O
many	O
weakly	O
co	O
-	O
expressed	O
genes	O
,	O
some	O
of	O
which	O
may	O
represent	O
ancestral	O
Salmonella	B-Organism
genes	O
recruited	O
into	O
the	O
SsrB	B-Protein
regulon	O
like	O
the	O
previously	O
reported	O
srfN	B-Protein
[	O
18	O
]	O
.	O

Some	O
of	O
these	O
genes	O
may	O
not	O
be	O
directly	O
regulated	O
by	O
SsrB	B-Protein
and	O
will	O
require	O
further	O
experimental	O
investigation	O
.	O

Direct	O
profiling	O
of	O
SsrB	B-Protein
-	O
DNA	O
interactions	O
using	O
ChIP	O
-	O
on	O
-	O
chip	O
was	O
used	O
to	O
identify	O
SsrB	B-Protein
binding	O
sites	O
in	O
the	O
genome	O
.	O

This	O
analysis	O
identified	O
many	O
interactions	O
which	O
have	O
not	O
been	O
previously	O
described	O
and	O
interaction	O
sites	O
within	O
coding	O
regions	O
of	O
genes	O
which	O
may	O
represent	O
non	O
-	O
canonical	O
functions	O
for	O
SsrB	B-Protein
.	O

Other	O
groups	O
have	O
reported	O
the	O
existence	O
of	O
similar	O
numbers	O
of	O
ChIP	O
-	O
on	O
-	O
chip	O
interactions	O
within	O
intragenic	O
regions	O
for	O
other	O
transcription	O
factors	O
[	O
35	O
]	O
,	O
[	O
36	O
]	O
suggesting	O
that	O
this	O
phenomenon	O
is	O
not	O
restricted	O
to	O
SsrB	B-Protein
.	O

In	O
light	O
of	O
the	O
disparate	O
number	O
of	O
microarray	O
genes	O
in	O
comparison	O
to	O
ChIP	O
-	O
on	O
-	O
chip	O
peaks	O
we	O
attempted	O
to	O
generate	O
a	O
more	O
comprehensive	O
picture	O
of	O
the	O
SsrB	B-Protein
regulon	O
by	O
combining	O
these	O
data	O
sets	O
at	O
the	O
operon	O
level	O
.	O

In	O
doing	O
so	O
we	O
believe	O
that	O
the	O
nineteen	O
operons	O
containing	O
differentially	O
expressed	O
genes	O
determined	O
by	O
microarray	O
and	O
containing	O
a	O
ChIP	O
-	O
on	O
-	O
chip	O
peak	O
three	O
standard	O
deviations	O
above	O
the	O
mean	O
captured	O
by	O
this	O
analysis	O
represent	O
the	O
genes	O
directly	O
activated	O
by	O
SsrB	B-Protein
(	O
Table	O
2	O
)	O
.	O

Those	O
operons	O
having	O
a	O
ChIP	O
-	O
on	O
-	O
chip	O
peak	O
directly	O
upstream	O
in	O
the	O
IGR	O
region	O
encompass	O
the	O
majority	O
of	O
known	O
SsrB	B-Protein
regulated	O
genes	O
while	O
those	O
possessing	O
a	O
ChIP	O
peak	O
within	O
the	O
CDS	O
of	O
the	O
first	O
gene	O
may	O
represent	O
non	O
-	O
functional	O
interactions	O
that	O
deserve	O
follow	O
-	O
up	O
experimental	O
investigation	O
.	O

The	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
not	O
only	O
provided	O
information	O
on	O
the	O
identities	O
of	O
SsrB	B-Protein
-	O
regulated	O
genes	O
but	O
also	O
gave	O
insight	O
as	O
to	O
the	O
identity	O
of	O
the	O
SsrB	B-Protein
recognition	O
element	O
specified	O
by	O
the	O
interaction	O
site	O
sequences	O
.	O

The	O
regulatory	O
architecture	O
governing	O
SsrB	B-Protein
input	O
has	O
been	O
elusive	O
despite	O
several	O
SsrB	B-Protein
footprints	O
being	O
defined	O
biochemically	O
[	O
19	O
]	O
,	O
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

Our	O
ChIP	O
-	O
on	O
-	O
chip	O
data	O
further	O
suggested	O
that	O
SsrB	B-Protein
binding	O
within	O
SPI	O
-	O
2	O
was	O
specific	O
,	O
with	O
binding	O
peaks	O
overlapping	O
precisely	O
with	O
regions	O
of	O
the	O
DNA	O
footprinted	O
by	O
SsrB	B-Protein
[	O
25	O
]	O
,	O
[	O
26	O
]	O
.	O

By	O
using	O
a	O
genetic	O
screening	O
strategy	O
together	O
with	O
functional	O
and	O
comparative	O
genomics	O
,	O
we	O
were	O
able	O
to	O
define	O
the	O
essential	O
SsrB	B-Protein
regulatory	O
element	O
as	O
being	O
an	O
18	O
-	O
bp	O
palindrome	O
with	O
a	O
conserved	O
7	O
-	O
4	O
-	O
7	O
internal	O
organization	O
.	O

In	O
support	O
of	O
the	O
palindrome	O
as	O
the	O
functional	O
entity	O
we	O
showed	O
the	O
loss	O
of	O
SsrB	B-Protein
dependence	O
as	O
a	O
result	O
of	O
deletion	O
of	O
this	O
element	O
for	O
the	O
ssaG	B-Protein
promoter	O
.	O

Evaluation	O
of	O
the	O
7	O
-	O
4	O
-	O
7	O
palindrome	O
in	O
the	O
ssaG	B-Protein
promoter	O
revealed	O
the	O
minimal	O
architecture	O
and	O
sequence	O
orientation	O
required	O
for	O
transcriptional	O
input	O
.	O

Deletion	O
of	O
the	O
entire	O
palindrome	O
resulted	O
in	O
less	O
than	O
1	O
%	O
activity	O
in	O
wild	O
-	O
type	O
cells	O
,	O
an	O
equivalent	O
level	O
of	O
activity	O
to	O
those	O
lacking	O
ssrB	B-Protein
entirely	O
.	O

A	O
search	O
of	O
the	O
S	B-Organism
.	I-Organism
enterica	I-Organism
genome	O
for	O
this	O
palindromic	O
motif	O
revealed	O
candidates	O
upstream	O
of	O
the	O
previously	O
noted	O
SsrB	O
dependent	O
genes	O
,	O
including	O
two	O
additional	O
SPI	O
-	O
2	O
sites	O
;	O
one	O
IGR	O
site	O
upstream	O
of	O
ssaR	O
that	O
until	O
now	O
had	O
been	O
cryptic	O
,	O
and	O
one	O
intragenic	O
palindrome	O
upstream	O
of	O
sseA	B-Protein
in	O
the	O
ssaE	B-Protein
CDS	O
.	O

In	O
both	O
cases	O
these	O
input	O
sites	O
were	O
found	O
to	O
be	O
functional	O
.	O

Although	O
palindrome	O
architecture	O
was	O
conserved	O
upstream	O
of	O
SsrB	B-Protein
-	O
regulated	O
genes	O
,	O
degenerate	O
palindromes	O
in	O
which	O
one	O
half	O
-	O
site	O
was	O
more	O
conserved	O
were	O
also	O
functional	O
.	O

As	O
a	O
result	O
of	O
our	O
mutational	O
analyses	O
we	O
conclude	O
that	O
so	O
long	O
as	O
the	O
orientation	O
of	O
a	O
single	O
heptamer	O
of	O
the	O
palindrome	O
is	O
conserved	O
with	O
respect	O
to	O
the	O
downstream	O
gene	O
,	O
SsrB	B-Protein
is	O
tolerant	O
of	O
degeneracy	O
in	O
the	O
adjacent	O
spacer	O
and	O
heptamer	O
sequences	O
.	O

While	O
we	O
were	O
able	O
to	O
identify	O
a	O
number	O
of	O
limited	O
palindrome	O
-	O
like	O
sequences	O
from	O
our	O
bacterial	O
one	O
-	O
hybrid	O
screen	O
,	O
this	O
tolerance	O
in	O
addition	O
to	O
the	O
library	O
size	O
required	O
to	O
pull	O
out	O
an	O
18	O
-	O
bp	O
palindrome	O
in	O
large	O
numbers	O
may	O
explain	O
why	O
we	O
isolated	O
functional	O
single	O
heptamer	O
sequences	O
and	O
why	O
degenerate	O
palindromes	O
naturally	O
exist	O
in	O
the	O
genome	O
.	O

A	O
recent	O
report	O
by	O
Carroll	O
et	O
al	O
,	O
postulated	O
that	O
SsrB	B-Protein
first	O
interacts	O
with	O
DNA	O
as	O
a	O
monomer	O
,	O
followed	O
by	O
dimerization	O
[	O
32	O
]	O
.	O

Our	O
findings	O
also	O
suggest	O
that	O
dimerization	O
is	O
likely	O
required	O
for	O
transcriptional	O
activation	O
however	O
strong	O
recognition	O
by	O
one	O
monomer	O
may	O
stabilize	O
interaction	O
of	O
a	O
second	O
monomer	O
with	O
a	O
less	O
than	O
ideal	O
sequence	O
.	O

The	O
finding	O
that	O
a	O
flexible	O
palindromic	O
sequence	O
can	O
be	O
selective	O
for	O
SsrB	B-Protein
input	O
raises	O
many	O
interesting	O
questions	O
around	O
the	O
nature	O
of	O
regulatory	O
evolution	O
.	O

The	O
ability	O
to	O
use	O
a	O
short	O
functional	O
half	O
-	O
site	O
adjacent	O
to	O
an	O
uncharacterized	O
threshold	O
level	O
of	O
tolerated	O
bases	O
would	O
reduce	O
the	O
period	O
of	O
neutral	O
evolution	O
required	O
to	O
generate	O
an	O
inverted	O
repeat	O
sequence	O
twice	O
the	O
length	O
[	O
37	O
]	O
,	O
and	O
would	O
limit	O
the	O
loss	O
of	O
intermediate	O
variations	O
to	O
drift	O
while	O
a	O
more	O
desirable	O
palindrome	O
is	O
created	O
by	O
regulatory	O
evolution	O
.	O

For	O
bacteria	O
that	O
make	O
use	O
of	O
horizontal	O
gene	O
transfer	O
,	O
this	O
could	O
increase	O
the	O
tempo	O
with	O
which	O
new	O
DNA	O
is	O
integrated	O
into	O
the	O
regulatory	O
circuitry	O
of	O
the	O
cell	O
.	O

We	O
showed	O
that	O
the	O
SsrB	B-Protein
regulatory	O
palindrome	O
is	O
also	O
present	O
in	O
the	O
orthologous	O
SSR	O
-	O
3	O
island	O
of	O
the	O
endosymbiont	O
Sodalis	B-Organism
glossinidius	I-Organism
and	O
that	O
the	O
palindrome	O
evolved	O
in	O
Sodalis	B-Organism
can	O
act	O
as	O
a	O
cis	O
regulatory	O
input	O
function	O
in	O
Salmonella	B-Organism
.	O

Thus	O
,	O
in	O
addition	O
to	O
supporting	O
a	O
pathogenic	O
lifestyle	O
within	O
a	O
host	O
in	O
Salmonella	B-Organism
,	O
it	O
seems	O
probable	O
that	O
this	O
common	O
promoter	O
architecture	O
may	O
direct	O
the	O
activation	O
of	O
the	O
SSR	O
-	O
3	O
T3SS	O
of	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
in	O
its	O
endosymbiotic	O
relationship	O
with	O
the	O
tsetse	B-Organism
fly	I-Organism
host	O
,	O
although	O
we	O
acknowledge	O
this	O
requires	O
experimental	O
validation	O
.	O

The	O
SSR	O
-	O
3	O
region	O
in	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
is	O
fully	O
conserved	O
in	O
gene	O
synteny	O
and	O
content	O
with	O
that	O
of	O
SPI	O
-	O
2	O
[	O
31	O
]	O
,	O
with	O
the	O
exception	O
of	O
two	O
effector	O
genes	O
missing	O
in	O
SSR	O
-	O
3	O
(	O
sseF	B-Protein
and	O
sseG	B-Protein
)	O
that	O
are	O
required	O
to	O
localize	O
vacuolar	O
Salmonella	B-Organism
to	O
the	O
perinuclear	O
Golgi	O
in	O
host	O
cells	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
.	O

The	O
SsrB	B-Protein
ortholog	O
in	O
S	B-Organism
.	I-Organism
glossinidius	I-Organism
is	O
approximately30	O
%	O
divergent	O
with	O
SsrB	B-Protein
at	O
the	O
protein	O
level	O
,	O
initially	O
leading	O
us	O
to	O
think	O
that	O
they	O
might	O
have	O
different	O
binding	O
site	O
preferences	O
.	O

To	O
the	O
contrary	O
,	O
high	O
local	O
conservation	O
in	O
the	O
promoters	O
evolved	O
in	O
Salmonella	B-Organism
and	O
Sodalis	B-Organism
was	O
the	O
crux	O
in	O
defining	O
the	O
functional	O
SsrB	B-Protein
input	O
among	O
stochastic	O
noise	O
.	O

This	O
analysis	O
revealed	O
strong	O
palindrome	O
sequence	O
conservation	O
in	O
five	O
promoters	O
identified	O
in	O
SPI	O
-	O
2	O
and	O
in	O
the	O
orthologous	O
sequences	O
in	O
Sodalis	B-Organism
SSR	O
-	O
3	O
.	O

Among	O
palindrome	O
-	O
containing	O
promoters	O
,	O
the	O
ssrA	B-Protein
promoter	O
is	O
exceptional	O
for	O
two	O
reasons	O
:	O
a	O
lack	O
of	O
conservation	O
between	O
Salmonella	B-Organism
and	O
Sodalis	B-Organism
,	O
and	O
the	O
evolution	O
of	O
tandem	O
palindromes	O
in	O
Salmonella	B-Organism
.	O

One	O
possible	O
interpretation	O
of	O
this	O
divergent	O
regulatory	O
architecture	O
in	O
front	O
of	O
ssrA	B-Protein
might	O
relate	O
to	O
bacterial	O
lifestyle	O
.	O

Salmonella	B-Organism
may	O
have	O
retained	O
or	O
evolved	O
SsrB	B-Protein
input	O
here	O
to	O
create	O
a	O
positive	O
feedback	O
loop	O
on	O
the	O
regulatory	O
system	O
to	O
rapidly	O
adapt	O
to	O
the	O
host	O
environment	O
during	O
infection	O
,	O
similar	O
to	O
transcriptional	O
surge	O
described	O
for	O
the	O
PhoP	B-Protein
response	O
regulator	O
[	O
40	O
]	O
.	O

The	O
endosymbiotic	O
relationship	O
of	O
Sodalis	O
with	O
the	O
tsetse	B-Organism
fly	I-Organism
-	O
where	O
long	O
-	O
term	O
vertical	O
transmission	O
has	O
ostensibly	O
been	O
formative	O
in	O
shaping	O
regulatory	O
circuitry	O
at	O
certain	O
promoters	O
-	O
may	O
obviate	O
the	O
need	O
for	O
rapid	O
transcriptional	O
surge	O
,	O
leading	O
to	O
regulatory	O
drift	O
or	O
selection	O
against	O
positive	O
feedback	O
.	O

With	O
the	O
structure	O
of	O
SsrB	B-Protein
available	O
[	O
32	O
]	O
and	O
its	O
recognized	O
sequence	O
now	O
identified	O
,	O
future	O
studies	O
will	O
be	O
able	O
to	O
build	O
a	O
picture	O
of	O
how	O
SsrB	B-Protein
interacts	O
with	O
both	O
its	O
target	O
DNA	O
,	O
RNA	O
polymerase	O
and	O
potentially	O
other	O
transcription	O
factors	O
including	O
nucleoid	O
associated	O
proteins	O
in	O
order	O
to	O
direct	O
transcription	O
of	O
its	O
regulon	O
.	O

In	O
summary	O
,	O
this	O
work	O
highlights	O
the	O
evolutionary	O
significance	O
of	O
cis	O
-	O
regulatory	O
mutation	O
for	O
the	O
adaptation	O
of	O
Salmonella	O
to	O
a	O
host	O
animal	O
.	O

The	O
DNA	O
module	O
that	O
choreographs	O
SsrB	B-Protein
-	O
mediated	O
pathogenic	O
behaviour	O
in	O
Salmonella	B-Organism
appears	O
to	O
have	O
been	O
conserved	O
for	O
mutualism	O
as	O
well	O
,	O
thereby	O
shedding	O
new	O
light	O
on	O
the	O
significance	O
of	O
cis	O
-	O
regulatory	O
mutations	O
for	O
bacteria	O
evolving	O
in	O
different	O
ecological	O
settings	O
.	O

Microevolution	O
of	O
Group	B-Organism
A	I-Organism
Streptococci	I-Organism
In	O
Vivo	O
:	O
Capturing	O
Regulatory	O
Networks	O
Engaged	O
in	O
Sociomicrobiology	O
,	O
Niche	O
Adaptation	O
,	O
and	O
Hypervirulence	O

The	O
onset	O
of	O
infection	O
and	O
the	O
switch	O
from	O
primary	O
to	O
secondary	O
niches	O
are	O
dramatic	O
environmental	O
changes	O
that	O
not	O
only	O
alter	O
bacterial	O
transcriptional	O
programs	O
,	O
but	O
also	O
perturb	O
their	O
sociomicrobiology	O
,	O
often	O
driving	O
minor	O
subpopulations	O
with	O
mutant	O
phenotypes	O
to	O
prevail	O
in	O
specific	O
niches	O
.	O

Having	O
previously	O
reported	O
that	O
M1T1	B-Organism
Streptococcus	I-Organism
pyogenes	I-Organism
become	O
hypervirulent	O
in	O
mice	B-Organism
due	O
to	O
selection	O
of	O
mutants	O
in	O
the	O
covRS	B-Protein
regulatory	O
genes	O
,	O
we	O
set	O
out	O
to	O
dissect	O
the	O
impact	O
of	O
these	O
mutations	O
in	O
vitro	O
and	O
in	O
vivo	O
from	O
the	O
impact	O
of	O
other	O
adaptive	O
events	O
.	O

Using	O
a	O
murine	B-Organism
subcutaneous	O
chamber	O
model	O
to	O
sample	O
the	O
bacteria	O
prior	O
to	O
selection	O
or	O
expansion	O
of	O
mutants	O
,	O
we	O
compared	O
gene	O
expression	O
dynamics	O
of	O
wild	O
type	O
(	O
WT	O
)	O
and	O
previously	O
isolated	O
animal	O
-	O
passaged	O
(	O
AP	O
)	O
covS	B-Protein
mutant	O
bacteria	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
we	O
found	O
extensive	O
transcriptional	O
alterations	O
of	O
pathoadaptive	O
and	O
metabolic	O
gene	O
sets	O
associated	O
with	O
invasion	O
,	O
immune	O
evasion	O
,	O
tissue	O
-	O
dissemination	O
,	O
and	O
metabolic	O
reprogramming	O
.	O

In	O
contrast	O
to	O
the	O
virulence	O
-	O
associated	O
differences	O
between	O
WT	O
and	O
AP	B-Organism
bacteria	O
,	O
Phenotype	O
Microarray	O
analysis	O
showed	O
minor	O
in	O
vitro	O
phenotypic	O
differences	O
between	O
the	O
two	O
isogenic	O
variants	O
.	O

Additionally	O
,	O
our	O
results	O
reflect	O
that	O
WT	O
bacteria	O
'	O
s	O
rapid	O
host	O
-	O
adaptive	O
transcriptional	O
reprogramming	O
was	O
not	O
sufficient	O
for	O
their	O
survival	O
,	O
and	O
they	O
were	O
outnumbered	O
by	O
hypervirulent	O
covS	B-Protein
mutants	O
with	O
SpeB	B-Protein
-	O
/	O
Sdahigh	O
phenotype	O
,	O
which	O
survived	O
up	O
to	O
14	O
days	O
in	O
mice	B-Organism
chambers	O
.	O

Our	O
findings	O
demonstrate	O
the	O
engagement	O
of	O
unique	O
regulatory	O
modules	O
in	O
niche	O
adaptation	O
,	O
implicate	O
a	O
critical	O
role	O
for	O
bacterial	O
genetic	O
heterogeneity	O
that	O
surpasses	O
transcriptional	O
in	O
vivo	O
adaptation	O
,	O
and	O
portray	O
the	O
dynamics	O
underlying	O
the	O
selection	O
of	O
hypervirulent	O
covS	B-Protein
mutants	O
over	O
their	O
parental	O
WT	O
cells	O
.	O

Introduction	O

Group	B-Organism
A	I-Organism
streptococci	I-Organism
(	O
GAS	B-Organism
)	O
are	O
human	B-Organism
pathogens	O
that	O
infect	O
over	O
700	O
million	O
children	O
and	O
adults	O
each	O
year	O
[	O
1	O
]	O
.	O

Whereas	O
the	O
overall	O
mortality	O
rate	O
of	O
GAS	B-Organism
infections	O
is	O
less	O
than	O
0	O
.	O
1	O
%	O
,	O
the	O
mortality	O
rate	O
of	O
invasive	O
GAS	B-Organism
infections	O
,	O
which	O
have	O
resurged	O
in	O
the	O
past	O
30	O
years	O
,	O
mounts	O
to	O
25	O
%	O
(	O
out	O
of	O
>	O
650	O
,	O
000	O
new	O
cases	O
per	O
year	O
)	O
[	O
1	O
]	O
.	O

Among	O
the	O
various	O
GAS	B-Organism
serotypes	O
,	O
the	O
globally	O
disseminated	O
M1T1	B-Organism
clonal	O
strain	O
remains	O
the	O
most	O
frequently	O
isolated	O
from	O
cases	O
of	O
invasive	O
and	O
non	O
-	O
invasive	O
infections	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
,	O
and	O
although	O
disease	O
severity	O
partially	O
depends	O
on	O
host	O
genetic	O
factors	O
[	O
4	O
]	O
,	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
,	O
M1T1	B-Organism
GAS	I-Organism
possesses	O
unique	O
genomic	O
features	O
that	O
contribute	O
to	O
its	O
evolutionary	O
fitness	O
[	O
7	O
]	O
,	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
10	O
]	O
.	O

Among	O
these	O
features	O
is	O
the	O
ability	O
of	O
M1T1	B-Organism
bacteria	O
to	O
switch	O
to	O
a	O
hypervirulent	O
phenotype	O
associated	O
with	O
invasive	O
diseases	O
in	O
vivo	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
a	O
phenomenon	O
that	O
is	O
not	O
fully	O
understood	O
and	O
whose	O
specificity	O
to	O
the	O
M1	B-Organism
serotype	O
remains	O
to	O
be	O
established	O
[	O
15	O
]	O
.	O

We	O
previously	O
reported	O
that	O
virulent	O
representatives	O
of	O
M1T1	B-Organism
GAS	I-Organism
,	O
with	O
the	O
phenotype	O
SpeBhi	B-Protein
/	O
SpeA	B-Protein
-	O
/	O
Sda1low	B-Protein
,	O
irreversibly	O
switch	O
to	O
the	O
hypervirulent	O
SpeB	B-Protein
-	O
/	O
SpeA	B-Protein
+	O
/	O
Sda1high	B-Protein
phenotype	O
after	O
>	O
/	O
=	O
3	O
days	O
in	O
vivo	O
[	O
12	O
]	O
,	O
[	O
16	O
]	O
and	O
that	O
the	O
parent	O
phenotype	O
vanishes	O
by	O
day	O
7	O
post	O
-	O
infection	O
[	O
16	O
]	O
.	O

Subsequent	O
studies	O
uncovered	O
that	O
this	O
genetic	O
switch	O
is	O
driven	O
by	O
host	O
innate	O
immune	O
pressure	O
that	O
selects	O
for	O
bacteria	O
with	O
pathoadaptive	O
mutations	O
in	O
the	O
covRS	B-Protein
genetic	O
locus	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

CovRS	B-Protein
is	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
in	O
which	O
CovS	B-Protein
transduces	O
external	O
signals	O
[	O
17	O
]	O
,	O
[	O
18	O
]	O
to	O
CovR	B-Protein
,	O
which	O
in	O
turn	O
represses	O
the	O
transcription	O
of	O
several	O
group	B-Organism
A	I-Organism
streptococcal	I-Organism
(	O
GAS	B-Organism
)	O
virulence	O
gene	O
sets	O
,	O
including	O
the	O
capsule	O
synthesis	O
operon	O
(	O
hasABC	B-Protein
)	O
,	O
the	O
streptolysin	B-Regulon-operon
S	I-Regulon-operon
operon	I-Regulon-operon
(	O
SLS	B-Regulon-operon
or	O
sagA	B-Protein
-	O
H	B-Protein
)	O
,	O
and	O
the	O
streptokinase	O
gene	O
(	O
ska	O
)	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
.	O

CovR	B-Protein
regulatory	O
activity	O
is	O
thought	O
to	O
be	O
triggered	O
when	O
the	O
protein	O
is	O
phosphorylated	O
at	O
D53	O
[	O
21	O
]	O
,	O
possibly	O
by	O
acetyl	B-Chemical
phosphate	I-Chemical
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

On	O
the	O
other	O
hand	O
,	O
under	O
stress	O
conditions	O
,	O
CovS	B-Protein
dephosphorylates	O
CovR	B-Protein
and	O
reverses	O
virulence	O
gene	O
repression	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
.	O

Mutations	O
in	O
covS	B-Protein
are	O
thus	O
expected	O
to	O
affect	O
CovR	B-Protein
phosphorylation	O
status	O
differentially	O
in	O
vitro	O
and	O
in	O
vivo	O
(	O
under	O
stress	O
conditions	O
)	O
,	O
and	O
to	O
consequently	O
modulate	O
CovRS	B-Protein
signaling	O
-	O
regulation	O
circuits	O
in	O
a	O
complex	O
manner	O
that	O
remains	O
largely	O
unexplored	O
.	O

This	O
complexity	O
is	O
further	O
magnified	O
by	O
the	O
reported	O
strain	O
-	O
specific	O
differences	O
in	O
the	O
impact	O
of	O
CovS	B-Protein
on	O
pathogenesis	O
[	O
24	O
]	O
,	O
by	O
the	O
finding	O
that	O
phosphorylated	O
CovR	B-Protein
has	O
different	O
affinities	O
to	O
different	O
streptococcal	O
promoters	O
[	O
21	O
]	O
,	O
and	O
by	O
the	O
possibility	O
that	O
CovR	B-Protein
promoter	O
binding	O
may	O
be	O
modulated	O
by	O
kinases	O
or	O
phosphatases	O
other	O
than	O
CovS	B-Protein
[	O
25	O
]	O
.	O

In	O
fact	O
,	O
CovR	B-Protein
retains	O
some	O
of	O
its	O
functions	O
in	O
the	O
absence	O
of	O
wild	O
type	O
CovS	B-Protein
[	O
26	O
]	O
,	O
and	O
different	O
covS	B-Protein
mutations	O
,	O
albeit	O
clustered	O
in	O
its	O
histidine	O
kinase	O
domain	O
,	O
might	O
have	O
different	O
effects	O
on	O
expression	O
of	O
CovR	B-Protein
-	O
regulated	O
genes	O
[	O
27	O
]	O
.	O

In	O
accordance	O
with	O
these	O
biochemical	O
findings	O
,	O
we	O
and	O
others	O
have	O
reported	O
that	O
some	O
covS	B-Protein
mutations	O
generate	O
hypervirulent	O
isolates	O
associated	O
with	O
invasive	O
forms	O
of	O
streptococcal	O
infection	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
28	O
]	O
.	O

One	O
of	O
the	O
most	O
striking	O
outcomes	O
of	O
these	O
mutations	O
is	O
the	O
constitutive	O
repression	O
of	O
a	O
gene	O
encoding	O
the	O
key	O
GAS	B-Organism
cysteine	O
protease	O
,	O
SpeB	B-Protein
,	O
which	O
remodels	O
the	O
host	O
-	O
pathogen	O
interface	O
[	O
29	O
]	O
by	O
differentially	O
degrading	O
bacterial	O
surface	O
and	O
secreted	O
proteins	O
[	O
12	O
]	O
,	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
as	O
well	O
as	O
host	O
proteins	O
[	O
32	O
]	O
,	O
[	O
33	O
]	O
,	O
[	O
34	O
]	O
.	O

Consequently	O
,	O
absence	O
of	O
a	O
proteolytically	O
active	O
SpeB	B-Protein
preserves	O
several	O
virulence	O
factors	O
that	O
it	O
normally	O
degrades	O
[	O
12	O
]	O
,	O
[	O
35	O
]	O
.	O

One	O
of	O
these	O
preserved	O
factors	O
is	O
the	O
highly	O
potent	O
DNase	O
,	O
Sda1	B-Protein
,	O
which	O
destroys	O
neutrophil	O
extracellular	O
traps	O
,	O
NETs	O
[	O
36	O
]	O
,	O
protecting	O
the	O
bacteria	O
from	O
neutrophil	O
killing	O
,	O
promoting	O
bacterial	O
invasion	O
,	O
and	O
facilitating	O
human	B-Organism
plasminogen	B-Protein
-	O
mediated	O
bacterial	O
dissemination	O
into	O
normally	O
sterile	O
sites	O
,	O
which	O
results	O
in	O
invasive	O
infections	O
[	O
14	O
]	O
.	O

Despite	O
the	O
association	O
between	O
covS	B-Protein
mutations	O
and	O
the	O
emergence	O
of	O
the	O
hypervirulent	O
phenotype	O
of	O
M1T1	B-Organism
strains	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
increased	O
virulence	O
can	O
be	O
entirely	O
attributed	O
to	O
the	O
modulation	O
of	O
the	O
CovR	B-Protein
regulon	O
or	O
if	O
other	O
networks	O
are	O
also	O
perturbed	O
in	O
vivo	O
directly	O
,	O
indirectly	O
,	O
or	O
independently	O
of	O
the	O
CovRS	B-Protein
system	O
.	O

Additionally	O
,	O
the	O
effects	O
of	O
covS	B-Protein
mutations	O
on	O
bacterial	O
niche	O
adaptability	O
are	O
still	O
undetermined	O
because	O
the	O
in	O
vivo	O
transcriptomes	O
of	O
the	O
wild	O
type	O
(	O
WT	O
)	O
and	O
animal	O
-	O
passaged	O
(	O
AP	B-Organism
)	O
bacteria	O
have	O
not	O
been	O
compared	O
under	O
the	O
same	O
experimental	O
conditions	O
.	O

To	O
address	O
these	O
issues	O
and	O
improve	O
our	O
understanding	O
of	O
the	O
gene	O
regulatory	O
impact	O
of	O
mutational	O
and	O
adaptive	O
events	O
contributing	O
to	O
the	O
hypervirulent	O
phenotype	O
of	O
M1T1	B-Organism
strains	O
,	O
we	O
analyzed	O
differences	O
in	O
growth	O
requirements	O
,	O
transcriptome	O
profiles	O
,	O
and	O
regulatory	O
circuits	O
of	O
the	O
virulent	O
(	O
WT	O
)	O
and	O
hypervirulent	O
(	O
AP	B-Organism
)	O
phenotypes	O
of	O
the	O
M1T1	B-Organism
strain	O
both	O
in	O
vitro	O
and	O
during	O
initial	O
in	O
vivo	O
infection	O
.	O

Such	O
comprehensive	O
analyses	O
highlighted	O
the	O
behavior	O
of	O
genomic	O
subsystems	O
that	O
may	O
be	O
involved	O
directly	O
or	O
indirectly	O
in	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
niche	O
adaptation	O
and	O
pathogenesis	O
.	O

In	O
addition	O
,	O
this	O
approach	O
offered	O
a	O
rare	O
transcriptional	O
snapshot	O
of	O
the	O
SpeBhi	B-Protein
/	O
SpeA	B-Protein
-	O
/	O
Sda1low	B-Protein
population	O
prior	O
to	O
its	O
extinction	O
in	O
vivo	O
.	O

Results	O

Phenotype	O
Microarrays	O
show	O
no	O
major	O
nutritional	O
or	O
metabolic	O
differences	O
between	O
wild	O
type	O
and	O
animal	O
-	O
passaged	O
,	O
hypervirulent	O
M1T1	B-Organism
GAS	I-Organism
We	O
used	O
Biolog	O
(	O
R	O
)	O
Phenotype	O
Microarrays	O
(	O
PM	O
)	O
to	O
screen	O
1900	O
different	O
growth	O
conditions	O
,	O
including	O
a	O
large	O
set	O
of	O
different	O
carbon	B-Chemical
and	O
nitrogen	B-Chemical
sources	O
,	O
pH	O
values	O
and	O
salt	B-Chemical
concentrations	O
,	O
as	O
well	O
as	O
different	O
concentrations	O
of	O
various	O
antimicrobial	O
agents	O
(	O
Fig	O
.	O
S1	O
)	O
,	O
and	O
found	O
that	O
both	O
WT	O
and	O
AP	B-Organism
GAS	I-Organism
have	O
similar	O
growth	O
requirements	O
in	O
vitro	O
with	O
minor	O
differences	O
.	O

For	O
example	O
,	O
AP	B-Organism
bacteria	O
grew	O
better	O
than	O
WT	O
bacteria	O
in	O
the	O
presence	O
of	O
N	B-Chemical
-	I-Chemical
acetyl	I-Chemical
-	I-Chemical
neuraminic	I-Chemical
acid	I-Chemical
,	O
and	O
were	O
more	O
sensitive	O
to	O
four	O
antimicrobials	O
(	O
out	O
of	O
373	O
screened	O
in	O
PM	O
)	O
,	O
including	O
the	O
calcium	O
-	O
specific	O
metal	O
chelator	O
EGTA	B-Chemical
,	O
the	O
lipophilic	O
chelator	O
5	B-Chemical
-	I-Chemical
chloro	I-Chemical
-	I-Chemical
7	I-Chemical
-	I-Chemical
iodo	I-Chemical
-	I-Chemical
8	I-Chemical
-	I-Chemical
hydroxyquinoline	I-Chemical
,	O
and	O
the	O
antibiotics	O
tobramycin	B-Chemical
and	O
cefotaxime	B-Chemical
(	O
Table	O
1	O
)	O
.	O

However	O
,	O
when	O
both	O
bacterial	O
variants	O
were	O
grown	O
at	O
37degreesC	O
in	O
the	O
enriched	O
Todd	O
Hewitt	O
broth	O
medium	O
,	O
their	O
growth	O
rates	O
were	O
indistinguishable	O
,	O
and	O
the	O
only	O
detectable	O
difference	O
was	O
that	O
AP	B-Organism
bacteria	O
were	O
more	O
buoyant	O
in	O
liquid	O
culture	O
compared	O
to	O
WT	O
.	O

This	O
difference	O
in	O
buoyancy	O
can	O
be	O
attributed	O
to	O
differences	O
in	O
proteolytic	O
activity	O
(	O
WT	O
>	O
>	O
AP	B-Organism
)	O
that	O
may	O
degrade	O
many	O
surface	O
proteins	O
,	O
including	O
pilin	B-Protein
,	O
or	O
induce	O
changes	O
in	O
the	O
surface	O
charge	O
making	O
bacterial	O
aggregates	O
more	O
compact	O
.	O

The	O
difference	O
in	O
buoyancy	O
can	O
also	O
be	O
attributed	O
to	O
differences	O
in	O
the	O
expression	O
of	O
hyaluronic	B-Chemical
acid	I-Chemical
capsule	O
(	O
AP	B-Organism
>	O
WT	O
)	O
.	O

Although	O
the	O
PM	O
results	O
confirm	O
previous	O
experiments	O
[	O
16	O
]	O
showing	O
a	O
few	O
minor	O
differences	O
between	O
WT	O
and	O
AP	B-Organism
bacteria	O
in	O
vitro	O
,	O
this	O
technology	O
is	O
limited	O
because	O
it	O
uses	O
minimal	O
media	O
and	O
measures	O
microbial	O
respiration	O
as	O
a	O
growth	O
indicator	O
(	O
http	O
:	O
/	O
/	O
www	O
.	O
biolog	O
.	O
com	O
)	O
.	O

Minimal	O
media	O
are	O
not	O
optimal	O
for	O
the	O
expression	O
of	O
GAS	B-Organism
proteins	O
,	O
which	O
may	O
explain	O
why	O
GAS	B-Organism
failed	O
to	O
grow	O
at	O
many	O
of	O
the	O
PM	O
conditions	O
(	O
Fig	O
.	O
S1	O
)	O
and	O
why	O
fewer	O
phenotypic	O
differences	O
were	O
observed	O
between	O
WT	O
and	O
AP	B-Organism
bacteria	O
than	O
transcriptomic	O
differences	O
(	O
see	O
below	O
)	O
.	O

In	O
vivo	O
murine	B-Organism
chamber	O
infection	O
model	O
allows	O
the	O
dissection	O
of	O
regulatory	O
vs	O
.	O
mutation	O
-	O
selection	O
events	O

Several	O
studies	O
,	O
including	O
ours	O
,	O
have	O
examined	O
phenotypic	O
,	O
proteomic	O
,	O
and	O
transcriptional	O
differences	O
between	O
WT	O
and	O
animal	O
-	O
passaged	O
M1T1	B-Organism
GAS	I-Organism
strains	O
[	O
For	O
example	O
,	O
11	O
,	O
12	O
,	O
13	O
,	O
16	O
,	O
26	O
,	O
27	O
,	O
37	O
]	O
,	O
but	O
none	O
attempted	O
to	O
capture	O
the	O
dynamic	O
changes	O
in	O
the	O
bacterial	O
population	O
in	O
vivo	O
.	O

Because	O
bacteria	O
recovered	O
from	O
animals	O
and	O
cultured	O
in	O
the	O
laboratory	O
are	O
likely	O
to	O
have	O
reprogrammed	O
many	O
regulatory	O
networks	O
to	O
re	O
-	O
adapt	O
to	O
the	O
in	O
vitro	O
growth	O
conditions	O
,	O
transcriptome	O
profiling	O
of	O
these	O
bacteria	O
may	O
not	O
reflect	O
their	O
actual	O
in	O
vivo	O
gene	O
expression	O
and	O
regulation	O
.	O

In	O
this	O
study	O
,	O
we	O
designed	O
and	O
performed	O
in	O
vivo	O
passage	O
experiments	O
in	O
which	O
equal	O
loads	O
of	O
in	O
vitro	O
-	O
grown	O
WT	O
and	O
AP	B-Organism
bacteria	O
were	O
separately	O
inoculated	O
into	O
murine	B-Organism
subcutaneous	O
chambers	O
[	O
16	O
]	O
and	O
collected	O
by	O
needle	O
aspiration	O
after	O
24	O
h	O
,	O
a	O
time	O
sufficient	O
for	O
the	O
bacteria	O
to	O
sense	O
the	O
host	O
environment	O
and	O
transcriptionally	O
respond	O
to	O
it	O
,	O
but	O
not	O
long	O
enough	O
to	O
allow	O
detectable	O
restructuring	O
of	O
the	O
bacterial	O
community	O
and	O
selection	O
of	O
mutants	O
.	O

The	O
concentrations	O
of	O
viable	O
WT	O
and	O
AP	B-Organism
bacteria	O
at	O
24	O
h	O
post	O
-	O
inoculation	O
remained	O
essentially	O
the	O
same	O
:	O
1	O
-	O
5x109	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
ml	O
vs	O
.	O
approximately2x109	O
CFU	O
/	O
ml	O
inoculum	O
.	O

We	O
extracted	O
RNA	O
from	O
these	O
bacteria	O
immediately	O
after	O
their	O
recovery	O
from	O
mouse	B-Organism
chambers	O
with	O
no	O
additional	O
culturing	O
and	O
used	O
the	O
extracted	O
RNA	O
for	O
transcriptome	O
profiling	O
as	O
detailed	O
in	O
Materials	O
and	O
Methods	O
.	O

For	O
transcriptional	O
profiling	O
,	O
we	O
followed	O
a	O
cyclic	O
,	O
two	O
-	O
color	O
design	O
and	O
performed	O
28	O
oligonucleotide	O
microarray	O
hybridization	O
experiments	O
representing	O
technical	O
and	O
biological	O
replicates	O
of	O
the	O
four	O
cell	O
states	O
under	O
investigation	O
:	O
WT	O
grown	O
in	O
vitro	O
(	O
WT	O
-	O
vitro	O
)	O
,	O
WT	O
grown	O
in	O
vivo	O
(	O
WT	O
-	O
vivo	O
)	O
,	O
AP	B-Organism
grown	O
in	O
vitro	O
(	O
AP	B-Organism
-	O
vitro	O
)	O
,	O
and	O
AP	B-Organism
grown	O
in	O
vivo	O
(	O
AP	B-Organism
-	O
vivo	O
)	O
,	O
Fig	O
.	O

1	O
.	O

Multiple	O
approaches	O
to	O
microarray	O
analysis	O
show	O
statistically	O
significant	O
and	O
biologically	O
relevant	O
differences	O
between	O
the	O
WT	O
and	O
AP	B-Organism
populations	O
in	O
vitro	O
and	O
in	O
vivo	O

To	O
gain	O
biologically	O
relevant	O
knowledge	O
from	O
the	O
transcriptome	O
studies	O
without	O
compromising	O
statistical	O
significance	O
,	O
we	O
interrogated	O
the	O
data	O
using	O
multiple	O
strategies	O
that	O
had	O
been	O
developed	O
for	O
microarray	O
analysis	O
and	O
visualization	O
,	O
taking	O
into	O
consideration	O
the	O
strengths	O
and	O
limitations	O
of	O
each	O
strategy	O
.	O

By	O
clustering	O
normalized	O
expression	O
values	O
from	O
different	O
biological	O
replicates	O
in	O
all	O
data	O
sets	O
,	O
we	O
generated	O
an	O
overall	O
"	O
pathovivogram	O
"	O
that	O
includes	O
276	O
genes	O
in	O
ten	O
coexpression	O
clusters	O
,	O
CCs	O
(	O
Fig	O
.	O
2	O
,	O
Fig	O
.	O
S2	O
,	O
and	O
Table	O
S1	O
)	O
.	O

This	O
pathovivogram	O
highlights	O
the	O
transcriptional	O
patterns	O
that	O
distinguish	O
WT	O
from	O
AP	B-Organism
bacteria	O
regardless	O
of	O
their	O
growth	O
habitat	O
(	O
pathogram	O
,	O
Fig	O
2	O
.	O
CC4	O
-	O
CC6	O
and	O
CC8	O
-	O
CC10	O
)	O
,	O
and	O
the	O
transcriptional	O
patterns	O
that	O
are	O
shared	O
by	O
WT	O
-	O
vitro	O
and	O
AP	B-Organism
-	O
vitro	O
bacteria	O
but	O
that	O
differentiate	O
them	O
from	O
their	O
corresponding	O
in	O
vivo	O
samples	O
(	O
vivogram	O
,	O
Fig	O
.	O
2	O
,	O
CC1	O
-	O
CC3	O
)	O
.	O

Moreover	O
,	O
we	O
identified	O
a	O
unique	O
cluster	O
,	O
CC7	O
,	O
that	O
includes	O
genes	O
upregulated	O
both	O
in	O
vivo	O
and	O
as	O
a	O
consequence	O
of	O
the	O
covS	B-Protein
mutation	O
(	O
e	O
.	O
g	O
.	O
,	O
those	O
encoding	O
M	B-Protein
protein	I-Protein
,	O
streptolysin	B-Protein
O	I-Protein
,	O
and	O
nicotinamide	B-Protein
adenine	I-Protein
dinucleotide	I-Protein
glycohydrolase	I-Protein
(	O
NADGH	B-Protein
)	O
,	O
Fig	O
.	O
2	O
,	O
CC7	O
)	O
.	O

The	O
patterns	O
in	O
clusters	O
CC1	O
-	O
CC3	O
describe	O
those	O
gene	O
sets	O
whose	O
transcription	O
was	O
turned	O
on	O
(	O
CC1	O
-	O
CC2	O
)	O
or	O
off	O
(	O
CC3	O
)	O
to	O
drive	O
the	O
bacterial	O
adaptation	O
to	O
the	O
host	O
environment	O
,	O
but	O
are	O
not	O
primarily	O
related	O
to	O
bacterial	O
pathogenesis	O
.	O

Many	O
of	O
these	O
genes	O
encode	O
metabolic	O
enzymes	O
(	O
e	O
.	O
g	O
.	O
,	O
carbohydrate	O
metabolism	O
,	O
arginine	O
degradation	O
,	O
and	O
pyrimidine	O
biosynthesis	O
)	O
,	O
ribosomal	O
proteins	O
(	O
mostly	O
downregulated	O
)	O
,	O
and	O
sugar	O
or	O
peptide	O
transport	O
systems	O
,	O
reflecting	O
the	O
transition	O
from	O
a	O
carbohydrate	O
-	O
rich	O
laboratory	O
medium	O
to	O
a	O
protein	O
-	O
rich	O
,	O
oxygen	B-Chemical
-	O
poor	O
subcutaneous	O
tissue	O
.	O

Such	O
transition	O
is	O
bound	O
to	O
have	O
major	O
downstream	O
effects	O
on	O
the	O
bacterial	O
virulence	O
gene	O
expression	O
[	O
38	O
]	O
,	O
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

While	O
the	O
expression	O
patterns	O
in	O
clusters	O
CC4	O
,	O
CC5	O
,	O
CC8	O
,	O
and	O
CC9	O
match	O
the	O
previously	O
described	O
in	O
vitro	O
differences	O
between	O
WT	O
and	O
AP	B-Organism
strains	O
[	O
10	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
(	O
e	O
.	O
g	O
.	O
,	O
downregulation	O
of	O
SpeB	B-Protein
,	O
CAMP	B-Protein
,	O
and	O
EndoS	B-Protein
genes	O
;	O
upregulation	O
of	O
SpeA	B-Protein
,	O
SIC	B-Protein
,	O
and	O
capsule	O
genes	O
)	O
,	O
the	O
combined	O
comparative	O
analysis	O
of	O
in	O
vitro	O
and	O
in	O
vivo	O
samples	O
revealed	O
novel	O
expression	O
patterns	O
exemplified	O
by	O
CC6	O
and	O
CC10	O
.	O

These	O
two	O
clusters	O
include	O
genes	O
whose	O
expression	O
has	O
been	O
repressed	O
(	O
CC6	O
)	O
or	O
induced	O
(	O
CC10	O
)	O
by	O
the	O
AP	B-Organism
mutation	O
,	O
but	O
the	O
repression	O
or	O
induction	O
becomes	O
observable	O
only	O
in	O
vivo	O
.	O

For	O
example	O
,	O
the	O
expression	O
of	O
genes	O
in	O
the	O
SLS	B-Regulon-operon
and	O
Trx	B-Regulon-operon
operons	I-Regulon-operon
is	O
induced	O
in	O
vivo	O
only	O
in	O
WT	O
bacteria	O
,	O
but	O
is	O
mostly	O
repressed	O
in	O
AP	B-Organism
bacteria	O
(	O
Fig	O
.	O
2	O
,	O
CC6	O
)	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Likewise	O
,	O
some	O
genes	O
are	O
only	O
induced	O
in	O
AP	B-Organism
-	O
vivo	O
,	O
including	O
those	O
encoding	O
the	O
toxin	O
/	O
enzyme	O
streptokinase	O
and	O
a	O
RofA	B-Protein
/	O
Nra	B-Protein
-	O
like	O
transcriptional	O
regulator	O
(	O
Fig	O
.	O
2	O
,	O
CC10	O
)	O
.	O

Subsequent	O
to	O
the	O
coexpression	O
analysis	O
,	O
we	O
calculated	O
differential	O
expression	O
ratios	O
between	O
each	O
pair	O
of	O
conditions	O
(	O
Table	O
S2	O
)	O
at	O
different	O
statistical	O
significance	O
cutoffs	O
,	O
starting	O
by	O
the	O
commonly	O
used	O
significance	O
threshold	O
of	O
twofold	O
ratio	O
and	O
P	O
value	O
<	O
0	O
.	O
05	O
,	O
and	O
moving	O
to	O
thresholds	O
that	O
are	O
more	O
conservative	O
.	O

At	O
all	O
significance	O
cutoffs	O
,	O
the	O
fewest	O
observed	O
transcriptional	O
changes	O
were	O
those	O
differentiating	O
WT	O
and	O
AP	B-Organism
bacteria	O
in	O
vitro	O
compared	O
to	O
other	O
pairs	O
of	O
conditions	O
.	O

By	O
contrast	O
,	O
the	O
most	O
dramatic	O
transcriptional	O
reprogramming	O
was	O
that	O
exhibited	O
by	O
the	O
WT	O
bacteria	O
in	O
their	O
attempt	O
to	O
adapt	O
to	O
the	O
in	O
vivo	O
environment	O
(	O
Table	O
2	O
)	O
.	O

Overall	O
,	O
at	O
the	O
least	O
conservative	O
statistical	O
threshold	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
the	O
transcription	O
of	O
557	O
(	O
23	O
.	O
9	O
%	O
)	O
out	O
of	O
2	O
,	O
329	O
genes	O
probed	O
in	O
the	O
microarrays	O
was	O
significantly	O
perturbed	O
(	O
up	O
or	O
down	O
,	O
at	O
one	O
or	O
more	O
conditions	O
,	O
Fig	O
.	O
S3	O
)	O
and	O
the	O
only	O
set	O
of	O
contiguous	O
genes	O
that	O
underwent	O
transcriptional	O
changes	O
at	O
all	O
tested	O
conditions	O
is	O
the	O
SpeB	B-Protein
operon	O
gene	O
set	O
(	O
CC4	O
in	O
Fig	O
.	O
2	O
)	O
.	O

However	O
,	O
the	O
fold	O
-	O
change	O
in	O
SpeB	B-Protein
operon	O
transcription	O
level	O
largely	O
varied	O
across	O
the	O
four	O
experimental	O
conditions	O
,	O
ranging	O
from	O
a	O
2	O
.	O
2	O
-	O
fold	O
to	O
a	O
30	O
-	O
fold	O
downregulation	O
(	O
Table	O
3	O
)	O
.	O

Inspired	O
by	O
the	O
recently	O
described	O
neighbor	O
clustering	O
method	O
for	O
microarray	O
analysis	O
[	O
41	O
]	O
,	O
we	O
also	O
mapped	O
the	O
significant	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
differential	O
expression	O
ratios	O
of	O
different	O
genes	O
to	O
their	O
chromosomal	O
loci	O
(	O
Fig	O
.	O
3	O
and	O
Fig	O
.	O
S4	O
)	O
to	O
allow	O
the	O
visualization	O
of	O
coexpressed	O
contiguous	O
genes	O
,	O
including	O
operons	O
.	O

This	O
mapping	O
highlighted	O
genes	O
that	O
might	O
otherwise	O
have	O
been	O
overlooked	O
by	O
the	O
CC	O
or	O
expression	O
ratio	O
methods	O
.	O

Examples	O
of	O
neighbor	O
clusters	O
(	O
NCs	O
)	O
enriched	O
in	O
differentially	O
expressed	O
genes	O
are	O
a	O
locus	O
involved	O
in	O
L	B-Chemical
-	I-Chemical
ascorbate	I-Chemical
utilization	O
(	O
SPy0175	B-Protein
-	O
SPy0179	B-Protein
)	O
;	O
the	O
citrate	O
lyase	O
locus	O
(	O
SPy1186	B-Protein
-	O
SPy1191	B-Protein
)	O
;	O
the	O
Trx	O
chromosomal	O
locus	O
(	O
SPy1582	B-Protein
-	O
SPy1596	B-Protein
)	O
that	O
includes	O
the	O
recently	O
described	O
,	O
CovR	B-Protein
-	O
repressed	O
two	O
-	O
component	O
response	O
regulator	O
TrxR	B-Protein
[	O
42	O
]	O
;	O
and	O
the	O
well	O
-	O
studied	O
Mga	B-Protein
(	O
SPy2010	B-Protein
-	O
SPy2025	B-Protein
)	O
,	O
SpeB	B-Protein
(	O
SPy2037	B-Protein
-	O
SPy2042	B-Protein
)	O
,	O
and	O
capsule	O
synthesis	O
(	O
SPy2200	B-Protein
-	O
SPy2202	B-Protein
)	O
loci	O
(	O
Fig	O
.	O
3	O
and	O
Fig	O
.	O
S4	O
)	O
.	O

NC	O
analysis	O
also	O
allowed	O
us	O
to	O
visualize	O
genomic	O
clusters	O
that	O
are	O
similarly	O
regulated	O
in	O
vitro	O
and	O
in	O
vivo	O
,	O
and	O
those	O
that	O
are	O
reciprocally	O
regulated	O
.	O

For	O
example	O
,	O
in	O
both	O
the	O
SLS	B-Regulon-operon
operon	I-Regulon-operon
and	O
the	O
Trx	O
locus	O
,	O
we	O
observed	O
a	O
striking	O
difference	O
between	O
the	O
effects	O
of	O
the	O
covS	B-Protein
mutation	O
and	O
the	O
in	O
vivo	O
adaptation	O
(	O
Fig	O
.	O
4	O
,	O
CC6	O
)	O
.	O

Genes	O
of	O
these	O
two	O
chromosomal	O
clusters	O
are	O
significantly	O
downregulated	O
in	O
AP	B-Organism
compared	O
to	O
WT	O
bacteria	O
,	O
but	O
significantly	O
upregulated	O
in	O
WT	O
-	O
vivo	O
relative	O
to	O
WT	O
-	O
vitro	O
conditions	O
(	O
Fig	O
.	O
4	O
,	O
CC6	O
)	O
.	O

As	O
a	O
final	O
step	O
of	O
our	O
multifaceted	O
data	O
analysis	O
approach	O
,	O
we	O
tabulated	O
significant	O
transcriptional	O
changes	O
of	O
individual	O
genes	O
that	O
encode	O
known	O
regulators	O
and	O
well	O
-	O
studied	O
virulence	O
factors	O
(	O
Table	O
3	O
)	O
.	O

Focusing	O
on	O
those	O
genes	O
highlights	O
the	O
pathogenesis	O
-	O
related	O
changes	O
and	O
allows	O
easy	O
comparison	O
of	O
our	O
data	O
with	O
those	O
in	O
the	O
literature	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
37	O
]	O
.	O

Data	O
integration	O
reveals	O
genomic	O
subsystems	O
influenced	O
by	O
the	O
covS	B-Protein
mutation	O
in	O
vitro	O
and	O
in	O
vivo	O

By	O
combining	O
different	O
strategies	O
for	O
microarray	O
data	O
analysis	O
,	O
we	O
took	O
advantage	O
of	O
the	O
strengths	O
of	O
each	O
strategy	O
to	O
generate	O
biologically	O
relevant	O
gene	O
sets	O
rather	O
than	O
gene	O
lists	O
ordered	O
solely	O
according	O
to	O
statistical	O
parameters	O
.	O

The	O
next	O
stage	O
in	O
our	O
analysis	O
was	O
to	O
integrate	O
microarray	O
data	O
,	O
moving	O
from	O
the	O
gene	O
/	O
cluster	O
level	O
to	O
the	O
level	O
of	O
biological	O
subsystems	O
.	O

A	O
subsystem	O
is	O
a	O
part	O
of	O
a	O
genome	O
that	O
represents	O
a	O
functional	O
module	O
,	O
e	O
.	O
g	O
.	O
,	O
an	O
operon	O
,	O
a	O
cellular	O
pathway	O
,	O
a	O
regulon	O
,	O
or	O
a	O
complex	O
regulatory	O
network	O
[	O
43	O
]	O
.	O

The	O
genes	O
perturbed	O
by	O
the	O
different	O
experimental	O
conditions	O
of	O
this	O
study	O
correspond	O
to	O
multiple	O
subsystems	O
(	O
Fig	O
.	O
5	O
)	O
.	O

Of	O
interest	O
,	O
among	O
the	O
genes	O
of	O
known	O
function	O
,	O
25	O
%	O
of	O
those	O
whose	O
transcription	O
was	O
modulated	O
as	O
a	O
consequence	O
of	O
the	O
covS	B-Protein
mutation	O
are	O
virulence	O
-	O
related	O
and	O
another	O
25	O
%	O
are	O
related	O
to	O
carbohydrate	O
metabolism	O
pathways	O
,	O
which	O
are	O
connected	O
to	O
virulence	O
in	O
streptococci	B-Organism
[	O
44	O
]	O
,	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

When	O
we	O
attempted	O
to	O
correlate	O
the	O
array	O
results	O
with	O
known	O
GAS	B-Organism
regulons	O
,	O
some	O
differentially	O
expressed	O
gene	O
sets	O
could	O
be	O
fitted	O
into	O
previously	O
described	O
regulatory	O
networks	O
while	O
others	O
did	O
not	O
belong	O
to	O
any	O
such	O
networks	O
.	O

For	O
example	O
,	O
the	O
upregulation	O
of	O
Ska	B-Protein
,	O
SLO	B-Protein
/	O
Nga	B-Protein
,	O
and	O
the	O
Has	B-Protein
operon	O
is	O
a	O
pattern	O
that	O
reflects	O
the	O
inhibition	O
of	O
CovR	B-Protein
repression	O
,	O
whereas	O
the	O
downregulation	O
of	O
both	O
SpeB	B-Protein
and	O
SLS	B-Regulon-operon
operons	I-Regulon-operon
is	O
a	O
pattern	O
associated	O
with	O
the	O
transcriptional	O
regulator	O
RopB	B-Protein
/	O
Rgg	B-Protein
[	O
47	O
]	O
,	O
[	O
48	O
]	O
but	O
that	O
may	O
also	O
reflect	O
augmented	O
CovR	B-Protein
repression	O
[	O
20	O
]	O
.	O

Although	O
CovS	B-Protein
is	O
expected	O
to	O
modulate	O
many	O
known	O
CovR	B-Protein
-	O
repressed	O
subsystems	O
,	O
certain	O
operons	O
may	O
be	O
differentially	O
modulated	O
or	O
may	O
be	O
influenced	O
by	O
other	O
regulator	O
(	O
s	O
)	O
.	O

Alternatively	O
,	O
the	O
mutation	O
in	O
covS	B-Protein
may	O
have	O
different	O
effects	O
on	O
CovR	B-Protein
-	O
mediated	O
regulation	O
of	O
different	O
genes	O
[	O
26	O
]	O
.	O

In	O
fact	O
,	O
our	O
in	O
vivo	O
data	O
show	O
that	O
covR	B-Protein
itself	O
is	O
downregulated	O
in	O
vivo	O
in	O
both	O
WT	O
and	O
AP	B-Organism
strains	O
(	O
Fig	O
.	O
2	O
,	O
CC2	O
and	O
Table	O
S1	O
)	O
;	O
however	O
,	O
the	O
SLS	B-Regulon-operon
operon	I-Regulon-operon
is	O
upregulated	O
in	O
vivo	O
in	O
WT	O
bacteria	O
,	O
suggesting	O
that	O
its	O
regulation	O
is	O
not	O
solely	O
modulated	O
by	O
CovRS	B-Protein
.	O

It	O
is	O
possible	O
that	O
SLS	O
is	O
regulated	O
by	O
the	O
catabolite	O
control	O
protein	O
(	O
CcpA	B-Protein
)	O
,	O
which	O
was	O
recently	O
shown	O
to	O
be	O
another	O
key	O
transcriptional	O
regulator	O
of	O
the	O
SLS	B-Regulon-operon
operon	I-Regulon-operon
[	O
46	O
]	O
and	O
which	O
may	O
override	O
CovR	B-Protein
-	O
mediated	O
repression	O
of	O
SLS	O
.	O

Another	O
complex	O
regulatory	O
pattern	O
is	O
exhibited	O
by	O
the	O
genes	O
of	O
the	O
Trx	O
locus	O
,	O
which	O
include	O
a	O
two	O
-	O
component	O
regulatory	O
system	O
,	O
TrxRS	B-Protein
.	O

The	O
TrxRS	B-Protein
system	O
reportedly	O
responds	O
to	O
a	O
yet	O
-	O
to	O
-	O
be	O
-	O
identified	O
extracellular	O
signal	O
while	O
TrxR	B-Protein
itself	O
is	O
directly	O
regulated	O
by	O
CovR	B-Protein
[	O
42	O
]	O
.	O

Most	O
genes	O
within	O
the	O
Trx	O
locus	O
are	O
downregulated	O
in	O
AP	B-Organism
GAS	I-Organism
relative	O
to	O
WT	O
,	O
but	O
upregulated	O
in	O
the	O
WT	O
bacteria	O
in	O
vivo	O
(	O
Fig	O
.	O
2	O
,	O
CC6	O
and	O
Fig	O
.	O
3	O
)	O
suggesting	O
the	O
possibility	O
of	O
CovS	B-Protein
-	O
dependent	O
in	O
vivo	O
signaling	O
.	O

One	O
last	O
factor	O
that	O
adds	O
to	O
the	O
complexity	O
of	O
data	O
integration	O
analysis	O
and	O
that	O
may	O
explain	O
unexpected	O
transcriptional	O
patterns	O
is	O
that	O
regulators	O
are	O
often	O
controlled	O
by	O
sensitive	O
feedback	O
mechanisms	O
.	O

Inactivation	O
or	O
downregulation	O
of	O
one	O
regulator	O
may	O
eventually	O
perturb	O
the	O
entire	O
system	O
,	O
and	O
several	O
other	O
regulators	O
are	O
likely	O
to	O
become	O
engaged	O
in	O
compensatory	O
mechanisms	O
to	O
maintain	O
cellular	O
homeostasis	O
.	O

Discussion	O

Group	O
A	O
streptococcal	O
sociomicrobiology	O
It	O
is	O
now	O
well	O
established	O
that	O
bacterial	O
populations	O
often	O
consist	O
of	O
heterogeneous	O
communities	O
rather	O
than	O
genetically	O
identical	O
cells	O
with	O
synchronized	O
gene	O
expression	O
profiles	O
[	O
49	O
]	O
,	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
how	O
gross	O
changes	O
in	O
the	O
bacterial	O
environment	O
,	O
such	O
as	O
the	O
onset	O
of	O
infection	O
,	O
can	O
profoundly	O
perturb	O
the	O
sociomicrobiological	O
structure	O
of	O
the	O
bacterial	O
population	O
,	O
driving	O
a	O
minor	O
subpopulation	O
with	O
a	O
mutant	O
hypervirulent	O
phenotype	O
to	O
thrive	O
,	O
prevail	O
,	O
and	O
cause	O
severe	O
disease	O
.	O

Although	O
a	O
number	O
of	O
informative	O
studies	O
have	O
compared	O
gene	O
and	O
protein	O
expression	O
in	O
virulent	O
and	O
hypervirulent	O
GAS	B-Organism
isolates	O
[	O
11	O
]	O
,	O
[	O
12	O
]	O
,	O
[	O
13	O
]	O
,	O
[	O
16	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
37	O
]	O
,	O
none	O
have	O
captured	O
the	O
transitional	O
state	O
that	O
reflects	O
the	O
dynamics	O
of	O
the	O
bacterial	O
struggle	O
to	O
survive	O
in	O
a	O
new	O
host	O
environment	O
.	O

Normally	O
,	O
capturing	O
such	O
evolutionary	O
events	O
in	O
real	O
time	O
is	O
difficult	O
,	O
both	O
because	O
multiple	O
sampling	O
of	O
the	O
bacteria	O
in	O
vivo	O
is	O
often	O
unfeasible	O
due	O
to	O
their	O
dissemination	O
,	O
and	O
because	O
the	O
fittest	O
members	O
of	O
the	O
community	O
usually	O
overtake	O
the	O
rest	O
of	O
the	O
population	O
rather	O
rapidly	O
,	O
thereby	O
hampering	O
the	O
ability	O
to	O
capture	O
dynamic	O
changes	O
associated	O
with	O
the	O
restructuring	O
of	O
the	O
bacterial	O
community	O
at	O
different	O
host	O
niches	O
.	O

Our	O
subcutaneous	O
chamber	O
model	O
of	O
infection	O
allowed	O
us	O
to	O
sample	O
the	O
inoculated	O
WT	O
and	O
AP	B-Organism
bacteria	O
at	O
specific	O
times	O
post	O
-	O
infection	O
,	O
during	O
their	O
adaptation	O
to	O
their	O
new	O
environment	O
,	O
to	O
determine	O
how	O
their	O
interaction	O
with	O
the	O
host	O
affects	O
their	O
community	O
structure	O
and	O
their	O
transcriptional	O
reprogramming	O
.	O

In	O
doing	O
so	O
,	O
we	O
were	O
able	O
to	O
dissect	O
changes	O
in	O
gene	O
expression	O
associated	O
with	O
niche	O
adaptation	O
from	O
those	O
resulting	O
from	O
restructuring	O
of	O
the	O
bacterial	O
community	O
,	O
where	O
undetected	O
minority	O
members	O
in	O
vitro	O
became	O
the	O
new	O
majority	O
in	O
vivo	O
,	O
armed	O
with	O
the	O
necessary	O
tools	O
to	O
survive	O
in	O
their	O
new	O
niche	O
.	O

These	O
in	O
vivo	O
-	O
selected	O
bacteria	O
with	O
the	O
AP	B-Organism
phenotype	O
could	O
be	O
differentiated	O
from	O
the	O
WT	O
bacteria	O
by	O
mutations	O
that	O
are	O
clustered	O
in	O
the	O
sensor	O
kinase	O
-	O
encoding	O
covS	B-Protein
gene	O
in	O
AP	B-Organism
bacteria	O
[	O
14	O
]	O
,	O
[	O
27	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
captured	O
dynamic	O
events	O
underlying	O
the	O
phenotypic	O
switch	O
resulting	O
from	O
this	O
population	O
restructuring	O
.	O

Environmental	O
adaptation	O
vs	O
.	O
covS	B-Protein
mutation	O

In	O
vitro	O
,	O
the	O
growth	O
of	O
these	O
two	O
variants	O
of	O
the	O
M1T1	B-Organism
bacteria	O
was	O
comparable	O
and	O
,	O
although	O
137	O
(	O
5	O
.	O
9	O
%	O
)	O
of	O
their	O
genes	O
were	O
differentially	O
expressed	O
(	O
Table	O
2	O
)	O
,	O
in	O
vitro	O
phenotypic	O
screening	O
revealed	O
negligible	O
differences	O
(	O
Table	O
1	O
)	O
.	O

This	O
suggests	O
that	O
the	O
majority	O
of	O
in	O
vitro	O
vs	O
.	O
in	O
vivo	O
differentially	O
expressed	O
genes	O
between	O
the	O
WT	O
and	O
AP	B-Organism
variants	O
may	O
be	O
involved	O
in	O
niche	O
adaptation	O
.	O

This	O
finding	O
is	O
in	O
agreement	O
with	O
studies	O
showing	O
that	O
the	O
CovRS	B-Protein
system	O
is	O
mainly	O
linked	O
to	O
the	O
regulation	O
of	O
virulence	O
factors	O
and	O
virulence	O
-	O
associated	O
pathways	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
,	O
[	O
24	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
,	O
[	O
28	O
]	O
,	O
[	O
52	O
]	O
,	O
[	O
53	O
]	O
,	O
[	O
54	O
]	O
,	O
[	O
55	O
]	O
.	O

Indeed	O
,	O
several	O
virulence	O
genes	O
were	O
among	O
the	O
137	O
in	O
vitro	O
differentially	O
expressed	O
genes	O
between	O
these	O
two	O
M1T1	B-Organism
variants	O
.	O

Upregulated	O
gene	O
sets	O
in	O
AP	B-Organism
vs	O
.	O
WT	O
bacteria	O
in	O
vitro	O
included	O
Mga	O
locus	O
genes	O
(	O
e	O
.	O
g	O
.	O
,	O
sic	B-Protein
,	O
emm	B-Protein
,	O
scp	B-Protein
)	O
;	O
hyaluronic	B-Chemical
acid	I-Chemical
capsule	O
-	O
encoding	O
genes	O
(	O
hasABC	B-Protein
)	O
;	O
and	O
genes	O
encoding	O
the	O
toxins	O
SpeA	B-Protein
,	O
SclA	B-Protein
,	O
SLO	B-Protein
,	O
and	O
the	O
streptodornase	O
Sda1	B-Protein
(	O
Fig	O
.	O
2	O
,	O
Fig	O
.	O
S2	O
,	O
and	O
Table	O
3	O
)	O
.	O

Other	O
well	O
-	O
studied	O
gene	O
sets	O
were	O
downregulated	O
in	O
AP	O
bacteria	O
grown	O
in	O
vitro	O
.	O

Besides	O
metabolic	O
gene	O
sets	O
involved	O
in	O
trehalose	B-Chemical
and	O
ascorbate	B-Chemical
utilization	O
,	O
several	O
known	O
virulence	O
factors	O
were	O
downregulated	O
in	O
AP	B-Organism
bacteria	O
,	O
and	O
these	O
included	O
the	O
SpeB	B-Protein
operon	O
,	O
GRAB	B-Protein
,	O
EndoS	B-Protein
,	O
and	O
CAMP	O
factor	O
.	O

SpeB	B-Protein
is	O
a	O
major	O
virulence	O
factor	O
in	O
GAS	B-Organism
pathogenesis	O
and	O
its	O
expression	O
is	O
regulated	O
by	O
different	O
systems	O
[	O
40	O
]	O
,	O
[	O
56	O
]	O
,	O
[	O
57	O
]	O
,	O
[	O
58	O
]	O
,	O
including	O
the	O
CovRS	B-Protein
system	O
[	O
20	O
]	O
,	O
[	O
53	O
]	O
.	O

Whereas	O
SpeB	B-Protein
expression	O
may	O
be	O
important	O
in	O
the	O
initial	O
stages	O
of	O
skin	O
infections	O
[	O
29	O
]	O
,	O
[	O
35	O
]	O
,	O
its	O
downregulation	O
has	O
been	O
associated	O
with	O
an	O
invasive	O
and	O
hypervirulent	O
phenotype	O
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
[	O
59	O
]	O
.	O

The	O
downregulation	O
of	O
GRAB	B-Protein
makes	O
biological	O
sense	O
because	O
this	O
protein	O
binds	O
alpha	B-Protein
-	I-Protein
2	I-Protein
-	I-Protein
macroglobulin	I-Protein
in	O
blood	O
[	O
60	O
]	O
to	O
protect	O
the	O
bacteria	O
against	O
its	O
own	O
protease	O
,	O
SpeB	B-Protein
,	O
and	O
thus	O
the	O
bacteria	O
no	O
longer	O
need	O
to	O
express	O
high	O
levels	O
of	O
GRAB	B-Protein
when	O
SpeB	B-Protein
is	O
not	O
expressed	O
.	O

Similarly	O
,	O
EndoS	B-Protein
,	O
an	O
IgG	B-Protein
protease	O
,	O
and	O
CAMP	O
,	O
a	O
hemolysin	B-Protein
,	O
are	O
likely	O
needed	O
in	O
blood	O
but	O
with	O
no	O
defined	O
function	O
in	O
subcutaneous	O
or	O
deep	O
tissue	O
.	O

Their	O
downregulation	O
in	O
AP	B-Organism
is	O
thus	O
consistent	O
with	O
the	O
hypothesis	O
that	O
this	O
hypervirulent	O
variant	O
is	O
adapted	O
for	O
deep	O
infection	O
.	O

In	O
addition	O
,	O
the	O
downregulation	O
of	O
SpeB	B-Protein
,	O
EndoS	B-Protein
,	O
and	O
CAMP	O
is	O
in	O
agreement	O
with	O
our	O
previous	O
proteomic	O
results	O
[	O
12	O
]	O
as	O
well	O
as	O
other	O
published	O
transcriptional	O
analyses	O
[	O
13	O
]	O
,	O
[	O
27	O
]	O
.	O

As	O
both	O
bacterial	O
variants	O
were	O
subjected	O
to	O
the	O
host	O
environment	O
,	O
they	O
underwent	O
additional	O
changes	O
in	O
gene	O
expression	O
.	O

In	O
vivo	O
,	O
both	O
WT	O
and	O
AP	B-Organism
bacteria	O
downregulated	O
a	O
substantial	O
number	O
of	O
their	O
genes	O
(	O
127	O
genes	O
in	O
CC1	O
and	O
CC2	O
,	O
Fig	O
.	O
2	O
and	O
Table	O
S1	O
)	O
,	O
and	O
upregulated	O
many	O
fewer	O
(	O
24	O
genes	O
in	O
CC3	O
,	O
Fig	O
.	O
2	O
and	O
Table	O
S1	O
)	O
.	O

By	O
parsing	O
these	O
differentially	O
expressed	O
genes	O
into	O
operons	O
,	O
subsystems	O
,	O
and	O
functional	O
pathways	O
,	O
we	O
found	O
that	O
many	O
reflect	O
the	O
engagement	O
of	O
several	O
regulatory	O
networks	O
involved	O
in	O
metabolic	O
adaptation	O
and	O
immune	O
camouflage	O
or	O
evasion	O
of	O
host	O
defenses	O
.	O

Many	O
of	O
the	O
in	O
vivo	O
changes	O
that	O
both	O
the	O
WT	O
and	O
AP	B-Organism
bacteria	O
underwent	O
are	O
suggestive	O
of	O
major	O
metabolic	O
reprogramming	O
associated	O
with	O
the	O
transition	O
from	O
a	O
saprophytic	O
lifestyle	O
in	O
the	O
carbohydrate	O
-	O
rich	O
laboratory	O
culture	O
medium	O
to	O
a	O
parasitic	O
lifestyle	O
in	O
the	O
vascularized	O
and	O
the	O
anaerobic	O
subcutaneous	O
environments	O
rich	O
in	O
peptides	O
,	O
amino	O
acids	O
,	O
nucleotides	O
,	O
and	O
different	O
types	O
of	O
complex	O
carbohydrates	O
.	O

For	O
example	O
,	O
among	O
the	O
downregulated	O
gene	O
sets	O
are	O
those	O
involved	O
in	O
citrate	B-Chemical
metabolism	O
,	O
arginine	O
degradation	O
,	O
and	O
de	O
novo	O
pyrimidine	B-Chemical
synthesis	O
;	O
many	O
of	O
those	O
gene	O
sets	O
were	O
previously	O
reported	O
to	O
be	O
perturbed	O
upon	O
blood	O
inoculation	O
and	O
to	O
be	O
controlled	O
by	O
CovR	B-Protein
[	O
61	O
]	O
and	O
RopB	B-Protein
/	O
Rgg	B-Protein
[	O
38	O
]	O
.	O

We	O
also	O
found	O
that	O
many	O
ribosomal	O
and	O
cell	O
-	O
division	O
proteins	O
were	O
downregulated	O
in	O
vivo	O
,	O
which	O
suggests	O
that	O
the	O
cells	O
may	O
be	O
slowing	O
down	O
protein	O
synthesis	O
to	O
preserve	O
energy	O
,	O
or	O
redirect	O
this	O
energy	O
to	O
colonizing	O
the	O
host	O
and	O
evading	O
its	O
immune	O
system	O
.	O

The	O
downregulation	O
of	O
arginine	O
deiminase	O
,	O
a	O
streptococcal	O
immunogen	O
and	O
a	O
potential	O
vaccine	O
target	O
(	O
Henningham	O
et	O
al	O
.	O
,	O
submitted	O
)	O
,	O
is	O
also	O
suggestive	O
of	O
immune	O
evasion	O
.	O

Among	O
the	O
upregulated	O
genes	O
are	O
dipepetide	O
and	O
sucrose	O
-	O
specific	O
transporters	O
,	O
whose	O
upregulation	O
supports	O
the	O
hypothesis	O
that	O
the	O
bacteria	O
are	O
switching	O
diets	O
[	O
39	O
]	O
and	O
attempting	O
to	O
scavenge	O
nutrients	O
available	O
in	O
their	O
new	O
host	O
environment	O
.	O

Several	O
phage	O
genes	O
are	O
split	O
between	O
the	O
upregulated	O
and	O
downregulated	O
gene	O
clusters	O
;	O
this	O
may	O
indicate	O
a	O
stress	O
-	O
dependent	O
reprogramming	O
of	O
prophage	O
induction	O
and	O
gene	O
expression	O
that	O
needs	O
to	O
be	O
explored	O
in	O
future	O
studies	O
.	O

Interestingly	O
,	O
what	O
this	O
study	O
revealed	O
is	O
that	O
some	O
of	O
the	O
downstream	O
regulatory	O
effects	O
of	O
the	O
covS	B-Protein
mutation	O
in	O
AP	B-Organism
bacteria	O
are	O
only	O
manifested	O
in	O
vivo	O
.	O

For	O
example	O
,	O
several	O
gene	O
sets	O
(	O
e	O
.	O
g	O
.	O
,	O
SLS	O
genes	O
,	O
Trx	O
-	O
locus	O
genes	O
,	O
L	B-Chemical
-	I-Chemical
ascorbate	I-Chemical
utilization	O
genes	O
)	O
were	O
upregulated	O
in	O
WT	O
bacteria	O
in	O
vivo	O
,	O
but	O
were	O
mostly	O
silenced	O
in	O
AP	B-Organism
bacteria	O
in	O
vivo	O
(	O
Fig	O
.	O
2	O
,	O
CC6	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
genes	O
encoding	O
the	O
fibrinolytic	O
enzyme	O
streptokinase	O
,	O
Ska	B-Protein
,	O
a	O
RofA	B-Protein
-	O
like	O
transcriptional	O
regulator	O
,	O
several	O
cell	O
division	O
proteins	O
,	O
and	O
some	O
phage	O
proteins	O
were	O
only	O
upregulated	O
when	O
the	O
AP	B-Organism
bacteria	O
sensed	O
the	O
in	O
vivo	O
environment	O
(	O
AP	B-Organism
-	O
vivo	O
,	O
Fig	O
.	O
2	O
,	O
CC10	O
)	O
.	O

Both	O
these	O
expression	O
patterns	O
suggest	O
CovS	B-Protein
-	O
dependent	O
in	O
vivo	O
signaling	O
via	O
different	O
downstream	O
pathways	O
.	O

Finally	O
,	O
genes	O
encoding	O
the	O
antiphagocytic	O
M	O
protein	O
,	O
and	O
the	O
toxins	O
streptolysin	B-Protein
O	I-Protein
and	O
NADGH	B-Protein
were	O
among	O
few	O
genes	O
that	O
were	O
upregulated	O
in	O
all	O
conditions	O
except	O
WT	O
-	O
vitro	O
(	O
Fig	O
.	O
2	O
,	O
CC7	O
)	O
,	O
which	O
suggests	O
that	O
their	O
transcription	O
is	O
dependent	O
on	O
multiple	O
signals	O
,	O
including	O
signals	O
from	O
the	O
host	O
as	O
well	O
as	O
covS	B-Protein
-	O
dependent	O
cues	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
how	O
the	O
murine	B-Organism
model	O
has	O
allowed	O
us	O
to	O
finely	O
dissect	O
two	O
classes	O
of	O
events	O
affecting	O
GAS	B-Organism
sociomicrobiology	O
:	O
those	O
related	O
to	O
reversible	O
transcriptional	O
adaptation	O
and	O
those	O
irreversibly	O
caused	O
by	O
the	O
covS	B-Protein
mutation	O
in	O
AP	B-Organism
bacteria	O
.	O

Microarray	O
validation	O
and	O
analysis	O

Although	O
our	O
microarray	O
studies	O
were	O
extensive	O
(	O
28	O
arrays	O
for	O
4	O
conditions	O
)	O
,	O
we	O
ran	O
qPCR	O
to	O
validate	O
the	O
microarray	O
findings	O
,	O
focusing	O
on	O
virulence	O
genes	O
that	O
are	O
biomarkers	O
of	O
the	O
bacterial	O
switch	O
to	O
a	O
hypervirulent	O
phenotype	O
.	O

These	O
include	O
SpeA	B-Protein
,	O
SpeB	B-Protein
,	O
Sda1	B-Protein
,	O
M	O
protein	O
,	O
and	O
SIC	B-Protein
[	O
data	O
published	O
in	O
14	O
]	O
.	O

Comparing	O
the	O
microarray	O
data	O
in	O
this	O
study	O
with	O
previously	O
published	O
work	O
provides	O
further	O
validation	O
of	O
these	O
results	O
.	O

For	O
example	O
,	O
the	O
in	O
vitro	O
microarray	O
results	O
are	O
consistent	O
with	O
our	O
previous	O
proteomic	O
studies	O
of	O
the	O
WT	O
and	O
AP	B-Organism
secreted	O
bacterial	O
proteomes	O
[	O
12	O
]	O
as	O
well	O
as	O
with	O
other	O
recently	O
published	O
studies	O
of	O
the	O
in	O
vitro	O
transcriptome	O
of	O
closely	O
related	O
strains	O
[	O
13	O
]	O
,	O
[	O
26	O
]	O
,	O
[	O
27	O
]	O
.	O

Importantly	O
,	O
we	O
did	O
not	O
base	O
our	O
analysis	O
on	O
single	O
measurements	O
of	O
gene	O
expression	O
,	O
nor	O
did	O
we	O
focus	O
on	O
individual	O
genes	O
;	O
rather	O
,	O
we	O
used	O
gene	O
expression	O
data	O
from	O
biological	O
replicates	O
to	O
rule	O
out	O
biological	O
variability	O
(	O
especially	O
between	O
bacteria	O
recovered	O
from	O
different	O
mice	B-Organism
)	O
and	O
to	O
look	O
for	O
changes	O
in	O
gene	O
clusters	O
,	O
operons	O
,	O
and	O
pathways	O
.	O

In	O
doing	O
so	O
,	O
we	O
were	O
able	O
to	O
assess	O
trends	O
across	O
experiments	O
rather	O
than	O
absolute	O
numerical	O
values	O
that	O
could	O
vary	O
due	O
to	O
technical	O
rather	O
than	O
biological	O
factors	O
.	O

We	O
believe	O
that	O
this	O
approach	O
provided	O
more	O
confidence	O
in	O
the	O
final	O
assessment	O
of	O
which	O
genes	O
/	O
pathways	O
were	O
expressed	O
similarly	O
or	O
differentially	O
in	O
both	O
WT	O
and	O
AP	B-Organism
bacteria	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

It	O
also	O
allowed	O
us	O
to	O
dissect	O
changes	O
related	O
to	O
niche	O
adaptation	O
from	O
those	O
reflecting	O
the	O
selection	O
of	O
the	O
fittest	O
members	O
of	O
the	O
bacterial	O
community	O
when	O
faced	O
with	O
different	O
environments	O
and	O
conditions	O
.	O

The	O
use	O
of	O
multiple	O
microarray	O
analysis	O
strategies	O
and	O
the	O
integration	O
of	O
their	O
results	O
strengthened	O
this	O
study	O
since	O
each	O
strategy	O
has	O
advantages	O
and	O
disadvantages	O
.	O

For	O
example	O
,	O
coexpression	O
clustering	O
-	O
one	O
of	O
the	O
earliest	O
developed	O
microarray	O
analysis	O
tools	O
[	O
62	O
]	O
,	O
[	O
63	O
]	O
-	O
provides	O
an	O
overall	O
view	O
of	O
expression	O
patterns	O
of	O
different	O
genes	O
,	O
and	O
greatly	O
helps	O
dissect	O
and	O
demonstrate	O
the	O
effect	O
of	O
each	O
condition	O
on	O
the	O
overall	O
transcriptome	O
.	O

However	O
,	O
coexpression	O
analysis	O
alone	O
can	O
miss	O
some	O
biologically	O
relevant	O
genes	O
that	O
could	O
fail	O
the	O
statistical	O
tests	O
for	O
non	O
-	O
biological	O
reasons	O
(	O
e	O
.	O
g	O
.	O
,	O
poorly	O
hybridizing	O
probes	O
,	O
low	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
,	O
or	O
high	O
variance	O
)	O
and	O
may	O
instead	O
include	O
some	O
irrelevant	O
genes	O
in	O
isolation	O
of	O
their	O
biological	O
networks	O
[	O
41	O
]	O
.	O

In	O
bacteria	O
,	O
biochemical	O
pathways	O
,	O
virulence	O
systems	O
,	O
and	O
multimeric	O
proteins	O
are	O
often	O
encoded	O
next	O
to	O
each	O
other	O
by	O
chromosomally	O
contiguous	O
or	O
clustered	O
genes	O
[	O
64	O
]	O
,	O
[	O
65	O
]	O
.	O

Analyzing	O
coexpressed	O
genes	O
in	O
the	O
context	O
of	O
chromosomal	O
clusters	O
is	O
thus	O
most	O
informative	O
.	O

Indeed	O
,	O
neighbor	O
clustering	O
[	O
41	O
]	O
has	O
allowed	O
the	O
enrichment	O
for	O
contiguous	O
gene	O
sets	O
and	O
the	O
prediction	O
of	O
more	O
context	O
-	O
related	O
expression	O
patterns	O
.	O

Genes	O
in	O
neighbor	O
clusters	O
could	O
have	O
been	O
otherwise	O
overlooked	O
either	O
because	O
they	O
were	O
misannotated	O
but	O
their	O
co	O
-	O
occurrence	O
in	O
known	O
clusters	O
revealed	O
their	O
importance	O
,	O
or	O
because	O
they	O
did	O
not	O
pass	O
the	O
statistical	O
tests	O
but	O
,	O
since	O
many	O
bacterial	O
transcripts	O
are	O
polycistronic	O
,	O
the	O
expression	O
of	O
two	O
or	O
more	O
members	O
of	O
a	O
polycistron	O
strongly	O
suggests	O
that	O
the	O
whole	O
operon	O
is	O
expressed	O
.	O

Besides	O
these	O
two	O
clustering	O
methods	O
,	O
expression	O
ratios	O
provided	O
pairwise	O
comparison	O
,	O
thereby	O
allowing	O
the	O
quantification	O
of	O
the	O
impact	O
of	O
each	O
individual	O
change	O
of	O
condition	O
on	O
overall	O
gene	O
expression	O
(	O
Table	O
2	O
)	O
as	O
well	O
as	O
on	O
specific	O
genes	O
of	O
interest	O
(	O
Table	O
3	O
)	O
.	O

However	O
,	O
the	O
use	O
of	O
ratios	O
alone	O
may	O
be	O
misleading	O
,	O
especially	O
when	O
they	O
are	O
calculated	O
between	O
two	O
transcripts	O
with	O
low	O
expression	O
levels	O
,	O
resulting	O
in	O
spurious	O
ratios	O
of	O
low	O
biological	O
significance	O
.	O

Similarly	O
,	O
the	O
common	O
use	O
of	O
statistical	O
constraints	O
with	O
ratio	O
calculation	O
(	O
e	O
.	O
g	O
.	O
,	O
two	O
-	O
fold	O
ratios	O
and	O
P	O
values	O
<	O
0	O
.	O
05	O
)	O
filters	O
out	O
many	O
biologically	O
relevant	O
genes	O
that	O
are	O
true	O
positives	O
.	O

Finally	O
,	O
the	O
use	O
of	O
operons	O
,	O
subsystems	O
,	O
and	O
pathways	O
to	O
describe	O
the	O
array	O
results	O
avoids	O
inappropriately	O
building	O
conclusions	O
on	O
the	O
transcriptional	O
changes	O
of	O
individual	O
genes	O
and	O
thus	O
better	O
reflects	O
biologically	O
relevant	O
perturbations	O
in	O
specific	O
pathways	O
.	O

The	O
bigger	O
picture	O
:	O
niche	O
adaptation	O
and	O
the	O
evolution	O
of	O
hypervirulence	O
in	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism

Having	O
used	O
multiple	O
strategies	O
and	O
integrated	O
the	O
PM	O
data	O
with	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
microarray	O
data	O
,	O
we	O
propose	O
the	O
following	O
hypotheses	O
about	O
streptococcal	O
niche	O
adaptation	O
and	O
switch	O
to	O
hypervirulence	O
:	O
(	O
1	O
)	O
Exposure	O
to	O
the	O
in	O
vivo	O
environment	O
perturbs	O
a	O
substantial	O
number	O
of	O
GAS	B-Organism
genes	O
and	O
regulatory	O
networks	O
.	O

This	O
has	O
been	O
demonstrated	O
by	O
the	O
larger	O
number	O
of	O
genes	O
affected	O
during	O
in	O
vivo	O
adaptation	O
of	O
both	O
M1T1	B-Organism
variants	O
compared	O
to	O
those	O
affected	O
by	O
the	O
covS	B-Protein
mutation	O
(	O
Table	O
2	O
)	O
.	O

However	O
,	O
many	O
of	O
the	O
genes	O
modulated	O
in	O
vivo	O
seem	O
to	O
be	O
involved	O
in	O
metabolic	O
reprogramming	O
and	O
stress	O
responses	O
rather	O
than	O
pathoadaptation	O
and	O
virulence	O
.	O

This	O
is	O
why	O
we	O
believe	O
that	O
transcriptional	O
reprogramming	O
by	O
environmental	O
adaptation	O
alone	O
was	O
insufficient	O
to	O
provide	O
WT	O
bacteria	O
with	O
an	O
in	O
vivo	O
survival	O
advantage	O
.	O

In	O
fact	O
,	O
WT	O
bacteria	O
underwent	O
the	O
most	O
dramatic	O
in	O
vivo	O
transcriptional	O
reprogramming	O
(	O
Table	O
2	O
)	O
;	O
yet	O
,	O
they	O
failed	O
to	O
survive	O
since	O
after	O
five	O
to	O
seven	O
days	O
post	O
-	O
infection	O
,	O
they	O
became	O
extinct	O
,	O
and	O
only	O
AP	O
bacteria	O
could	O
be	O
isolated	O
from	O
the	O
mice	B-Organism
chambers	O
[	O
16	O
]	O
.	O

(	O
2	O
)	O
The	O
covS	B-Protein
mutation	O
in	O
AP	B-Organism
bacteria	O
seems	O
to	O
be	O
preferentially	O
modulating	O
virulence	O
mechanisms	O
,	O
as	O
about	O
25	O
%	O
of	O
the	O
known	O
genes	O
perturbed	O
by	O
the	O
mutation	O
belong	O
to	O
virulence	O
subsystems	O
(	O
Fig	O
.	O
5	O
)	O
and	O
many	O
of	O
the	O
other	O
perturbed	O
genes	O
are	O
indirectly	O
associated	O
with	O
virulence	O
(	O
e	O
.	O
g	O
.	O
,	O
carbohydrate	O
metabolism	O
[	O
66	O
]	O
and	O
arginine	O
utilization	O
proteins	O
[	O
38	O
]	O
)	O
.	O

In	O
addition	O
,	O
the	O
pathoadaptive	O
clusters	O
(	O
CC4	O
-	O
CC10	O
in	O
Fig	O
.	O
2	O
)	O
are	O
more	O
enriched	O
in	O
virulence	O
-	O
related	O
genes	O
than	O
the	O
clusters	O
involved	O
in	O
in	O
vivo	O
adaption	O
(	O
CC1	O
-	O
CC3	O
in	O
Fig	O
.	O
2	O
)	O
.	O

This	O
finding	O
suggests	O
that	O
AP	B-Organism
bacteria	O
are	O
somehow	O
"	O
pre	O
-	O
adapted	O
"	O
to	O
invasiveness	O
and	O
,	O
consequently	O
,	O
when	O
injected	O
into	O
mice	B-Organism
,	O
they	O
do	O
not	O
undergo	O
much	O
virulence	O
-	O
related	O
changes	O
as	O
they	O
already	O
possess	O
a	O
thicker	O
capsule	O
,	O
lack	O
a	O
functional	O
SpeB	B-Protein
,	O
are	O
equipped	O
with	O
surface	O
virulence	O
proteins	O
,	O
and	O
secrete	O
ready	O
-	O
to	O
-	O
use	O
toxins	O
,	O
including	O
the	O
potent	O
DNase	O
,	O
Sda1	B-Protein
.	O

However	O
,	O
the	O
degree	O
of	O
AP	B-Organism
invasiveness	O
might	O
vary	O
depending	O
on	O
the	O
route	O
of	O
infection	O
and	O
animal	O
model	O
[	O
15	O
]	O
.	O

It	O
is	O
noteworthy	O
that	O
SpeB	B-Protein
expression	O
has	O
a	O
dominant	O
effect	O
,	O
since	O
even	O
if	O
secreted	O
in	O
low	O
amounts	O
by	O
a	O
minor	O
subpopulation	O
,	O
this	O
broad	O
-	O
spectrum	O
protease	O
would	O
still	O
be	O
able	O
to	O
degrade	O
,	O
fully	O
or	O
partially	O
,	O
many	O
GAS	B-Organism
virulence	O
proteins	O
,	O
including	O
Sda1	B-Protein
,	O
thereby	O
rendering	O
the	O
bacteria	O
vulnerable	O
to	O
different	O
effector	O
mechanisms	O
of	O
the	O
host	O
'	O
s	O
innate	O
immune	O
system	O
including	O
neutrophil	O
killing	O
[	O
14	O
]	O
,	O
[	O
67	O
]	O
,	O
[	O
68	O
]	O
.	O

Thus	O
,	O
a	O
complete	O
shutdown	O
of	O
proteolytically	O
active	O
SpeB	B-Protein
is	O
essential	O
to	O
preserve	O
effective	O
extracellular	O
virulence	O
factors	O
[	O
15	O
]	O
.	O

This	O
dominant	O
SpeB	B-Protein
effect	O
may	O
explain	O
why	O
WT	O
bacteria	O
parish	O
in	O
vivo	O
even	O
though	O
they	O
partially	O
downregulate	O
SpeB	B-Protein
transcription	O
(	O
Table	O
3	O
)	O
.	O

(	O
3	O
)	O
The	O
GAS	B-Organism
genome	O
has	O
at	O
least	O
13	O
two	O
-	O
component	O
regulatory	O
systems	O
[	O
69	O
]	O
in	O
addition	O
to	O
several	O
stand	O
-	O
alone	O
transcriptional	O
regulators	O
[	O
47	O
]	O
,	O
[	O
70	O
]	O
.	O

However	O
,	O
the	O
CovRS	B-Protein
system	O
is	O
a	O
major	O
player	O
,	O
among	O
these	O
regulators	O
,	O
in	O
driving	O
the	O
bacterial	O
adaptation	O
to	O
the	O
host	O
'	O
s	O
environment	O
and	O
regulating	O
virulence	O
directly	O
or	O
through	O
other	O
downstream	O
regulators	O
[	O
20	O
]	O
,	O
[	O
54	O
]	O
.	O

It	O
is	O
thus	O
counterintuitive	O
that	O
bacteria	O
lacking	O
the	O
important	O
environmental	O
sensor	O
,	O
CovS	B-Protein
,	O
would	O
prevail	O
in	O
one	O
of	O
the	O
most	O
stressful	O
environments	O
.	O

However	O
,	O
losing	O
this	O
sensor	O
might	O
be	O
the	O
last	O
resort	O
for	O
these	O
bacteria	O
stranded	O
away	O
from	O
their	O
primary	O
niche	O
and	O
surrounded	O
by	O
hostile	O
immune	O
cells	O
and	O
proteins	O
.	O

From	O
an	O
evolutionary	O
point	O
of	O
view	O
,	O
it	O
is	O
possible	O
to	O
speculate	O
that	O
the	O
bacteria	O
lose	O
their	O
danger	O
sensor	O
to	O
keep	O
their	O
"	O
weapons	O
"	O
constitutively	O
expressed	O
and	O
fight	O
to	O
survive	O
when	O
escape	O
is	O
not	O
an	O
option	O
.	O

Such	O
mutation	O
is	O
likely	O
detrimental	O
to	O
the	O
bacterial	O
long	O
-	O
term	O
survival	O
and	O
dissemination	O
via	O
colonization	O
of	O
new	O
hosts	O
[	O
71	O
]	O
,	O
as	O
they	O
need	O
a	O
WT	O
sensor	O
for	O
better	O
adaptability	O
[	O
72	O
]	O
(	O
e	O
.	O
g	O
.	O
,	O
in	O
less	O
hostile	O
niches	O
like	O
throat	O
or	O
saliva	O
[	O
26	O
]	O
)	O
.	O

An	O
intact	O
CovRS	B-Protein
system	O
would	O
offer	O
the	O
bacteria	O
enough	O
versatility	O
to	O
turn	O
on	O
and	O
off	O
many	O
regulatory	O
networks	O
through	O
CovS	B-Protein
signaling	O
.	O

This	O
flexible	O
mechanism	O
allows	O
the	O
bacteria	O
to	O
initially	O
hide	O
from	O
the	O
immune	O
system	O
through	O
SpeB	B-Protein
-	O
driven	O
camouflaging	O
,	O
i	O
.	O
e	O
.	O
degradation	O
of	O
most	O
of	O
their	O
immunogenic	O
virulence	O
factors	O
[	O
2	O
]	O
,	O
[	O
3	O
]	O
.	O

(	O
4	O
)	O
We	O
also	O
show	O
that	O
the	O
impact	O
of	O
the	O
covS	B-Protein
mutation	O
goes	O
beyond	O
the	O
defined	O
CovR	B-Protein
regulon	O
.	O

This	O
finding	O
is	O
in	O
accordance	O
with	O
previous	O
observations	O
that	O
CovR	B-Protein
and	O
CovS	B-Protein
are	O
not	O
committed	O
to	O
each	O
other	O
,	O
as	O
CovR	B-Protein
could	O
be	O
phosphorylated	O
in	O
the	O
absence	O
of	O
a	O
functional	O
CovS	B-Protein
[	O
22	O
]	O
and	O
as	O
different	O
covS	B-Protein
mutations	O
,	O
albeit	O
clustered	O
in	O
the	O
histidine	O
kinase	O
domain	O
,	O
might	O
have	O
different	O
transcriptional	O
effects	O
[	O
27	O
]	O
,	O
including	O
opposite	O
effects	O
on	O
different	O
members	O
of	O
the	O
CovR	B-Protein
regulon	O
[	O
26	O
]	O
.	O

Concluding	O
remarks	O

In	O
conclusion	O
,	O
we	O
have	O
established	O
a	O
model	O
that	O
allowed	O
us	O
to	O
resolve	O
two	O
sets	O
of	O
complex	O
transcriptional	O
events	O
:	O
(	O
i	O
)	O
those	O
occurring	O
in	O
response	O
to	O
the	O
host	O
environment	O
and	O
(	O
ii	O
)	O
those	O
caused	O
by	O
a	O
mutation	O
in	O
covS	B-Protein
sensor	O
kinase	O
.	O

We	O
believe	O
that	O
our	O
results	O
offer	O
a	O
proof	O
of	O
principle	O
that	O
in	O
vivo	O
-	O
extracted	O
RNA	O
can	O
provide	O
transcriptional	O
profiles	O
that	O
better	O
reflect	O
the	O
complexity	O
of	O
heterogeneous	O
bacterial	O
communities	O
,	O
and	O
,	O
as	O
shown	O
in	O
this	O
study	O
,	O
can	O
provide	O
a	O
transcriptional	O
snapshot	O
of	O
a	O
bacterial	O
population	O
right	O
before	O
its	O
extinction	O
.	O

The	O
use	O
of	O
in	O
vivo	O
-	O
driven	O
RNA	O
in	O
understanding	O
virulence	O
has	O
been	O
appreciated	O
in	O
streptococcal	O
research	O
[	O
73	O
]	O
,	O
but	O
the	O
technique	O
has	O
not	O
previously	O
been	O
used	O
to	O
explain	O
the	O
switch	O
to	O
hypervirulent	O
,	O
invasive	O
phenotypes	O
or	O
to	O
dissect	O
heterogeneous	O
microbial	O
subpopulations	O
.	O

This	O
study	O
is	O
a	O
first	O
step	O
towards	O
exploring	O
the	O
sociomicrobiology	O
of	O
invasive	O
GAS	B-Organism
in	O
vivo	O
.	O

Having	O
captured	O
snapshots	O
of	O
different	O
transcriptional	O
programs	O
within	O
the	O
same	O
bacterial	O
community	O
,	O
we	O
plan	O
to	O
follow	O
with	O
single	O
cell	O
studies	O
[	O
74	O
]	O
,	O
[	O
75	O
]	O
of	O
bacteria	O
associated	O
with	O
immune	O
cells	O
to	O
further	O
dissect	O
the	O
different	O
roles	O
played	O
by	O
members	O
of	O
the	O
same	O
bacterial	O
community	O
.	O

Inactivation	O
of	O
DNA	O
-	O
Binding	O
Response	O
Regulator	O
Sak189	B-Protein
Abrogates	O
beta	B-Protein
-	I-Protein
Antigen	I-Protein
Expression	O
and	O
Affects	O
Virulence	O
of	O
Streptococcus	B-Organism
agalactiae	I-Organism

Background	O
Streptococcus	B-Organism
agalactiae	I-Organism
is	O
able	O
to	O
colonize	O
numerous	O
tissues	O
employing	O
different	O
mechanisms	O
of	O
gene	O
regulation	O
,	O
particularly	O
via	O
two	O
-	O
component	O
regulatory	O
systems	O
.	O

These	O
systems	O
sense	O
the	O
environmental	O
stimuli	O
and	O
regulate	O
expression	O
of	O
the	O
genes	O
including	O
virulence	O
genes	O
.	O

Recently	O
,	O
the	O
novel	O
two	O
-	O
component	O
regulatory	O
system	O
Sak188	B-Protein
/	O
Sak189	B-Protein
was	O
identified	O
.	O

In	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
genome	O
,	O
it	O
was	O
adjacent	O
to	O
the	O
bac	B-Protein
gene	O
encoding	O
for	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
,	O
an	O
important	O
virulence	O
factor	O
.	O

Methodology	O
/	O
Principal	O
Findings	O
In	O
this	O
study	O
,	O
the	O
sak188	B-Protein
and	O
sak189	B-Protein
genes	O
were	O
inactivated	O
,	O
and	O
the	O
functional	O
role	O
of	O
Sak188	B-Protein
/	O
Sak189	B-Protein
two	O
-	O
component	O
system	O
in	O
regulation	O
of	O
the	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
expression	O
was	O
investigated	O
.	O

It	O
was	O
demonstrated	O
that	O
both	O
transcription	O
of	O
bac	B-Protein
gene	O
and	O
expression	O
of	O
encoded	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
were	O
controlled	O
by	O
Sak189	B-Protein
response	O
regulator	O
,	O
but	O
not	O
Sak188	B-Protein
histidine	O
kinase	O
.	O

It	O
was	O
also	O
found	O
that	O
the	O
regulation	O
occurred	O
at	O
transcriptional	O
level	O
.	O

Finally	O
,	O
insertional	O
inactivation	O
of	O
sak189	B-Protein
gene	O
,	O
but	O
not	O
sak188	B-Protein
gene	O
,	O
significantly	O
affected	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

Conclusions	O
/	O
Significance	O
Sak189	B-Protein
response	O
regulator	O
is	O
necessary	O
for	O
activation	O
of	O
bac	B-Protein
gene	O
transcription	O
.	O

It	O
also	O
controls	O
the	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

Given	O
that	O
the	O
primary	O
functional	O
role	O
of	O
Sak188	B-Protein
/	O
Sak189	B-Protein
two	O
-	O
component	O
systems	O
is	O
a	O
control	O
of	O
bac	B-Protein
gene	O
transcription	O
,	O
this	O
system	O
can	O
be	O
annotated	O
as	O
BgrR	B-Protein
/	O
S	B-Protein
(	O
bac	B-Protein
gene	O
regulatory	O
system	O
)	O
.	O

Introduction	O

Streptococcus	B-Organism
agalactiae	I-Organism
(	O
group	B-Organism
B	I-Organism
streptococcus	I-Organism
)	O
is	O
an	O
important	O
cause	O
of	O
neonatal	O
invasive	O
infections	O
and	O
variety	O
of	O
diseases	O
in	O
human	B-Organism
and	O
animals	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

This	O
bacterium	O
is	O
able	O
to	O
sense	O
the	O
changing	O
environmental	O
conditions	O
and	O
colonize	O
numerous	O
tissues	O
employing	O
different	O
mechanisms	O
of	O
gene	O
regulation	O
.	O

One	O
mechanism	O
for	O
adaptation	O
to	O
changing	O
environment	O
is	O
transcriptional	O
regulation	O
by	O
two	O
-	O
component	O
regulatory	O
systems	O
(	O
TCSs	O
)	O
,	O
a	O
family	O
of	O
systems	O
that	O
are	O
widely	O
distributed	O
among	O
many	O
bacterial	O
genera	O
[	O
3	O
]	O
.	O

These	O
regulatory	O
systems	O
comprise	O
two	O
proteins	O
,	O
sensor	O
histidine	O
kinase	O
,	O
HK	O
,	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
,	O
RR	O
.	O

HK	O
is	O
a	O
sensor	O
protein	O
,	O
responding	O
to	O
the	O
environmental	O
changes	O
by	O
autophosphorylating	O
a	O
conserved	O
histidine	O
residue	O
.	O

Subsequently	O
,	O
phosphoryl	O
group	O
is	O
transferred	O
to	O
RR	O
protein	O
resulting	O
in	O
conformational	O
changes	O
in	O
RR	O
molecule	O
.	O

Conformationally	O
modified	O
RR	O
molecule	O
functions	O
as	O
transcriptional	O
regulator	O
(	O
activator	O
or	O
repressor	O
)	O
by	O
binding	O
with	O
promoter	O
regions	O
of	O
the	O
genes	O
through	O
helix	O
-	O
turn	O
-	O
helix	O
(	O
HTH	O
)	O
motif	O
.	O

In	O
many	O
cases	O
,	O
two	O
-	O
component	O
systems	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
multiple	O
genes	O
encoding	O
products	O
which	O
are	O
essential	O
for	O
adaptation	O
of	O
bacteria	O
to	O
a	O
particular	O
environment	O
and	O
development	O
of	O
bacterial	O
diseases	O
[	O
3	O
]	O
-	O
[	O
5	O
]	O
.	O

In	O
contrast	O
to	O
other	O
pathogenic	O
gram	O
-	O
positive	O
cocci	O
such	O
as	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
and	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
,	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
has	O
larger	O
number	O
of	O
TCSs	O
.	O

For	O
example	O
,	O
20	O
TCSs	O
have	O
been	O
identified	O
after	O
the	O
complete	O
genome	O
sequencing	O
in	O
the	O
strain	O
NEM316	B-Organism
[	O
6	O
]	O
,	O
and	O
17	O
TCSs	O
-	O
in	O
the	O
strain	B-Organism
2603	I-Organism
V	I-Organism
/	I-Organism
R	I-Organism
[	O
7	O
]	O
.	O

Three	O
of	O
them	O
,	O
CsrRS	B-Protein
/	O
CovRS	B-Protein
,	O
DltR	B-Protein
/	O
DltS	B-Protein
,	O
and	O
RgfA	B-Protein
/	O
RgfC	B-Protein
,	O
have	O
been	O
previously	O
investigated	O
[	O
8	O
]	O
-	O
[	O
12	O
]	O
.	O

S	B-Organism
.	I-Organism
agalactiae	I-Organism
CsrRS	B-Protein
/	O
CovRS	B-Protein
demonstrated	O
high	O
similarity	O
with	O
CsrRS	B-Protein
/	O
CovRS	B-Protein
of	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
[	O
8	O
]	O
.	O

Inactivation	O
of	O
covR	B-Protein
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
increased	O
transcription	O
levels	O
of	O
hemolysin	O
cylE	B-Protein
gene	O
and	O
C5a	O
peptidase	O
scpB	B-Protein
gene	O
,	O
and	O
reduced	O
the	O
level	O
of	O
CAMP	O
factor	O
cfb	B-Protein
gene	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

Inactivation	O
of	O
CovRS	B-Protein
was	O
also	O
observed	O
at	O
phenotypic	O
level	O
:	O
the	O
mutant	O
strains	O
became	O
less	O
virulent	O
compared	O
to	O
the	O
parental	O
wild	O
-	O
type	O
strain	O
[	O
9	O
]	O
.	O

Transcriptome	O
analysis	O
revealed	O
the	O
CovRS	B-Protein
core	O
-	O
regulon	O
which	O
consisted	O
of	O
39	O
genes	O
including	O
genes	O
of	O
the	O
stress	O
response	O
,	O
the	O
genes	O
important	O
for	O
adhesion	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
to	O
the	O
host	O
cells	O
and	O
others	O
[	O
10	O
]	O
.	O

DltR	B-Protein
/	O
DltS	B-Protein
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
is	O
important	O
for	O
transcription	O
of	O
dlt	B-Regulon-operon
operon	I-Regulon-operon
(	O
dltA	B-Protein
,	O
dltB	B-Protein
,	O
dltC	B-Protein
,	O
and	O
dltD	B-Protein
genes	O
)	O
,	O
which	O
is	O
necessary	O
for	O
incorporation	O
of	O
D	O
-	O
alanine	O
residues	O
in	O
lipoteichoic	B-Chemical
acids	I-Chemical
.	O

The	O
role	O
of	O
DltR	B-Protein
/	O
DltS	B-Protein
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
virulence	O
was	O
shown	O
by	O
the	O
attenuated	O
virulent	O
properties	O
of	O
dltA	B-Protein
and	O
dltR	B-Protein
mutant	O
strains	O
in	O
vivo	O
[	O
11	O
]	O
.	O

RgfA	B-Protein
/	O
RgfC	B-Protein
controls	O
adhesion	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
to	O
epithelial	O
cells	O
.	O

In	O
addition	O
,	O
inactivation	O
of	O
histidine	O
kinase	O
gene	O
rgfC	B-Protein
resulted	O
in	O
increased	O
transcription	O
of	O
scpB	B-Protein
gene	O
[	O
12	O
]	O
.	O

Recently	O
,	O
putative	O
two	O
-	O
component	O
regulatory	O
system	O
genes	O
encoding	O
for	O
sensor	O
histidine	O
kinase	O
(	O
sak188	B-Protein
)	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
(	O
sak189	B-Protein
)	O
were	O
identified	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strains	I-Organism
98	I-Organism
-	I-Organism
D60C	I-Organism
and	O
A909	B-Organism
[	O
13	O
]	O
,	O
[	O
14	O
]	O
.	O

sak188	B-Protein
and	O
sak189	B-Protein
genes	O
were	O
located	O
on	O
putative	O
pathogenicity	O
island	O
[	O
13	O
]	O
adjacent	O
to	O
the	O
bac	B-Protein
gene	O
encoding	O
for	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
.	O

This	O
surface	O
protein	O
has	O
capacity	O
to	O
bind	O
IgA	B-Protein
and	O
factor	B-Protein
H	I-Protein
of	O
complement	O
,	O
and	O
it	O
is	O
supposed	O
to	O
be	O
an	O
important	O
virulence	O
factor	O
[	O
15	O
]	O
.	O

Sak188	B-Protein
and	O
Sak189	B-Protein
proteins	O
revealed	O
78	O
%	O
and	O
83	O
%	O
similarity	O
with	O
sensor	O
histidine	O
kinase	O
HK06	B-Protein
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
RR06	B-Protein
of	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
strains	O
,	O
respectively	O
[	O
13	O
]	O
,	O
[	O
16	O
]	O
-	O
[	O
19	O
]	O
.	O

In	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
genome	O
,	O
the	O
hk06	B-Protein
and	O
rr06	B-Protein
genes	O
are	O
adjacent	O
to	O
cbpA	B-Protein
gene	O
encoding	O
choline	B-Chemical
binding	O
protein	O
,	O
CbpA	B-Protein
,	O
a	O
surface	O
-	O
exposed	O
protective	O
antigen	O
and	O
virulence	O
factor	O
of	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

Similarly	O
to	O
the	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
,	O
CbpA	B-Protein
has	O
capacity	O
to	O
bind	O
factor	B-Protein
H	I-Protein
of	O
complement	O
.	O

In	O
addition	O
,	O
some	O
regions	O
of	O
CbpA	B-Protein
protein	O
has	O
the	O
certain	O
similarity	O
with	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
.	O

Inactivation	O
of	O
RR06	B-Protein
in	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
resulted	O
in	O
the	O
loss	O
of	O
CbpA	B-Protein
expression	O
[	O
22	O
]	O
-	O
[	O
24	O
]	O
.	O

HK06	B-Protein
/	O
RR06	B-Protein
was	O
also	O
important	O
for	O
the	O
ability	O
of	O
pneumococci	B-Organism
to	O
adhere	O
to	O
epithelial	O
cells	O
in	O
vitro	O
and	O
to	O
survive	O
and	O
proliferate	O
in	O
an	O
in	O
vivo	O
mouse	B-Organism
model	O
[	O
22	O
]	O
.	O

Given	O
the	O
certain	O
similarity	O
in	O
the	O
sequences	O
,	O
functions	O
and	O
relative	O
locations	O
of	O
Sak188	B-Protein
/	O
Sak189	B-Protein
and	O
HK06	B-Protein
/	O
RR06	B-Protein
,	O
and	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
and	O
CbpA	B-Protein
,	O
we	O
suggested	O
that	O
Sak188	B-Protein
/	O
Sak189	B-Protein
TCS	O
affected	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
expression	O
and	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
in	O
the	O
same	O
manner	O
as	O
HK06	B-Protein
/	O
RR06	B-Protein
affected	O
CbpA	B-Protein
in	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
function	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
Sak188	B-Protein
/	O
Sak189	B-Protein
TCS	O
.	O

Results	O

An	O
occurrence	O
of	O
bac	B-Protein
gene	O
,	O
sak188	B-Protein
,	O
sak189	B-Protein
TCS	O
genes	O
and	O
erythromycin	B-Chemical
resistance	O
among	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strains	I-Organism
A	O
total	O
of	O
239	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strains	O
isolated	O
from	O
human	B-Organism
and	O
animals	O
were	O
studied	O
.	O

The	O
strains	O
were	O
tested	O
by	O
PCR	O
for	O
the	O
presence	O
of	O
virulence	O
gene	O
bac	B-Protein
and	O
sak188	B-Protein
and	O
sak189	B-Protein
TCS	O
genes	O
,	O
which	O
were	O
previously	O
found	O
to	O
be	O
located	O
on	O
pathogenicity	O
island	O
[	O
13	O
]	O
.	O

As	O
result	O
,	O
53	O
strains	O
isolated	O
from	O
pregnant	O
women	B-Organism
and	O
5	O
strains	O
isolated	O
from	O
the	O
cow	B-Organism
'	O
s	O
milk	O
were	O
found	O
to	O
be	O
bac	B-Protein
gene	O
positive	O
.	O

They	O
were	O
selected	O
for	O
further	O
study	O
.	O

PCR	O
analysis	O
of	O
the	O
bac	B-Protein
gene	O
positive	O
strains	O
revealed	O
that	O
the	O
presence	O
of	O
bac	B-Protein
gene	O
correlated	O
with	O
the	O
presence	O
of	O
sensor	O
histidine	O
kinase	O
gene	O
sak188	B-Protein
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
gene	O
sak189	B-Protein
(	O
data	O
not	O
shown	O
)	O
.	O

Genomic	O
architecture	O
of	O
DNA	O
fragments	O
containing	O
sak188	B-Protein
,	O
sak189	B-Protein
and	O
bac	B-Protein
genes	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
[	O
13	O
]	O
,	O
[	O
14	O
]	O
,	O
and	O
rr06	B-Protein
,	O
hk06	B-Protein
and	O
cbpA	B-Protein
genes	O
in	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
[	O
22	O
]	O
is	O
presented	O
in	O
the	O
Fig	O
.	O

1	O
.	O

For	O
the	O
purpose	O
of	O
insertional	O
inactivation	O
,	O
the	O
vector	O
pVA891	O
-	O
2	O
that	O
provides	O
erythromycin	B-Chemical
(	O
Em	B-Chemical
)	O
resistance	O
was	O
used	O
.	O

Thus	O
,	O
the	O
strains	O
were	O
additionally	O
screened	O
for	O
sensitivity	O
to	O
Em	B-Chemical
.	O

As	O
result	O
,	O
most	O
of	O
human	B-Organism
bac	B-Protein
gene	O
positive	O
strains	O
showed	O
resistance	O
or	O
intermediate	O
resistance	O
to	O
Em	B-Chemical
in	O
the	O
standard	O
diffusion	O
disk	O
test	O
,	O
that	O
is	O
in	O
agreement	O
with	O
previous	O
observations	O
demonstrating	O
an	O
increase	O
in	O
Em	B-Chemical
resistance	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
population	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
.	O

One	O
of	O
the	O
strains	O
,	O
168	B-Organism
/	I-Organism
00	I-Organism
,	O
which	O
demonstrated	O
the	O
large	O
diameter	O
of	O
growth	O
inhibition	O
zone	O
,	O
was	O
selected	O
for	O
further	O
study	O
.	O

In	O
this	O
strain	O
,	O
the	O
bac	B-Protein
gene	O
has	O
unique	O
allele	O
with	O
the	O
closest	O
similarity	O
with	O
676a	O
and	O
676b	O
alleles	O
according	O
to	O
classification	O
of	O
Kong	O
et	O
al	O
.	O

[	O
32	O
]	O
.	O

Construction	O
and	O
characterization	O
of	O
mutant	O
strains	O

To	O
investigate	O
a	O
functional	O
role	O
of	O
the	O
two	O
-	O
component	O
regulatory	O
system	O
Sak188	B-Protein
/	O
Sak189	B-Protein
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
,	O
the	O
sak188	B-Protein
and	O
sak189	B-Protein
genes	O
were	O
inactivated	O
by	O
insertional	O
mutagenesis	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Briefly	O
,	O
DNA	O
fragments	O
of	O
sak188	B-Protein
and	O
sak189	B-Protein
genes	O
were	O
PCR	O
amplified	O
using	O
pairs	O
of	O
primers	O
hkFor	O
,	O
hkRev	O
,	O
and	O
rrFor	O
,	O
rrRev	O
(	O
Table	O
1	O
)	O
,	O
respectively	O
.	O

PCR	O
products	O
were	O
cloned	O
into	O
pGEM	O
-	O
T	O
Easy	O
vector	O
(	O
Promega	O
,	O
USA	O
)	O
,	O
and	O
the	O
recombinant	O
plasmids	O
named	O
as	O
pGEM	O
-	O
Tsak188	B-Protein
and	O
pGEM	O
-	O
Tsak189	B-Protein
were	O
digested	O
with	O
EcoRI	B-Protein
.	O

Subsequently	O
,	O
EcoRI	B-Protein
fragments	O
were	O
cloned	O
into	O
suicide	O
vector	O
pVA891	O
-	O
2	O
,	O
and	O
the	O
recombinant	O
plasmids	O
named	O
as	O
pHK	O
and	O
pRR	O
,	O
respectively	O
,	O
were	O
used	O
to	O
transform	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strain	O
168	O
/	O
00	O
according	O
to	O
the	O
protocol	O
[	O
33	O
]	O
.	O

The	O
recombinant	O
clones	O
were	O
selected	O
on	O
THB	O
agar	O
plates	O
containing	O
2	O
.	O
5	O
microg	O
/	O
ml	O
of	O
erythromycin	B-Chemical
.	O

Construction	O
of	O
the	O
strains	O
was	O
confirmed	O
by	O
PCR	O
and	O
nucleotide	O
sequencing	O
(	O
data	O
not	O
shown	O
)	O
.	O

Given	O
that	O
insertional	O
inactivation	O
of	O
RR	O
gene	O
results	O
in	O
inactivation	O
of	O
HK	O
gene	O
[	O
22	O
]	O
which	O
are	O
co	O
-	O
transcribed	O
(	O
Fig	O
.	O
1	O
)	O
,	O
the	O
strain	O
with	O
insertionally	O
inactivated	O
sak189	B-Protein
gene	O
can	O
be	O
considered	O
as	O
sak189	B-Protein
/	O
sak188	B-Protein
double	O
mutant	O
strain	O
,	O
while	O
the	O
strain	O
with	O
insertionally	O
inactivated	O
sak188	B-Protein
gene	O
-	O
as	O
sak188	B-Protein
mutant	O
strain	O
.	O

Comparative	O
analysis	O
of	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
mutant	O
strains	O
revealed	O
no	O
difference	O
in	O
morphological	O
properties	O
.	O

The	O
size	O
,	O
shape	O
and	O
color	O
of	O
the	O
colonies	O
,	O
diameter	O
of	O
zone	O
of	O
hemolysis	O
,	O
morphology	O
of	O
the	O
cells	O
and	O
the	O
chain	O
length	O
were	O
similar	O
in	O
all	O
the	O
strains	O
.	O

At	O
the	O
same	O
time	O
the	O
growth	O
curves	O
of	O
mutant	O
strains	O
in	O
THB	O
slightly	O
differed	O
from	O
the	O
growth	O
curve	O
of	O
the	O
strain	O
168	O
/	O
00	O
(	O
data	O
not	O
shown	O
)	O
.	O

Two	O
time	O
points	O
(	O
2	O
hrs	O
and	O
5	O
hrs	O
)	O
corresponding	O
to	O
the	O
middle	O
-	O
exponential	O
and	O
post	O
-	O
exponential	O
phases	O
of	O
growth	O
,	O
respectively	O
,	O
were	O
selected	O
for	O
further	O
study	O
.	O

Effect	O
of	O
insertional	O
inactivation	O
on	O
expression	O
of	O
beta	B-Protein
-	I-Protein
antigen	I-Protein

Several	O
approaches	O
were	O
used	O
to	O
prepare	O
the	O
cell	O
lysates	O
of	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
mutant	O
strains	O
.	O

As	O
result	O
,	O
10	O
min	O
boiling	O
of	O
the	O
cells	O
in	O
2	B-Chemical
-	I-Chemical
mercaptoethanol	I-Chemical
(	O
10	O
%	O
,	O
w	O
/	O
w	O
)	O
was	O
found	O
to	O
be	O
most	O
effective	O
with	O
respect	O
to	O
higher	O
yield	O
and	O
quality	O
of	O
the	O
protein	O
bands	O
observed	O
after	O
SDS	O
-	O
PAGE	O
(	O
data	O
not	O
shown	O
)	O
.	O

Subsequently	O
,	O
bacterial	O
cell	O
lysates	O
and	O
secreted	O
proteins	O
after	O
2	O
hrs	O
and	O
5	O
hrs	O
of	O
growth	O
in	O
THB	O
were	O
analyzed	O
.	O

SDS	O
-	O
PAGE	O
of	O
secreted	O
proteins	O
did	O
not	O
reveal	O
any	O
difference	O
among	O
the	O
wild	O
-	O
type	O
strain	O
and	O
mutant	O
strains	O
(	O
data	O
not	O
shown	O
)	O
.	O

However	O
,	O
SDS	O
-	O
PAGE	O
of	O
the	O
cell	O
lysates	O
revealed	O
that	O
at	O
least	O
one	O
protein	O
band	O
of	O
approximately140	O
kDa	O
was	O
present	O
in	O
the	O
wild	O
-	O
type	O
strain	O
168	O
/	O
00	O
and	O
sak188	B-Protein
mutant	O
strain	O
,	O
and	O
was	O
absent	O
in	O
sak189	B-Protein
/	O
sak188	B-Protein
double	O
mutant	O
strain	O
.	O

Western	O
-	O
blotting	O
with	O
labeled	O
human	B-Organism
IgA	B-Protein
identified	O
this	O
protein	O
as	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
(	O
Fig	O
.	O
3	O
)	O
.	O

Effect	O
of	O
insertional	O
inactivation	O
on	O
transcription	O
of	O
bac	B-Protein
gene	O

In	O
order	O
to	O
analyze	O
if	O
changes	O
in	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
expression	O
are	O
regulated	O
at	O
transcriptional	O
level	O
,	O
the	O
quantitative	O
RT	O
-	O
PCR	O
was	O
performed	O
using	O
RNA	O
samples	O
isolated	O
during	O
the	O
middle	O
-	O
exponential	O
phase	O
corresponding	O
to	O
2	O
hrs	O
of	O
growth	O
.	O

As	O
result	O
,	O
transcription	O
of	O
bac	B-Protein
gene	O
in	O
sak189	B-Protein
/	O
sak188	B-Protein
double	O
mutant	O
strain	O
was	O
17	O
-	O
fold	O
less	O
than	O
in	O
168	O
/	O
00	O
wild	O
-	O
type	O
strain	O
(	O
Fig	O
.	O
3	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
bac	B-Protein
gene	O
transcription	O
level	O
in	O
sak188	B-Protein
mutant	O
strain	O
was	O
almost	O
similar	O
to	O
that	O
in	O
the	O
wild	O
-	O
type	O
strain	O
that	O
confirmed	O
the	O
results	O
of	O
SDS	O
-	O
PAGE	O
and	O
western	O
-	O
blotting	O
.	O

Thus	O
,	O
these	O
data	O
demonstrate	O
that	O
Sak189	B-Protein
protein	O
regulates	O
expression	O
of	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
at	O
transcriptional	O
level	O
.	O

In	O
vivo	O
virulent	O
properties	O
of	O
the	O
wild	O
-	O
type	O
strain	O
and	O
mutant	O
strains	O

Murine	B-Organism
intraperitoneal	O
model	O
of	O
streptococcal	O
infection	O
was	O
developed	O
to	O
compare	O
the	O
virulent	O
properties	O
of	O
the	O
strains	O
under	O
study	O
.	O

Mice	B-Organism
were	O
injected	O
with	O
0	O
.	O
5	O
ml	O
of	O
PBS	O
containing	O
108	O
CFUs	O
and	O
observed	O
for	O
10	O
days	O
.	O

As	O
seen	O
from	O
the	O
Fig	O
.	O

4	O
,	O
the	O
mortality	O
rate	O
caused	O
by	O
sak189	B-Protein
/	O
sak188	B-Protein
double	O
mutant	O
strain	O
significantly	O
differed	O
in	O
comparison	O
with	O
that	O
caused	O
by	O
the	O
wild	O
-	O
type	O
and	O
sak188	B-Protein
mutant	O
strains	O
.	O

Compared	O
to	O
the	O
wild	O
-	O
type	O
strain	O
,	O
the	O
differences	O
in	O
virulent	O
properties	O
were	O
statistically	O
significant	O
in	O
case	O
of	O
sak189	B-Protein
/	O
sak188	B-Protein
double	O
mutant	O
strain	O
(	O
P	O
-	O
value	O
<	O
0	O
.	O
02	O
)	O
,	O
and	O
not	O
significant	O
in	O
case	O
of	O
sak188	B-Protein
mutant	O
strain	O
(	O
P	O
-	O
value	O
=	O
0	O
.	O
73	O
)	O
.	O

Discussion	O

Transcriptional	O
regulation	O
of	O
the	O
genes	O
is	O
important	O
process	O
for	O
successful	O
adaptation	O
of	O
pathogenic	O
bacteria	O
to	O
changing	O
environments	O
,	O
particularly	O
,	O
during	O
the	O
interaction	O
of	O
pathogen	O
with	O
human	B-Organism
host	O
.	O

In	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
,	O
a	O
total	O
of	O
21	O
TCSs	O
are	O
involved	O
in	O
the	O
regulatory	O
network	O
essential	O
for	O
successful	O
colonization	O
,	O
penetration	O
and	O
/	O
or	O
invasion	O
as	O
well	O
as	O
for	O
resistance	O
to	O
human	B-Organism
immune	O
system	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
functional	O
role	O
of	O
Sak188	B-Protein
/	O
Sak189	B-Protein
two	O
-	O
component	O
system	O
in	O
regulation	O
of	O
the	O
expression	O
of	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
,	O
an	O
important	O
virulence	O
factor	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

It	O
was	O
demonstrated	O
that	O
both	O
transcription	O
of	O
bac	B-Protein
gene	O
and	O
expression	O
of	O
encoded	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
were	O
controlled	O
by	O
the	O
Sak189	B-Protein
response	O
regulator	O
,	O
but	O
not	O
Sak188	B-Protein
histidine	O
kinase	O
.	O

It	O
was	O
also	O
found	O
that	O
regulation	O
occurred	O
at	O
transcriptional	O
level	O
.	O

Finally	O
,	O
insertional	O
inactivation	O
of	O
sak189	B-Protein
gene	O
,	O
but	O
not	O
sak188	B-Protein
gene	O
,	O
significantly	O
affects	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

Variety	O
of	O
publications	O
are	O
currently	O
available	O
regarding	O
the	O
occurrence	O
of	O
bac	B-Protein
gene	O
among	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
strains	O
as	O
well	O
as	O
genetic	O
polymorphism	O
of	O
bac	B-Protein
gene	O
and	O
use	O
of	O
encoded	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
as	O
a	O
vaccine	O
component	O
[	O
32	O
]	O
,	O
[	O
34	O
]	O
-	O
[	O
38	O
]	O
.	O

In	O
some	O
strains	O
,	O
the	O
mutations	O
in	O
bac	B-Protein
gene	O
resulted	O
in	O
expression	O
of	O
truncated	O
non	O
-	O
functional	O
forms	O
of	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
[	O
39	O
]	O
,	O
[	O
40	O
]	O
.	O

However	O
,	O
the	O
regulatory	O
mechanism	O
of	O
bac	B-Protein
gene	O
expression	O
has	O
not	O
been	O
studied	O
.	O

In	O
present	O
study	O
,	O
the	O
sak188	B-Protein
and	O
sak189	B-Protein
genes	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
were	O
inactivated	O
.	O

Given	O
that	O
insertional	O
inactivation	O
does	O
not	O
delete	O
the	O
entire	O
gene	O
from	O
the	O
chromosome	O
and	O
often	O
results	O
in	O
truncated	O
or	O
modified	O
protein	O
,	O
we	O
analyzed	O
which	O
functional	O
activities	O
of	O
Sak188	B-Protein
and	O
Sak189	B-Protein
proteins	O
could	O
potentially	O
retain	O
if	O
the	O
modified	O
proteins	O
expressed	O
.	O

Comparative	O
analysis	O
of	O
Sak188	B-Protein
and	O
Sak189	B-Protein
amino	O
acid	O
sequences	O
in	O
the	O
wild	O
-	O
type	O
strain	O
168	B-Organism
/	I-Organism
00	I-Organism
and	O
deduced	O
protein	O
sequences	O
in	O
mutant	O
strains	O
predicted	O
the	O
replacement	O
of	O
95	O
amino	O
acids	O
at	O
the	O
C	O
-	O
terminal	O
end	O
of	O
Sak188	B-Protein
protein	O
by	O
191	O
amino	O
acids	O
,	O
and	O
replacement	O
of	O
51	O
amino	O
acids	O
at	O
the	O
C	O
-	O
terminal	O
end	O
of	O
Sak189	B-Protein
protein	O
by	O
15	O
amino	O
acids	O
(	O
Fig	O
.	O
5	O
)	O
.	O

Importantly	O
,	O
8	O
out	O
of	O
9	O
amino	O
acids	O
,	O
which	O
composed	O
HTH	O
motif	O
presumably	O
involved	O
in	O
DNA	O
-	O
binding	O
according	O
to	O
BLASTp	O
analysis	O
(	O
http	O
:	O
/	O
/	O
blast	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
Blast	O
.	O
cgi	O
)	O
,	O
were	O
lost	O
in	O
Sak189	B-Protein
protein	O
due	O
to	O
insertional	O
mutagenesis	O
.	O

Similarly	O
,	O
ATP	B-Chemical
-	O
binding	O
and	O
Mg2	B-Chemical
+	I-Chemical
-	O
binding	O
sites	O
located	O
at	O
C	O
-	O
terminal	O
end	O
of	O
Sak188	B-Protein
,	O
which	O
are	O
essential	O
for	O
phosphorylation	O
,	O
were	O
lost	O
in	O
Sak188	B-Protein
protein	O
due	O
to	O
the	O
mutagenesis	O
.	O

Theoretically	O
,	O
in	O
both	O
sak188	B-Protein
mutant	O
strain	O
and	O
sak189	B-Protein
/	O
sak188	B-Protein
double	O
mutant	O
strain	O
,	O
the	O
Sak188	B-Protein
/	O
Sak189	B-Protein
TCS	O
can	O
be	O
inactive	O
.	O

In	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
,	O
inactivation	O
of	O
the	O
response	O
regulator	O
RR06	B-Protein
(	O
83	O
%	O
similarity	O
with	O
Sak189	B-Protein
)	O
,	O
which	O
binds	O
promoter	O
region	O
of	O
cbpA	B-Protein
,	O
repressed	O
transcription	O
of	O
the	O
cbpA	B-Protein
gene	O
[	O
22	O
]	O
.	O

In	O
this	O
study	O
,	O
western	O
blotting	O
and	O
quantitative	O
RT	O
-	O
PCR	O
revealed	O
that	O
DNA	O
-	O
binding	O
response	O
regulator	O
Sak189	B-Protein
is	O
necessary	O
for	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
expression	O
suggesting	O
direct	O
binding	O
of	O
Sak189	B-Protein
with	O
bac	B-Protein
gene	O
promoter	O
.	O

This	O
is	O
not	O
surprising	O
given	O
the	O
high	O
similarity	O
in	O
the	O
sequences	O
,	O
functions	O
and	O
relative	O
locations	O
of	O
Sak188	B-Protein
/	O
Sak189	B-Protein
and	O
HK06	B-Protein
/	O
RR06	B-Protein
,	O
and	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
and	O
CbpA	B-Protein
(	O
Fig	O
.	O
1	O
)	O
.	O

Importantly	O
,	O
insertional	O
inactivation	O
can	O
have	O
a	O
polar	O
effect	O
on	O
the	O
genes	O
located	O
downstream	O
.	O

In	O
this	O
study	O
,	O
both	O
sak188	B-Protein
and	O
bac	B-Protein
genes	O
located	O
downstream	O
the	O
sak189	B-Protein
gene	O
(	O
Fig	O
.	O
1	O
)	O
.	O

As	O
seen	O
from	O
the	O
Fig	O
.	O

3	O
,	O
insertional	O
inactivation	O
of	O
sak189	B-Protein
affected	O
bac	B-Protein
gene	O
transcription	O
,	O
while	O
insertional	O
inactivation	O
of	O
the	O
sak188	B-Protein
did	O
not	O
affect	O
.	O

Thus	O
,	O
we	O
can	O
conclude	O
that	O
sak188	B-Protein
and	O
bac	B-Protein
gene	O
are	O
not	O
in	O
the	O
operon	O
,	O
and	O
repression	O
of	O
bac	B-Protein
gene	O
transcription	O
in	O
sak189	B-Protein
/	O
sak188	B-Protein
double	O
mutant	O
strain	O
is	O
not	O
due	O
to	O
the	O
polar	O
effect	O
.	O

Given	O
that	O
insertional	O
inactivation	O
of	O
sak188	B-Protein
gene	O
does	O
not	O
affect	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
expression	O
,	O
we	O
suggest	O
that	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
expression	O
can	O
be	O
activated	O
independently	O
of	O
Sak188	B-Protein
,	O
perhaps	O
through	O
small	O
-	O
molecular	O
-	O
weight	O
phosphodonors	O
such	O
as	O
acetyl	O
phosphate	O
or	O
other	O
noncognate	O
histidine	O
kinases	O
.	O

Thus	O
,	O
we	O
can	O
not	O
rule	O
out	O
the	O
possibility	O
of	O
a	O
cross	O
-	O
talk	O
between	O
Sak189	B-Protein
response	O
regulator	O
and	O
sensor	O
kinase	O
(	O
s	O
)	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
,	O
and	O
Sak189	B-Protein
can	O
potentially	O
recruit	O
another	O
histidine	O
kinase	O
for	O
proper	O
functioning	O
.	O

The	O
cross	O
-	O
talk	O
among	O
different	O
TCSs	O
has	O
been	O
described	O
for	O
many	O
bacterial	O
species	O
[	O
3	O
]	O
including	O
pathogenic	O
streptococci	B-Organism
.	O

For	O
example	O
,	O
in	O
S	B-Organism
.	I-Organism
pneumoniae	I-Organism
inactivation	O
of	O
histidine	O
kinase	O
HK06	B-Protein
(	O
78	O
%	O
similarity	O
with	O
Sak188	B-Protein
)	O
,	O
in	O
contrast	O
to	O
RR06	B-Protein
(	O
83	O
%	O
similarity	O
with	O
Sak189	B-Protein
)	O
,	O
did	O
not	O
repress	O
transcription	O
of	O
the	O
adjacent	O
cbpA	B-Protein
gene	O
[	O
22	O
]	O
indicating	O
a	O
cross	O
-	O
talk	O
between	O
RR06	B-Protein
and	O
noncognate	O
histidine	O
kinase	O
(	O
s	O
)	O
.	O

Intraperitoneal	O
infection	O
of	O
laboratory	O
mice	B-Organism
demonstrated	O
that	O
Sak189	B-Protein
DNA	O
-	O
binding	O
response	O
regulatory	O
protein	O
is	O
important	O
for	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

It	O
could	O
be	O
predicted	O
given	O
that	O
inactivation	O
of	O
other	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
TCSs	O
(	O
CovS	B-Protein
/	O
CovR	B-Protein
,	O
DltR	B-Protein
/	O
DltS	B-Protein
,	O
RgfA	B-Protein
/	O
RgfC	B-Protein
)	O
resulted	O
in	O
the	O
changes	O
of	O
virulent	O
properties	O
,	O
however	O
,	O
in	O
all	O
these	O
studies	O
the	O
mutant	O
strains	O
became	O
less	O
virulent	O
compared	O
to	O
the	O
wild	O
-	O
type	O
strains	O
[	O
8	O
]	O
-	O
[	O
12	O
]	O
.	O

In	O
the	O
present	O
study	O
,	O
insertional	O
inactivation	O
of	O
sak189	B-Protein
gene	O
abrogated	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
expression	O
but	O
resulted	O
in	O
increased	O
virulence	O
(	O
Fig	O
.	O
4	O
)	O
.	O

Thus	O
,	O
we	O
suggest	O
that	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
located	O
on	O
the	O
bacterial	O
surface	O
can	O
interfere	O
with	O
the	O
disease	O
process	O
and	O
play	O
a	O
role	O
of	O
anti	O
-	O
virulent	O
factor	O
(	O
at	O
least	O
,	O
in	O
mice	B-Organism
)	O
similarly	O
to	O
hyaluronate	O
lyase	O
of	O
S	B-Organism
.	I-Organism
pyogenes	I-Organism
[	O
41	O
]	O
.	O

It	O
is	O
also	O
in	O
agreement	O
with	O
results	O
of	O
Kong	O
et	O
al	O
.	O
who	O
demonstrated	O
that	O
presence	O
of	O
shorter	O
variants	O
of	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
is	O
associated	O
with	O
increased	O
virulence	O
[	O
32	O
]	O
.	O

It	O
is	O
also	O
possible	O
that	O
bac	O
gene	O
encoding	O
for	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
is	O
not	O
only	O
target	O
for	O
Sak188	B-Protein
/	O
Sak189	B-Protein
TCS	O
.	O

The	O
difference	O
among	O
the	O
growth	O
curves	O
of	O
the	O
wild	O
-	O
type	O
and	O
mutant	O
strains	O
(	O
data	O
not	O
shown	O
)	O
indicate	O
that	O
in	O
addition	O
to	O
bac	O
gene	O
,	O
some	O
metabolic	O
genes	O
can	O
be	O
controlled	O
by	O
Sak188	B-Protein
/	O
Sak189	B-Protein
TCS	O
.	O

This	O
suggestion	O
is	O
confirmed	O
by	O
the	O
numerous	O
studies	O
demonstrating	O
the	O
genome	O
-	O
wide	O
location	O
of	O
the	O
genes	O
affected	O
by	O
TCSs	O
[	O
10	O
]	O
,	O
[	O
42	O
]	O
,	O
[	O
43	O
]	O
,	O
and	O
set	O
of	O
the	O
genes	O
controlled	O
by	O
Sak188	B-Protein
/	O
Sak189	B-Protein
(	O
TCS	O
regulon	O
)	O
can	O
be	O
identified	O
using	O
microarray	O
technology	O
.	O

As	O
seen	O
from	O
the	O
data	O
of	O
this	O
study	O
,	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
encoded	O
beta	O
-	O
antigen	O
are	O
the	O
primary	O
genotypic	O
/	O
phenotypic	O
properties	O
controlled	O
by	O
Sak188	B-Protein
/	O
Sak189	B-Protein
TCS	O
.	O

Therefore	O
,	O
it	O
is	O
reasonable	O
to	O
annotate	O
this	O
system	O
as	O
BgrR	B-Protein
/	O
S	B-Protein
(	O
bac	B-Protein
gene	O
regulatory	O
system	O
)	O
,	O
and	O
DNA	O
-	O
binding	O
response	O
regulator	O
Sak189	B-Protein
and	O
sensor	O
histidine	O
kinase	O
Sak188	B-Protein
as	O
BgrR	B-Protein
and	O
BgrS	B-Protein
proteins	O
,	O
respectively	O
.	O

In	O
conclusion	O
,	O
the	O
data	O
presented	O
here	O
characterize	O
the	O
functional	O
role	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
Sak188	B-Protein
/	O
Sak189	B-Protein
two	O
-	O
component	O
system	O
.	O

Both	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
encoded	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
are	O
controlled	O
by	O
Sak189	B-Protein
response	O
regulator	O
,	O
and	O
the	O
regulation	O
occurs	O
at	O
transcriptional	O
level	O
.	O

Inactivation	O
of	O
histidine	O
kinase	O
Sak188	B-Protein
does	O
not	O
affect	O
transcription	O
of	O
bac	O
gene	O
and	O
expression	O
of	O
beta	B-Protein
-	I-Protein
antigen	I-Protein
,	O
that	O
suggests	O
the	O
cross	O
-	O
talk	O
between	O
Sak189	B-Protein
and	O
other	O
sensor	O
kinase	O
(	O
s	O
)	O
in	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
.	O

Finally	O
,	O
Sak189	B-Protein
,	O
but	O
not	O
Sak188	B-Protein
,	O
controls	O
virulent	O
properties	O
of	O
S	B-Organism
.	I-Organism
agalactiae	I-Organism
in	O
vivo	O
.	O

